Bill Text: NY A08807 | 2023-2024 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Enacts into law major components of legislation necessary to implement the state health and mental hygiene budget for the 2024-2025 state fiscal year; requires the commissioner of health to provide a quarterly report on known and expected department of health state funds Medicaid expenditures (Part A); extends various provisions related to health and mental hygiene (Part B); relates to the provision of certain early intervention services for children with handicapping conditions (Part C); reduces the hospital capital rate add-on; relates to the payment of certain funds for uncompensated care; extends provisions relating to certain Medicaid management; increases operating cost component of rates of payment for general hospital outpatient services; authorizes the department of health to make Medicaid payment increases for county operated free-standing clinics (Part D); freezes the operating component of the rates for skilled nursing facilities; reduces the capital component of the rates for skilled nursing facilities by an additional ten percent; expands admission eligibility to the NYS veteran's home for certain veterans of the Persian Gulf conflict (Part E); provides that the program for individuals living with Alzheimer's disease and dementia who are not eligible for medical assistance and reside in a special needs assisted living residence shall, subject to appropriations, authorize vouchers to individuals (Part F); eliminates the one percent Medicaid rate increase to managed care organizations (Part H); relates to coverage and reimbursement of certain drugs under the Medicaid drug cap program and pharmacy cost reporting (Part I); renames the basic health program to the essential plan; extends provisions related to providing long-term services and supports under the essential plan; adds references to the 1332 state innovation waiver; provides a new subsidy to assist low and moderate income New Yorkers; adds the 1332 state innovation program to the functions of the marketplace (Part J); extends certain provisions of law relating to malpractice and professional medical conduct (Part K); authorizes continuous coverage under medical assistance for needy persons and child health plus for eligible children up to age six (Part M); expands financial assistance for medical debt; provides additional consumer protection for medical debt; restricts the applications for and use of credit cards and medical financial products (Part O); extends authorization for pharmacists to order and administer certain tests and perform collaborative drug therapy management with physicians in certain settings (Part P); establishes the healthcare safety net transformation program for the purpose of supporting the transformation of safety net hospitals to improve access, equity, quality, and outcomes while increasing the financial sustainability of safety net hospitals (Part S); extends the effectiveness of certain provisions relating to membership of subcommittees for mental health of community service boards and the duties of such subcommittees and the community mental health and workforce reinvestment account (Part Y); extends certain provisions clarifying the authority of the commissioners in the department of mental hygiene to design and implement time-limited demonstration programs (Part Z); provides for reimbursement insurance rates for the provision of outpatient, intensive outpatient, outpatient rehabilitation and opioid treatment (Part AA); extends certain provisions of law relating to psychiatric emergency programs (Part BB); extends provisions for the care and custody of funds belonging to patients in facilities operated by the office of mental health (Part DD); establishes a cost of living adjustment for certain human services programs (Part FF); provides contracting flexibility in relation to 1115 Medicaid waivers (Part GG); relates to statewide fiscal intermediaries; creates a registration process for statewide fiscal intermediaries (Part HH); establishes a New York managed care organization provider tax (Part II); provides that services provided in school-based health centers shall not be provided to medical assistance recipients through certain managed care programs before April 1, 2025 (Part JJ); establishes a community doula expansion grant program to support community-based doulas and community-based doula organizations; provides for the repeal of such program upon expiration thereof (Part KK); provides for Medicaid reimbursement rates for treatment of medically fragile children at pediatric diagnostic and treatment centers and repeals such provisions upon expiration thereof (Part LL); establishes the nine member community advisory board for the modernization and revitalization of SUNY downstate health sciences university; requires such advisory board to solicit recommendations from healthcare experts, county health departments, community-based organizations, state and regional health care industry associations, labor unions, experts in hospital operations, and other interested parties; requires recommendations and a report to the governor, the temporary president of the senate and the speaker of the assembly no later than April 1, 2025; makes related provisions (Part MM); extends certain provisions relating to certain Medicaid payments made for hospital services (Part NN).

Spectrum: Committee Bill

Status: (Introduced) 2024-04-19 - substituted by s8307c [A08807 Detail]

Download: New_York-2023-A08807-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

            S. 8307                                                  A. 8807

                SENATE - ASSEMBLY

                                    January 17, 2024
                                       ___________

        IN  SENATE -- A BUDGET BILL, submitted by the Governor pursuant to arti-
          cle seven of the Constitution -- read twice and ordered  printed,  and
          when printed to be committed to the Committee on Finance

        IN  ASSEMBLY  --  A  BUDGET  BILL, submitted by the Governor pursuant to
          article seven of the Constitution -- read once  and  referred  to  the
          Committee on Ways and Means

        AN  ACT  to amend part H of chapter 59 of the laws of 2011, amending the
          public  health  law  and  other  laws  relating  to  general  hospital
          reimbursement  for  annual  rates,  in relation to known and projected
          department of health state fund medicaid  expenditures  (Part  A);  to
          amend  the  public  health  law,  in  relation  to  extending  certain
          provisions related to the issuance of  accountable  care  organization
          certifications  and  state  oversight  of antitrust provisions; and to
          amend part D of chapter 56 of the laws of  2013  amending  the  social
          services  law  relating  to eligibility conditions, chapter 649 of the
          laws of 1996 amending the public health law, the  mental  hygiene  law
          and  the social services law relating to authorizing the establishment
          of special needs plans, part V of chapter  57  of  the  laws  of  2022
          amending  the  public  health  law  and  the insurance law relating to
          reimbursement for commercial and Medicaid services provided via  tele-
          health, chapter 659 of the laws of 1997 amending the public health law
          and  other  laws  relating  to  creation of continuing care retirement
          communities, part NN of chapter 57 of the laws of  2018  amending  the
          public  health  law and the state finance law relating to enacting the
          opioid stewardship act, part II of chapter 54  of  the  laws  of  2016
          amending  part C of chapter 58 of the laws of 2005 relating to author-
          izing reimbursements for expenditures made by or on behalf  of  social
          services districts for medical assistance for needy persons and admin-
          istration  thereof,  part B of chapter 57 of the laws of 2015 amending
          the social services law and  other  laws  relating  to  energy  audits
          and/or disaster preparedness reviews of residential healthcare facili-
          ties by the commissioner, and part H of chapter 57 of the laws of 2019
          amending  the  public  health  law relating to waiver of certain regu-
          lations, in relation to the effectiveness thereof (Part B);  to  amend
          the  education  law,  in relation to removing the exemption for school
          psychologists to render early  intervention  services;  and  to  amend

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD12671-01-4

        S. 8307                             2                            A. 8807

          chapter  217  of the laws of 2015, amending the education law relating
          to certified school psychologists and special education  services  and
          programs  for  preschool  children  with  handicapping  conditions, in
          relation  to  the  effectiveness thereof (Part C); to amend the public
          health law, in relation to reducing the hospital capital rate  add-on;
          to  amend  part  ZZ of chapter 56 of the laws of 2020 amending the tax
          law and the  social services law relating to certain Medicaid  manage-
          ment,  in  relation  to  the effectiveness thereof; to amend part E of
          chapter 57 of the laws of 2015, amending the public health law  relat-
          ing  to  the  payment  of  certain  funds  for  uncompensated care, in
          relation to certain payments being made as  outpatient  upper  payment
          limit  payments  for outpatient hospital services during certain state
          fiscal years and calendar years; to amend part B of chapter 57 of  the
          laws  of  2015,  amending  the social services law relating to supple-
          mental rebates, in relation to authorizing the department of health to
          increase operating cost component of  rates  of  payment  for  general
          hospital  outpatient services and authorizing the department of health
          to pay a public hospital adjustment to public general hospitals during
          certain state fiscal years and calendar years;  to  amend  the  public
          health  law, in relation to authorizing the commissioner to make addi-
          tional inpatient hospital payments during certain state  fiscal  years
          and  calendar  years; and to amend part B of chapter 58 of the laws of
          2010, amending the social services  law  and  the  public  health  law
          relating  to  prescription  drug coverage for needy persons and health
          care initiatives pools, in relation to authorizing the  department  of
          health  to  make  Medicaid payment increases for county operated free-
          standing clinics during certain state fiscal years and calendar  years
          (Part  D); to amend the public health law, in relation to freezing the
          operating component of  the  rates  for  skilled  nursing  facilities,
          reducing the capital component of the rates for skilled nursing facil-
          ities  by  an additional ten percent, and eligibility for admission to
          the New York state veterans'  home  (Part  E);  to  amend  the  social
          services  law, in relation to making the special needs assisted living
          residence voucher program permanent; and to amend  the  public  health
          law,  in  relation  to  assisted  living quality improvement standards
          (Part F); to amend  the public health law, in relation  to  home  care
          worker  wage  parity;  and  to repeal certain provisions of the public
          health law relating thereto (Part G); to amend the financial  services
          law,  in relation to excluding managed care plans from the independent
          resolution process; to amend the social services law  and  the  public
          health  law,  in relation to providing authority for the department of
          health to competitively procure managed care organizations participat-
          ing in medicaid managed care programs; to amend part I of  chapter  57
          of  the laws of 2022, providing a one percent across the board payment
          increase to all qualifying fee-for-service Medicaid rates, in relation
          to eliminating the one percent rate increase to managed care organiza-
          tions; and to repeal certain provisions of  the  social  services  law
          relating  thereto  (Part  H);  to  amend  the  social services law, in
          relation to copayments for drugs; to amend the public health  law,  in
          relation  to  prescriber  prevails; to amend the public health law, in
          relation to the Medicaid drug cap and pharmacy cost reporting; and  to
          repeal  certain  provisions  of  the  social  services law relating to
          coverage for certain prescription drugs (Part I); to amend the  social
          services  law, in relation to renaming the basic health program to the
          essential plan; to amend part H of chapter 57 of  the  laws  of  2021,
          amending the social services law relating to eliminating consumer-paid

        S. 8307                             3                            A. 8807

          premium  payments  in  the  basic  health  program, in relation to the
          effectiveness thereof; and to amend part BBB of chapter 56 of the laws
          of 2022, amending the public health law and  other  laws  relating  to
          permitting  the commissioner of health to submit a waiver that expands
          eligibility for New York's basic  health  program  and  increases  the
          federal  poverty  limit  cap for basic health program eligibility from
          two hundred to two hundred fifty percent,  in  relation  to  extending
          certain   provisions  related  to  providing  long-term  services  and
          supports under the essential plan; and to amend the public health law,
          in relation to adding references to the 1332 state innovation  waiver,
          providing  a  new  subsidy  to  assist low-income New Yorkers with the
          payment of premiums, cost sharing or both through the marketplace, and
          adding the 1332 state innovation  program  to  the  functions  of  the
          marketplace  (Part J); to amend chapter 266 of the laws of 1986 amend-
          ing the civil practice law and rules and other laws relating to  malp-
          ractice  and  professional  medical  conduct, in relation to insurance
          coverage paid for by funds from the hospital excess liability pool and
          extending the effectiveness of certain provisions  thereof;  to  amend
          part  J  of chapter 63 of the laws of 2001 amending chapter 266 of the
          laws of 1986 amending the civil practice law and rules and other  laws
          relating  to malpractice and professional medical conduct, in relation
          to extending certain provisions concerning the hospital excess liabil-
          ity pool; and to amend part H of chapter 57 of the laws of 2017 amend-
          ing the New York Health Care Reform Act of 1996 and other laws  relat-
          ing  to  extending certain provisions relating thereto, in relation to
          extending provisions relating to excess coverage (Part  K);  to  amend
          the  public  health  law and the state finance law, in relation to the
          discontinuation of the empire clinical research investigator  program;
          to  amend  the public health law, in relation to the discontinuance of
          participation and membership during a three year demonstration  period
          in  a  physician  committee of the Medical Society of the State of New
          York or the New York State Osteopathic Society; to repeal  subdivision
          9  of  section 2803 of the public health law, relating to the hospital
          audit program; to repeal section 461-s of  the  social  services  law,
          relating  to  enhancing  the quality of adult living program for adult
          care facilities; to repeal paragraph (c) of subdivision 1  of  section
          461-b  of  the  social services law, relating to an appropriation made
          available for the purposes of funding the  operating  assistance  sub-
          program  for  enriched  housing;  to repeal article 27-H of the public
          health law, relating to  the  tick-borne  disease  institute;  and  to
          repeal  paragraph  (g)  of subdivision 11 of section 230 of the public
          health law, relating to reporting of professional misconduct (Part L);
          to amend the social  services  law  and  the  public  health  law,  in
          relation  to  authorizing  continuous  coverage  in Medicaid and child
          health plus, for eligible children ages zero to six (Part M); to amend
          the public health law, in relation to authorizing the commissioner  of
          health  to issue a statewide standing order for the provision of doula
          services, providing medical services to pregnant minors,  and  to  the
          provision  of  contraception (Part N); to amend the public health law,
          in relation to expanding financial assistance; and to amend the gener-
          al business law, in relation to  additional  consumer  protection  for
          medical  debt  and  restricting the applications for and use of credit
          cards and medical financial products (Part O);  to  amend  part  C  of
          chapter  57 of the laws of 2022 amending the public health law and the
          education law relating  to  allowing  pharmacists  to  direct  limited
          service  laboratories  and order and administer COVID-19 and influenza

        S. 8307                             4                            A. 8807

          tests and modernizing nurse practitioners, and chapter 21 of the  laws
          of 2011 amending the education law relating to authorizing pharmacists
          to  perform  collaborative  drug therapy management with physicians in
          certain  settings,  in relation to the effectiveness thereof (Part P);
          to amend the education law and the public health law, in  relation  to
          the  scope of practice of physician assistants, certified nurse aides,
          medical assistants, dentists and dental hygienists (Part Q); to  amend
          the  education  law,  in  relation  to enacting the interstate medical
          licensure compact; and to amend the  education  law,  in  relation  to
          enacting  the  nurse  licensure  compact (Part R); to amend the public
          health law, in relation to  establishing  the  healthcare  safety  net
          transformation  program  (Part  S); to amend the public health law and
          the education law, in relation to making necessary changes to end  the
          HIV,  HCV,  HBV,  syphilis  and  mpox epidemics; and to repeal certain
          provisions the public health law relating thereto (Part T);  to  amend
          the public health law, in relation to increasing prescription monitor-
          ing  program data retention periods and allowing enhanced data sharing
          to combat the opioid crisis, updating controlled  substance  schedules
          to  conform with those of the federal drug enforcement administration,
          permitting providers to distribute  three-day  supplies  of  buprenor-
          phine,  and updating the term "addict" to "person with a substance use
          disorder" in certain provisions of such law;  and  to  repeal  section
          3372  of such law relating to practitioner patient reporting (Part U);
          to amend the public health law,  in  relation  to  expanding  hospital
          services  and  home care collaboration into the home and community; to
          amend the public health law and the  education  law,  in  relation  to
          modernizing the state of New York's emergency medical system and work-
          force; to amend the public health law, in relation to establishing the
          paramedic urgent care program; and to amend chapter 137 of the laws of
          2023  amending the public health law relating to establishing a commu-
          nity-based paramedicine demonstration program, in relation to  extend-
          ing  the  effectiveness  thereof  (Part V); to amend the elder law, in
          relation to establishing the interagency  elder  justice  coordinating
          council  (Part  W); to amend part NN of chapter  57  of  the  laws  of
          2018 amending the public health law and other laws relating to  enact-
          ing  the  opioid  stewardship  act,  in  relation to making the opioid
          stewardship fund permanent (Part X); to amend chapter 62 of  the  laws
          of  2003,  amending  the  mental hygiene law and the state finance law
          relating to the community mental health support  and  workforce  rein-
          vestment program, the membership of subcommittees for mental health of
          community  services  boards  and  the duties of such subcommittees and
          creating  the  community  mental  health  and  workforce  reinvestment
          account,  in  relation to the effectiveness thereof (Part Y); to amend
          part NN of chapter 58 of the laws of 2015, amending the mental hygiene
          law relating to clarifying the authority of the commissioners  in  the
          department  of  mental  hygiene  to  design and implement time-limited
          demonstration programs, in relation to making such  provisions  perma-
          nent  (Part  Z);  to  amend  the insurance law, in relation to setting
          minimal reimbursement for behavioral health treatment  (Part  AA);  to
          amend  chapter 723 of the laws of 1989 amending the mental hygiene law
          and  other  laws  relating  to  comprehensive  psychiatric   emergency
          programs,  in    relation  to  the effectiveness of certain provisions
          thereof (Part BB); to amend the social services law,  in  relation  to
          clarifying  the  requirements  related  to  referrals of substantiated
          reports of abuse or neglect from the justice center to the  office  of
          the  Medicaid  inspector general (Part CC); to amend part A of chapter

        S. 8307                             5                            A. 8807

          111 of the laws of 2010 amending the mental hygiene  law  relating  to
          the  receipt  of  federal  and  state benefits received by individuals
          receiving care in facilities  operated by an office of the  department
          of mental hygiene, in relation to the effectiveness thereof (Part DD);
          to  amend  the education law, in relation to expanding the description
          of certain services which are not prohibited by statutes governing the
          practice of nursing (Part EE); and  to  establish  a  cost  of  living
          adjustment for designated human services programs (Part FF)

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. This act enacts into law major  components  of  legislation
     2  necessary  to  implement  the state health and mental hygiene budget for
     3  the 2024-2025 state fiscal year.  Each  component  is  wholly  contained
     4  within  a  Part identified as Parts A through FF. The effective date for
     5  each particular provision contained within such Part is set forth in the
     6  last section of such Part. Any provision in any section contained within
     7  a Part, including the effective date of the Part, which makes  a  refer-
     8  ence  to  a  section  "of  this  act", when used in connection with that
     9  particular component, shall be deemed to mean and refer  to  the  corre-
    10  sponding section of the Part in which it is found. Section three of this
    11  act sets forth the general effective date of this act.

    12                                   PART A

    13    Section  1.  Paragraph (a) of subdivision 1 of section 92 of part H of
    14  chapter 59 of the laws of 2011, amending the public health law and other
    15  laws relating to general hospital reimbursement  for  annual  rates,  as
    16  amended  by  section  1  of part A of chapter 57 of the laws of 2023, is
    17  amended to read as follows:
    18    (a) For state fiscal years  2011-12  through  [2024-25]  2025-26,  the
    19  director  of the budget, in consultation with the commissioner of health
    20  referenced as "commissioner" for purposes of this section, shall  assess
    21  on  a  quarterly  basis,  as  reflected in quarterly reports pursuant to
    22  subdivision five of this  section  known  and  projected  department  of
    23  health  state  funds medicaid expenditures by category of service and by
    24  geographic regions, as defined by the commissioner.
    25    § 2. This act shall take effect immediately and  shall  be  deemed  to
    26  have been in full force and effect on and after April 1, 2024.

    27                                   PART B

    28    Section  1. Subdivision p of section 76 of part D of chapter 56 of the
    29  laws of 2013 amending the social services law  relating  to  eligibility
    30  conditions,  as amended by section 2 of part E of chapter 57 of the laws
    31  of 2019, is amended to read as follows:
    32    p. the amendments to subparagraph 7 of paragraph (b) of subdivision  1
    33  of  section  366  of the social services law made by section one of this
    34  act shall expire and be deemed repealed October 1, [2024] 2029.
    35    § 2. Section 10 of chapter 649 of the laws of 1996 amending the public
    36  health law, the mental hygiene law and the social services law  relating
    37  to  authorizing  the establishment of special needs plans, as amended by
    38  section 21 of part E of chapter 57 of the laws of 2019,  is  amended  to
    39  read as follows:

        S. 8307                             6                            A. 8807

     1    §  10.  This  act shall take effect immediately and shall be deemed to
     2  have been in full force and effect on and after July 1, 1996;  provided,
     3  however,  that  sections one, two and three of this act shall expire and
     4  be deemed repealed [on] March 31, [2025] 2030 provided, however that the
     5  amendments  to  section 364-j of the social services law made by section
     6  four of this act shall not affect the expiration  of  such  section  and
     7  shall  be  deemed  to  expire  therewith and provided, further, that the
     8  provisions of subdivisions 8, 9 and 10 of section  4401  of  the  public
     9  health  law,  as added by section one of this act; section 4403-d of the
    10  public health law as added by section two of this act and the provisions
    11  of section seven of this act, except for the provisions relating to  the
    12  establishment  of  no  more  than twelve comprehensive HIV special needs
    13  plans, shall expire and be deemed repealed on July 1, 2000.
    14    § 3. Subdivision 3 of section 2999-p of  the  public  health  law,  as
    15  amended  by  section  8 of part BB of chapter 56 of the laws of 2020, is
    16  amended to read as follows:
    17    3. The commissioner may issue a certificate of authority to an  entity
    18  that  meets conditions for ACO certification as set forth in regulations
    19  made by the commissioner pursuant to section twenty-nine  hundred  nine-
    20  ty-nine-q  of  this  article.  The  commissioner shall not issue any new
    21  certificate under this article after December thirty-first, two thousand
    22  [twenty-four] twenty-eight.
    23    § 4. Subdivision 1 of section 2999-aa of the  public  health  law,  as
    24  amended  by  section  9  of part S of chapter 57 of the laws of 2021, is
    25  amended to read as follows:
    26    1. In order to promote improved quality and efficiency of, and  access
    27  to,  health  care  services and to promote improved clinical outcomes to
    28  the residents of New York, it shall  be  the  policy  of  the  state  to
    29  encourage, where appropriate, cooperative, collaborative and integrative
    30  arrangements  including  but  not  limited  to, mergers and acquisitions
    31  among health care providers or  among  others  who  might  otherwise  be
    32  competitors,  under  the  active supervision of the commissioner. To the
    33  extent such arrangements, or the planning and negotiations that  precede
    34  them,  might  be  anti-competitive  within the meaning and intent of the
    35  state and federal antitrust laws, the intent of the state is to supplant
    36  competition with such arrangements  under  the  active  supervision  and
    37  related  administrative  actions  of  the  commissioner  as necessary to
    38  accomplish the purposes of this article, and  to  provide  state  action
    39  immunity  under  the  state  and  federal antitrust laws with respect to
    40  activities undertaken by health care providers and  others  pursuant  to
    41  this  article,  where  the benefits of such active supervision, arrange-
    42  ments and actions of the commissioner outweigh any disadvantages  likely
    43  to  result  from  a reduction of competition. The commissioner shall not
    44  approve an arrangement for which state action immunity is  sought  under
    45  this  article without first consulting with, and receiving a recommenda-
    46  tion from, the public health and health planning council. No arrangement
    47  under this article shall be approved after  December  thirty-first,  two
    48  thousand [twenty-four] twenty-eight.
    49    §  5.  Section  7 of part V of chapter 57 of the laws of 2022 amending
    50  the public health law and the insurance law  relating  to  reimbursement
    51  for commercial and Medicaid services provided via telehealth, is amended
    52  to read as follows:
    53    §  7.  This  act  shall take effect immediately and shall be deemed to
    54  have been in full force and effect on and after April 1, 2022; provided,
    55  however, this act shall expire and be deemed repealed on and after April
    56  1, [2024] 2025.

        S. 8307                             7                            A. 8807

     1    § 6. Section 97 of chapter 659 of the laws of 1997 amending the public
     2  health law and other  laws  relating  to  creation  of  continuing  care
     3  retirement communities, as amended by section 11 of part Z of chapter 57
     4  of the laws of 2018, is amended to read as follows:
     5    §  97. This act shall take effect immediately, provided, however, that
     6  the amendments to subdivision 4 of section 854 of the general  municipal
     7  law  made by section seventy of this act shall not affect the expiration
     8  of such subdivision and shall be deemed to expire therewith and provided
     9  further that sections sixty-seven and  sixty-eight  of  this  act  shall
    10  apply  to  taxable  years  beginning  on  or  after  January 1, 1998 and
    11  provided further that sections eighty-one through eighty-seven  of  this
    12  act  shall expire and be deemed repealed on December 31, [2024] 2029 and
    13  provided further, however, that the amendments to section ninety of this
    14  act shall take effect January 1, 1998 and shall apply to  all  policies,
    15  contracts,  certificates,  riders or other evidences of coverage of long
    16  term care insurance issued, renewed, altered  or  modified  pursuant  to
    17  section 3229 of the insurance law on or after such date.
    18    §  7.  Section 5 of part NN of chapter 57 of the laws of 2018 amending
    19  the public health law and the state finance law relating to enacting the
    20  opioid stewardship act, as amended by section 5 of part XX of chapter 59
    21  of the laws of 2019, is amended to read as follows:
    22    § 5. This act shall take effect July 1, 2018 and shall expire  and  be
    23  deemed  to be repealed on June 30, [2024] 2027, provided that, effective
    24  immediately, the addition, amendment and/or repeal of any rule or  regu-
    25  lation  necessary  for  the  implementation of this act on its effective
    26  date are authorized to be made and completed on or before such effective
    27  date, and, provided that this act  shall  only  apply  to  the  sale  or
    28  distribution  of  opioids in the state of New York on or before December
    29  31, 2018.
    30    § 8. Section 2 of part II of chapter 54 of the laws of  2016  amending
    31  part  C  of  chapter  58  of  the  laws  of 2005 relating to authorizing
    32  reimbursements for expenditures made by or on behalf of social  services
    33  districts  for  medical  assistance for needy persons and administration
    34  thereof, as amended by section 6 of part CC of chapter 57 of the laws of
    35  2022, is amended to read as follows:
    36    § 2. This act shall take effect immediately and shall  expire  and  be
    37  deemed repealed March 31, [2024] 2026.
    38    §  9.  Subdivision 5 of section 60 of part B of chapter 57 of the laws
    39  of 2015 amending the social services law  and  other  laws  relating  to
    40  energy  audits  and/or  disaster  preparedness  reviews  of  residential
    41  healthcare facilities by the commissioner, as amended by chapter 125  of
    42  the laws of 2021, is amended to read as follows:
    43    5.  section  thirty-eight  of  this  act  shall  expire  and be deemed
    44  repealed July 1, [2024] 2027;
    45    § 10. Section 7 of part H of chapter 57 of the laws of 2019,  amending
    46  the  public  health  law  relating  to waiver of certain regulations, as
    47  amended by section 1 of part GG of chapter 57 of the laws  of  2022,  is
    48  amended to read as follows:
    49    §  7.  This  act  shall take effect immediately and shall be deemed to
    50  have been in full force and effect on and after April 1, 2019, provided,
    51  however, that section two of this act shall expire on  April  1,  [2024]
    52  2026.
    53    § 11. This act shall take effect immediately.

    54                                   PART C

        S. 8307                             8                            A. 8807

     1    Section  1. Paragraph d of subdivision 6 of section 4410 of the educa-
     2  tion law, as amended by chapter 217 of the laws of 2015, is  amended  to
     3  read as follows:
     4    d.  Notwithstanding  any  other  provision of law to the contrary, the
     5  exemption in subdivision one of section seventy-six hundred five of this
     6  chapter shall apply to persons employed  on  a  full-time  or  part-time
     7  salary  basis, which may include on an hourly, weekly, or monthly basis,
     8  or on a fee for evaluation services basis provided that such  person  is
     9  employed by and under the dominion and control of a center-based program
    10  approved  pursuant  to  subdivision  nine of this section as a certified
    11  school psychologist to provide activities, services and use of the title
    12  psychologist to students enrolled in such approved center-based program;
    13  and to certified school psychologists employed on a full-time  or  part-
    14  time  salary  basis,  which may include on an hourly, weekly, or monthly
    15  basis, or on a fee for  evaluation  services  basis  provided  that  the
    16  school psychologist is employed by and under the dominion and control of
    17  a  program that has been approved pursuant to paragraph b of subdivision
    18  nine of this section, or subdivision nine-a of this section, to  conduct
    19  a multi-disciplinary evaluation of a preschool child having or suspected
    20  of  having a disability where authorized by paragraph a [or b] of subdi-
    21  vision six of section sixty-five hundred three-b of this  chapter[;  and
    22  to  certified  school psychologists employed on a full-time or part-time
    23  salary basis, which may include on an hourly, weekly, or monthly  basis,
    24  or  on  a  fee for evaluation services basis provided that such psychol-
    25  ogist is employed by and under the dominion and  control  of  an  agency
    26  approved  in  accordance  with title two-A of article twenty-five of the
    27  public health law to deliver early intervention  program  multidiscipli-
    28  nary  evaluations,  service coordination services and early intervention
    29  program services, where authorized by paragraph a or  b  of  subdivision
    30  six of section sixty-five hundred three-b of this chapter, each], in the
    31  course  of  their employment. Nothing in this section shall be construed
    32  to authorize a certified school psychologist or  group  of  such  school
    33  psychologists  to  engage in independent practice or practice outside of
    34  an employment relationship.
    35    § 2. Subdivision 1 of section 7605 of the education law, as amended by
    36  chapter 217 of the laws of 2015, is amended to read as follows:
    37    1. The activities, services, and use of the title of psychologist,  or
    38  any  derivation  thereof,  on  the  part  of a person in the employ of a
    39  federal, state, county or municipal agency, or other political  subdivi-
    40  sion,  or  a chartered elementary or secondary school or degree-granting
    41  educational institution insofar as such activities and  services  are  a
    42  part  of the duties of his salaried position; or on the part of a person
    43  in the employ as a certified school psychologist on a full-time or part-
    44  time salary basis, which may include on an hourly,  weekly,  or  monthly
    45  basis,  or  on  a  fee  for evaluation services basis provided that such
    46  person employed as a certified school psychologist is  employed  by  and
    47  under  the dominion and control of a preschool special education program
    48  approved pursuant to paragraph b  of  subdivision  nine  or  subdivision
    49  nine-a  of  section  forty-four  hundred  ten of this chapter to provide
    50  activities, services and to use the  title  "certified  school  psychol-
    51  ogist",  so long as this shall not be construed to permit the use of the
    52  title "licensed psychologist", to students  enrolled  in  such  approved
    53  program  or  to  conduct  a  multidisciplinary evaluation of a preschool
    54  child having or suspected of having a disability[; or on the part  of  a
    55  person  in  the employ as a certified school psychologist on a full-time
    56  or part-time salary basis, which may include on  an  hourly,  weekly  or

        S. 8307                             9                            A. 8807

     1  monthly  basis,  or on a fee for evaluation services basis provided that
     2  such person employed as a certified school psychologist is  employed  by
     3  and  under  the dominion and control of an agency approved in accordance
     4  with  title  two-A  of  article  twenty-five of the public health law to
     5  deliver  early  intervention  program   multidisciplinary   evaluations,
     6  service  coordination services and early intervention program services],
     7  where each such preschool special education  program  [or  early  inter-
     8  vention provider] is authorized by paragraph a [or b] of subdivision six
     9  of  section  sixty-five hundred [three] three-b of this title[, each] in
    10  the course of their employment. Nothing in  this  subdivision  shall  be
    11  construed  to authorize a certified school psychologist or group of such
    12  school psychologists to  engage  in  independent  practice  or  practice
    13  outside of an employment relationship.
    14    § 3. Section 3 of chapter 217 of the laws of 2015, amending the educa-
    15  tion  law  relating to certified school psychologists and special educa-
    16  tion services and programs  for  preschool  children  with  handicapping
    17  conditions, as amended by chapter 339 of the laws of 2022, is amended to
    18  read as follows:
    19    §  3.  This  act  shall take effect immediately and shall be deemed to
    20  have been in full force and effect on and after July 1, 2014,  provided,
    21  however  that  the  provisions  of  this  act shall expire and be deemed
    22  repealed June 30, [2024] 2026.
    23    § 4. This act shall take effect immediately and  shall  be  deemed  to
    24  have been in full force and effect on and after April 1, 2024; provided,
    25  however,  that the amendments to paragraph d of subdivision 6 of section
    26  4410 of the education law made by section one  of  this  act  shall  not
    27  affect  the  expiration  of such paragraph and shall be deemed to expire
    28  therewith; provided further, however, that the amendments to subdivision
    29  1 of section 7605 of the education law made by section two of  this  act
    30  shall  not affect the expiration of such subdivision and shall be deemed
    31  to expire therewith.

    32                                   PART D

    33    Section 1. Paragraph (c) of subdivision 8 of  section  2807-c  of  the
    34  public  health  law,  as amended by section 1 of part D of chapter 57 of
    35  the laws of 2021, is amended to read as follows:
    36    (c) In order to reconcile capital related inpatient expenses  included
    37  in  rates of payment based on a budget to actual expenses and statistics
    38  for the rate period for a general  hospital,  rates  of  payment  for  a
    39  general  hospital  shall  be adjusted to reflect the dollar value of the
    40  difference between capital related inpatient expenses  included  in  the
    41  computation of rates of payment for a prior rate period based on a budg-
    42  et  and  actual  capital  related inpatient expenses for such prior rate
    43  period, each as determined in accordance  with  paragraph  (a)  of  this
    44  subdivision,  adjusted  to  reflect  increases or decreases in volume of
    45  service in such prior rate period  compared  to  statistics  applied  in
    46  determining the capital related inpatient expenses component of rates of
    47  payment based on a budget for such prior rate period.
    48    For  rates  effective  April  first, two thousand twenty through March
    49  thirty-first, two  thousand  twenty-one,  the  budgeted  capital-related
    50  expenses add-on as described in paragraph (a) of this subdivision, based
    51  on  a  budget  submitted in accordance to paragraph (a) of this subdivi-
    52  sion, shall be reduced by five percent relative to the rate in effect on
    53  such date; and the actual capital expenses add-on as described in  para-
    54  graph  (a)  of this subdivision, based on actual expenses and statistics

        S. 8307                            10                            A. 8807

     1  through appropriate audit procedures in accordance with paragraph (a) of
     2  this subdivision shall be reduced by five percent relative to  the  rate
     3  in effect on such date.
     4    For  rates  effective [on and after] April first, two thousand twenty-
     5  one through September thirtieth, two thousand twenty-four, the  budgeted
     6  capital-related  expenses  add-on  as described in paragraph (a) of this
     7  subdivision, based on a budget submitted in accordance to paragraph  (a)
     8  of  this  subdivision,  shall  be reduced by ten percent relative to the
     9  rate in effect on such date; and the actual capital expenses  add-on  as
    10  described in paragraph (a) of this subdivision, based on actual expenses
    11  and  statistics  through appropriate audit procedures in accordance with
    12  paragraph (a) of this subdivision shall be reduced by ten percent  rela-
    13  tive to the rate in effect on such date.
    14    For  rates  effective on and after October first, two thousand twenty-
    15  four, the budgeted capital-related expenses add-on as described in para-
    16  graph (a) of this subdivision, based on a budget submitted in accordance
    17  with paragraph (a) of this  subdivision,  shall  be  reduced  by  twenty
    18  percent  relative  to  the  rate  in effect on such date; and the actual
    19  capital expenses add-on as described in paragraph (a) of  this  subdivi-
    20  sion  shall  be reduced by twenty percent relative to the rate in effect
    21  on such date.
    22    For any rate year, all reconciliation add-on  amounts  calculated  [on
    23  and  after]  for  the period of April first, two thousand twenty through
    24  September thirtieth, two thousand twenty-four shall be  reduced  by  ten
    25  percent,  and  all  reconciliation  recoupment amounts calculated [on or
    26  after] for the period  of  April  first,  two  thousand  twenty  through
    27  September  thirtieth,  two  thousand  twenty-four  shall increase by ten
    28  percent.
    29    For any rate year, all reconciliation add-on amounts calculated on and
    30  after October first, two thousand twenty-four shall be reduced by twenty
    31  percent, and all reconciliation  recoupment  amounts  calculated  on  or
    32  after  October  first, two thousand twenty-four shall increase by twenty
    33  percent.
    34    Notwithstanding any inconsistent  provision  of  subparagraph  (i)  of
    35  paragraph (e) of subdivision nine of this section, capital related inpa-
    36  tient  expenses  of  a  general  hospital included in the computation of
    37  rates of payment based on a budget shall not be included in the computa-
    38  tion of a volume adjustment made in accordance with  such  subparagraph.
    39  Adjustments  to rates of payment for a general hospital made pursuant to
    40  this paragraph shall be made in accordance with paragraph (c) of  subdi-
    41  vision  eleven  of  this  section. Such adjustments shall not be carried
    42  forward except for such  volume  adjustment  as  may  be  authorized  in
    43  accordance with subparagraph (i) of paragraph (e) of subdivision nine of
    44  this section for such general hospital.
    45    §  2.  Section 5 of part ZZ of chapter 56 of the laws of 2020 amending
    46  the tax law and the social services law  relating  to  certain  Medicaid
    47  management, as amended by section 3 of part RR of chapter 57 of the laws
    48  of 2022, is amended to read as follows:
    49    §  5.  This  act  shall  take  effect  immediately and shall be deemed
    50  repealed [five] eight years after such effective date.
    51    § 3. Section 2 of part E of chapter 57 of the laws of  2015,  amending
    52  the  public  health  law  relating  to  the payment of certain funds for
    53  uncompensated care, is amended to read as follows:
    54    § 2. Notwithstanding any inconsistent provision of law, rule or  regu-
    55  lation  to  the  contrary,  and  subject  to the availability of federal
    56  financial participation pursuant to title  XIX  of  the  federal  social

        S. 8307                            11                            A. 8807

     1  security  act,  effective  for  [periods on and after] each state fiscal
     2  year from April 1, 2015, through December 31, 2024; and for the calendar
     3  year January 1, 2025 through December 31, 2025; and  for  each  calendar
     4  year thereafter, payments pursuant to paragraph (i) of subdivision 35 of
     5  section  2807-c of the public health law may be made as outpatient upper
     6  payment limit payments for outpatient hospital services, not  to  exceed
     7  an  amount of three hundred thirty-nine million dollars annually between
     8  payments authorized under this section and such section  of  the  public
     9  health  law.  Such payments shall be made as medical assistance payments
    10  for outpatient services pursuant to title 11 of article 5 of the  social
    11  services  law  for patients eligible for federal financial participation
    12  under title XIX of the federal social security act for general  hospital
    13  outpatient  services and general hospital emergency room services issued
    14  pursuant to paragraph (g) of subdivision 2 of section 2807 of the public
    15  health law to general hospitals, other than major public general  hospi-
    16  tals,  providing emergency room services and including safety net hospi-
    17  tals, which shall, for the purpose of  this  paragraph,  be  defined  as
    18  having  either:  a Medicaid share of total inpatient hospital discharges
    19  of at least thirty-five  percent,  including  both  fee-for-service  and
    20  managed  care  discharges  for  acute and exempt services; or a Medicaid
    21  share of total discharges of at least  thirty  percent,  including  both
    22  fee-for-service  and  managed  care  discharges  for  acute  and  exempt
    23  services, and also  providing  obstetrical  services.    Eligibility  to
    24  receive  such additional payments shall be based on data from the period
    25  two years prior to the rate year, as reported on the institutional  cost
    26  report submitted to the department as of October first of the prior rate
    27  year.  No  eligible general hospital's annual payment amount pursuant to
    28  this section shall exceed the lower of the sum of the annual amounts due
    29  that hospital pursuant  to  section  twenty-eight  hundred  seven-k  and
    30  section  twenty-eight  hundred  seven-w of the public health law; or the
    31  hospital's facility specific projected disproportionate  share  hospital
    32  payment  ceiling established pursuant to federal law, provided, however,
    33  that payment amounts to eligible hospitals in excess  of  the  lower  of
    34  such  sum  or payment ceiling shall be reallocated to eligible hospitals
    35  that do not have excess payment amounts.  Such  reallocations  shall  be
    36  proportional  to  each such hospital's aggregate payment amount pursuant
    37  to paragraph (i) of subdivision 35  of  section  2807-c  of  the  public
    38  health law and this section to the total of all payment amounts for such
    39  eligible  hospitals.  Such  adjustment  payment may be added to rates of
    40  payment or made as aggregate  payments  to  eligible  general  hospitals
    41  other  than  major  public general hospitals.   The distribution of such
    42  payments shall be pursuant to a methodology approved by the commissioner
    43  of health in regulation.
    44    § 4. Section 21 of part B of chapter 57 of the laws of 2015,  amending
    45  the  social services law relating to supplemental rebates, is amended to
    46  read as follows:
    47    § 21. Notwithstanding any inconsistent provision of law, rule or regu-
    48  lation to the contrary, and  subject  to  the  availability  of  federal
    49  financial  participation  pursuant  to  title  XIX of the federal social
    50  security act, effective for [the period] each  state  fiscal  year  from
    51  April  1, 2011 through [March 31, 2012, and state fiscal years] December
    52  31, 2024; and for the calendar year January 1, 2025 through December 31,
    53  2025; and for each calendar year thereafter, the department of health is
    54  authorized to increase the operating cost component of rates of  payment
    55  for  general hospital outpatient services and general hospital emergency
    56  room services issued pursuant to  paragraph  (g)  of  subdivision  2  of

        S. 8307                            12                            A. 8807

     1  section  2807  of the public health law for public general hospitals, as
     2  defined in subdivision 10 of section 2801  of  the  public  health  law,
     3  other  than those operated by the state of New York or the state univer-
     4  sity  of  New  York,  and  located  in a city with a population over one
     5  million, up to two hundred  eighty-seven  million  dollars  annually  as
     6  medical assistance payments for outpatient services pursuant to title 11
     7  of article 5 of the social services law for patients eligible for feder-
     8  al financial participation under title XIX of the federal social securi-
     9  ty  act based on such criteria and methodologies as the commissioner may
    10  from time to time set through a memorandum of understanding with the New
    11  York city health and hospitals corporation, and such  adjustments  shall
    12  be  paid by means of one or more estimated payments, with such estimated
    13  payments to be reconciled to the commissioner of health's final  adjust-
    14  ment  determinations  after  the disproportionate share hospital payment
    15  adjustment caps have been calculated  for  such  period  under  sections
    16  1923(f)  and  (g)  of  the  federal social security act. Such adjustment
    17  payment may be added to rates of payment or made as  aggregate  payments
    18  to eligible public general hospitals.
    19    §  5.  The  opening  paragraph of subparagraph (i) of paragraph (i) of
    20  subdivision 35 of section 2807-c of the public health law, as amended by
    21  section 4 of part C of chapter 56 of the laws of  2013,  is  amended  to
    22  read as follows:
    23    Notwithstanding  any inconsistent provision of this subdivision or any
    24  other contrary provision of law  and  subject  to  the  availability  of
    25  federal financial participation, for [the period] each state fiscal year
    26  from July first, two thousand ten through [March thirty-first, two thou-
    27  sand eleven,] December thirty-first, two thousand twenty-four; and [each
    28  state fiscal year period] for the calendar year January first, two thou-
    29  sand  twenty-five  through  December  thirty-first, two thousand twenty-
    30  five; and for each calendar year thereafter, the commissioner shall make
    31  additional inpatient hospital payments up to the aggregate upper payment
    32  limit for inpatient hospital services after all other medical assistance
    33  payments, but not to exceed two hundred thirty-five million five hundred
    34  thousand dollars for the period July first,  two  thousand  ten  through
    35  March  thirty-first, two thousand eleven, three hundred fourteen million
    36  dollars for each state fiscal year beginning April first,  two  thousand
    37  eleven,  through  March thirty-first, two thousand thirteen, and no less
    38  than three hundred thirty-nine million dollars  for  each  state  fiscal
    39  year [thereafter] until December thirty-first, two thousand twenty-four;
    40  and  then  from  calendar  year  January first, two thousand twenty-five
    41  through December thirty-first, two thousand twenty-five;  and  for  each
    42  calendar  year thereafter, to general hospitals, other than major public
    43  general hospitals, providing emergency room services and including safe-
    44  ty net hospitals, which shall, for the purpose  of  this  paragraph,  be
    45  defined  as  having either: a Medicaid share of total inpatient hospital
    46  discharges of at least thirty-five percent, including both  fee-for-ser-
    47  vice  and  managed  care  discharges for acute and exempt services; or a
    48  Medicaid share of total discharges of at least thirty percent, including
    49  both fee-for-service and managed care discharges for  acute  and  exempt
    50  services,  and  also  providing  obstetrical  services.  Eligibility  to
    51  receive such additional payments shall be based on data from the  period
    52  two  years prior to the rate year, as reported on the institutional cost
    53  report submitted to the department as of October first of the prior rate
    54  year. Such payments shall be made as  medical  assistance  payments  for
    55  fee-for-service  inpatient hospital services pursuant to title eleven of
    56  article five of the social services law for patients eligible for feder-

        S. 8307                            13                            A. 8807

     1  al financial participation under title XIX of the federal social securi-
     2  ty act and in accordance with the following:
     3    §  6. Section 18 of part B of chapter 57 of the laws of 2015, amending
     4  the social services law relating to supplemental rebates, is amended  to
     5  read as follows:
     6    §  18. Notwithstanding any inconsistent provision of law or regulation
     7  to the contrary, and subject to the availability  of  federal  financial
     8  participation  pursuant to title XIX of the federal social security act,
     9  effective for [the period] each state fiscal year from  April  1,  2012,
    10  through  [March 31, 2013, and state fiscal years] December 31, 2024; and
    11  for the calendar year from January 1, 2025 through  December  31,  2025;
    12  and  for  each  calendar  year  thereafter,  the department of health is
    13  authorized to pay a public hospital adjustment to public general  hospi-
    14  tals,  as defined in subdivision 10 of section 2801 of the public health
    15  law, other than those operated by the state of New  York  or  the  state
    16  university  of New York, and located in a city with a population of over
    17  1 million, of up to one  billion  eighty  million  dollars  annually  as
    18  medical  assistance payments for inpatient services pursuant to title 11
    19  of article 5 of the social services law for patients eligible for feder-
    20  al financial participation under title XIX of the federal social securi-
    21  ty act based on such criteria and methodologies as the commissioner  may
    22  from time to time set through a memorandum of understanding with the New
    23  York  city  health and hospitals corporation, and such adjustments shall
    24  be paid by means of one or more estimated payments, with such  estimated
    25  payments  to be reconciled to the commissioner of health's final adjust-
    26  ment determinations after the disproportionate  share  hospital  payment
    27  adjustment  caps  have  been  calculated  for such period under sections
    28  1923(f) and (g) of the federal  social  security  act.  Such  adjustment
    29  payment  may  be added to rates of payment or made as aggregate payments
    30  to eligible public general hospitals.
    31    § 7. Subdivision 1 of section 3-a of part B of chapter 58 of the  laws
    32  of  2010,  amending  the  social  services law and the public health law
    33  relating to prescription drug coverage for needy persons and health care
    34  initiatives pools, is amended to read as follows:
    35    1. Notwithstanding any inconsistent provision of law,  rule  or  regu-
    36  lation  to  the  contrary,  and  subject  to the availability of federal
    37  financial participation, effective for [the period]  each  state  fiscal
    38  year  from August 1, 2010 through [March 31, 2011, and each state fiscal
    39  year] December 31, 2024; and for the calendar year from January 1,  2025
    40  through  December  31,  2025; and for each calendar year thereafter, the
    41  department of health is authorized to make  Medicaid  payment  increases
    42  for  diagnostic  and treatment centers (DTC) services issued pursuant to
    43  section 2807 of the public health law for public DTCs  operated  by  the
    44  New  York  City Health and Hospitals Corporation, at the election of the
    45  social services district in which an eligible DTC is physically located,
    46  of up to twelve million six hundred thousand dollars  on  an  annualized
    47  basis  for  DTC services pursuant to title 11 of article 5 of the social
    48  services law for patients eligible for federal  financial  participation
    49  under  title  XIX  of the federal social security act based on each such
    50  DTC's proportionate share of the sum of all clinic visits for all facil-
    51  ities eligible for an adjustment pursuant to this section for  the  base
    52  year two years prior to the rate year. Such proportionate share payments
    53  may be added to rates of payment or made as aggregate payments to eligi-
    54  ble DTCs.
    55    §  8. Subdivision 1 of section 3-b of part B of chapter 58 of the laws
    56  of 2010, amending the social services law  and  the  public  health  law

        S. 8307                            14                            A. 8807

     1  relating to prescription drug coverage for needy persons and health care
     2  initiatives pools, is amended to read as follows:
     3    1.  Notwithstanding  any  inconsistent provision of law, rule or regu-
     4  lation to the contrary, and  subject  to  the  availability  of  federal
     5  financial  participation,  effective  for [the period] each state fiscal
     6  year from August 1, 2010 through [March 31, 2011, and each state  fiscal
     7  year]  December 31, 2024; and for the calendar year from January 1, 2025
     8  through December 31, 2025; and for each calendar  year  thereafter,  the
     9  department  of  health, is authorized to make Medicaid payment increases
    10  for county operated diagnostic  and  treatment  centers  (DTC)  services
    11  issued  pursuant  to  section  2807  of  the  public  health law and for
    12  services provided by  county  operated  free-standing  clinics  licensed
    13  pursuant  to  articles  31  and  32  of  the mental hygiene law, but not
    14  including facilities operated by the New York City Health and  Hospitals
    15  Corporation,  of  up to five million four hundred thousand dollars on an
    16  annualized basis for such services pursuant to title 11 of article 5  of
    17  the  social  services  law  for  patients eligible for federal financial
    18  participation under title XIX of the federal social security act.  Local
    19  social  services  districts may decline such increased payments to their
    20  sponsored DTCs and free-standing clinics, provided they provide  written
    21  notification to the commissioner of health, within thirty days following
    22  receipt of notification of a payment pursuant to this section.  Distrib-
    23  utions  pursuant  to  this  section  shall  be  based on each facility's
    24  proportionate share of the sum of all DTC  and  clinic  visits  for  all
    25  facilities receiving payments pursuant to this section for the base year
    26  two  years prior to the rate year. Such proportionate share payments may
    27  be added to rates or payment or made as aggregate payments  to  eligible
    28  facilities.
    29    §  9.  Paragraph (e-1) of subdivision 12 of section 2808 of the public
    30  health law, as amended by section 15 of part B of chapter 57 of the laws
    31  of 2023, is amended to read as follows:
    32    (e-1) Notwithstanding any inconsistent provision of law or regulation,
    33  the commissioner shall provide,  in  addition  to  payments  established
    34  pursuant  to  this  article  prior to application of this section, addi-
    35  tional payments under the medical assistance program pursuant  to  title
    36  eleven of article five of the social services law for non-state operated
    37  public  residential health care facilities, including public residential
    38  health care facilities located in the county of Nassau,  the  county  of
    39  Westchester  and  the  county  of Erie, but excluding public residential
    40  health care facilities operated by a town or city within  a  county,  in
    41  aggregate  annual  amounts of up to one hundred fifty million dollars in
    42  additional payments for the state fiscal year beginning April first, two
    43  thousand six and for the state fiscal year beginning  April  first,  two
    44  thousand  seven and for the state fiscal year beginning April first, two
    45  thousand eight and of up to three hundred million dollars in such aggre-
    46  gate annual additional payments for  the  state  fiscal  year  beginning
    47  April  first, two thousand nine, and for the state fiscal year beginning
    48  April first, two thousand ten and for the state  fiscal  year  beginning
    49  April  first, two thousand eleven, and for the state fiscal years begin-
    50  ning April first, two thousand twelve  and  April  first,  two  thousand
    51  thirteen,  and  of  up to five hundred million dollars in such aggregate
    52  annual additional payments for the state fiscal  years  beginning  April
    53  first,  two  thousand  fourteen,  April  first, two thousand fifteen and
    54  April first, two thousand sixteen and of  up  to  five  hundred  million
    55  dollars  in  such  aggregate  annual  additional  payments for the state
    56  fiscal years beginning April first, two thousand seventeen, April first,

        S. 8307                            15                            A. 8807

     1  two thousand eighteen, and April first, two thousand nineteen, and of up
     2  to five hundred million dollars  in  such  aggregate  annual  additional
     3  payments  for the state fiscal years beginning April first, two thousand
     4  twenty, April first, two thousand twenty-one, and April first, two thou-
     5  sand  twenty-two,  and  of  up  to  five hundred million dollars in such
     6  aggregate annual additional payments for the state fiscal  years  begin-
     7  ning  April  first, two thousand twenty-three, and from April first, two
     8  thousand twenty-four until December thirty-first, two  thousand  twenty-
     9  four,  and [April first, two thousand twenty-five] for the calendar year
    10  January first, two thousand twenty-five through  December  thirty-first,
    11  two  thousand  twenty-five,  and for each calendar year thereafter.  The
    12  amount allocated to each eligible public residential health care facili-
    13  ty for this period shall be computed in accordance with  the  provisions
    14  of  paragraph  (f)  of this subdivision, provided, however, that patient
    15  days shall be utilized for such computation reflecting  actual  reported
    16  data  for  two thousand three and each representative succeeding year as
    17  applicable, and provided further, however, that,  in  consultation  with
    18  impacted providers, of the funds allocated for distribution in the state
    19  fiscal  year beginning April first, two thousand thirteen, up to thirty-
    20  two million dollars may be allocated in accordance with paragraph  (f-1)
    21  of this subdivision.
    22    §  10.  This  act  shall  take  effect immediately; provided, however,
    23  section one of this act shall take effect October 1, 2024; and provided,
    24  further, that sections three, four, five, six, seven, eight and nine  of
    25  this act shall take effect January 1, 2025.

    26                                   PART E

    27    Section  1.  Subparagraph  (ii) of paragraph (b) of subdivision 2-b of
    28  section 2808 of the public health law, as added by section 47 of part  C
    29  of chapter 109 of the laws of 2006, is amended to read as follows:
    30    (ii) (A) The operating component of rates shall be subject to case mix
    31  adjustment  through  application  of  the  relative resource utilization
    32  groups system of patient classification (RUG-III) employed by the feder-
    33  al government with regard to  payments  to  skilled  nursing  facilities
    34  pursuant  to  title XVIII of the federal social security act (Medicare),
    35  as revised by regulation to reflect New  York  state  wages  and  fringe
    36  benefits,  provided,  however,  that  such RUG-III classification system
    37  weights shall be increased in the following amounts  for  the  following
    38  categories  of  residents:  [(A)]  (1)  thirty  minutes for the impaired
    39  cognition A category, [(B)] (2) forty minutes for the impaired cognition
    40  B category, and [(C)] (3) twenty-five minutes for the  reduced  physical
    41  functions  B  category.    Such adjustments shall be made in January and
    42  July of each calendar year. Such adjustments and related patient classi-
    43  fications in each facility shall be subject to audit review  in  accord-
    44  ance with regulations promulgated by the commissioner.
    45    (B)  Effective  April  first,  two thousand twenty-four, the operating
    46  component of the rates  for  skilled  nursing  facilities  shall  remain
    47  unchanged  from  the  January  two thousand twenty-four rates during the
    48  development and until full implementation  of  a  case  mix  methodology
    49  using the Patient Driven Payment Model.
    50    §  2. Subparagraph (iv) of paragraph (b) of subdivision 2-b of section
    51  2808 of the public health law, as amended by section 1  of  part  NN  of
    52  chapter 56 of the laws of 2020, is amended to read as follows:
    53    (iv)  The  capital cost component of rates on and after January first,
    54  two thousand nine shall: (A) fully reflect the cost  of  local  property

        S. 8307                            16                            A. 8807

     1  taxes  and payments made in lieu of local property taxes, as reported in
     2  each facility's cost report submitted for the year two  years  prior  to
     3  the  rate  year; (B) provided, however, notwithstanding any inconsistent
     4  provision  of  this article, commencing April first, two thousand twenty
     5  for rates of payment for patients eligible for payments  made  by  state
     6  governmental  agencies, the capital cost component determined in accord-
     7  ance with this subparagraph and inclusive  of  any  shared  savings  for
     8  eligible  facilities that elect to refinance their mortgage loans pursu-
     9  ant to paragraph (d) of subdivision two-a  of  this  section,  shall  be
    10  reduced  by the commissioner by five percent; and (C) provided, however,
    11  notwithstanding any inconsistent provision of this  article,  commencing
    12  April  first, two thousand twenty-four for rates of payment for patients
    13  eligible for payments made by state governmental agencies,  the  capital
    14  cost  component  determined  in  accordance  with  this subparagraph and
    15  inclusive of any shared savings for eligible facilities  that  elect  to
    16  refinance  their mortgage loans pursuant to paragraph (d) of subdivision
    17  two-a of this section, shall be reduced by the commissioner by an  addi-
    18  tional ten percent.
    19    §  3.  Paragraph  (h)  of  subdivision 1 of section 2632 of the public
    20  health law, as amended by chapter 414 of the laws of 2015, is amended to
    21  read as follows:
    22    (h) in the Persian Gulf conflict from the second day of August,  nine-
    23  teen  hundred  ninety  to  the  end  of such conflict including military
    24  service in Operation Enduring Freedom, Operation Iraqi  Freedom,  Opera-
    25  tion New Dawn or Operation Inherent Resolve and was the recipient of the
    26  global  war  on terrorism expeditionary medal or the Iraq campaign medal
    27  or the Afghanistan campaign medal; and who was a resident of  the  state
    28  of New York at the time of entry upon such active duty or who shall have
    29  been  a  resident of this state for [one year] six months next preceding
    30  the application for admission shall be entitled  to  admission  to  said
    31  home  after  the  approval  of the application by the board of visitors,
    32  subject to the provisions of this article and to the conditions, limita-
    33  tions and penalties prescribed by the regulations of the department. Any
    34  such veteran or dependent, who otherwise fulfills the  requirements  set
    35  forth  in  this section, may be admitted directly to the skilled nursing
    36  facility or the health related facility provided such veteran or depend-
    37  ent is certified by a physician designated or approved by the department
    38  to require the type of care provided by such facilities.
    39    § 4. This act shall take effect immediately and  shall  be  deemed  to
    40  have been in full force and effect on and after April 1, 2024.

    41                                   PART F

    42    Section  1.  Paragraph  (n)  of  subdivision 3 of section 461-l of the
    43  social services law, as amended by section 2 of part B of chapter 57  of
    44  the laws of 2018, is amended to read as follows:
    45    (n)  The  commissioner  of health is authorized to create a program to
    46  subsidize the cost of assisted living for those individuals living  with
    47  Alzheimer's  disease  and  dementia  who  are  not  eligible for medical
    48  assistance pursuant to title eleven of article five of this chapter  and
    49  reside  in  a  special  needs  assisted living residence certified under
    50  section forty-six hundred fifty-five of the  public  health  law.    The
    51  program  shall  authorize  up  to  two  hundred  vouchers to individuals
    52  through an application process and pay for up to seventy-five percent of
    53  the average private pay rate in the respective region. The  commissioner

        S. 8307                            17                            A. 8807

     1  of   health  may  propose  rules  and  regulations  to  effectuate  this
     2  provision.
     3    § 2. Subdivisions 7 and 8 of section 4656 of the public health law, as
     4  added  by  chapter  2 of the laws of 2004, are renumbered subdivisions 8
     5  and 9 and a new subdivision 7 is added to read as follows:
     6    7. (a) All assisted living residences, as defined in  subdivision  one
     7  of  section forty-six hundred fifty-one of this article, including those
     8  licensed and certified as an assisted living  residence,  special  needs
     9  assisted living residence, or enhanced assisted living residence, shall:
    10    (i)  report  annually  on  quality  measures  to be established by the
    11  department, in the form and format prescribed by  the  department,  with
    12  the  first  report  due no later than January thirty-first, two thousand
    13  twenty-five; and
    14    (ii) post the monthly  service  rate,  staffing  complement,  approved
    15  admission or residency agreement, and a consumer-friendly summary of all
    16  service  fees  in a conspicuous place on the facility's website and in a
    17  public space within the facility. Such information shall be made  avail-
    18  able  to  the  public on forms developed by the department. Beginning on
    19  January first, two thousand twenty-five, this information shall also  be
    20  reported to the department.
    21    (b)  The  department  shall  score  the results of the assisted living
    22  quality reporting obtained pursuant to paragraph (a)  of  this  subdivi-
    23  sion.    Top  scoring  facilities shall be granted the classification of
    24  advanced standing on their annual surveillance schedules.
    25    (i) Notwithstanding subparagraph one of paragraph (a)  of  subdivision
    26  two  of  section  four  hundred  sixty-one-a of the social services law,
    27  facilities  achieving  an  advanced  standing  classification  shall  be
    28  surveyed  every twelve to eighteen months. All other facilities shall be
    29  surveyed on an unannounced basis no less than annually; provided, howev-
    30  er, that this shall not apply to surveys, inspections or  investigations
    31  based on complaints received by the department under any other provision
    32  of law.
    33    (ii)   Facilities  may  remain  on  advanced  standing  classification
    34  provided they meet the scoring requirements in the assisted living qual-
    35  ity reporting.
    36    (c) Effective January  thirty-first,  two  thousand  twenty-five,  the
    37  department  may  post  on its website the results of the assisted living
    38  quality reporting collected pursuant to subparagraph  (i)  of  paragraph
    39  (a) of this subdivision.
    40    § 3. Subparagraph 1 of paragraph (a) of subdivision 2 of section 461-a
    41  of  the  social  services  law, as amended by chapter 735 of the laws of
    42  1994, is amended and a new subparagraph 1-a is added to read as follows:
    43    (1) Such facilities receiving the department's highest rating shall be
    44  inspected at least once every eighteen months on an  unannounced  basis.
    45  Such  rating  determination  shall  be made pursuant to an evaluation of
    46  quality indicators as developed by the department and published  on  the
    47  department's website.
    48    (1-a)  (i)  Adult  care facilities dually licensed to provide assisted
    49  living pursuant to  the  requirements  specified  in  section  forty-six
    50  hundred  fifty-three  of the public health law may seek accreditation by
    51  one or more nationally recognized accrediting agencies determined by the
    52  commissioner.
    53    (ii) Such accreditation agencies shall report data and information, in
    54  a manner and form as determined by the department, pertaining  to  those
    55  assisted  living  residences accredited by such agencies, those assisted
    56  living residences that seek but do not receive such  accreditation,  and

        S. 8307                            18                            A. 8807

     1  those  assisted  living  residences  which obtain but lose such accredi-
     2  tation.
     3    (iii) Notwithstanding the provisions of subparagraph one of this para-
     4  graph,  or  any other provision of law, assisted living residences which
     5  have obtained accreditation from a nationally  recognized  accreditation
     6  organization  approved  by  the  department  and  which meet eligibility
     7  criteria, as determined by the department, may, at the discretion of the
     8  commissioner, be exempt from the department inspection required in  this
     9  subdivision  for  the duration they maintain their accreditation in good
    10  standing. The operator of an adult care facility that obtains but subse-
    11  quently loses accreditation shall report such  loss  to  the  department
    12  within  ten business days in a manner and form determined by the depart-
    13  ment and will  no  longer  be  exempt  from  the  department  inspection
    14  required in this subdivision. The department shall post on its website a
    15  list of all accredited assisted living residences.
    16    §  4.  This  act  shall take effect immediately and shall be deemed to
    17  have been in full force and effect on and after April 1, 2024; provided,
    18  however, the provisions of sections two and three of this act shall take
    19  effect on the one hundred twentieth day after it  shall  have  become  a
    20  law.

    21                                   PART G

    22    Section  1.  Paragraph  (i)  of subdivision 1 of section 3614-c of the
    23  public health law is REPEALED.
    24    § 2. Paragraph (d) of subdivision 1, and subdivisions 2, 4, 5, 5-a, 6,
    25  6-a, 7, 7-a, 9 and 10 of section 3614-c of the public health law, subdi-
    26  visions 2, 4, 5, 6, 7, 9 and 10 as amended and subdivisions 6-a and  7-a
    27  as  added  by  section  1 and subdivision 5-a as added by section 1-a of
    28  part OO of chapter 56 of the laws  of  2020,  are  amended  to  read  as
    29  follows:
    30    (d)  "Home  care  aide"  means a home health aide, personal care aide,
    31  home  attendant,  [personal  assistant  performing   consumer   directed
    32  personal  assistance  services  pursuant to section three hundred sixty-
    33  five-f of the social services law,]  or  other  licensed  or  unlicensed
    34  person  whose  primary  responsibility includes the provision of in-home
    35  assistance with activities of daily living, instrumental  activities  of
    36  daily  living or health-related tasks; provided, however, that home care
    37  aide does not include any individual (i) working on a casual  basis,  or
    38  (ii) [(except for a person employed under the consumer directed personal
    39  assistance  program  under  section  three  hundred  sixty-five-f of the
    40  social services law)] who is  a  relative  through  blood,  marriage  or
    41  adoption  of: (1) the employer; or (2) the person for whom the worker is
    42  delivering services, under a program funded or administered by  federal,
    43  state or local government.
    44    2.  Notwithstanding  any  inconsistent provision of law, rule or regu-
    45  lation, no payments by government agencies shall be  made  to  certified
    46  home  health agencies, long term home health care programs, managed care
    47  plans, [fiscal intermediaries,] the nursing home transition  and  diver-
    48  sion  waiver program under section three hundred sixty-six of the social
    49  services law, or the traumatic brain injury waiver program under section
    50  twenty-seven hundred forty of this  chapter  for  any  episode  of  care
    51  furnished, in whole or in part, by any home care aide who is compensated
    52  at amounts less than the applicable minimum rate of home care aide total
    53  compensation established pursuant to this section.

        S. 8307                            19                            A. 8807

     1    4.  The terms of this section shall apply equally to services provided
     2  by home care aides who work on episodes of care as direct  employees  of
     3  certified  home health agencies, long term home health care programs, or
     4  managed care plans, or as employees of licensed home care services agen-
     5  cies,  limited licensed home care services agencies, [or fiscal interme-
     6  diaries,] or under any other arrangement.
     7    5. No payments by government agencies shall be made to certified  home
     8  health  agencies,  licensed  home care services agencies, long term home
     9  health care programs, managed care plans[,  fiscal  intermediaries]  for
    10  any  episode  of care without the certified home health agency, licensed
    11  home care services agency,  long  term  home  health  care  program,  or
    12  managed  care  plan [or the fiscal intermediary], having delivered prior
    13  written certification to the commissioner annually, at a time prescribed
    14  by the commissioner, on forms prepared by the department in consultation
    15  with the department of labor, that  all  services  provided  under  each
    16  episode  of  care  during the period covered by the certification are in
    17  full compliance with the terms  of  this  section  and  any  regulations
    18  promulgated  pursuant to this section and that no portion of the dollars
    19  spent or to be spent to satisfy the wage or benefit portion  under  this
    20  section  shall be returned to the certified home health agency, licensed
    21  home care services agency,  long  term  home  health  care  program,  or
    22  managed  care  plan,  [or fiscal intermediary,] related persons or enti-
    23  ties, other than to a home care aide as defined in this section to  whom
    24  the  wage  or benefits are due, as a refund, dividend, profit, or in any
    25  other manner.  Such written certification shall  also  verify  that  the
    26  certified  home  health  agency,  long term home health care program, or
    27  managed care plan has received from  the  licensed  home  care  services
    28  agency,  [fiscal intermediary,] or other third party an annual statement
    29  of wage parity hours and expenses on a form provided by  the  department
    30  of  labor  accompanied  by  an independently-audited financial statement
    31  verifying such expenses.
    32    5-a. No portion of the dollars spent or to be  spent  to  satisfy  the
    33  wage  or  benefit  portion  under  this section shall be returned to the
    34  certified home health agency, licensed home care services  agency,  long
    35  term home health care program, or managed care plan, [or fiscal interme-
    36  diary,]  related  persons or entities, other than to a home care aide as
    37  defined in this section to whom the wage  or  benefits  are  due,  as  a
    38  refund, dividend, profit, or in any other manner.
    39    6.  If  a  certified  home  health  agency, long term home health care
    40  program or managed care plan elects to provide home care  aide  services
    41  through  contracts  with  licensed  home care services agencies, [fiscal
    42  intermediaries,] or through  other  third  parties,  provided  that  the
    43  episode  of  care on which the home care aide works is covered under the
    44  terms of this section, the certified home health agency, long term  home
    45  health  care  program,  or  managed  care  plan  shall  include  in  its
    46  contracts, a requirement that it be  provided  with  a  written  certif-
    47  ication,  verified by oath, from the licensed home care services agency,
    48  [fiscal intermediary,] or other third party, on forms  prepared  by  the
    49  department  in  consultation with the department of labor, which attests
    50  to the licensed home care services agency's, [fiscal intermediary's,] or
    51  other third party's compliance with the  terms  of  this  section.  Such
    52  contracts  shall  also  obligate the licensed home care services agency,
    53  [fiscal intermediary,] or other third party  to  provide  the  certified
    54  home  health agency, long term home health care program, or managed care
    55  plan all information  from  the  licensed  home  care  services  agency,
    56  [fiscal  intermediary]  or other third party necessary to verify compli-

        S. 8307                            20                            A. 8807

     1  ance with the terms of this  section,  which  shall  include  an  annual
     2  compliance  statement  of  wage  parity  hours  and  expenses  on a form
     3  provided by the department of labor accompanied by an  independently-au-
     4  dited  financial  statement  verifying such expenses. Such annual state-
     5  ments shall be available no less than annually for the previous calendar
     6  year, at a time as prescribed by the commissioner.  Such certifications,
     7  the information necessary to verify compliance, and the  annual  compli-
     8  ance  statement and financial statements shall be retained by all certi-
     9  fied home health agencies, long  term  home  health  care  programs,  or
    10  managed  care  plans,  and  all  licensed  home  care services agencies,
    11  [fiscal intermediaries,] or other third parties for a period of no  less
    12  than  ten  years, and made available to the department upon request. Any
    13  licensed home care services  agency,  [fiscal  intermediary,]  or  other
    14  third  party  who  shall  upon  oath verify any statement required to be
    15  transmitted under this section and any regulations promulgated  pursuant
    16  to this section which is known by such party to be false shall be guilty
    17  of perjury and punishable as provided by the penal law.
    18    6-a.  The  certified  home  health  agency, long term home health care
    19  program, or managed care plan shall review and assess the annual compli-
    20  ance statement of wage parity hours and  expenses  and  make  a  written
    21  referral  to  the department of labor for any reasonably suspected fail-
    22  ures of licensed home care services agencies,  [fiscal  intermediaries,]
    23  or  third  parties  to  conform  to the wage parity requirements of this
    24  section.
    25    7. The commissioner shall distribute  to  all  certified  home  health
    26  agencies,  long  term home health care programs, managed care plans, and
    27  licensed home care services agencies[, and fiscal intermediaries]  offi-
    28  cial notice of the minimum rates of home care aide compensation at least
    29  one hundred twenty days prior to the effective date of each minimum rate
    30  for each social services district covered by the terms of this section.
    31    7-a.  Any  certified  home  health agency, licensed home care services
    32  agency, long term home health  care  program,  managed  care  plan,  [or
    33  fiscal intermediary,] or other third party that willfully pays less than
    34  such stipulated minimums regarding wages and supplements, as established
    35  in  this  section,  shall be guilty of a misdemeanor and upon conviction
    36  shall be punished, for a first offense by a fine of five hundred dollars
    37  or by imprisonment for not more than thirty days, or by  both  fine  and
    38  imprisonment;  for  a  second offense by a fine of one thousand dollars,
    39  and in addition thereto the contract on which the violation has occurred
    40  shall be forfeited; and no such person or corporation shall be  entitled
    41  to receive any sum nor shall any officer, agent or employee of the state
    42  pay  the  same  or authorize its payment from the funds under his or her
    43  charge or control to any person or corporation for work  done  upon  any
    44  contract,  on which the certified home health agency, licensed home care
    45  services agency, long term home health care program, managed care  plan,
    46  [or  fiscal  intermediary,] or other third party has been convicted of a
    47  second offense in violation of the provisions of this section.
    48    9. Nothing in this section should be construed as  applicable  to  any
    49  service  provided  by certified home health agencies, licensed home care
    50  services agencies, long term home health  care  programs[,]  or  managed
    51  care  plans[,  or fiscal intermediaries] except for all episodes of care
    52  reimbursed in whole or in part by the New York Medicaid program.
    53    10. No certified home health agency, managed care plan, or  long  term
    54  home  health  care program shall be liable for recoupment of payments or
    55  any other penalty under this section for  services  provided  through  a
    56  licensed  home  care  services  agency,  [fiscal intermediary,] or other

        S. 8307                            21                            A. 8807

     1  third party with which the certified home health agency, long term  home
     2  health  care  program,  or  managed care plan has a contract because the
     3  licensed agency, [fiscal intermediary,] or other third party  failed  to
     4  comply  with the provisions of this section if the certified home health
     5  agency, long term home health care program, or  managed  care  plan  has
     6  reasonably  and  in good faith collected certifications and all informa-
     7  tion required pursuant to this section and conducts the  monitoring  and
     8  reporting required by this section.
     9    § 3. This act shall take effect October 1, 2024.

    10                                   PART H

    11    Section  1.  Section  602  of  the financial services law, as added by
    12  section 26 of part H of chapter 60 of the laws of 2014,  is  amended  to
    13  read as follows:
    14    §  602.  Applicability.  [(a)]  This article shall not apply to health
    15  care services, including emergency services, where  physician  fees  are
    16  subject  to schedules or other monetary limitations under any other law,
    17  including the workers' compensation law and  article  fifty-one  of  the
    18  insurance  law,  and  shall  not preempt any such law. This article also
    19  shall not apply to health care services, including  emergency  services,
    20  subject  to  medical  assistance  program  coverage provided pursuant to
    21  section three hundred sixty-four-j of the social services law.
    22    § 2. Subdivision 2 of section 364-j of  the  social  services  law  is
    23  amended by adding a new paragraph (e) to read as follows:
    24    (e)  Effective  April  first, two thousand twenty-four and expiring on
    25  the date the  commissioner  publishes  on  the  department's  website  a
    26  request  for  proposals  in accordance with paragraph (a) of subdivision
    27  five of this section, the commissioner shall place a moratorium  on  the
    28  processing and approval of applications seeking authority to establish a
    29  managed  care  provider, including applications seeking authorization to
    30  expand the scope of eligible enrollee populations. Such moratorium shall
    31  not apply to:
    32    (i) applications submitted to the department prior to  January  first,
    33  two thousand twenty-four;
    34    (ii) applications seeking approval to transfer ownership or control of
    35  an existing managed care provider;
    36    (iii) applications seeking authorization to expand an existing managed
    37  care provider's approved service area;
    38    (iv)  applications  seeking authorization to form or operate a managed
    39  care provider through  an  entity  certified  under  section  forty-four
    40  hundred three-c or forty-four hundred three-g of the public health law;
    41    (v) applications demonstrating to the commissioner's satisfaction that
    42  submission  of the application for consideration would be appropriate to
    43  address a serious concern with care delivery, such as a lack of adequate
    44  access to managed care providers in a  geographic  area  or  a  lack  of
    45  adequate  and  appropriate  care,  language  and cultural competence, or
    46  special needs services.
    47    § 3. Subdivision 5 of section 364-j of the  social  services  law,  as
    48  amended by section 15 of part C of chapter 58 of the laws of 2004, para-
    49  graph  (a)  as amended by section 40 of part A of chapter 56 of the laws
    50  of 2013, and paragraphs (d), (e) and (f) as amended  by  section  80  of
    51  part H of chapter 59 of the laws of 2011, is amended to read as follows:
    52    5.  Managed  care  programs  shall be conducted in accordance with the
    53  requirements of this section and, to the extent  practicable,  encourage

        S. 8307                            22                            A. 8807

     1  the  provision of comprehensive medical services, pursuant to this arti-
     2  cle.
     3    (a) The [managed care program] commissioner of health shall, through a
     4  competitive  bid process based on proposals submitted to the department,
     5  provide for the selection of qualified managed care  providers  [by  the
     6  commissioner  of  health]  to  participate  in  the managed care program
     7  pursuant to a contract with the department, including [comprehensive HIV
     8  special needs plans and] special needs managed care plans in  accordance
     9  with the provisions of section three hundred sixty-five-m of this title;
    10  provided, however, that the commissioner of health may contract directly
    11  with  comprehensive  HIV  special needs plans [consistent with standards
    12  set forth in this section] without a competitive bid process, and assure
    13  that such providers are accessible taking  into  account  the  needs  of
    14  persons  with  disabilities and the differences between rural, suburban,
    15  and urban settings, and in sufficient numbers to meet  the  health  care
    16  needs  of  participants,  and  shall  consider the extent to which major
    17  public hospitals are included within such  providers'  networks[.];  and
    18  provided further that:
    19    [(b) A proposal] (i) Proposals submitted by a managed care provider to
    20  participate in the managed care program shall:
    21    [(i)]  (A)  designate  the  geographic [area] areas, as defined by the
    22  commissioner in the request for proposals, to be served [by the  provid-
    23  er], and estimate the number of eligible participants and actual partic-
    24  ipants in such designated area;
    25    [(ii)]  (B)  include  a network of health care providers in sufficient
    26  numbers and geographically accessible to service program participants;
    27    [(iii)] (C) describe the  procedures  for  marketing  in  the  program
    28  location,  including the designation of other entities which may perform
    29  such functions under contract with the organization;
    30    [(iv)] (D) describe the quality assurance, utilization review and case
    31  management mechanisms to be implemented;
    32    [(v)] (E) demonstrate the applicant's ability to meet the data  analy-
    33  sis and reporting requirements of the program;
    34    [(vi)] (F) demonstrate financial feasibility of the program; and
    35    [(vii)]  (G)  include  such  other  information as the commissioner of
    36  health may deem appropriate.
    37    [(c) The commissioner of health shall make a determination whether  to
    38  approve, disapprove or recommend modification of the proposal.
    39    (d)  Notwithstanding  any  inconsistent  provision  of  this title and
    40  section one hundred sixty-three of the state finance  law,  the  commis-
    41  sioner of health may contract with managed care providers approved under
    42  paragraph  (b) of this subdivision, without a competitive bid or request
    43  for proposal process, to provide coverage for participants  pursuant  to
    44  this title.
    45    (e)  Notwithstanding  any  inconsistent  provision  of  this title and
    46  section one hundred forty-three of  the  economic  development  law,  no
    47  notice in the procurement opportunities newsletter shall be required for
    48  contracts  awarded  by  the commissioner of health, to qualified managed
    49  care providers pursuant to this section.
    50    (f)] (ii) In addition to the criteria described in subparagraph (i) of
    51  this paragraph, the commissioner shall also consider:
    52    (A) accessibility and geographic distribution  of  network  providers,
    53  taking  into  account  the  needs  of  persons with disabilities and the
    54  differences between rural, suburban, and urban settings;
    55    (B) the extent to which major public hospitals  are  included  in  the
    56  submitted provider network;

        S. 8307                            23                            A. 8807

     1    (C)  demonstrated  cultural  and language competencies specific to the
     2  population of participants;
     3    (D)  the corporate organization and status of the bidder as a charita-
     4  ble corporation under the not-for-profit corporation law;
     5    (E) the ability of a bidder to offer plans in multiple regions;
     6    (F) the type and number of products the bidder  proposes  to  operate,
     7  including products bid for in accordance with the provisions of subdivi-
     8  sion six of section forty-four hundred three-f of the public health law,
     9  and  other  products  determined  by the commissioner, including but not
    10  necessarily limited to those operated under title one-A of article twen-
    11  ty-five of the public health law and section three hundred sixty-nine-gg
    12  of this article;
    13    (G) whether the bidder participates in products  for  integrated  care
    14  for participants who are dually eligible for Medicaid and medicare;
    15    (H)  whether  the  bidder participates in value based payment arrange-
    16  ments as defined by the department, including the delegation of  signif-
    17  icant financial risk to clinically integrated provider networks;
    18    (I)  the  bidder's  commitment to participation in managed care in the
    19  state;
    20    (J) the bidder's commitment to quality improvement;
    21    (K) the bidder's commitment to  community  reinvestment  spending,  as
    22  shall be defined in the procurement;
    23    (L)  for current or previously authorized managed care providers, past
    24  performance in  meeting  managed  care  contract  or  federal  or  state
    25  requirements, and if the commissioner issued any statements of findings,
    26  statements  of deficiency, intermediate sanctions or enforcement actions
    27  to a bidder for  non-compliance  with  such  requirements,  whether  the
    28  bidder addressed such issues in a timely manner; and
    29    (M) any other criteria deemed appropriate by the commissioner.
    30    (iii) Subparagraphs (i) and (ii) of this paragraph describing proposal
    31  content  and  selection  criteria requirements shall not be construed as
    32  limiting or requiring the  commissioner  to  evaluate  such  content  or
    33  criteria  on  a pass/fail scale, or other methodological basis; provided
    34  however, that the commissioner must consider all such content and crite-
    35  ria using methods determined by the  commissioner  in  their  discretion
    36  and, as applicable, in consultation with the commissioners of the office
    37  of mental health, the office for people with developmental disabilities,
    38  the  office  of addiction services and supports, and the office of chil-
    39  dren and family services.
    40    (iv) The department shall post on its website:
    41    (A) The request for  proposals  and  a  description  of  the  proposed
    42  services  to  be  provided pursuant to contracts in accordance with this
    43  subdivision;
    44    (B) The criteria on which the  department  shall  determine  qualified
    45  bidders  and evaluate their proposals, including all criteria identified
    46  in this subdivision;
    47    (C) The manner by which a proposal may be submitted, which may include
    48  submission by electronic means;
    49    (D) The manner by which  a  managed  care  provider  may  continue  to
    50  participate  in  the  managed care program pending award of managed care
    51  providers through a competitive bid process pursuant  to  this  subdivi-
    52  sion; and
    53    (E)  Upon  award,  the  managed  care  providers that the commissioner
    54  intends to contract with pursuant to this subdivision, provided that the
    55  commissioner shall update such list  to  indicate  the  final  slate  of
    56  contracted managed care providers.

        S. 8307                            24                            A. 8807

     1    (v)  (A)  All responsible and responsive submissions that are received
     2  from bidders in a timely fashion shall be reviewed by  the  commissioner
     3  of health in consultation with the commissioners of the office of mental
     4  health,  the  office  for  people  with  developmental disabilities, the
     5  office  of  addiction  services and supports, and the office of children
     6  and family services, as  applicable.  The  commissioner  shall  consider
     7  comments  resulting  from  the  review  of  proposals and make awards in
     8  consultation with such agencies.
     9    (B) The commissioner may make awards under this subdivision  for  each
    10  product, for which proposals were requested, to two or more managed care
    11  providers  in  each geographic region defined by the commissioner in the
    12  request for proposals for which at least two managed care providers have
    13  submitted a proposal, and shall have discretion to offer more  contracts
    14  based on need for access.
    15    (C)  Managed  care  providers  awarded under this subdivision shall be
    16  entitled to enter into a contract with the department for the purpose of
    17  participating in the managed care program. Such contracts shall run  for
    18  a  term  to  be  determined by the commissioner, which may be renewed or
    19  modified from time to time without  a  new  request  for  proposals,  to
    20  ensure  consistency  with changes in federal and state laws, regulations
    21  and policies, including but not limited to the expansion or reduction of
    22  medical assistance services available  to  the  participants  through  a
    23  managed care provider.
    24    (D) Nothing in this paragraph or other provision of this section shall
    25  be construed to limit in any way the ability of the department to termi-
    26  nate awarded contracts for cause, which shall include but not be limited
    27  to  any  violation of the terms of such contracts or violations of state
    28  or federal laws and regulations and  any  loss  of  necessary  state  or
    29  federal funding.
    30    (E) Nothing in this paragraph or other provision of this section shall
    31  be  construed to limit in any way the ability of the department to issue
    32  a new request for proposals for a term following an existing term of  an
    33  award.
    34    (b)  If  necessary  to ensure access to a sufficient number of managed
    35  care providers on a geographic or  other  basis,  including  a  lack  of
    36  adequate  and  appropriate  care,  language  and cultural competence, or
    37  special needs services, the  commissioner  may  reissue  a  request  for
    38  proposals  as  provided  for  under  paragraph  (a) of this subdivision,
    39  provided however that such request may be limited to the  geographic  or
    40  other  basis  of  need  that  the  request  for  proposals is seeking to
    41  address. Any awards made shall be subject to the  requirements  of  this
    42  section,  including but not limited to the minimum and maximum number of
    43  awards in a region.
    44    (c) The care and  services  described  in  subdivision  four  of  this
    45  section  will  be  furnished  by a managed care provider pursuant to the
    46  provisions of this section when such services are furnished  in  accord-
    47  ance  with an agreement with the department of health, and meet applica-
    48  ble federal law and regulations.
    49    [(g)] (d) The commissioner of health may delegate some or all  of  the
    50  tasks identified in this section to the local districts.
    51    [(h)]  (e)  Any  delegation  pursuant  to  paragraph [(g)] (d) of this
    52  subdivision shall be reflected in the contract between  a  managed  care
    53  provider and the commissioner of health.
    54    §  4.  Subdivision  4  of  section 365-m of the social services law is
    55  REPEALED and a new subdivision 4 is added to read as follows:

        S. 8307                            25                            A. 8807

     1    4. The commissioner of health, jointly with the commissioners  of  the
     2  office  of  mental  health  and  the  office  of  addiction services and
     3  supports, shall select a limited number of special  needs  managed  care
     4  plans under section three hundred sixty-four-j of this title, in accord-
     5  ance  with  subdivision  five  of  such section, capable of managing the
     6  behavioral and physical health needs  of  medical  assistance  enrollees
     7  with significant behavioral health needs.
     8    §  5.  The opening paragraph of subdivision 2 of section 4403-f of the
     9  public health law, as amended by section 8 of part C of  chapter  58  of
    10  the laws of 2007, is amended to read as follows:
    11    An eligible applicant shall submit an application for a certificate of
    12  authority to operate a managed long term care plan upon forms prescribed
    13  by  the  commissioner,  including  any such forms or processes as may be
    14  required or prescribed  by  the  commissioner  in  accordance  with  the
    15  competitive  bid  process  under  subdivision  six of this section. Such
    16  eligible applicant shall submit information  and  documentation  to  the
    17  commissioner which shall include, but not be limited to:
    18    §  6.  Subdivision  3  of  section 4403-f of the public health law, as
    19  amended by section 41-a of part H of chapter 59 of the laws of 2011,  is
    20  amended to read as follows:
    21    3.  Certificate of authority; approval. (a) The commissioner shall not
    22  approve an application for a certificate of authority unless the  appli-
    23  cant demonstrates to the commissioner's satisfaction:
    24    [(a)]  (i)  that  it  will  have in place acceptable quality-assurance
    25  mechanisms, grievance procedures, mechanisms to protect  the  rights  of
    26  enrollees  and  case  management services to ensure continuity, quality,
    27  appropriateness and coordination of care;
    28    [(b)] (ii) that it will include  an  enrollment  process  which  shall
    29  ensure  that  enrollment  in the plan is informed. The application shall
    30  describe the disenrollment process, which shall provide that  an  other-
    31  wise  eligible  enrollee  shall  not be involuntarily disenrolled on the
    32  basis of health status;
    33    [(c)] (iii) satisfactory evidence of the character and  competence  of
    34  the  proposed operators and reasonable assurance that the applicant will
    35  provide high quality services to an enrolled population;
    36    [(d)] (iv) sufficient management systems capacity to meet the require-
    37  ments of this section and the ability to efficiently process payment for
    38  covered services;
    39    [(e)] (v) readiness and capability to maximize  reimbursement  of  and
    40  coordinate  services  reimbursed  pursuant to title XVIII of the federal
    41  social security act and all other applicable benefits, with such benefit
    42  coordination including, but not limited to, measures  to  support  sound
    43  clinical  decisions, reduce administrative complexity, coordinate access
    44  to services, maximize benefits available  pursuant  to  such  title  and
    45  ensure that necessary care is provided;
    46    [(f)]  (vi)  readiness  and  capability  to arrange and manage covered
    47  services and coordinate non-covered services which could include  prima-
    48  ry,  specialty, and acute care services reimbursed pursuant to title XIX
    49  of the federal social security act;
    50    [(g)] (vii) willingness and capability of taking, or  cooperating  in,
    51  all  steps  necessary  to  secure and integrate any potential sources of
    52  funding for services provided  by  the  managed  long  term  care  plan,
    53  including,  but  not  limited  to,  funding  available under titles XVI,
    54  XVIII, XIX and XX of the federal social security act, the federal  older
    55  Americans act of nineteen hundred sixty-five, as amended, or any succes-
    56  sor  provisions  subject to approval of the director of the state office

        S. 8307                            26                            A. 8807

     1  for aging, and through financing options such as those authorized pursu-
     2  ant to section three hundred sixty-seven-f of the social services law;
     3    [(h)] (viii) that the contractual arrangements for providers of health
     4  and  long  term  care  services in the benefit package are sufficient to
     5  ensure the availability  and  accessibility  of  such  services  to  the
     6  proposed  enrolled  population consistent with guidelines established by
     7  the commissioner;  with  respect  to  individuals  in  receipt  of  such
     8  services  prior to enrollment, such guidelines shall require the managed
     9  long term care plan to contract with agencies currently  providing  such
    10  services,  in  order  to  promote  continuity of care. In addition, such
    11  guidelines shall require managed long term care plans to offer and cover
    12  consumer directed personal assistance services for eligible  individuals
    13  who  elect  such services pursuant to section three hundred sixty-five-f
    14  of the social services law; and
    15    [(i)] (ix) that the applicant is financially responsible  and  may  be
    16  expected to meet its obligations to its enrolled members.
    17    (b) Notwithstanding paragraph (a) of this subdivision, the approval of
    18  any application for certification as a managed long term care plan under
    19  this  section  for  a plan that seeks to cover a population of enrollees
    20  eligible for services under title XIX of  the  federal  social  security
    21  act,  shall  be  subject  to  and  conditioned  on selection through the
    22  competitive bid process provided under subdivision six of this section.
    23    § 7. Subdivision 6 of section 4403-f of  the  public  health  law,  as
    24  amended  by  section  41-b  of part H of chapter 59 of the laws of 2011,
    25  paragraph (a) as amended by section 2 of part I of  chapter  57  of  the
    26  laws of 2023, paragraphs (d), (e), and (f) as added by section 5 of part
    27  MM  of  chapter  56  of  the  laws of 2020, and the opening paragraph of
    28  subparagraph (i) of paragraph (d) as amended by section 3 of part  I  of
    29  chapter 57 of the laws of 2023, is amended to read as follows:
    30    6.  Approval authority.   [(a)] An applicant shall be issued a certif-
    31  icate of authority as a managed long term care plan upon a determination
    32  by the commissioner that  the  applicant  complies  with  the  operating
    33  requirements  for  a  managed  long  term  care plan under this section;
    34  provided, however, that any managed  long  term  care  plan  seeking  to
    35  provide  health and long term care services to a population of enrollees
    36  that are eligible under title XIX of the  federal  social  security  act
    37  shall  not  receive  a  certificate  of authority, nor be eligible for a
    38  contract to provide such services with the department,  unless  selected
    39  through  the competitive bid process described in this subdivision. [The
    40  commissioner shall issue  no  more  than  seventy-five  certificates  of
    41  authority to managed long term care plans pursuant to this section.
    42    (a-1)  Nothing  in  this  section  shall be construed as requiring the
    43  department to contract with or to contract  for  a  particular  line  of
    44  business  with  an entity certified under this section for the provision
    45  of services available under title eleven of article five of  the  social
    46  services  law.  A  managed  long  term  care plan that has been issued a
    47  certificate of authority, or an applicant for a certificate of authority
    48  as a managed long term care plan that has in any of the  three  calendar
    49  years  immediately  preceding  the application, met any of the following
    50  criteria shall not be eligible for  a  contract  for  the  provision  of
    51  services  available  under  title  eleven  of article five of the social
    52  services law: (i) classified as a poor performer, or substantially simi-
    53  lar terminology, by the centers for medicare and medicaid  services;  or
    54  (ii)  an  excessive  volume of penalties, statements of findings, state-
    55  ments of deficiency,  intermediate  sanctions  or  enforcement  actions,

        S. 8307                            27                            A. 8807

     1  regardless of whether the applicant has addressed such issues in a time-
     2  ly manner.
     3    (b)  An  operating  demonstration  shall  be  issued  a certificate of
     4  authority as a managed long term care plan upon a determination  by  the
     5  commissioner   that  such  demonstration  complies  with  the  operating
     6  requirements for a managed long  term  care  plan  under  this  section.
     7  Nothing in this section shall be construed to affect the continued legal
     8  authority  of  an  operating  demonstration  to  operate  its previously
     9  approved program.
    10    (c) For the period beginning April  first,  two  thousand  twelve  and
    11  ending  March thirty-first, two thousand fifteen, the majority leader of
    12  the senate and the speaker of the assembly may  each  recommend  to  the
    13  commissioner,  in  writing, up to four eligible applicants to convert to
    14  be approved managed long term care plans. An  applicant  shall  only  be
    15  approved  and  issued  a  certificate  of  authority if the commissioner
    16  determines that the applicant  meets  the  requirements  of  subdivision
    17  three  of this section. The majority leader of the senate or the speaker
    18  of the assembly may assign their authority  to  recommend  one  or  more
    19  applicants under this section to the commissioner]
    20    (a)  Notwithstanding  sections  one  hundred  twelve  and  one hundred
    21  sixty-three of the state finance law, sections one hundred forty-two and
    22  one hundred forty-three of the economic development law, and  any  other
    23  inconsistent provision of law, the commissioner shall, through a compet-
    24  itive  bid  process  based  on  proposals  submitted  to the department,
    25  provide for the selection of qualified managed long term care  plans  to
    26  provide health and long term care services to enrollees who are eligible
    27  under  title  XIX  of  the  federal  social  security  act pursuant to a
    28  contract with the department; provided, however, that:
    29    (i) A proposal submitted by  a  managed  long  term  care  plan  shall
    30  include information sufficient to allow the commissioner to evaluate the
    31  bidder  in  accordance  with the requirements identified in subdivisions
    32  two, three and four of this section.
    33    (ii) In addition to the criteria described in subparagraph (i) of this
    34  paragraph, the commissioner shall also consider:
    35    (A) accessibility and geographic distribution  of  network  providers,
    36  taking  into  account  the  needs  of  persons with disabilities and the
    37  differences between rural, suburban, and urban settings;
    38    (B) the extent to which major public hospitals  are  included  in  the
    39  submitted provider network;
    40    (C)  demonstrated  cultural  and language competencies specific to the
    41  population of participants;
    42    (D) the corporate organization and status of the bidder as a  charita-
    43  ble corporation under the not-for-profit corporation law;
    44    (E) the ability of a bidder to offer plans in multiple regions;
    45    (F)  the  type  and number of products the bidder proposes to operate,
    46  including products applied for in  accordance  with  the  provisions  of
    47  subdivision  five  of  section  three hundred sixty-four-j of the social
    48  services law, and other products determined by the commissioner, includ-
    49  ing but not necessarily limited to those operated under title  one-A  of
    50  article  twenty-five  of  this  chapter and section three hundred sixty-
    51  nine-gg of the social services law;
    52    (G) whether the bidder participates in products  for  integrated  care
    53  for participants who are dually eligible for Medicaid and medicare;
    54    (H)  whether  the  bidder participates in value based payment arrange-
    55  ments as defined by the department, including the delegation of  signif-
    56  icant financial risk to clinically integrated provider networks;

        S. 8307                            28                            A. 8807

     1    (I)  the  bidder's  commitment to participation in managed care in the
     2  state;
     3    (J) the bidder's commitment to quality improvement;
     4    (K)  the  bidder's  commitment  to community reinvestment spending, as
     5  shall be defined in the procurement;
     6    (L) for current or previously authorized managed care providers,  past
     7  performance  in  meeting  managed  care  contract  or  federal  or state
     8  requirements, and if the commissioner issued any statements of findings,
     9  statements of deficiency, intermediate sanctions or enforcement  actions
    10  to  a  bidder  for  non-compliance  with  such requirements, whether the
    11  bidder addressed such issues in a timely manner; and
    12    (M) any other criteria deemed appropriate by the commissioner.
    13    (iii) Subparagraphs (i) and (ii) of this paragraph describing proposal
    14  content and selection criteria requirements shall not  be  construed  as
    15  limiting  or  requiring  the  commissioner  to  evaluate such content or
    16  criteria on a pass/fail scale, or other particular methodological basis;
    17  provided however, that the commissioner must consider all  such  content
    18  and  criteria  using  methods  determined  by  the commissioner in their
    19  discretion and, as applicable, in consultation with the commissioners of
    20  the office of mental health, the office for  people  with  developmental
    21  disabilities,  the  office  of  addiction services and supports, and the
    22  office of children and family services.
    23    (iv) The department shall post on its website:
    24    (A) The request for  proposals  and  a  description  of  the  proposed
    25  services  to  be  provided pursuant to contracts in accordance with this
    26  subdivision;
    27    (B) The criteria on which the  department  shall  determine  qualified
    28  bidders  and evaluate their applications, including all criteria identi-
    29  fied in this subdivision;
    30    (C) The manner by which a proposal may be submitted, which may include
    31  submission by electronic means;
    32    (D) The manner by which a managed long term care plan may continue  to
    33  provide health and long term care services to enrollees who are eligible
    34  under  title  XIX  of  the federal social security act pending awards to
    35  managed long term care plans through a competitive bid process  pursuant
    36  to this subdivision; and
    37    (E) Upon award, the managed long term care plans that the commissioner
    38  intends to contract with pursuant to this subdivision, provided that the
    39  commissioner  shall  update  such  list  to  indicate the final slate of
    40  contracted managed long term care plans.
    41    (v) (A) All responsible and responsive submissions that  are  received
    42  from  bidders  in a timely fashion shall be reviewed by the commissioner
    43  in consultation with the commissioners of the office of  mental  health,
    44  the  office  for  people  with developmental disabilities, the office of
    45  addiction services and supports, and the office of children  and  family
    46  services,  as  applicable.  The  commissioner  shall  consider  comments
    47  resulting from the review of proposals and make awards  in  consultation
    48  with such agencies.
    49    (B)  The commissioner may make awards under this subdivision, for each
    50  product for which proposals were requested, to two or more managed  long
    51  term care plans in each geographic region defined by the commissioner in
    52  the  request for proposals for which at least two managed long term care
    53  plans have submitted a proposal, and shall have discretion to offer more
    54  contracts based on need for access.
    55    (C) Managed long term care plans awarded under this subdivision  shall
    56  be entitled to enter into a contract with the department for the purpose

        S. 8307                            29                            A. 8807

     1  of  providing  health  and  long term care services to enrollees who are
     2  eligible under title XIX  of  the  federal  social  security  act.  Such
     3  contracts  shall  run  for  a term to be determined by the commissioner,
     4  which may be renewed or modified from time to time without a new request
     5  for  proposals,  to ensure consistency with changes in federal and state
     6  laws, regulations and policies, including but not limited to the  expan-
     7  sion  or  reduction  of  medical  assistance  services  available to the
     8  participants through a managed long term care plan.
     9    (D) Nothing in this paragraph or other provision of this section shall
    10  be construed to limit in any way the ability of the department to termi-
    11  nate awarded contracts for cause, which shall include but not be limited
    12  to any violation of the terms of such contracts or violations  of  state
    13  or  federal  laws  and  regulations  and  any loss of necessary state or
    14  federal funding.
    15    (E) Nothing in this paragraph or other provision of this section shall
    16  be construed to limit in any way the ability of the department to  issue
    17  a  new request for proposals for a term following an existing term of an
    18  award.
    19    (b) Addressing needs for additional managed long term  care  plans  to
    20  ensure  access  and choice for enrollees eligible under title XIX of the
    21  federal social security act. If necessary to ensure access to  a  suffi-
    22  cient  number  of  managed long term care plans on a geographic or other
    23  basis, including a lack of adequate and appropriate care,  language  and
    24  cultural  competence,  or  special  needs services, the commissioner may
    25  reissue a request for proposals as provided for under paragraph  (a)  of
    26  this  subdivision,  provided however that such request may be limited to
    27  the geographic or other basis of need that  the  request  for  proposals
    28  seeks  to  address. Any awards made shall be subject to the requirements
    29  of this section, including but not limited to the  minimum  and  maximum
    30  number of awards in a region.
    31    [(d)] (c) (i) Effective April first, two thousand twenty, and expiring
    32  [March  thirty-first, two thousand twenty-seven] on the date the commis-
    33  sioner publishes on the department's website a request for proposals  in
    34  accordance  with subparagraph (iv) of paragraph (a) of this subdivision,
    35  the commissioner shall place a moratorium on the processing and approval
    36  of applications seeking a certificate of authority  as  a  managed  long
    37  term  care plan pursuant to this section, including applications seeking
    38  authorization to expand  an  existing  managed  long  term  care  plan's
    39  approved  service  area  or scope of eligible enrollee populations. Such
    40  moratorium shall not apply to:
    41    (A) applications submitted to the department prior to  January  first,
    42  two thousand twenty;
    43    (B)  applications seeking approval to transfer ownership or control of
    44  an existing managed long term care plan;
    45    (C) applications demonstrating to the commissioner's satisfaction that
    46  submission of the application for consideration would be appropriate  to
    47  address a serious concern with care delivery, such as a lack of adequate
    48  access to managed long term care plans in a geographic area or a lack of
    49  adequate  and  appropriate  care,  language  and cultural competence, or
    50  special needs services; and
    51    (D) applications seeking to operate under the PACE (Program of All-In-
    52  clusive Care for the Elderly) model as authorized by federal public  law
    53  105-33, subtitle I of title IV of the Balanced Budget Act of 1997, or to
    54  serve individuals dually eligible for services and benefits under titles
    55  XVIII  and XIX of the federal social security act in conjunction with an
    56  affiliated Medicare Dual Eligible Special Needs Plan, based on the  need

        S. 8307                            30                            A. 8807

     1  for such plans and the experience of applicants in serving dually eligi-
     2  ble individuals as determined by the commissioner in their discretion.
     3    (ii) For the duration of the moratorium, the commissioner shall assess
     4  the public need for managed long term care plans that are not integrated
     5  with  an  affiliated Medicare plan, the ability of such plans to provide
     6  high quality and cost effective care for their membership, and based  on
     7  such  assessment  develop a process and conduct an orderly wind-down and
     8  elimination of such plans, which shall coincide with the  expiration  of
     9  the  moratorium  unless  the commissioner determines that a longer wind-
    10  down period is needed.
    11    [(e) For the duration of the moratorium under paragraph  (d)  of  this
    12  subdivision]  (d)  From  April  first,  two thousand twenty, until March
    13  thirty-first, two thousand twenty-four, the  commissioner  shall  estab-
    14  lish,  and  enforce  by  means  of  a premium withholding equal to three
    15  percent of the base rate, an annual cap on total enrollment  (enrollment
    16  cap) for each managed long term care plan, subject to subparagraphs (ii)
    17  and  (iii)  of  this  paragraph,  based  on  a percentage of each plan's
    18  reported enrollment as of October first, two thousand twenty.
    19    (i) The specific percentage of each plan's  enrollment  cap  shall  be
    20  established by the commissioner based on: (A) the ability of individuals
    21  eligible  for  such  plans to access health and long term care services,
    22  (B) plan quality of care scores, (C) historical plan disenrollment,  (D)
    23  the projected growth of individuals eligible for such plans in different
    24  regions  of  the  state, (E) historical plan enrollment of patients with
    25  varying levels of need and acuity, and (F) other factors in the  commis-
    26  sioner's  discretion  to  ensure  compliance  with federal requirements,
    27  appropriate access to plan services, and choice by eligible individuals.
    28    (ii) In the event that a plan exceeds its annual enrollment  cap,  the
    29  commissioner  is  authorized  under  this  paragraph  to retain all or a
    30  portion of the premium withheld based on the amount over  which  a  plan
    31  exceeds its enrollment cap. Penalties assessed pursuant to this subdivi-
    32  sion shall be determined by regulation.
    33    (iii)  The  commissioner  may  not  establish  an  annual cap on total
    34  enrollment under this paragraph for plans' lines of  business  operating
    35  under  the PACE (Program of All-Inclusive Care for the Elderly) model as
    36  authorized by federal public law 105-33, subtitle I of title IV  of  the
    37  Balanced  Budget  Act of 1997, or that serve individuals dually eligible
    38  for services and benefits under titles XVIII  and  XIX  of  the  federal
    39  social  security  act  in  conjunction  with an affiliated Medicare Dual
    40  Eligible Special Needs Plan.
    41    [(f) In implementing the provisions of paragraphs (d) and (e) of  this
    42  subdivision, the commissioner shall, to the extent practicable, consider
    43  and  select  methodologies  that seek to maximize continuity of care and
    44  minimize disruption to the provider labor workforce, and shall,  to  the
    45  extent  practicable  and  consistent  with  the ratios set forth herein,
    46  continue to support contracts between managed long term care  plans  and
    47  licensed  home  care services agencies that are based on a commitment to
    48  quality and value.]
    49    § 8. Section 1 of part I of chapter 57 of the laws of 2022,  providing
    50  a  one  percent across the board payment increase to all qualifying fee-
    51  for-service Medicaid rates, is amended by adding two new subdivisions  3
    52  and 4 to read as follows:
    53    3. For the state fiscal years beginning April 1, 2024, and thereafter,
    54  all department of health Medicaid payments made to Medicaid managed care
    55  organizations  will no longer be subject to the uniform rate increase in
    56  subdivision one of this section.

        S. 8307                            31                            A. 8807

     1    4. Rate adjustments made pursuant to subdivisions one through three of
     2  this section shall not be subject to the notification  requirements  set
     3  forth in subdivision 7 of section 2807 of the public health law.
     4    §  9.  Section 364-j of the social services law is amended by adding a
     5  new subdivision 40 to read as follows:
     6    40. (a) The commissioner  shall  be  entitled  to  recover  liquidated
     7  damages from managed care organizations for failure to meet the contrac-
     8  tual obligations and performance standards of their contract.
     9    (b) The commissioner shall have sole discretion in determining whether
    10  to impose a recovery of the financial loss and damages for noncompliance
    11  with any provision of the contract.
    12    (c)  (i)  Liquidated  damages  imposed  by  this subdivision against a
    13  managed care organization shall be from two hundred fifty dollars up  to
    14  twenty-five  thousand dollars per violation depending on the severity of
    15  the noncompliance determined by the commissioner.
    16    (ii) Any liquidated  damages  findings  as  a  result  of  the  review
    17  required  by  this  subdivision  shall be due and payable sixty calendar
    18  days from the issuance of a  statement  of  damages  regardless  of  any
    19  dispute  in  the amount or interpretation of the amount due contained in
    20  the notice.
    21    (iii) The commissioner may elect, in their sole discretion, to collect
    22  damages imposed by this section from, and as a set off against, payments
    23  due to the managed care organization, or payments that becomes  due  any
    24  time  after  the  calculation  of  liquidated  damages. Deductions shall
    25  continue until the full amount of the noticed damages are paid in full.
    26    (iv) All liquidated damages imposed by this subdivision shall be  paid
    27  out  of  the administrative costs and profits of the managed care organ-
    28  ization.
    29    (v) The managed  care  organization  shall  not  pass  the  liquidated
    30  damages  imposed  under  this subdivision through to any provider and/or
    31  subcontractor.
    32    (d) (i) To dispute liquidated damages imposed by this subdivision  the
    33  managed  care  organization must submit a written request of its dispute
    34  to the commissioner within thirty calendar days from  the  date  of  the
    35  statement  of damages. Such dispute shall be made in the form and manner
    36  prescribed by the commissioner.
    37    (ii) The department will deny any disputes that are not  delivered  in
    38  the format and timeframe specified by the department.
    39    (iii)  The  managed  care  organization  waives any dispute not raised
    40  within thirty calendar days of issuance of the statement of damages.  It
    41  also  waives  any  arguments  it fails to raise in writing within thirty
    42  calendar days of issuance of the statement of damages,  and  waives  the
    43  right to use any materials, data, and/or information not contained in or
    44  accompanying the managed care organization's submission submitted within
    45  the  thirty calendar days of issuance of the statement of damages in any
    46  subsequent legal or administrative proceeding.
    47    (iv) The commissioner or their  designee  shall  decide  the  dispute,
    48  reduce  the  decision to writing and issue their decision to the managed
    49  care organization within ninety calendar days of receipt of the dispute.
    50  This written decision shall be final.
    51    (e) For purposes of this subdivision a violation shall mean a determi-
    52  nation by the commissioner that the managed care organization failed  to
    53  act as required under the model contract or applicable federal and state
    54  statutes,  rules or regulations governing managed care organization. For
    55  the purposes of this subdivision, each day  that  an  ongoing  violation
    56  continues  shall  be a separate violation. In addition, each instance of

        S. 8307                            32                            A. 8807

     1  failing to furnish necessary and/or required medical services  or  items
     2  to  each  enrollee shall be a separate violation. As well, each day that
     3  the managed care organization fails to furnish necessary and/or required
     4  medical services or items to enrollees shall be a separate violation.
     5    (f)  For  purposes of this subdivision managed care organization shall
     6  mean any managed care organizations subject to this section and  article
     7  forty-four  of  the  public health law, including managed long term care
     8  plans.
     9    (g) Nothing in this  subdivision  shall  prohibit  the  imposition  of
    10  damages, penalties or other relief, otherwise authorized by law, includ-
    11  ing but not limited to cases of fraud, waste or abuse.
    12    § 10. This act shall not be construed to prohibit managed care provid-
    13  ers participating in the managed care program and managed long term care
    14  plans  approved  to provide health and long term care services to enrol-
    15  lees who are eligible under title XIX of  the  federal  social  security
    16  act,  that  were so authorized as of the effective date of this act from
    17  continuing operations as authorized until such time as awards  are  made
    18  in  accordance  with this act and such additional time subject to direc-
    19  tion from the commissioner of health to  ensure  the  safe  and  orderly
    20  transfer of participants.
    21    §  11.  This  act  shall  take  effect  immediately and shall apply to
    22  disputes filed with the superintendent of financial services pursuant to
    23  article six of the financial services law on  or  after  such  effective
    24  date; provided that:
    25    (a) the amendments to section 364-j of the social services law made by
    26  sections  two, three and nine of this act shall not affect the repeal of
    27  such section and shall be deemed repealed therewith; and
    28    (b) the amendments to section 4403-f of the public health law made  by
    29  sections  five, six and seven of this act shall not affect the repeal of
    30  such section and shall be deemed repealed therewith.

    31                                   PART I

    32    Section 1. Paragraph (a) of subdivision 4  of  section  365-a  of  the
    33  social  services  law, as amended by chapter 493 of the laws of 2010, is
    34  amended to read as follows:
    35    (a) drugs which may be dispensed without a prescription as required by
    36  section sixty-eight hundred ten of the education law; provided, however,
    37  that the state commissioner of health may by regulation specify  certain
    38  of  such  drugs which may be reimbursed as an item of medical assistance
    39  in accordance with the price schedule established by such  commissioner.
    40  Notwithstanding any other provision of law, [additions] modifications to
    41  the  list  of  drugs  reimbursable  under this paragraph may be filed as
    42  regulations by the commissioner  of  health  without  prior  notice  and
    43  comment;
    44    §  2.  Paragraph  (b)  of  subdivision  3 of section 273 of the public
    45  health law, as added by section 10 of part C of chapter 58 of  the  laws
    46  of 2005, is amended to read as follows:
    47    (b)  In the event that the patient does not meet the criteria in para-
    48  graph (a) of this subdivision, the  prescriber  may  provide  additional
    49  information  to  the  program  to justify the use of a prescription drug
    50  that is not on the preferred drug list.  The  program  shall  provide  a
    51  reasonable opportunity for a prescriber to reasonably present his or her
    52  justification  of  prior authorization. [If, after consultation with the
    53  program, the prescriber, in his or her reasonable professional judgment,
    54  determines that] The program will consider  the  additional  information

        S. 8307                            33                            A. 8807

     1  and  the  justification  presented  to  determine  whether  the use of a
     2  prescription drug that is not on the preferred drug list  is  warranted,
     3  and the [prescriber's] program's determination shall be final.
     4    §  3. Subdivisions 25 and 25-a of section 364-j of the social services
     5  law are REPEALED.
     6    § 4. Section 280 of the public health law, as amended by section 8  of
     7  part D of chapter 57 of the laws of 2018, paragraph (b) of subdivision 2
     8  as  amended  by  section 5, subdivision 3 as amended by section 6, para-
     9  graph (a) of subdivision 5 as amended by section 7,  subparagraph  (iii)
    10  of  paragraph (e) as amended by section 6-a and subdivision 8 as amended
    11  by section 9 of part B of chapter 57 of the laws of  2019,    paragraphs
    12  (c) and (d) of subdivision 2 as amended and paragraph (e) of subdivision
    13  2  as  added by section 2 of part FFF of chapter 56 of the laws of 2020,
    14  the opening paragraph of paragraph (a) of subdivision  6  and  paragraph
    15  (a)  of  subdivision  7 as amended by sections 3 and 4, respectively, of
    16  part GG of chapter 56 of the laws of  2020,    is  amended  to  read  as
    17  follows:
    18    § 280. Medicaid drug cap. 1. The legislature hereby finds and declares
    19  that  there is a significant public interest for the Medicaid program to
    20  manage drug costs in a manner that ensures patient access while  provid-
    21  ing  financial  stability  for  the  state  and participating providers.
    22  Since two thousand eleven, the state  has  taken  significant  steps  to
    23  contain  costs  in the Medicaid program by imposing a statutory limit on
    24  annual growth. Drug expenditures,  however,  continually  outpace  other
    25  cost  components  causing  significant pressure on the state, providers,
    26  and patient access operating under the Medicaid global cap. It is there-
    27  fore intended that the department establish a [Medicaid drug  cap  as  a
    28  separate  component  within the Medicaid global cap] supplemental rebate
    29  program as part of a focused and sustained effort to balance the  growth
    30  of drug expenditures with the growth of total Medicaid expenditures.
    31    2.  The  commissioner shall [establish a year to year] review at least
    32  annually the department of health state funds Medicaid drug [expenditure
    33  growth target as follows:
    34    (a) for state fiscal year two thousand seventeen--two  thousand  eigh-
    35  teen,  be  limited to the ten-year rolling average of the medical compo-
    36  nent of the consumer price index plus five percent and minus a  pharmacy
    37  savings target of fifty-five million dollars; and
    38    (b)  for  state  fiscal year two thousand eighteen--two thousand nine-
    39  teen, be limited to the ten-year rolling average of the  medical  compo-
    40  nent  of the consumer price index plus four percent and minus a pharmacy
    41  savings target of eighty-five million dollars;
    42    (c) for state fiscal year two thousand nineteen--two thousand  twenty,
    43  be  limited  to the ten-year rolling average of the medical component of
    44  the consumer price index plus four percent and minus a pharmacy  savings
    45  target of eighty-five million dollars;
    46    (d)  for  state  fiscal year two thousand twenty--two thousand twenty-
    47  one, be limited to the ten-year rolling average of the medical component
    48  of the consumer price index plus two percent; and
    49    (e) for state fiscal year two thousand twenty-one--two thousand  twen-
    50  ty-two and fiscal years thereafter, be limited in accordance with subdi-
    51  vision  one of section ninety-one of part H of chapter fifty-nine of the
    52  laws of two thousand eleven, as amended] expenditures to identify drugs,
    53  including but not limited to, drugs in the eightieth percentile or high-
    54  er of total spend, net of rebate or in the eightieth percentile or high-
    55  er based on cost per claim, net of rebate.

        S. 8307                            34                            A. 8807

     1    3. (a) The [department and the division of the budget shall assess  on
     2  a  quarterly basis the projected total amount to be expended in the year
     3  on a cash basis by the Medicaid program for each drug, and the projected
     4  annual amount of state funds Medicaid drug expenditures on a cash  basis
     5  for all drugs, which shall be a component of the projected department of
     6  health  state  funds  Medicaid  expenditures  calculated for purposes of
     7  sections ninety-one and ninety-two of part H of  chapter  fifty-nine  of
     8  the  laws  of  two  thousand eleven. For purposes of this section, state
     9  funds Medicaid drug expenditures include amounts expended for  drugs  in
    10  both  the  Medicaid  fee-for-service  program  and Medicaid managed care
    11  programs, minus the amount of any  drug  rebates  or  supplemental  drug
    12  rebates received by the department, including rebates pursuant to subdi-
    13  vision  five of this section with respect to rebate targets. The depart-
    14  ment and the division of the budget shall report  in  December  of  each
    15  year,  for  the  prior  April  through  October, to the drug utilization
    16  review board  the  projected  state  funds  Medicaid  drug  expenditures
    17  including  the  amounts,  in  aggregate thereof, attributable to the net
    18  cost of: changes in the utilization of  drugs  by  Medicaid  recipients;
    19  changes  in  the  number  of Medicaid recipients; changes to the cost of
    20  brand name drugs and changes to the cost of generic drugs. The  informa-
    21  tion  contained in the report shall not be publicly released in a manner
    22  that allows for the identification of an individual drug or manufacturer
    23  or that is likely to compromise the financial competitive,  or  proprie-
    24  tary nature of the information.
    25    (a) In the event the director of the budget determines, based on Medi-
    26  caid drug expenditures for the previous quarter or other relevant infor-
    27  mation,  that  the  total department of health state funds Medicaid drug
    28  expenditure is projected to exceed the annual growth limitation  imposed
    29  by  subdivision  two of this section, the] commissioner may identify and
    30  refer drugs, including but  not  limited  to,  drugs  in  the  eightieth
    31  percentile  or  higher of total spend, net of rebate or in the eightieth
    32  percentile or higher based on cost per claim, net of rebate, to the drug
    33  utilization review board established by  section  three  hundred  sixty-
    34  nine-bb  of the social services law for a recommendation as to whether a
    35  target supplemental Medicaid rebate should be paid by  the  manufacturer
    36  of the drug to the department and the target amount of the rebate.
    37    (b)  If the department intends to refer a drug to the drug utilization
    38  review board pursuant to paragraph (a) of this subdivision, the  depart-
    39  ment  shall  notify  the  manufacturer of such drug and shall attempt to
    40  reach agreement with the manufacturer on a rebate for the drug prior  to
    41  referring  the  drug  to  the  drug utilization review board for review.
    42  Such rebate may be based on evidence-based research, including, but  not
    43  limited  to,  such  research operated or conducted by or for other state
    44  governments, the federal government, the governments of  other  nations,
    45  and  third party payers or multi-state coalitions, provided however that
    46  the department shall account for the effectiveness of the drug in treat-
    47  ing the conditions  for  which  it  is  prescribed  or  in  improving  a
    48  patient's  health,  quality of life, or overall health outcomes, and the
    49  likelihood that use of the drug will reduce the need for  other  medical
    50  care, including hospitalization.
    51    (c)  In  the  event  that  the  commissioner and the manufacturer have
    52  previously agreed to a supplemental rebate for a drug pursuant to  para-
    53  graph  (b)  of this subdivision or paragraph (e) of subdivision seven of
    54  section three hundred sixty-seven-a of the social services law, the drug
    55  shall not be referred to the  drug  utilization  review  board  for  any
    56  further  supplemental  rebate  for  the  duration of the previous rebate

        S. 8307                            35                            A. 8807

     1  agreement, provided however, the commissioner may refer a  drug  to  the
     2  drug  utilization  review board if the commissioner determines there are
     3  significant  and  substantiated  utilization  or  market  changes,   new
     4  evidence-based research, or statutory or federal regulatory changes that
     5  warrant  additional  rebates. In such cases, the department shall notify
     6  the manufacturer and provide evidence of the changes  or  research  that
     7  would  warrant  additional rebates, and shall attempt to reach agreement
     8  with the manufacturer on a rebate for the drug prior  to  referring  the
     9  drug to the drug utilization review board for review.
    10    (d)  The  department shall consider a drug's actual cost to the state,
    11  including current rebate amounts, prior to seeking an additional  rebate
    12  pursuant to paragraph (b) or (c) of this subdivision.
    13    (e)  [The  commissioner  shall  be  authorized  to  take  the  actions
    14  described in this section only so long as total Medicaid  drug  expendi-
    15  tures  are  projected  to exceed the annual growth limitation imposed by
    16  subdivision two of this section.] If the commissioner is unsuccessful in
    17  entering into a rebate arrangement with the  manufacturer  of  the  drug
    18  satisfactory  to  the  department,  the drug manufacturer shall, in that
    19  event be required to provide to the department, on a standard  reporting
    20  form developed by the department, the following information:
    21    (i) the actual cost of developing, manufacturing, producing (including
    22  the cost per dose of production), and distributing the drug;
    23    (ii) research and development costs of the drug, including payments to
    24  predecessor  entities  conducting  research  and  development,  such  as
    25  biotechnology companies, universities and medical schools,  and  private
    26  research institutions;
    27    (iii)  administrative,  marketing, and advertising costs for the drug,
    28  apportioned by marketing activities  that  are  directed  to  consumers,
    29  marketing  activities  that  are  directed to prescribers, and the total
    30  cost of all marketing and advertising  that  is  directed  primarily  to
    31  consumers  and  prescribers  in  New  York, including but not limited to
    32  prescriber detailing, copayment discount programs, and direct-to-consum-
    33  er marketing;
    34    (iv) the extent of utilization of the drug;
    35    (v) prices for the drug that are charged  to  purchasers  outside  the
    36  United States;
    37    (vi)  prices charged to typical purchasers in the state, including but
    38  not limited to pharmacies, pharmacy  chains,  pharmacy  wholesalers,  or
    39  other direct purchasers;
    40    (vii) the average rebates and discounts provided per payer type in the
    41  state; and
    42    (viii) the average profit margin of each drug over the prior five-year
    43  period and the projected profit margin anticipated for such drug.
    44    (f) All information disclosed pursuant to paragraph (e) of this subdi-
    45  vision  shall  be  considered confidential and shall not be disclosed by
    46  the department in a form that  identifies  a  specific  manufacturer  or
    47  prices charged for drugs by such manufacturer.
    48    4.  In  determining  whether to recommend a target supplemental rebate
    49  for a drug, the drug utilization review board shall consider the  actual
    50  cost  of  the  drug to the Medicaid program, including federal and state
    51  rebates, and may consider, among other things:
    52    (a) the drug's impact on the Medicaid drug spending growth target  and
    53  the  adequacy of capitation rates of participating Medicaid managed care
    54  plans, and the drug's affordability and value to the  Medicaid  program;
    55  or
    56    (b) significant and unjustified increases in the price of the drug; or

        S. 8307                            36                            A. 8807

     1    (c) whether the drug may be priced disproportionately to its therapeu-
     2  tic benefits.
     3    5. (a) If the drug utilization review board recommends a target rebate
     4  amount  on  a  drug  referred  by the commissioner, the department shall
     5  negotiate with the drug's manufacturer for a supplemental rebate  to  be
     6  paid  by  the manufacturer in an amount not to exceed such target rebate
     7  amount. [A rebate requirement shall apply beginning with the  first  day
     8  of  the  state  fiscal year during which the rebate was required without
     9  regard to the date the department enters into the rebate agreement  with
    10  the manufacturer.]
    11    (b) The supplemental rebate required by paragraph (a) of this subdivi-
    12  sion shall apply to drugs dispensed to enrollees of managed care provid-
    13  ers  pursuant  to  section  three  hundred  sixty-four-j  of  the social
    14  services law and to drugs dispensed to Medicaid recipients who  are  not
    15  enrollees of such providers.
    16    (c)  [If  the drug utilization review board recommends a target rebate
    17  amount for a drug and the department is unable  to  negotiate  a  rebate
    18  from the manufacturer in an amount that is at least seventy-five percent
    19  of the target rebate amount, the commissioner is authorized to waive the
    20  provisions  of paragraph (b) of subdivision three of section two hundred
    21  seventy-three of this article and the provisions of  subdivisions  twen-
    22  ty-five  and  twenty-five-a of section three hundred sixty-four-j of the
    23  social services law with respect to  such  drug;  however,  this  waiver
    24  shall  not be implemented in situations where it would prevent access by
    25  a Medicaid recipient to a drug which is the only treatment for a partic-
    26  ular disease or condition. Under no circumstances shall the commissioner
    27  be authorized to waive such provisions with respect  to  more  than  two
    28  drugs in a given time.
    29    (d)]  Where  the  department  and  a  manufacturer enter into a rebate
    30  agreement pursuant to this section, which may be in addition to existing
    31  rebate agreements entered into by the manufacturer with respect  to  the
    32  same  drug,  no  additional  rebates shall be required to be paid by the
    33  manufacturer to a managed care provider or any of a managed care provid-
    34  er's agents, including but not limited to any pharmacy benefit  manager,
    35  while the department is collecting the rebate pursuant to this section.
    36    [(e)]  (d)  In formulating a recommendation concerning a target rebate
    37  amount for a drug, the drug utilization review board may consider:
    38    (i) publicly available information relevant  to  the  pricing  of  the
    39  drug;
    40    (ii) information supplied by the department relevant to the pricing of
    41  the drug;
    42    (iii)  information  relating to value-based pricing provided, however,
    43  if the department directly invites any third party to  provide  cost-ef-
    44  fectiveness analysis or research related to value-based pricing, and the
    45  department  receives  and considers such analysis or research for use by
    46  the board, such third party shall disclose any  funding  sources.    The
    47  department  shall,  if  reasonably possible, make publicly available the
    48  following documents in its possession that it  relies  upon  to  provide
    49  cost  effectiveness analyses or research related to value-based pricing:
    50  (A) descriptions of underlying methodologies; (B) assumptions and  limi-
    51  tations  of  research findings; and (C) if available, data that presents
    52  results in a way that reflects different outcomes for affected  subpopu-
    53  lations;
    54    (iv)  the  seriousness and prevalence of the disease or condition that
    55  is treated by the drug;
    56    (v) the extent of utilization of the drug;

        S. 8307                            37                            A. 8807

     1    (vi) the effectiveness of the drug  in  treating  the  conditions  for
     2  which  it  is prescribed, or in improving a patient's health, quality of
     3  life, or overall health outcomes;
     4    (vii)  the  likelihood  that  use of the drug will reduce the need for
     5  other medical care, including hospitalization;
     6    (viii) the average wholesale price, wholesale acquisition cost, retail
     7  price of the drug, and the cost of the  drug  to  the  Medicaid  program
     8  minus rebates received by the state;
     9    (ix)  in  the  case  of  generic  drugs,  the number of pharmaceutical
    10  manufacturers that produce the drug;
    11    (x) whether there are pharmaceutical equivalents to the drug; and
    12    (xi) information supplied by the manufacturer, if any, explaining  the
    13  relationship between the pricing of the drug and the cost of development
    14  of  the  drug  and/or  the  therapeutic  benefit of the drug, or that is
    15  otherwise pertinent to the manufacturer's  pricing  decision;  any  such
    16  information,  including  the  information on the standard reporting form
    17  requirement in paragraph (e)  of  subdivision  three  of  this  section,
    18  provided  shall be considered confidential and shall not be disclosed by
    19  the drug utilization review board in a form that identifies  a  specific
    20  manufacturer or prices charged for drugs by such manufacturer.
    21    6.  [(a)  If  the  drug  utilization  review board recommends a target
    22  rebate amount or if the commissioner identifies a drug as  a  high  cost
    23  drug pursuant to subparagraph (vii) of paragraph (e) of subdivision 7 of
    24  section  three  hundred sixty-seven-a of the social services law and the
    25  department is unsuccessful in entering into a  rebate  arrangement  with
    26  the  manufacturer  of  the drug satisfactory to the department, the drug
    27  manufacturer shall in that event be required to provide to  the  depart-
    28  ment,  on  a  standard  reporting  form developed by the department, the
    29  following information:
    30    (i) the actual cost of developing, manufacturing, producing (including
    31  the cost per dose of production), and distributing the drug;
    32    (ii) research and development costs of the drug, including payments to
    33  predecessor  entities  conducting  research  and  development,  such  as
    34  biotechnology  companies,  universities and medical schools, and private
    35  research institutions;
    36    (iii) administrative, marketing, and advertising costs for  the  drug,
    37  apportioned  by  marketing  activities  that  are directed to consumers,
    38  marketing activities that are directed to  prescribers,  and  the  total
    39  cost  of  all  marketing  and  advertising that is directed primarily to
    40  consumers and prescribers in New York,  including  but  not  limited  to
    41  prescriber detailing, copayment discount programs, and direct-to-consum-
    42  er marketing;
    43    (iv) the extent of utilization of the drug;
    44    (v)  prices  for  the  drug that are charged to purchasers outside the
    45  United States;
    46    (vi) prices charged to typical purchasers in the state, including  but
    47  not  limited  to  pharmacies,  pharmacy chains, pharmacy wholesalers, or
    48  other direct purchasers;
    49    (vii) the average rebates and discounts provided per payer type in the
    50  State; and
    51    (viii) the average profit margin of each drug over the prior five-year
    52  period and the projected profit margin anticipated for such drug.
    53    (b) All information disclosed pursuant to paragraph (a) of this subdi-
    54  vision shall be considered confidential and shall not  be  disclosed  by
    55  the  department  in  a  form  that identifies a specific manufacturer or
    56  prices charged for drugs by such manufacturer.

        S. 8307                            38                            A. 8807

     1    7.] (a) [If, after] After taking into account all rebates and  supple-
     2  mental rebates received by the department, including rebates received to
     3  date  pursuant  to  this  section[, total Medicaid drug expenditures are
     4  still projected to exceed the annual growth limitation imposed by subdi-
     5  vision two of this section], the commissioner may: subject any drug of a
     6  manufacturer  referred  to  the drug utilization review board under this
     7  section to prior approval in  accordance  with  existing  processes  and
     8  procedures  when  such  manufacturer has not entered into a supplemental
     9  rebate arrangement as required by this section; direct  a  managed  care
    10  plan  to  limit or reduce reimbursement for a drug provided by a medical
    11  practitioner if the drug utilization review board  recommends  a  target
    12  rebate  amount  for  such  drug and the manufacturer has failed to enter
    13  into a rebate arrangement required by this section; direct managed  care
    14  plans  to remove from their Medicaid formularies any drugs of a manufac-
    15  turer who has a drug that the drug utilization review board recommends a
    16  target rebate amount for and the manufacturer has failed to enter into a
    17  rebate arrangement required by this section; promote  the  use  of  cost
    18  effective  and  clinically  appropriate  drugs  other  than  those  of a
    19  manufacturer who has a drug  that  the  drug  utilization  review  board
    20  recommends  a  target  rebate  amount and the manufacturer has failed to
    21  enter into a rebate arrangement required by this section; allow manufac-
    22  turers to accelerate rebate payments under  existing  rebate  contracts;
    23  and  such  other  actions  as authorized by law. [The commissioner shall
    24  provide written notice to the legislature thirty days  prior  to  taking
    25  action  pursuant  to  this  paragraph, unless action is necessary in the
    26  fourth quarter of a fiscal year to prevent total Medicaid drug  expendi-
    27  tures  from  exceeding the limitation imposed by subdivision two of this
    28  section, in which case such notice to the legislature may be  less  than
    29  thirty days.]
    30    (b) The commissioner shall be authorized to take the actions described
    31  in  paragraph  (a)  of  this subdivision [only so long as total Medicaid
    32  drug expenditures are projected to exceed the annual  growth  limitation
    33  imposed  by  subdivision  two  of  this  section].  In addition, no such
    34  actions shall be deemed to supersede the provisions of paragraph (b)  of
    35  subdivision  three  of section two hundred seventy-three of this article
    36  or the provisions  of  subdivisions  twenty-five  and  twenty-five-a  of
    37  section  three  hundred sixty-four-j of the social services law[, except
    38  as allowed by paragraph  (c)  of  subdivision  five  of  this  section];
    39  provided  further that nothing in this section shall prevent access by a
    40  Medicaid recipient to a drug which is the only treatment for  a  partic-
    41  ular disease or condition.
    42    [8.] 7. The commissioner, upon request of the chair of the drug utili-
    43  zation  review  board, shall provide a report [by July first annually to
    44  the drug utilization review board] on savings achieved through the  drug
    45  cap  in  the  last  fiscal  year. Such report shall provide data on what
    46  savings were achieved [through actions pursuant to  subdivisions  three,
    47  five  and  seven  of  this  section, respectively, and what savings were
    48  achieved through other means] and how such savings were  calculated  and
    49  implemented.
    50    §  5.  Paragraph  (e)  of subdivision 7 of section 367-a of the social
    51  services law, as amended by section 1 of part GG of chapter  56  of  the
    52  laws  of  2020, the opening paragraph as amended by section 24 of part B
    53  of chapter 57 of the laws of 2023, is amended to read as follows:
    54    (e) During the period from April first, two thousand  fifteen  through
    55  March  thirty-first,  two  thousand twenty-six, the commissioner may, in
    56  lieu of a managed care provider or pharmacy benefit  manager,  negotiate

        S. 8307                            39                            A. 8807

     1  directly and enter into an arrangement with a pharmaceutical manufactur-
     2  er  for the provision of supplemental rebates relating to pharmaceutical
     3  utilization by enrollees of managed care providers pursuant  to  section
     4  three hundred sixty-four-j of this title and may also negotiate directly
     5  and  enter into such an agreement relating to pharmaceutical utilization
     6  by medical assistance recipients not so enrolled. Such  rebate  arrange-
     7  ments shall be limited to the following: antiretrovirals approved by the
     8  FDA  for  the  treatment  of HIV/AIDS, accelerated approval drugs estab-
     9  lished pursuant to subparagraph (ix) of this paragraph,  opioid  depend-
    10  ence  agents  and  opioid  antagonists  listed  in a statewide formulary
    11  established pursuant to subparagraph (vii) of this paragraph,  hepatitis
    12  C agents, high cost drugs as provided for in subparagraph (viii) of this
    13  paragraph,  gene  therapies as provided for in subparagraph (ix) of this
    14  paragraph, and any other class or drug designated  by  the  commissioner
    15  for  which  the  pharmaceutical  manufacturer  has  in  effect  a rebate
    16  arrangement with the federal secretary  of  health  and  human  services
    17  pursuant to 42 U.S.C. § 1396r-8, and for which the state has established
    18  standard  clinical  criteria. No agreement entered into pursuant to this
    19  paragraph shall have an initial term or be extended beyond  the  expira-
    20  tion or repeal of this paragraph.
    21    (i) The manufacturer shall not enter into any rebate arrangements with
    22  a  managed  care  provider,  or any of a managed care provider's agents,
    23  including but not limited to any pharmacy benefit manager  on  the  gene
    24  therapy,  drug, or drug classes subject to this paragraph when the state
    25  has a rebate arrangement in place and  standard  clinical  criteria  are
    26  imposed on the managed care provider.
    27    (ii)  The commissioner shall establish adequate rates of reimbursement
    28  which shall take into account both the impact of the commissioner  nego-
    29  tiating  such  arrangements  and  any limitations imposed on the managed
    30  care provider's ability to establish clinical criteria relating  to  the
    31  utilization  of  such  drugs.  In developing the managed care provider's
    32  reimbursement rate,  the  commissioner  shall  identify  the  amount  of
    33  reimbursement  for  such drugs as a separate and distinct component from
    34  the reimbursement otherwise made for prescription drugs as prescribed by
    35  this section.
    36    (iii) [The commissioner shall submit a report to the temporary  presi-
    37  dent  of the senate and the speaker of the assembly annually by December
    38  thirty-first. The report shall analyze the adequacy of rates to  managed
    39  care  providers  for drug expenditures related to the classes under this
    40  paragraph.
    41    (iv)] Nothing in this paragraph shall be construed to require a  phar-
    42  maceutical  manufacturer to enter into a rebate arrangement satisfactory
    43  to the commissioner relating to pharmaceutical utilization by  enrollees
    44  of managed care providers pursuant to section three hundred sixty-four-j
    45  of  this  title  or  relating  to  pharmaceutical utilization by medical
    46  assistance recipients not so enrolled.
    47    [(v)] (iv) All clinical criteria,  including  requirements  for  prior
    48  approval,  and  all utilization review determinations established by the
    49  state as described in this paragraph for the gene therapies,  drugs,  or
    50  drug  classes  subject  to  this  paragraph  shall  be  developed  using
    51  evidence-based and peer-reviewed clinical review criteria in  accordance
    52  with article two-A of the public health law, as applicable.
    53    [(vi)]  (v)  All  prior  authorization and utilization review determi-
    54  nations related to the coverage of any drug subject  to  this  paragraph
    55  shall be subject to article forty-nine of the public health law, section
    56  three  hundred sixty-four-j of this title, and article forty-nine of the

        S. 8307                            40                            A. 8807

     1  insurance law, as applicable. Nothing in this paragraph  shall  diminish
     2  any  rights  relating to access, prior authorization, or appeal relating
     3  to any drug class or drug  afforded  to  a  recipient  under  any  other
     4  provision of law.
     5    [(vii)]  (vi)  The  department  shall publish a statewide formulary of
     6  opioid dependence agents and opioid antagonists, which shall include  as
     7  "preferred  drugs"  all  drugs  in such classes, which shall include all
     8  subclasses of a given drug that have a different  pharmacological  route
     9  of administration, provided that:
    10    (A) for all drugs that are included as of the date of the enactment of
    11  this  subparagraph on a formulary of a managed care provider, as defined
    12  in section three hundred sixty-four-j of this title, or in the  Medicaid
    13  fee-for-service  preferred  drug program pursuant to section two hundred
    14  seventy-two of the public health law, the cost  to  the  department  for
    15  such  drug is equal to or less than the lowest cost paid for the drug by
    16  any managed care provider or by  the  Medicaid  fee-for-service  program
    17  after the application of any rebates, as of the date that the department
    18  implements  the  statewide  formulary  established by this subparagraph.
    19  Where there is a generic version of the drug approved by  the  Food  and
    20  Drug Administration as bioequivalent to a brand name drug pursuant to 21
    21  U.S.C.  §  355(j)(8)(B),  the  cost  to the department for the brand and
    22  generic versions shall be equal to or less than the  lower  of  the  two
    23  maximum costs determined pursuant to the previous sentence; and
    24    (B)  for  all drugs that are not included as of the date of the enact-
    25  ment of this subparagraph on a formulary of a managed care provider,  as
    26  defined  in  section three hundred sixty-four-j of this title, or in the
    27  Medicaid fee-for-service preferred drug program pursuant to section  two
    28  hundred  seventy-two of the public health law, the department is able to
    29  obtain the drug at a cost that is equal to or less than the lowest  cost
    30  to  the  department  of  other  comparable drugs in the class, after the
    31  application of any rebates. Where there is a generic version of the drug
    32  approved by the Food and Drug Administration as bioequivalent to a brand
    33  name drug pursuant to 21 U.S.C. § 355(j)(8)(B), the cost to the  depart-
    34  ment  for  the brand and generic versions shall be equal to or less than
    35  the lower of the two maximum costs determined pursuant to  the  previous
    36  sentence.
    37    [(viii)]  (vii)  The  commissioner  may  identify  and refer high cost
    38  drugs, as defined in clause (D)  of  this  subparagraph,  that  are  not
    39  included  as  of  the  date  of  the enactment of this subparagraph on a
    40  formulary of a managed care provider or covered by the Medicaid fee  for
    41  service  of  program to the drug utilization review board established by
    42  section three hundred sixty-nine-bb of this article for a recommendation
    43  as to whether a target supplemental Medicaid rebate should  be  paid  by
    44  the  manufacturer of the drug to the department and the target amount of
    45  the rebate.
    46    (A) If the commissioner intends to refer a high cost drug to the  drug
    47  utilization review board pursuant to this subparagraph, the commissioner
    48  shall  notify  the  manufacturer of such drug and shall attempt to reach
    49  agreement with the manufacturer on a rebate arrangement satisfactory  to
    50  the  commissioner  for  the drug prior to referring the drug to the drug
    51  utilization review board for review. Such arrangement may  be  based  on
    52  evidence  based  research,  including, but not limited to, such research
    53  operated or conducted by or for other  state  governments,  the  federal
    54  government,  the governments of other nations, and third party payers or
    55  multi-state coalitions,  provided  however  that  the  department  shall
    56  account for the effectiveness of the drug in treating the conditions for

        S. 8307                            41                            A. 8807

     1  which  it  is  prescribed or in improving a patient's health, quality of
     2  life, or overall health outcomes, and the likelihood  that  use  of  the
     3  drug will reduce the need for other medical care, including hospitaliza-
     4  tion.
     5    (B)  In  the  event  that  the  commissioner and the manufacturer have
     6  previously agreed to a rebate arrangement for a drug  pursuant  to  this
     7  paragraph, the drug shall not be referred to the drug utilization review
     8  board  for any further rebate agreement for the duration of the previous
     9  rebate agreement, provided however, the commissioner may refer a drug to
    10  the drug utilization review board if the commissioner  determines  there
    11  are  significant  and  substantiated  utilization or market changes, new
    12  evidence-based research, or statutory or federal regulatory changes that
    13  warrant additional rebates. In such cases, the department  shall  notify
    14  the  manufacturer  and  provide evidence of the changes or research that
    15  would warrant additional rebates, and shall attempt to  reach  agreement
    16  with  the  manufacturer  on a rebate for the drug prior to referring the
    17  drug to the drug utilization review board for review.
    18    (C) If the commissioner is unsuccessful  in  entering  into  a  rebate
    19  arrangement  with  the  manufacturer  of  the  drug  satisfactory to the
    20  department, the drug manufacturer shall in that  event  be  required  to
    21  provide to the department, on a standard reporting form developed by the
    22  department, the information as described in paragraph (e) of subdivision
    23  [six]  three of section two hundred eighty of the public health law. All
    24  information disclosed pursuant to this clause shall be considered confi-
    25  dential and shall not be disclosed by the  department  in  a  form  that
    26  identifies  a  specific manufacturer or prices charged for drugs by such
    27  manufacturer.
    28    (D) For the purposes of this subparagraph, the term "high  cost  drug"
    29  shall  mean  a  brand  name drug or biologic that has a launch wholesale
    30  acquisition cost of thirty thousand dollars or more per year  or  course
    31  of  treatment, or a biosimilar drug that has a launch wholesale acquisi-
    32  tion cost that is not at least fifteen percent lower than the referenced
    33  brand biologic at the time the biosimilar is launched, or a generic drug
    34  that has a wholesale acquisition cost of one hundred dollars or more for
    35  a thirty day supply or recommended dosage approved for labeling  by  the
    36  federal  Food  and Drug Administration, or a brand name drug or biologic
    37  that has a wholesale acquisition cost increase of three thousand dollars
    38  or more in any twelve-month period, or course of treatment if less  than
    39  twelve months.
    40    [(ix)]  (viii)  For  purposes of this paragraph, a "gene therapy" is a
    41  drug (A) approved under section  505  of  the  Federal  Food,  Drug  and
    42  Cosmetics  Act or licensed under subsection (a) or (k) of section 351 of
    43  the Public Health Services Act; (B) that treats a rare disease or condi-
    44  tion, as defined in 21 USC § 360bb(a)(2), that is  life-threatening,  as
    45  defined in 42 CFR 321.18; (C) is considered a gene therapy by the feder-
    46  al  Food  and Drug Administration for which a biologics license pursuant
    47  to 21 CFR 600-680 is held; (D) if administered in  accordance  with  the
    48  labeling  of such drug, is expected to result in either the cure of such
    49  disease or condition or a reduction in the symptoms of such  disease  or
    50  condition  that  materially  improves the patient's length or quality of
    51  life; and (E) is expected to achieve the result described in clause  (D)
    52  of this subparagraph after not more than three administrations.
    53    (ix)  For  purposes  of this paragraph, an "accelerated approval" is a
    54  drug or labeled indication of a drug authorized  by  the  Federal  Food,
    55  Drug  and  Cosmetic  Act  for  drugs for serious conditions that fill an
    56  unmet medical need based on whether the drug has an effect on  a  surro-

        S. 8307                            42                            A. 8807

     1  gate  clinical  endpoint,  and  contingent upon verification of clinical
     2  benefit in confirmatory trials.
     3    §  6.  Paragraph  (g)  of subdivision 2 of section 365-a of the social
     4  services law, as amended by section 21 of part A of chapter  56  of  the
     5  laws of 2013, is amended to read as follows:
     6    (g)  sickroom  supplies,  eyeglasses, prosthetic appliances and dental
     7  prosthetic appliances furnished in accordance with  the  regulations  of
     8  the department; provided further that: (i) the commissioner of health is
     9  authorized  to implement a preferred diabetic supply program wherein the
    10  department of  health  will  receive  enhanced  rebates  from  preferred
    11  manufacturers  [of] for products and supplies, including but not limited
    12  to, glucometers and test strips, and may subject non-preferred  manufac-
    13  turers' products and supplies, including but not limited to, glucometers
    14  and  test strips to prior authorization under section two hundred seven-
    15  ty-three of the public health law;  (ii)  enteral  formula  therapy  and
    16  nutritional  supplements  are  limited to coverage only for nasogastric,
    17  jejunostomy, or gastrostomy tube feeding, for  treatment  of  an  inborn
    18  metabolic  disorder,  or  to  address growth and development problems in
    19  children, or, subject to standards established by the commissioner,  for
    20  persons  with  a diagnosis of HIV infection, AIDS or HIV-related illness
    21  or other  diseases  and  conditions;  (iii)  prescription  footwear  and
    22  inserts  are limited to coverage only when used as an integral part of a
    23  lower limb orthotic appliance, as part of a diabetic treatment plan,  or
    24  to address growth and development problems in children; (iv) compression
    25  and  support  stockings  are  limited  to coverage only for pregnancy or
    26  treatment of venous stasis ulcers; and (v) the commissioner of health is
    27  authorized to implement an incontinence  supply  utilization  management
    28  program  to  reduce  costs  without limiting access through the existing
    29  provider network, including but not limited to single or multiple source
    30  contracts or,  a  preferred  incontinence  supply  program  wherein  the
    31  department  of  health  will  receive  enhanced  rebates  from preferred
    32  manufacturers of incontinence supplies, and  may  subject  non-preferred
    33  manufacturers' incontinence supplies to prior approval pursuant to regu-
    34  lations of the department, provided any necessary approvals under feder-
    35  al  law have been obtained to receive federal financial participation in
    36  the costs of incontinence supplies provided pursuant  to  this  subpara-
    37  graph;
    38    § 7. The public health law is amended by adding a new section 280-d to
    39  read as follows:
    40    §  280-d. Pharmacy cost reporting. 1. The department shall develop and
    41  implement a cost reporting program for licensed pharmacies that  partic-
    42  ipate  in the Medicaid program. Such program shall include a requirement
    43  to submit an annual cost report  on a form designated by the department.
    44  Information shall include, but not be limited to, costs incurred  during
    45  procurement and dispensing of prescription drugs.
    46    2.  Such  cost  reports  are  subject  to audit. In the event that any
    47  information or data which a pharmacy has submitted to the department, on
    48  the  required reporting forms is inaccurate or incorrect, such  pharmacy
    49  shall   within  fifteen  business  days,  submit  to  the  department  a
    50  correction of such information or data.
    51    3. Timely filing of such report is a requirement of  participation  in
    52  the  Medicaid  pharmacy  program.  In the event that a pharmacy fails to
    53  file the required reports on or before the required due date, such phar-
    54  macy may be subject to removal as a provider  from  the  fee-for-service
    55  pharmacy program.

        S. 8307                            43                            A. 8807

     1    §  8. Paragraphs (a), (b) and (c) of subdivision 9 of section 367-a of
     2  the social services law, paragraphs (a) and (c) as amended by chapter 19
     3  of the laws of 1998, paragraph (b) as amended by section 3 of part C  of
     4  chapter  58 of the laws of 2004, subparagraphs (i) and (ii) of paragraph
     5  (b) as amended by section 7 of part D of chapter 57 of the laws of 2017,
     6  and subparagraph (iii) of paragraph (b) as added by section 29 of part E
     7  of chapter 63 of the laws of 2005, are amended to read as follows:
     8    (a) for drugs provided by medical practitioners and claimed separately
     9  by  the  practitioners[, the actual cost of the drugs to the practition-
    10  ers; and] the lower of:
    11    (i) (1) an amount equal to the national average drug acquisition  cost
    12  set  by  the  federal centers for medicare and medicaid services for the
    13  drug, if any, or if such amount is not available, the wholesale acquisi-
    14  tion cost of the drug based on  the  package  size  dispensed  from,  as
    15  reported  by  the  prescription drug pricing service used by the depart-
    16  ment, (2) the federal upper limit, if any, established  by  the  federal
    17  centers for medicare and medicaid services; (3) the state maximum acqui-
    18  sition  cost,  if  any,  established  pursuant  to paragraph (e) of this
    19  subdivision; or (4) the actual cost of the drug to the practitioner.
    20    (ii) Notwithstanding subparagraph (i) and paragraph (e) of this subdi-
    21  vision, if a drug has been purchased from a manufacturer  by  a  covered
    22  entity pursuant to section 340B of the federal public health service act
    23  (42  USCA  §  256b),  the actual amount paid by such covered entity. For
    24  purposes of this subparagraph, a "covered  entity"  is  an  entity  that
    25  meets  the  requirements  of  paragraph  four  of subsection (a) of such
    26  section, that elects to participate in the program established  by  such
    27  section,  and  that  causes claims for payment for drugs covered by this
    28  subparagraph to be submitted to the medical assistance  program,  either
    29  directly  or through an authorized contract pharmacy. No medical assist-
    30  ance payments may be made to  a  covered  entity  or  to  an  authorized
    31  contract  pharmacy  of  a covered entity for drugs that are eligible for
    32  purchase under the section 340B program and are dispensed on  an  outpa-
    33  tient  basis  to  patients  of  the covered entity, other than under the
    34  provisions of this subparagraph.
    35    (b) for drugs dispensed by pharmacies:
    36    (i) (A) if the drug dispensed is  a  generic  prescription  drug,  the
    37  lower  of:  (1) an amount equal to the national average drug acquisition
    38  cost set by the federal centers for medicare and medicaid  services  for
    39  the  drug,  if  any,  or  if such amount if not available, the wholesale
    40  acquisition cost of the drug based on the package size  dispensed  from,
    41  as reported by the prescription drug pricing service used by the depart-
    42  ment, less seventeen and one-half percent thereof; (2) the federal upper
    43  limit, if any, established by the federal centers for medicare and medi-
    44  caid  services;  (3)  the state maximum acquisition cost, if any, estab-
    45  lished pursuant to  paragraph  (e)  of  this  subdivision;  or  (4)  the
    46  dispensing  pharmacy's  usual and customary price charged to the general
    47  public; (B) if the drug dispensed is available without a prescription as
    48  required by section sixty-eight hundred ten of the education law but  is
    49  reimbursed as an item of medical assistance pursuant to paragraph (a) of
    50  subdivision  four  of  section three hundred sixty-five-a of this title,
    51  the lower of (1) an amount equal to the national average  drug  acquisi-
    52  tion  cost set by the federal centers for medicare and medicaid services
    53  for the drug, if any, or if such amount is not available, the  wholesale
    54  acquisition  cost  of the drug based on the package size dispensed from,
    55  as reported by the prescription drug pricing service used by the depart-
    56  ment, (2) the federal upper limit, if any, established  by  the  federal

        S. 8307                            44                            A. 8807

     1  centers for medicare and medicaid services; (3) the state maximum acqui-
     2  sition cost if any, established pursuant to paragraph (e) of this subdi-
     3  vision;  or  (4)  the  dispensing  pharmacy's  usual and customary price
     4  charged to the general public;
     5    (ii)  if  the  drug  dispensed  is a brand-name prescription drug, the
     6  lower of:
     7    (A) an amount equal to the national average drug acquisition cost  set
     8  by  the federal centers for medicare and medicaid services for the drug,
     9  if any, or if such amount is not available,  the  wholesale  acquisition
    10  cost  of  the drug based on the package size dispensed from, as reported
    11  by the prescription drug pricing service used by the  department[,  less
    12  three  and  three-tenths percent thereof]; or (B) the dispensing pharma-
    13  cy's usual and customary price charged to the general public; and
    14    (iii) notwithstanding subparagraphs (i) and (ii) of this paragraph and
    15  paragraphs (d) and (e) of this subdivision, if the drug dispensed  is  a
    16  drug  that  has  been  purchased from a manufacturer by a covered entity
    17  pursuant to section 340B of the federal public health  service  act  (42
    18  USCA  § 256b), the actual amount paid by such covered entity pursuant to
    19  such section, plus the reasonable administrative costs, as determined by
    20  the commissioner, incurred by the covered entity  or  by  an  authorized
    21  contract pharmacy in connection with the purchase and dispensing of such
    22  drug and the tracking of such transactions. For purposes of this subpar-
    23  agraph,  a  "covered entity" is an entity that meets the requirements of
    24  paragraph four of subsection (a) of such section, that elects to partic-
    25  ipate in the program established by such section, and that causes claims
    26  for payment for drugs covered by this subparagraph to  be  submitted  to
    27  the medical assistance program, either directly or through an authorized
    28  contract  pharmacy.  No  medical  assistance  payments  may be made to a
    29  covered entity or to an authorized contract pharmacy of a covered entity
    30  for drugs that are eligible for purchase under the section 340B  program
    31  and  are  dispensed  on  an  outpatient basis to patients of the covered
    32  entity, other than under the provisions of this subparagraph. Pharmacies
    33  submitting claims for  reimbursement  of  drugs  purchased  pursuant  to
    34  section  340B  of the public health service act shall notify the depart-
    35  ment that the claim is eligible for purchase  under  the  340B  program,
    36  consistent  with claiming instructions issued by the department to iden-
    37  tify such claims.
    38    (c) Notwithstanding subparagraph (i) of paragraph (b) of this subdivi-
    39  sion, if a qualified prescriber certifies "brand medically necessary" or
    40  "brand necessary" in his or her own handwriting directly on the face  of
    41  a  prescription,  or in the case of electronic prescriptions, inserts an
    42  electronic direction to clarify "brand medically  necessary"  or  "brand
    43  necessary",  for a multiple source drug for which a specific upper limit
    44  of reimbursement has been established by the federal agency, in addition
    45  to writing "d a  w"  in  the  box  provided  for  such  purpose  on  the
    46  prescription  form,  payment under this title for such drug must be made
    47  under the provisions of subparagraph (ii) of such paragraph.
    48    § 9. This act  shall  take  effect  October  1,  2024;  provided  that
    49  sections two and three of this act shall take effect  January  1,  2025;
    50  and  provided  however, that the amendments to paragraph (e) of subdivi-
    51  sion 7 of section 367-a of the social services law made by section  five
    52  of  this  act shall not affect the repeal of such paragraph and shall be
    53  deemed repealed therewith provided,  further,  that  the  amendments  to
    54  subdivision  9  of  section  367-a  of  the  social services law made by
    55  section eight of this act shall not affect the expiration of such subdi-

        S. 8307                            45                            A. 8807

     1  vision pursuant to section 4 of chapter 19  of  the  laws  of  1998,  as
     2  amended, and shall expire therewith.

     3                                   PART J

     4    Section  1. The title heading of title 11-D of article 5 of the social
     5  services law, as amended by section 1 of part H of  chapter  57  of  the
     6  laws of 2021, is amended to read as follows:
     7                     [BASIC HEALTH PROGRAM] ESSENTIAL PLAN
     8    §  2.  Section 3 of part H of chapter 57 of the laws of 2021, amending
     9  the social services law relating to  eliminating  consumer-paid  premium
    10  payments in the basic health program, is amended to read as follows:
    11    § 3. This act shall take effect June 1, 2021 [and]; provided, however,
    12  section  two  of  this  act  shall  expire and be deemed repealed should
    13  federal approval be withdrawn or 42 U.S.C. 18051 be  repealed;  provided
    14  that the commissioner of health shall notify the legislative bill draft-
    15  ing  commission upon the withdrawal of federal approval or the repeal of
    16  42 U.S.C. 18051 in order that the commission may  maintain  an  accurate
    17  and  timely  effective data base of the official text of the laws of the
    18  state of New York in  furtherance  of  effectuating  the  provisions  of
    19  section  44  of the legislative law and section 70-b of the public offi-
    20  cers law.
    21    § 3. Subdivisions (b) and (c) of section 8 of part BBB of  chapter  56
    22  of  the  laws  of  2022,  amending  the public health law and other laws
    23  relating to permitting the commissioner of health  to  submit  a  waiver
    24  that  expands  eligibility  for  New  York's  basic  health  program and
    25  increases the federal poverty limit cap for basic health  program eligi-
    26  bility from  two hundred to two hundred  fifty percent, are  amended  to
    27  read as follows:
    28    (b)  section  four  of  this  act  shall expire and be deemed repealed
    29  December 31, [2024] 2025; provided, however, the amendments to paragraph
    30  (c) of subdivision 1 of section 369-gg of the social services  law  made
    31  by  such  section  of  this  act  shall be subject to the expiration and
    32  reversion of such paragraph pursuant to section 2 of part H  of  chapter
    33  57  of  the  laws of 2021 when upon such date, the provisions of section
    34  five of this act shall take effect; provided, however, the amendments to
    35  such paragraph made by section five of this  act  shall  expire  and  be
    36  deemed repealed December 31, [2024] 2025;
    37    (c)  section six of this act shall take effect January 1, [2025] 2026;
    38  provided, however, the amendments to paragraph (c) of subdivision  1  of
    39  section  369-gg  of the social services law made by such section of this
    40  act shall be subject to the expiration and reversion of  such  paragraph
    41  pursuant  to  section 2 of part H of chapter 57 of the laws of 2021 when
    42  upon such date, the provisions of section seven of this act  shall  take
    43  effect; and
    44    §  4.  Paragraph  (a)  of subdivision 1 of section 268-c of the public
    45  health law, as added by section 2 of part T of chapter 57 of the laws of
    46  2019, is amended to read as follows:
    47    (a) Perform eligibility determinations for federal and state insurance
    48  affordability programs including medical assistance in  accordance  with
    49  section three hundred sixty-six of the social services law, child health
    50  plus in accordance with section twenty-five hundred eleven of this chap-
    51  ter,  the  basic health program in accordance with section three hundred
    52  sixty-nine-gg of the social services  law,  the  1332  state  innovation
    53  program  in  accordance  with section three hundred sixty-nine-ii of the
    54  social services law, premium tax credits and cost-sharing reductions and

        S. 8307                            46                            A. 8807

     1  qualified health plans in  accordance  with  applicable  law  and  other
     2  health insurance programs as determined by the commissioner;
     3    §  5.  Subdivision  16  of  section 268-c of the public health law, as
     4  added by section 2 of part T of chapter 57  of  the  laws  of  2019,  is
     5  amended to read as follows:
     6    16.  In accordance with applicable federal and state law, inform indi-
     7  viduals of eligibility requirements for the Medicaid program under title
     8  XIX of the social security act and the social services  law,  the  chil-
     9  dren's  health  insurance  program  (CHIP) under title XXI of the social
    10  security act and this chapter, the basic health  program  under  section
    11  three  hundred  sixty-nine-gg of the social services law, the 1332 state
    12  innovation program in accordance with section three hundred  sixty-nine-
    13  ii  of  the social services law, or any applicable state or local public
    14  health insurance program and if, through screening of the application by
    15  the Marketplace, the Marketplace determines that  such  individuals  are
    16  eligible for any such program, enroll such individuals in such program.
    17    § 6. Section 268-c of the public health law is amended by adding a new
    18  subdivision 26 to read as follows:
    19    26.  Subject  to  federal approval if required, the use of state funds
    20  and the availability of funds in the 1332 state innovation program  fund
    21  established pursuant to section ninety-eight-d of the state finance law,
    22  the  commissioner  shall  have  the  authority to establish a program to
    23  provide subsidies for the payment of premium or cost sharing or both  to
    24  assist  individuals  who are eligible to purchase qualified health plans
    25  through the marketplace, or take such other  action  as  appropriate  to
    26  reduce  or  eliminate  qualified health plan premiums or cost-sharing or
    27  both.
    28    § 7. Subparagraph (i) of paragraph (a) of  subdivision  4  of  section
    29  268-e of the public health law, as added by section 2 of part T of chap-
    30  ter 57 of the laws of 2019, is amended to read as follows:
    31    (i) An initial determination of eligibility, including:
    32    (A) eligibility to enroll in a qualified health plan;
    33    (B) eligibility for Medicaid;
    34    (C) eligibility for Child Health Plus;
    35    (D) eligibility for the Basic Health Program;
    36    (E) eligibility for the 1332 state innovation program;
    37    (F) the amount of advance payments of the premium tax credit and level
    38  of cost-sharing reductions;
    39    [(F)]  (G) the amount of any other subsidy that may be available under
    40  law; and
    41    [(G)] (H) eligibility for such  other  health  insurance  programs  as
    42  determined by the commissioner; and
    43    §  8.  This  act  shall take effect immediately and shall be deemed to
    44  have been in full force and effect on and after April 1, 2024; provided,
    45  however, that sections four, five, six, and seven of this act shall take
    46  effect January 1, 2025; provided, further, that section six of this  act
    47  shall  only  take  effect  upon the commissioner of health obtaining and
    48  maintaining all necessary approvals from the  secretary  of  health  and
    49  human  services  and  the  secretary of the treasury based on an amended
    50  application for a waiver for state innovation pursuant to  section  1332
    51  of  the  patient  protection  and affordable care act (P.L. 111-148) and
    52  subdivision 25 of section 268-c of the public health law; and  provided,
    53  further,  that  the  commissioner of health shall notify the legislative
    54  bill drafting commission upon the occurrence of  the  enactment  of  the
    55  legislation  provided  for  in section six of this act in order that the
    56  commission may maintain an accurate and timely effective  data  base  of

        S. 8307                            47                            A. 8807

     1  the official text of the laws of the state of New York in furtherance of
     2  effectuating  the  provisions  of  section 44 of the legislative law and
     3  section 70-b of the public officers law.

     4                                   PART K

     5    Section 1. Paragraph (a) of subdivision 1 of section 18 of chapter 266
     6  of the laws of 1986, amending the civil practice law and rules and other
     7  laws  relating  to  malpractice  and  professional  medical  conduct, as
     8  amended by section 1 of part F of chapter 57 of the  laws  of  2023,  is
     9  amended and a new subdivision 9 is added to read as follows:
    10    (a)  The  superintendent of financial services and the commissioner of
    11  health or their designee shall, from funds  available  in  the  hospital
    12  excess liability pool created pursuant to subdivision 5 of this section,
    13  purchase  a policy or policies for excess insurance coverage, as author-
    14  ized by paragraph 1 of subsection (e) of section 5502 of  the  insurance
    15  law; or from an insurer, other than an insurer described in section 5502
    16  of the insurance law, duly authorized to write such coverage and actual-
    17  ly  writing  medical  malpractice  insurance  in  this  state;  or shall
    18  purchase equivalent excess coverage in a form previously approved by the
    19  superintendent of financial services for purposes  of  providing  equiv-
    20  alent  excess  coverage  in accordance with section 19 of chapter 294 of
    21  the laws of 1985, for medical or dental malpractice occurrences  between
    22  July  1, 1986 and June 30, 1987, between July 1, 1987 and June 30, 1988,
    23  between July 1, 1988 and June 30, 1989, between July 1,  1989  and  June
    24  30,  1990,  between July 1, 1990 and June 30, 1991, between July 1, 1991
    25  and June 30, 1992, between July 1, 1992 and June 30, 1993, between  July
    26  1,  1993  and  June  30,  1994,  between July 1, 1994 and June 30, 1995,
    27  between July 1, 1995 and June 30, 1996, between July 1,  1996  and  June
    28  30,  1997,  between July 1, 1997 and June 30, 1998, between July 1, 1998
    29  and June 30, 1999, between July 1, 1999 and June 30, 2000, between  July
    30  1,  2000  and  June  30,  2001,  between July 1, 2001 and June 30, 2002,
    31  between July 1, 2002 and June 30, 2003, between July 1,  2003  and  June
    32  30,  2004,  between July 1, 2004 and June 30, 2005, between July 1, 2005
    33  and June 30, 2006, between July 1, 2006 and June 30, 2007, between  July
    34  1,  2007  and  June  30,  2008,  between July 1, 2008 and June 30, 2009,
    35  between July 1, 2009 and June 30, 2010, between July 1,  2010  and  June
    36  30,  2011,  between July 1, 2011 and June 30, 2012, between July 1, 2012
    37  and June 30, 2013, between July 1, 2013 and June 30, 2014, between  July
    38  1,  2014  and  June  30,  2015,  between July 1, 2015 and June 30, 2016,
    39  between July 1, 2016 and June 30, 2017, between July 1,  2017  and  June
    40  30,  2018,  between July 1, 2018 and June 30, 2019, between July 1, 2019
    41  and June 30, 2020, between July 1, 2020 and June 30, 2021, between  July
    42  1, 2021 and June 30, 2022, between July 1, 2022 and June 30, 2023, [and]
    43  between  July  1,  2023  and June 30, 2024, and between July 1, 2024 and
    44  June 30, 2025 or reimburse the hospital  where  the  hospital  purchases
    45  equivalent  excess  coverage as defined in subparagraph (i) of paragraph
    46  (a) of subdivision 1-a of this section for medical or dental malpractice
    47  occurrences between July 1, 1987 and June 30, 1988, between July 1, 1988
    48  and June 30, 1989, between July 1, 1989 and June 30, 1990, between  July
    49  1,  1990  and  June  30,  1991,  between July 1, 1991 and June 30, 1992,
    50  between July 1, 1992 and June 30, 1993, between July 1,  1993  and  June
    51  30,  1994,  between July 1, 1994 and June 30, 1995, between July 1, 1995
    52  and June 30, 1996, between July 1, 1996 and June 30, 1997, between  July
    53  1,  1997  and  June  30,  1998,  between July 1, 1998 and June 30, 1999,
    54  between July 1, 1999 and June 30, 2000, between July 1,  2000  and  June

        S. 8307                            48                            A. 8807

     1  30,  2001,  between July 1, 2001 and June 30, 2002, between July 1, 2002
     2  and June 30, 2003, between July 1, 2003 and June 30, 2004, between  July
     3  1,  2004  and  June  30,  2005,  between July 1, 2005 and June 30, 2006,
     4  between  July  1,  2006 and June 30, 2007, between July 1, 2007 and June
     5  30, 2008, between July 1, 2008 and June 30, 2009, between July  1,  2009
     6  and  June 30, 2010, between July 1, 2010 and June 30, 2011, between July
     7  1, 2011 and June 30, 2012, between July  1,  2012  and  June  30,  2013,
     8  between  July  1,  2013 and June 30, 2014, between July 1, 2014 and June
     9  30, 2015, between July 1, 2015 and June 30, 2016, between July  1,  2016
    10  and  June 30, 2017, between July 1, 2017 and June 30, 2018, between July
    11  1, 2018 and June 30, 2019, between July  1,  2019  and  June  30,  2020,
    12  between  July  1,  2020 and June 30, 2021, between July 1, 2021 and June
    13  30, 2022, between July 1, 2022 and June 30, 2023, [and] between July  1,
    14  2023  and  June 30, 2024, and between July 1, 2024 and June 30, 2025 for
    15  physicians or dentists certified as eligible for  each  such  period  or
    16  periods  pursuant to subdivision 2 of this section by a general hospital
    17  licensed pursuant to article 28 of the public health law; provided  that
    18  no  single  insurer  shall  write  more  than fifty percent of the total
    19  excess premium for a given policy year; and provided, however, that such
    20  eligible physicians or dentists must have in force an individual policy,
    21  from an insurer licensed in this state of primary malpractice  insurance
    22  coverage  in  amounts of no less than one million three hundred thousand
    23  dollars for each  claimant  and  three  million  nine  hundred  thousand
    24  dollars  for  all  claimants under that policy during the period of such
    25  excess coverage for  such  occurrences  or  be  endorsed  as  additional
    26  insureds under a hospital professional liability policy which is offered
    27  through a voluntary attending physician ("channeling") program previous-
    28  ly  permitted  by  the  superintendent  of financial services during the
    29  period of such excess coverage for such occurrences. During such period,
    30  such policy for excess  coverage  or  such  equivalent  excess  coverage
    31  shall,  when combined with the physician's or dentist's primary malprac-
    32  tice insurance coverage or coverage provided through a voluntary attend-
    33  ing physician ("channeling") program, total an aggregate  level  of  two
    34  million three hundred thousand dollars for each claimant and six million
    35  nine  hundred  thousand dollars for all claimants from all such policies
    36  with respect to occurrences in each of such years provided, however,  if
    37  the  cost  of  primary  malpractice  insurance coverage in excess of one
    38  million dollars, but below  the  excess  medical  malpractice  insurance
    39  coverage provided pursuant to this act, exceeds the rate of nine percent
    40  per  annum,  then  the  required  level of primary malpractice insurance
    41  coverage in excess of one million dollars for each claimant shall be  in
    42  an  amount of not less than the dollar amount of such coverage available
    43  at nine percent per annum; the required level of such coverage  for  all
    44  claimants  under  that  policy shall be in an amount not less than three
    45  times the dollar amount of coverage for each claimant; and excess cover-
    46  age, when combined with such  primary  malpractice  insurance  coverage,
    47  shall  increase  the  aggregate  level  for each claimant by one million
    48  dollars and three  million  dollars  for  all  claimants;  and  provided
    49  further,  that,  with respect to policies of primary medical malpractice
    50  coverage that include occurrences between April 1,  2002  and  June  30,
    51  2002,  such  requirement  that  coverage  be in amounts no less than one
    52  million three hundred thousand  dollars  for  each  claimant  and  three
    53  million  nine hundred thousand dollars for all claimants for such occur-
    54  rences shall be effective April 1, 2002.
    55    (9) This subdivision shall apply only to excess insurance coverage  or
    56  equivalent  excess  coverage for physicians or dentists that is eligible

        S. 8307                            49                            A. 8807

     1  to be paid for from funds available in  the  hospital  excess  liability
     2  pool.
     3    (a)  Notwithstanding  any  law  to the contrary, for any policy period
     4  beginning on or after July 1, 2023, excess coverage shall  be  purchased
     5  by  a  physician or dentist directly from a provider of excess insurance
     6  coverage or equivalent excess coverage. At the conclusion of the  policy
     7  period  the superintendent of financial services and the commissioner of
     8  health or their designee shall, from funds  available  in  the  hospital
     9  excess liability pool created pursuant to subdivision 5 of this section,
    10  pay  fifty  percent  of  the premium to the provider of excess insurance
    11  coverage or equivalent excess coverage, and the remaining fifty  percent
    12  shall be paid one year thereafter.
    13    (b)  Notwithstanding  any  law  to the contrary, for any policy period
    14  beginning on or after July 1, 2024, excess coverage shall  be  purchased
    15  by  a  physician or dentist directly from a provider of excess insurance
    16  coverage or equivalent excess coverage. Such provider of  excess  insur-
    17  ance  coverage  or  equivalent  excess  coverage shall bill, in a manner
    18  consistent with paragraph (f) of  this  subdivision,  the  physician  or
    19  dentist  for  an  amount  equal to fifty percent of the premium for such
    20  coverage, as established pursuant to paragraph (d) of this  subdivision,
    21  during  the  policy  period.  At the conclusion of the policy period the
    22  superintendent of financial services and the commissioner of  health  or
    23  their  designee  shall,  from  funds  available  in  the hospital excess
    24  liability pool created pursuant to subdivision 5 of  this  section,  pay
    25  half  of  the  remaining fifty percent of the premium to the provider of
    26  excess insurance coverage or equivalent excess coverage, and the remain-
    27  ing twenty-five percent shall be paid one year thereafter. If the  funds
    28  available in the hospital excess liability pool are insufficient to meet
    29  the  percent  of  the  costs  of  the excess coverage, the provisions of
    30  subdivision 8 of this section shall apply.
    31    (c) If at the conclusion of the policy period, a physician or dentist,
    32  eligible for excess coverage paid for from funds available in the hospi-
    33  tal excess liability pool, has failed to pay an amount  equal  to  fifty
    34  percent  of the premium as established pursuant to paragraph (d) of this
    35  subdivision, such excess coverage shall be cancelled and shall  be  null
    36  and  void  as  of the first day on or after the commencement of a policy
    37  period where the liability for payment pursuant to this subdivision  has
    38  not been met. The provider of excess coverage shall remit any portion of
    39  premium  paid  by  the  eligible  physician or dentist for such a policy
    40  period.
    41    (d) The superintendent of financial services shall  establish  a  rate
    42  consistent  with  subdivision 3 of this section that providers of excess
    43  insurance coverage or equivalent excess coverage will  charge  for  such
    44  coverage for each policy period. For the policy period beginning July 1,
    45  2024,  the  superintendent  of  financial  services  may direct that the
    46  premium for that policy period be the same as  it  was  for  the  policy
    47  period that concluded June 30, 2023.
    48    (e)  No  provider  of  excess  insurance coverage or equivalent excess
    49  coverage shall issue excess coverage to which this  subdivision  applies
    50  to  any  physician or dentist unless that physician or dentist meets the
    51  eligibility requirements for such coverage set forth  in  this  section.
    52  The  superintendent of financial services and the commissioner of health
    53  or their designee shall not make any payment under this subdivision to a
    54  provider of excess insurance coverage or equivalent excess coverage  for
    55  excess  coverage  issued to a physician or dentist who does not meet the

        S. 8307                            50                            A. 8807

     1  eligibility  requirements  for  participation  in  the  hospital  excess
     2  liability pool program set forth in this section.
     3    (f)  A  provider  of  excess insurance coverage or equivalent coverage
     4  that issues excess coverage under this subdivision shall bill the physi-
     5  cian or dentist for the portion of the premium required under  paragraph
     6  (a)  of this subdivision in twelve equal monthly installments or in such
     7  other manner as the physician or dentist may agree.
     8    (g) The superintendent of financial services in consultation with  the
     9  commissioner  of  health may promulgate regulations giving effect to the
    10  provisions of this subdivision.
    11    § 2. Subdivision 3 of section 18 of chapter 266 of the laws  of  1986,
    12  amending  the  civil  practice  law and rules and other laws relating to
    13  malpractice and professional medical conduct, as amended by section 2 of
    14  part F of chapter 57 of the laws of 2023, is amended to read as follows:
    15    (3)(a) The superintendent of financial services  shall  determine  and
    16  certify  to  each general hospital and to the commissioner of health the
    17  cost of excess malpractice insurance for medical or  dental  malpractice
    18  occurrences between July 1, 1986 and June 30, 1987, between July 1, 1988
    19  and  June 30, 1989, between July 1, 1989 and June 30, 1990, between July
    20  1, 1990 and June 30, 1991, between July  1,  1991  and  June  30,  1992,
    21  between  July  1,  1992 and June 30, 1993, between July 1, 1993 and June
    22  30, 1994, between July 1, 1994 and June 30, 1995, between July  1,  1995
    23  and  June 30, 1996, between July 1, 1996 and June 30, 1997, between July
    24  1, 1997 and June 30, 1998, between July  1,  1998  and  June  30,  1999,
    25  between  July  1,  1999 and June 30, 2000, between July 1, 2000 and June
    26  30, 2001, between July 1, 2001 and June 30, 2002, between July  1,  2002
    27  and  June 30, 2003, between July 1, 2003 and June 30, 2004, between July
    28  1, 2004 and June 30, 2005, between July  1,  2005  and  June  30,  2006,
    29  between  July  1,  2006 and June 30, 2007, between July 1, 2007 and June
    30  30, 2008, between July 1, 2008 and June 30, 2009, between July  1,  2009
    31  and  June 30, 2010, between July 1, 2010 and June 30, 2011, between July
    32  1, 2011 and June 30, 2012, between July  1,  2012  and  June  30,  2013,
    33  between  July  1,  2013 and June 30, 2014, between July 1, 2014 and June
    34  30, 2015, between July 1, 2015 and June 30, 2016, between July  1,  2016
    35  and  June 30, 2017, between July 1, 2017 and June 30, 2018, between July
    36  1, 2018 and June 30, 2019, between July  1,  2019  and  June  30,  2020,
    37  between  July  1,  2020 and June 30, 2021, between July 1, 2021 and June
    38  30, 2022, between July 1, 2022 and June 30, 2023, [and] between July  1,
    39  2023 and June 30, 2024, and between July 1, 2024 and June 30, 2025 allo-
    40  cable  to  each general hospital for physicians or dentists certified as
    41  eligible for purchase of a policy for excess insurance coverage by  such
    42  general  hospital  in accordance with subdivision 2 of this section, and
    43  may amend such determination and certification as necessary.
    44    (b) The superintendent  of  financial  services  shall  determine  and
    45  certify  to  each general hospital and to the commissioner of health the
    46  cost of excess malpractice insurance or equivalent excess  coverage  for
    47  medical  or dental malpractice occurrences between July 1, 1987 and June
    48  30, 1988, between July 1, 1988 and June 30, 1989, between July  1,  1989
    49  and  June 30, 1990, between July 1, 1990 and June 30, 1991, between July
    50  1, 1991 and June 30, 1992, between July  1,  1992  and  June  30,  1993,
    51  between  July  1,  1993 and June 30, 1994, between July 1, 1994 and June
    52  30, 1995, between July 1, 1995 and June 30, 1996, between July  1,  1996
    53  and  June 30, 1997, between July 1, 1997 and June 30, 1998, between July
    54  1, 1998 and June 30, 1999, between July  1,  1999  and  June  30,  2000,
    55  between  July  1,  2000 and June 30, 2001, between July 1, 2001 and June
    56  30, 2002, between July 1, 2002 and June 30, 2003, between July  1,  2003

        S. 8307                            51                            A. 8807

     1  and  June 30, 2004, between July 1, 2004 and June 30, 2005, between July
     2  1, 2005 and June 30, 2006, between July  1,  2006  and  June  30,  2007,
     3  between  July  1,  2007 and June 30, 2008, between July 1, 2008 and June
     4  30,  2009,  between July 1, 2009 and June 30, 2010, between July 1, 2010
     5  and June 30, 2011, between July 1, 2011 and June 30, 2012, between  July
     6  1,  2012  and  June  30,  2013,  between July 1, 2013 and June 30, 2014,
     7  between July 1, 2014 and June 30, 2015, between July 1,  2015  and  June
     8  30,  2016,  between July 1, 2016 and June 30, 2017, between July 1, 2017
     9  and June 30, 2018, between July 1, 2018 and June 30, 2019, between  July
    10  1,  2019  and  June  30,  2020,  between July 1, 2020 and June 30, 2021,
    11  between July 1, 2021 and June 30, 2022, between July 1,  2022  and  June
    12  30, 2023, [and] between July 1, 2023 and June 30, 2024, and between July
    13  1,  2024 and June 30, 2025 allocable to each general hospital for physi-
    14  cians or dentists certified as eligible for purchase  of  a  policy  for
    15  excess  insurance coverage or equivalent excess coverage by such general
    16  hospital in accordance with subdivision 2 of this section, and may amend
    17  such determination and certification as necessary. The superintendent of
    18  financial services shall determine and certify to each general  hospital
    19  and to the commissioner of health the ratable share of such cost alloca-
    20  ble to the period July 1, 1987 to December 31, 1987, to the period Janu-
    21  ary 1, 1988 to June 30, 1988, to the period July 1, 1988 to December 31,
    22  1988, to the period January 1, 1989 to June 30, 1989, to the period July
    23  1,  1989 to December 31, 1989, to the period January 1, 1990 to June 30,
    24  1990, to the period July 1, 1990 to December 31,  1990,  to  the  period
    25  January 1, 1991 to June 30, 1991, to the period July 1, 1991 to December
    26  31,  1991, to the period January 1, 1992 to June 30, 1992, to the period
    27  July 1, 1992 to December 31, 1992, to the period January 1, 1993 to June
    28  30, 1993, to the period July 1, 1993 to December 31, 1993, to the period
    29  January 1, 1994 to June 30, 1994, to the period July 1, 1994 to December
    30  31, 1994, to the period January 1, 1995 to June 30, 1995, to the  period
    31  July 1, 1995 to December 31, 1995, to the period January 1, 1996 to June
    32  30, 1996, to the period July 1, 1996 to December 31, 1996, to the period
    33  January 1, 1997 to June 30, 1997, to the period July 1, 1997 to December
    34  31,  1997, to the period January 1, 1998 to June 30, 1998, to the period
    35  July 1, 1998 to December 31, 1998, to the period January 1, 1999 to June
    36  30, 1999, to the period July 1, 1999 to December 31, 1999, to the period
    37  January 1, 2000 to June 30, 2000, to the period July 1, 2000 to December
    38  31, 2000, to the period January 1, 2001 to June 30, 2001, to the  period
    39  July  1,  2001  to June 30, 2002, to the period July 1, 2002 to June 30,
    40  2003, to the period July 1, 2003 to June 30, 2004, to the period July 1,
    41  2004 to June 30, 2005, to the period July 1, 2005 and June 30, 2006,  to
    42  the  period  July  1, 2006 and June 30, 2007, to the period July 1, 2007
    43  and June 30, 2008, to the period July 1, 2008 and June 30, 2009, to  the
    44  period  July  1,  2009 and June 30, 2010, to the period July 1, 2010 and
    45  June 30, 2011, to the period July 1, 2011 and  June  30,  2012,  to  the
    46  period  July  1,  2012 and June 30, 2013, to the period July 1, 2013 and
    47  June 30, 2014, to the period July 1, 2014 and  June  30,  2015,  to  the
    48  period  July  1,  2015 and June 30, 2016, to the period July 1, 2016 and
    49  June 30, 2017, to the period July 1, 2017 to June 30, 2018, to the peri-
    50  od July 1, 2018 to June 30, 2019, to the period July 1, 2019 to June 30,
    51  2020, to the period July 1, 2020 to June 30, 2021, to the period July 1,
    52  2021 to June 30, 2022, to the period July 1,  2022  to  June  30,  2023,
    53  [and]  to  the  period  July 1, 2023 to June 30, 2024, and to the period
    54  July 1, 2024 to June 30, 2025.
    55    § 3. Paragraphs (a), (b), (c), (d) and (e) of subdivision 8 of section
    56  18 of chapter 266 of the laws of 1986, amending the civil  practice  law

        S. 8307                            52                            A. 8807

     1  and  rules  and  other  laws  relating  to  malpractice and professional
     2  medical conduct, as amended by section 3 of part F of chapter 57 of  the
     3  laws of 2023, are amended to read as follows:
     4    (a)  To  the  extent  funds available to the hospital excess liability
     5  pool pursuant to subdivision 5 of this section as amended, and  pursuant
     6  to  section  6  of part J of chapter 63 of the laws of 2001, as may from
     7  time to time be amended, which amended this  subdivision,  are  insuffi-
     8  cient  to  meet  the  costs  of  excess insurance coverage or equivalent
     9  excess coverage for coverage periods during the period July 1,  1992  to
    10  June  30,  1993, during the period July 1, 1993 to June 30, 1994, during
    11  the period July 1, 1994 to June 30, 1995, during the period July 1, 1995
    12  to June 30, 1996, during the period July  1,  1996  to  June  30,  1997,
    13  during  the period July 1, 1997 to June 30, 1998, during the period July
    14  1, 1998 to June 30, 1999, during the period July 1,  1999  to  June  30,
    15  2000, during the period July 1, 2000 to June 30, 2001, during the period
    16  July  1,  2001  to  October 29, 2001, during the period April 1, 2002 to
    17  June 30, 2002, during the period July 1, 2002 to June 30,  2003,  during
    18  the period July 1, 2003 to June 30, 2004, during the period July 1, 2004
    19  to  June  30,  2005,  during  the  period July 1, 2005 to June 30, 2006,
    20  during the period July 1, 2006 to June 30, 2007, during the period  July
    21  1,  2007  to  June  30, 2008, during the period July 1, 2008 to June 30,
    22  2009, during the period July 1, 2009 to June 30, 2010, during the period
    23  July 1, 2010 to June 30, 2011, during the period July 1,  2011  to  June
    24  30,  2012,  during  the period July 1, 2012 to June 30, 2013, during the
    25  period July 1, 2013 to June 30, 2014, during the period July 1, 2014  to
    26  June  30,  2015, during the period July 1, 2015 to June 30, 2016, during
    27  the period July 1, 2016 to June 30, 2017, during the period July 1, 2017
    28  to June 30, 2018, during the period July  1,  2018  to  June  30,  2019,
    29  during  the period July 1, 2019 to June 30, 2020, during the period July
    30  1, 2020 to June 30, 2021, during the period July 1,  2021  to  June  30,
    31  2022,  during the period July 1, 2022 to June 30, 2023, [and] during the
    32  period July 1, 2023 to June 30, 2024, and during the period July 1, 2024
    33  to June 30, 2025 allocated or reallocated in accordance  with  paragraph
    34  (a) of subdivision 4-a of this section to rates of payment applicable to
    35  state governmental agencies, each physician or dentist for whom a policy
    36  for excess insurance coverage or equivalent excess coverage is purchased
    37  for  such  period  shall  be  responsible for payment to the provider of
    38  excess insurance coverage or equivalent excess coverage of an  allocable
    39  share  of  such  insufficiency,  based on the ratio of the total cost of
    40  such coverage for such physician to the sum of the total  cost  of  such
    41  coverage for all physicians applied to such insufficiency.
    42    (b)  Each  provider  of excess insurance coverage or equivalent excess
    43  coverage covering the period July 1, 1992 to June 30, 1993, or  covering
    44  the period July 1, 1993 to June 30, 1994, or covering the period July 1,
    45  1994  to  June 30, 1995, or covering the period July 1, 1995 to June 30,
    46  1996, or covering the period July 1, 1996 to June 30, 1997, or  covering
    47  the period July 1, 1997 to June 30, 1998, or covering the period July 1,
    48  1998  to  June 30, 1999, or covering the period July 1, 1999 to June 30,
    49  2000, or covering the period July 1, 2000 to June 30, 2001, or  covering
    50  the  period  July  1,  2001  to October 29, 2001, or covering the period
    51  April 1, 2002 to June 30, 2002, or covering the period July 1,  2002  to
    52  June  30, 2003, or covering the period July 1, 2003 to June 30, 2004, or
    53  covering the period July 1, 2004 to June 30, 2005, or covering the peri-
    54  od July 1, 2005 to June 30, 2006, or covering the period July 1, 2006 to
    55  June 30, 2007, or covering the period July 1, 2007 to June 30, 2008,  or
    56  covering the period July 1, 2008 to June 30, 2009, or covering the peri-

        S. 8307                            53                            A. 8807

     1  od July 1, 2009 to June 30, 2010, or covering the period July 1, 2010 to
     2  June  30, 2011, or covering the period July 1, 2011 to June 30, 2012, or
     3  covering the period July 1, 2012 to June 30, 2013, or covering the peri-
     4  od July 1, 2013 to June 30, 2014, or covering the period July 1, 2014 to
     5  June  30, 2015, or covering the period July 1, 2015 to June 30, 2016, or
     6  covering the period July 1, 2016 to June 30, 2017, or covering the peri-
     7  od July 1, 2017 to June 30, 2018, or covering the period July 1, 2018 to
     8  June 30, 2019, or covering the period July 1, 2019 to June 30, 2020,  or
     9  covering the period July 1, 2020 to June 30, 2021, or covering the peri-
    10  od July 1, 2021 to June 30, 2022, or covering the period July 1, 2022 to
    11  June  30, 2023, or covering the period July 1, 2023 to June 30, 2024, or
    12  covering the period July 1, 2024 to June 30, 2025 shall notify a covered
    13  physician or dentist by mail, mailed to the address shown  on  the  last
    14  application for excess insurance coverage or equivalent excess coverage,
    15  of  the  amount  due to such provider from such physician or dentist for
    16  such coverage period determined in accordance with paragraph (a) of this
    17  subdivision. Such amount shall be due from such physician or dentist  to
    18  such provider of excess insurance coverage or equivalent excess coverage
    19  in  a  time  and  manner  determined  by the superintendent of financial
    20  services.
    21    (c) If a physician or dentist liable for payment of a portion  of  the
    22  costs  of excess insurance coverage or equivalent excess coverage cover-
    23  ing the period July 1, 1992 to June 30, 1993,  or  covering  the  period
    24  July  1,  1993  to June 30, 1994, or covering the period July 1, 1994 to
    25  June 30, 1995, or covering the period July 1, 1995 to June 30, 1996,  or
    26  covering the period July 1, 1996 to June 30, 1997, or covering the peri-
    27  od July 1, 1997 to June 30, 1998, or covering the period July 1, 1998 to
    28  June  30, 1999, or covering the period July 1, 1999 to June 30, 2000, or
    29  covering the period July 1, 2000 to June 30, 2001, or covering the peri-
    30  od July 1, 2001 to October 29, 2001, or covering  the  period  April  1,
    31  2002  to  June 30, 2002, or covering the period July 1, 2002 to June 30,
    32  2003, or covering the period July 1, 2003 to June 30, 2004, or  covering
    33  the period July 1, 2004 to June 30, 2005, or covering the period July 1,
    34  2005  to  June 30, 2006, or covering the period July 1, 2006 to June 30,
    35  2007, or covering the period July 1, 2007 to June 30, 2008, or  covering
    36  the period July 1, 2008 to June 30, 2009, or covering the period July 1,
    37  2009  to  June 30, 2010, or covering the period July 1, 2010 to June 30,
    38  2011, or covering the period July 1, 2011 to June 30, 2012, or  covering
    39  the period July 1, 2012 to June 30, 2013, or covering the period July 1,
    40  2013  to  June 30, 2014, or covering the period July 1, 2014 to June 30,
    41  2015, or covering the period July 1, 2015 to June 30, 2016, or  covering
    42  the period July 1, 2016 to June 30, 2017, or covering the period July 1,
    43  2017  to  June 30, 2018, or covering the period July 1, 2018 to June 30,
    44  2019, or covering the period July 1, 2019 to June 30, 2020, or  covering
    45  the period July 1, 2020 to June 30, 2021, or covering the period July 1,
    46  2021  to  June 30, 2022, or covering the period July 1, 2022 to June 30,
    47  2023, or covering the period July 1, 2023 to June 30, 2024, or  covering
    48  the  period  July 1, 2024 to June 30, 2025 determined in accordance with
    49  paragraph (a) of this subdivision fails, refuses  or  neglects  to  make
    50  payment  to  the  provider  of  excess  insurance coverage or equivalent
    51  excess coverage in such time and manner as determined by the superinten-
    52  dent of financial services pursuant to paragraph (b)  of  this  subdivi-
    53  sion,  excess insurance coverage or equivalent excess coverage purchased
    54  for such physician or dentist in accordance with this section  for  such
    55  coverage  period shall be cancelled and shall be null and void as of the

        S. 8307                            54                            A. 8807

     1  first day on or after the commencement of  a  policy  period  where  the
     2  liability for payment pursuant to this subdivision has not been met.
     3    (d)  Each  provider  of excess insurance coverage or equivalent excess
     4  coverage shall notify the superintendent of financial services  and  the
     5  commissioner  of  health or their designee of each physician and dentist
     6  eligible for purchase of a  policy  for  excess  insurance  coverage  or
     7  equivalent  excess coverage covering the period July 1, 1992 to June 30,
     8  1993, or covering the period July 1, 1993 to June 30, 1994, or  covering
     9  the period July 1, 1994 to June 30, 1995, or covering the period July 1,
    10  1995  to  June 30, 1996, or covering the period July 1, 1996 to June 30,
    11  1997, or covering the period July 1, 1997 to June 30, 1998, or  covering
    12  the period July 1, 1998 to June 30, 1999, or covering the period July 1,
    13  1999  to  June 30, 2000, or covering the period July 1, 2000 to June 30,
    14  2001, or covering the period July 1, 2001 to October 29, 2001, or cover-
    15  ing the period April 1, 2002 to June 30, 2002, or  covering  the  period
    16  July  1,  2002  to June 30, 2003, or covering the period July 1, 2003 to
    17  June 30, 2004, or covering the period July 1, 2004 to June 30, 2005,  or
    18  covering the period July 1, 2005 to June 30, 2006, or covering the peri-
    19  od July 1, 2006 to June 30, 2007, or covering the period July 1, 2007 to
    20  June  30, 2008, or covering the period July 1, 2008 to June 30, 2009, or
    21  covering the period July 1, 2009 to June 30, 2010, or covering the peri-
    22  od July 1, 2010 to June 30, 2011, or covering the period July 1, 2011 to
    23  June 30, 2012, or covering the period July 1, 2012 to June 30, 2013,  or
    24  covering the period July 1, 2013 to June 30, 2014, or covering the peri-
    25  od July 1, 2014 to June 30, 2015, or covering the period July 1, 2015 to
    26  June  30, 2016, or covering the period July 1, 2016 to June 30, 2017, or
    27  covering the period July 1, 2017 to June 30, 2018, or covering the peri-
    28  od July 1, 2018 to June 30, 2019, or covering the period July 1, 2019 to
    29  June 30, 2020, or covering the period July 1, 2020 to June 30, 2021,  or
    30  covering the period July 1, 2021 to June 30, 2022, or covering the peri-
    31  od July 1, 2022 to June 30, 2023, or covering the period July 1, 2023 to
    32  June 30, 2024, or covering the period July 1, 2024 to June 30, 2025 that
    33  has made payment to such provider of excess insurance coverage or equiv-
    34  alent  excess coverage in accordance with paragraph (b) of this subdivi-
    35  sion and of each physician  and  dentist  who  has  failed,  refused  or
    36  neglected to make such payment.
    37    (e)  A  provider  of  excess  insurance  coverage or equivalent excess
    38  coverage shall refund to the hospital excess liability pool  any  amount
    39  allocable to the period July 1, 1992 to June 30, 1993, and to the period
    40  July  1,  1993  to June 30, 1994, and to the period July 1, 1994 to June
    41  30, 1995, and to the period July 1, 1995 to June 30, 1996,  and  to  the
    42  period  July 1, 1996 to June 30, 1997, and to the period July 1, 1997 to
    43  June 30, 1998, and to the period July 1, 1998 to June 30, 1999,  and  to
    44  the period July 1, 1999 to June 30, 2000, and to the period July 1, 2000
    45  to  June  30,  2001, and to the period July 1, 2001 to October 29, 2001,
    46  and to the period April 1, 2002 to June 30, 2002, and to the period July
    47  1, 2002 to June 30, 2003, and to the period July 1,  2003  to  June  30,
    48  2004, and to the period July 1, 2004 to June 30, 2005, and to the period
    49  July  1,  2005  to June 30, 2006, and to the period July 1, 2006 to June
    50  30, 2007, and to the period July 1, 2007 to June 30, 2008,  and  to  the
    51  period  July 1, 2008 to June 30, 2009, and to the period July 1, 2009 to
    52  June 30, 2010, and to the period July 1, 2010 to June 30, 2011,  and  to
    53  the period July 1, 2011 to June 30, 2012, and to the period July 1, 2012
    54  to  June  30, 2013, and to the period July 1, 2013 to June 30, 2014, and
    55  to the period July 1, 2014 to June 30, 2015, and to the period  July  1,
    56  2015  to June 30, 2016, to the period July 1, 2016 to June 30, 2017, and

        S. 8307                            55                            A. 8807

     1  to the period July 1, 2017 to June 30, 2018, and to the period  July  1,
     2  2018  to June 30, 2019, and to the period July 1, 2019 to June 30, 2020,
     3  and to the period July 1, 2020 to June 30, 2021, and to the period  July
     4  1,  2021  to  June  30, 2022, and to the period July 1, 2022 to June 30,
     5  2023, and to the period July 1, 2023 to June 30, 2024, and to the period
     6  July 1, 2024 to June 30, 2025 received from the hospital excess  liabil-
     7  ity  pool for purchase of excess insurance coverage or equivalent excess
     8  coverage covering the period July 1, 1992 to June 30, 1993, and covering
     9  the period July 1, 1993 to June 30, 1994, and covering the  period  July
    10  1,  1994  to June 30, 1995, and covering the period July 1, 1995 to June
    11  30, 1996, and covering the period July 1, 1996 to  June  30,  1997,  and
    12  covering  the  period  July  1,  1997 to June 30, 1998, and covering the
    13  period July 1, 1998 to June 30, 1999, and covering the  period  July  1,
    14  1999  to June 30, 2000, and covering the period July 1, 2000 to June 30,
    15  2001, and covering the period July 1, 2001  to  October  29,  2001,  and
    16  covering  the  period  April  1, 2002 to June 30, 2002, and covering the
    17  period July 1, 2002 to June 30, 2003, and covering the  period  July  1,
    18  2003  to June 30, 2004, and covering the period July 1, 2004 to June 30,
    19  2005, and covering the period July 1, 2005 to June 30, 2006, and  cover-
    20  ing  the  period  July 1, 2006 to June 30, 2007, and covering the period
    21  July 1, 2007 to June 30, 2008, and covering the period July 1,  2008  to
    22  June  30,  2009,  and covering the period July 1, 2009 to June 30, 2010,
    23  and covering the period July 1, 2010 to June 30, 2011, and covering  the
    24  period  July  1,  2011 to June 30, 2012, and covering the period July 1,
    25  2012 to June 30, 2013, and covering the period July 1, 2013 to June  30,
    26  2014,  and covering the period July 1, 2014 to June 30, 2015, and cover-
    27  ing the period July 1, 2015 to June 30, 2016, and  covering  the  period
    28  July  1,  2016 to June 30, 2017, and covering the period July 1, 2017 to
    29  June 30, 2018, and covering the period July 1, 2018 to  June  30,  2019,
    30  and  covering the period July 1, 2019 to June 30, 2020, and covering the
    31  period July 1, 2020 to June 30, 2021, and covering the  period  July  1,
    32  2021  to June 30, 2022, and covering the period July 1, 2022 to June 30,
    33  2023 for, and covering the period July 1, 2023 to  June  30,  2024,  and
    34  covering the period July 1, 2024 to June 30, 2025 a physician or dentist
    35  where  such  excess  insurance coverage or equivalent excess coverage is
    36  cancelled in accordance with paragraph (c) of this subdivision.
    37    § 4. Section 40 of chapter 266 of the laws of 1986, amending the civil
    38  practice law and rules  and  other  laws  relating  to  malpractice  and
    39  professional medical conduct, as amended by section 4 of part F of chap-
    40  ter 57 of the laws of 2023, is amended to read as follows:
    41    §  40.  The superintendent of financial services shall establish rates
    42  for policies providing coverage  for  physicians  and  surgeons  medical
    43  malpractice  for the periods commencing July 1, 1985 and ending June 30,
    44  [2024] 2025; provided, however, that notwithstanding any other provision
    45  of law, the superintendent shall not establish or approve  any  increase
    46  in  rates  for  the  period  commencing July 1, 2009 and ending June 30,
    47  2010. The superintendent shall direct insurers to  establish  segregated
    48  accounts  for premiums, payments, reserves and investment income attrib-
    49  utable to such premium periods and shall require periodic reports by the
    50  insurers regarding claims and expenses attributable to such  periods  to
    51  monitor whether such accounts will be sufficient to meet incurred claims
    52  and  expenses. On or after July 1, 1989, the superintendent shall impose
    53  a surcharge on premiums  to  satisfy  a  projected  deficiency  that  is
    54  attributable  to the premium levels established pursuant to this section
    55  for such periods; provided, however, that such  annual  surcharge  shall
    56  not  exceed  eight  percent of the established rate until July 1, [2024]

        S. 8307                            56                            A. 8807

     1  2025, at which time and thereafter such surcharge shall not exceed twen-
     2  ty-five percent of the approved adequate  rate,  and  that  such  annual
     3  surcharges shall continue for such period of time as shall be sufficient
     4  to  satisfy  such  deficiency.  The superintendent shall not impose such
     5  surcharge during the period commencing July 1, 2009 and ending June  30,
     6  2010.  On  and  after  July  1,  1989,  the surcharge prescribed by this
     7  section shall be retained by insurers to the extent  that  they  insured
     8  physicians  and surgeons during the July 1, 1985 through June 30, [2024]
     9  2025 policy periods; in the event  and  to  the  extent  physicians  and
    10  surgeons  were  insured by another insurer during such periods, all or a
    11  pro rata share of the surcharge, as the case may be, shall  be  remitted
    12  to  such  other  insurer  in accordance with rules and regulations to be
    13  promulgated by the superintendent.  Surcharges collected from physicians
    14  and surgeons who were not insured during such policy  periods  shall  be
    15  apportioned  among  all insurers in proportion to the premium written by
    16  each insurer during such policy periods; if a physician or  surgeon  was
    17  insured by an insurer subject to rates established by the superintendent
    18  during  such  policy  periods,  and  at  any time thereafter a hospital,
    19  health maintenance organization, employer or institution is  responsible
    20  for  responding in damages for liability arising out of such physician's
    21  or surgeon's practice of medicine, such responsible  entity  shall  also
    22  remit  to  such  prior  insurer the equivalent amount that would then be
    23  collected as a surcharge if the physician or surgeon  had  continued  to
    24  remain  insured  by  such  prior  insurer. In the event any insurer that
    25  provided coverage during such policy  periods  is  in  liquidation,  the
    26  property/casualty  insurance  security fund shall receive the portion of
    27  surcharges to which the insurer in liquidation would have been entitled.
    28  The surcharges authorized herein shall be deemed to be income earned for
    29  the purposes of section 2303 of the insurance law.  The  superintendent,
    30  in  establishing  adequate  rates and in determining any projected defi-
    31  ciency pursuant to the requirements of this section  and  the  insurance
    32  law,  shall  give  substantial  weight, determined in his discretion and
    33  judgment, to the  prospective  anticipated  effect  of  any  regulations
    34  promulgated  and  laws  enacted  and the public benefit of   stabilizing
    35  malpractice rates and minimizing rate level fluctuation during the peri-
    36  od of time necessary for the development of  more  reliable  statistical
    37  experience  as  to  the  efficacy of such laws and regulations affecting
    38  medical, dental or podiatric malpractice enacted or promulgated in 1985,
    39  1986, by this act and at any other time.  Notwithstanding any  provision
    40  of the insurance law, rates already established and to be established by
    41  the  superintendent pursuant to this section are deemed adequate if such
    42  rates would be adequate when taken together with the maximum  authorized
    43  annual  surcharges to be imposed for a reasonable period of time whether
    44  or not any such annual surcharge has been actually  imposed  as  of  the
    45  establishment of such rates.
    46    §  5. Section 5 and subdivisions (a) and (e) of section 6 of part J of
    47  chapter 63 of the laws of 2001, amending chapter  266  of  the  laws  of
    48  1986,  amending the civil practice law and rules and other laws relating
    49  to malpractice and professional medical conduct, as amended by section 5
    50  of part F of chapter 57 of the laws of 2023,  are  amended  to  read  as
    51  follows:
    52    §  5. The superintendent of financial services and the commissioner of
    53  health shall determine, no later than June 15, 2002, June 15, 2003, June
    54  15, 2004, June 15, 2005, June 15, 2006, June 15, 2007,  June  15,  2008,
    55  June  15,  2009,  June  15, 2010, June 15, 2011, June 15, 2012, June 15,
    56  2013, June 15, 2014, June 15, 2015, June 15, 2016, June 15,  2017,  June

        S. 8307                            57                            A. 8807

     1  15,  2018,  June  15, 2019, June 15, 2020, June 15, 2021, June 15, 2022,
     2  June 15, 2023, [and] June 15, 2024, and June  15,  2025  the  amount  of
     3  funds  available in the hospital excess liability pool, created pursuant
     4  to section 18 of chapter 266 of the laws of 1986, and whether such funds
     5  are  sufficient for purposes of purchasing excess insurance coverage for
     6  eligible participating physicians and dentists during the period July 1,
     7  2001 to June 30, 2002, or July 1, 2002 to June 30, 2003, or July 1, 2003
     8  to June 30, 2004, or July 1, 2004 to June 30, 2005, or July 1,  2005  to
     9  June 30, 2006, or July 1, 2006 to June 30, 2007, or July 1, 2007 to June
    10  30,  2008, or July 1, 2008 to June 30, 2009, or July 1, 2009 to June 30,
    11  2010, or July 1, 2010 to June 30, 2011, or July  1,  2011  to  June  30,
    12  2012,  or  July  1,  2012  to June 30, 2013, or July 1, 2013 to June 30,
    13  2014, or July 1, 2014 to June 30, 2015, or July  1,  2015  to  June  30,
    14  2016,  or  July  1,  2016  to June 30, 2017, or July 1, 2017 to June 30,
    15  2018, or July 1, 2018 to June 30, 2019, or July  1,  2019  to  June  30,
    16  2020,  or  July  1,  2020  to June 30, 2021, or July 1, 2021 to June 30,
    17  2022, or July 1, 2022 to June 30, 2023, or July  1,  2023  to  June  30,
    18  2024, or July 1, 2024 to June 30, 2025 as applicable.
    19    (a)  This section shall be effective only upon a determination, pursu-
    20  ant to section five of this act,  by  the  superintendent  of  financial
    21  services  and  the  commissioner  of health, and a certification of such
    22  determination to the state director of the  budget,  the  chair  of  the
    23  senate  committee  on finance and the chair of the assembly committee on
    24  ways and means, that the amount of funds in the hospital excess  liabil-
    25  ity  pool,  created pursuant to section 18 of chapter 266 of the laws of
    26  1986, is insufficient for purposes of purchasing excess insurance cover-
    27  age for eligible participating physicians and dentists during the period
    28  July 1, 2001 to June 30, 2002, or July 1, 2002 to June 30, 2003, or July
    29  1, 2003 to June 30, 2004, or July 1, 2004 to June 30, 2005, or  July  1,
    30  2005 to June 30, 2006, or July 1, 2006 to June 30, 2007, or July 1, 2007
    31  to  June  30, 2008, or July 1, 2008 to June 30, 2009, or July 1, 2009 to
    32  June 30, 2010, or July 1, 2010 to June 30, 2011, or July 1, 2011 to June
    33  30, 2012, or July 1, 2012 to June 30, 2013, or July 1, 2013 to June  30,
    34  2014,  or  July  1,  2014  to June 30, 2015, or July 1, 2015 to June 30,
    35  2016, or July 1, 2016 to June 30, 2017, or July  1,  2017  to  June  30,
    36  2018,  or  July  1,  2018  to June 30, 2019, or July 1, 2019 to June 30,
    37  2020, or July 1, 2020 to June 30, 2021, or July  1,  2021  to  June  30,
    38  2022, or July 1, 2022 to June 30, 2023, or July 1, 2023 to June 30, 2024
    39  , or July 1, 2024 to June 30, 2025 as applicable.
    40    (e)  The  commissioner  of  health  shall  transfer for deposit to the
    41  hospital excess liability pool created pursuant to section 18 of chapter
    42  266 of the laws of 1986 such amounts as directed by  the  superintendent
    43  of  financial  services  for  the purchase of excess liability insurance
    44  coverage for eligible participating  physicians  and  dentists  for  the
    45  policy  year  July 1, 2001 to June 30, 2002, or July 1, 2002 to June 30,
    46  2003, or July 1, 2003 to June 30, 2004, or July  1,  2004  to  June  30,
    47  2005,  or  July  1,  2005  to June 30, 2006, or July 1, 2006 to June 30,
    48  2007, as applicable, and the cost of administering the  hospital  excess
    49  liability pool for such applicable policy year,  pursuant to the program
    50  established  in  chapter  266  of the laws of 1986, as amended, no later
    51  than June 15, 2002, June 15, 2003, June 15, 2004, June  15,  2005,  June
    52  15,  2006,  June  15, 2007, June 15, 2008, June 15, 2009, June 15, 2010,
    53  June 15, 2011, June 15, 2012, June 15, 2013, June  15,  2014,  June  15,
    54  2015,  June  15, 2016, June 15, 2017, June 15, 2018, June 15, 2019, June
    55  15, 2020, June 15, 2021, June 15, 2022, June 15, 2023,  [and]  June  15,
    56  2024, and June 15, 2025 as applicable.

        S. 8307                            58                            A. 8807

     1    §  6. Section 20 of part H of chapter 57 of the laws of 2017, amending
     2  the New York Health Care Reform Act of 1996 and other laws  relating  to
     3  extending  certain provisions thereto, as amended by section 6 of part F
     4  of chapter 57 of the laws of 2023, is amended to read as follows:
     5    §  20.  Notwithstanding  any  law, rule or regulation to the contrary,
     6  only physicians or dentists who were eligible, and for whom  the  super-
     7  intendent of financial services and the commissioner of health, or their
     8  designee, purchased, with funds available in the hospital excess liabil-
     9  ity  pool,  a  full  or partial policy for excess coverage or equivalent
    10  excess coverage for the coverage period ending the  thirtieth  of  June,
    11  two  thousand [twenty-three] twenty-four, shall be eligible to apply for
    12  such coverage for the coverage period beginning the first of  July,  two
    13  thousand  [twenty-three]  twenty-four;  provided,  however, if the total
    14  number of physicians or dentists for whom such excess coverage or equiv-
    15  alent excess coverage was purchased for the policy year ending the thir-
    16  tieth of June, two thousand [twenty-three] twenty-four exceeds the total
    17  number of physicians or dentists certified as eligible for the  coverage
    18  period  beginning the first of July, two thousand [twenty-three] twenty-
    19  four, then the general hospitals may certify additional eligible  physi-
    20  cians  or  dentists in a number equal to such general hospital's propor-
    21  tional share of the total number of  physicians  or  dentists  for  whom
    22  excess  coverage  or equivalent excess coverage was purchased with funds
    23  available in the hospital excess liability pool as of the  thirtieth  of
    24  June, two thousand [twenty-three] twenty-four, as applied to the differ-
    25  ence  between  the  number of eligible physicians or dentists for whom a
    26  policy for excess coverage or equivalent excess coverage  was  purchased
    27  for  the  coverage  period  ending  the  thirtieth of June, two thousand
    28  [twenty-three] twenty-four and the number of such eligible physicians or
    29  dentists who have applied  for  excess  coverage  or  equivalent  excess
    30  coverage  for the coverage period beginning the first of July, two thou-
    31  sand [twenty-three] twenty-four.
    32    § 7. This act shall take effect immediately and  shall  be  deemed  to
    33  have been in full force and effect on and after April 1, 2024.

    34                                   PART L

    35    Section  1.  Subdivision 9 of section 2803 of the public health law is
    36  REPEALED.
    37    § 2. Section 461-s of the social services law is REPEALED.
    38    § 3. Subdivision 1, paragraph (f) of subdivision 3, paragraphs (a) and
    39  (d) of subdivision 5 and subdivisions 5-a and 12 of  section  2807-m  of
    40  the  public  health  law, subdivision 1, paragraph (f) of subdivision 3,
    41  paragraph (a) of subdivision 5 and subdivision 12 as amended  and  para-
    42  graph (d) of subdivision 5 as added by section 6 of part Y of chapter 56
    43  of  the laws of 2020 and subdivision 5-a as amended by section 6 of part
    44  C of chapter 57 of the laws of 2023, are amended to read as follows:
    45    1.  Definitions. For purposes of this  section,  the  following  defi-
    46  nitions shall apply, unless the context clearly requires otherwise:
    47    (a) ["Clinical research" means patient-oriented research, epidemiolog-
    48  ic  and  behavioral  studies,  or  outcomes research and health services
    49  research that is approved by an institutional review board by  the  time
    50  the clinical research position is filled.
    51    (b) "Clinical research plan" means a plan submitted by a consortium or
    52  teaching  general hospital for a clinical research position which demon-
    53  strates, in a form to be provided by the commissioner, the following:

        S. 8307                            59                            A. 8807

     1    (i) financial support for overhead, supervision, equipment  and  other
     2  resources  equal  to the amount of funding provided pursuant to subpara-
     3  graph (i) of paragraph (b) of subdivision five-a of this section by  the
     4  teaching  general hospital or consortium for the clinical research posi-
     5  tion;
     6    (ii)  experience  the sponsor-mentor and teaching general hospital has
     7  in clinical research and the medical field of the study;
     8    (iii) methods, data collection and anticipated measurable outcomes  of
     9  the clinical research to be performed;
    10    (iv)  training goals, objectives and experience the researcher will be
    11  provided to assess a future career in clinical research;
    12    (v)  scientific  relevance,  merit  and  health  implications  of  the
    13  research to be performed;
    14    (vi)  information  on  potential  scientific  meetings and peer review
    15  journals where research results can be disseminated;
    16    (vii) clear and comprehensive details on the clinical  research  posi-
    17  tion;
    18    (viii) qualifications necessary for the clinical research position and
    19  strategy for recruitment;
    20    (ix)  non-duplication  with other clinical research positions from the
    21  same teaching general hospital or consortium;
    22    (x) methods to track the career of the clinical  researcher  once  the
    23  term of the position is complete; and
    24    (xi)  any  other information required by the commissioner to implement
    25  subparagraph (i) of paragraph (b) of subdivision five-a of this section.
    26    (xii) The clinical review plan submitted in accordance with this para-
    27  graph may be reviewed by the commissioner in consultation  with  experts
    28  outside the department of health.
    29    (c) "Clinical research position" means a post-graduate residency posi-
    30  tion which:
    31    (i)  shall  not  be required in order for the researcher to complete a
    32  graduate medical education program;
    33    (ii) may be reimbursed by other sources but only for costs  in  excess
    34  of  the funding distributed in accordance with subparagraph (i) of para-
    35  graph (b) of subdivision five-a of this section;
    36    (iii) shall exceed the minimum standards  that  are  required  by  the
    37  residency  review  committee in the specialty the researcher has trained
    38  or is currently training;
    39    (iv) shall not be previously funded by the teaching  general  hospital
    40  or  supported by another funding source at the teaching general hospital
    41  in the past three years from the date  the  clinical  research  plan  is
    42  submitted to the commissioner;
    43    (v) may supplement an existing research project;
    44    (vi) shall be equivalent to a full-time position comprising of no less
    45  than thirty-five hours per week for one or two years;
    46    (vii)  shall  provide, or be filled by a researcher who has formalized
    47  instruction in  clinical  research,  including  biostatistics,  clinical
    48  trial design, grant writing and research ethics;
    49    (viii) shall be supervised by a sponsor-mentor who shall either (A) be
    50  employed, contracted for employment or paid through an affiliated facul-
    51  ty  practice  plan  by a teaching general hospital which has received at
    52  least one research grant from the National Institutes of Health  in  the
    53  past five years from the date the clinical research plan is submitted to
    54  the  commissioner;  (B)  maintain  a  faculty  appointment at a medical,
    55  dental or podiatric school located in New York state that  has  received
    56  at  least  one  research grant from the National Institutes of Health in

        S. 8307                            60                            A. 8807

     1  the past five years from the date the clinical research plan is  submit-
     2  ted  to  the  commissioner;  or  (C)  be  collaborating  in the clinical
     3  research plan with  a  researcher  from  another  institution  that  has
     4  received  at  least  one  research grant from the National Institutes of
     5  Health in the past five years from the date the clinical  research  plan
     6  is submitted to the commissioner; and
     7    (ix)  shall  be  filled  by  a  researcher  who is (A) enrolled or has
     8  completed a graduate medical education program, as defined in  paragraph
     9  (i)  of  this  subdivision;  (B)  a  United States citizen, national, or
    10  permanent resident of the  United  States;  and  (C)  a  graduate  of  a
    11  medical,  dental or podiatric school located in New York state, a gradu-
    12  ate or resident in a graduate medical education program, as  defined  in
    13  paragraph  (i) of this subdivision, where the sponsoring institution, as
    14  defined in paragraph (q) of this subdivision, is  located  in  New  York
    15  state,  or  resides  in New York state at the time the clinical research
    16  plan is submitted to the commissioner.
    17    (d)] "Consortium" means an organization or  association,  approved  by
    18  the  commissioner in consultation with the council, of general hospitals
    19  which provide graduate medical education, together with  any  affiliated
    20  site;  provided  that  such organization or association may also include
    21  other providers of health care  services,  medical  schools,  payors  or
    22  consumers,  and which meet other criteria pursuant to subdivision six of
    23  this section.
    24    [(e)] (b) "Council" means the  New  York  state  council  on  graduate
    25  medical education.
    26    [(f)]  (c)  "Direct medical education" means the direct costs of resi-
    27  dents, interns and supervising physicians.
    28    [(g)] (d) "Distribution period" means each calendar year set forth  in
    29  subdivision two of this section.
    30    [(h)]  (e)  "Faculty"  means  persons  who  are  employed  by or under
    31  contract for employment with a teaching general  hospital  or  are  paid
    32  through  a  teaching general hospital's affiliated faculty practice plan
    33  and maintain a faculty appointment at a  medical  school.  Such  persons
    34  shall not be limited to persons with a degree in medicine.
    35    [(i)]  (f)  "Graduate medical education program" means a post-graduate
    36  medical education residency in the  United  States  which  has  received
    37  accreditation  from  a  nationally  recognized accreditation body or has
    38  been approved by  a  nationally  recognized  organization  for  medical,
    39  osteopathic,  podiatric  or dental residency programs including, but not
    40  limited to, specialty boards.
    41    [(j)] (g) "Indirect medical education" means the  estimate  of  costs,
    42  other than direct costs, of educational activities in teaching hospitals
    43  as determined in accordance with the methodology applicable for purposes
    44  of  determining  an  estimate  of  indirect  medical education costs for
    45  reimbursement for inpatient hospital service pursuant to title XVIII  of
    46  the federal social security act (medicare).
    47    [(k)]  (h) "Medicare" means the methodology used for purposes of reim-
    48  bursing inpatient hospital services provided to beneficiaries  of  title
    49  XVIII of the federal social security act.
    50    [(l)]  (i)  "Primary  care" residents specialties shall include family
    51  medicine, general pediatrics, primary care internal medicine, and prima-
    52  ry care obstetrics and gynecology. In determining whether a residency is
    53  in primary care, the commissioner shall consult with the council.
    54    [(m)] (j) "Regions", for purposes of  this  section,  shall  mean  the
    55  regions  as  defined  in paragraph (b) of subdivision sixteen of section
    56  twenty-eight hundred seven-c of this article as in effect on June  thir-

        S. 8307                            61                            A. 8807

     1  tieth, nineteen hundred ninety-six. For purposes of distributions pursu-
     2  ant  to subdivision five-a of this section, except distributions made in
     3  accordance with paragraph (a) of subdivision  five-a  of  this  section,
     4  "regions" shall be defined as New York city and the rest of the state.
     5    [(n)]  (k)  "Regional pool" means a professional education pool estab-
     6  lished on a regional basis by  the  commissioner  from  funds  available
     7  pursuant  to  sections  twenty-eight  hundred  seven-s  and twenty-eight
     8  hundred seven-t of this article.
     9    [(o)] (l) "Resident" means a person in a  graduate  medical  education
    10  program  which  has  received accreditation from a nationally recognized
    11  accreditation body or in a program  approved  by  any  other  nationally
    12  recognized  organization  for  medical,  osteopathic or dental residency
    13  programs including, but not limited to, specialty boards.
    14    [(p) "Shortage specialty" means a specialty determined by the  commis-
    15  sioner,  in  consultation with the council, to be in short supply in the
    16  state of New York.
    17    (q)] (m) "Sponsoring institution" means the entity that has the  over-
    18  all  responsibility  for  a  program of graduate medical education. Such
    19  institutions shall include teaching general hospitals, medical  schools,
    20  consortia and diagnostic and treatment centers.
    21    [(r)]  (n)  "Weighted  resident count" means a teaching general hospi-
    22  tal's total number of residents as of July first, nineteen hundred nine-
    23  ty-five,  including  residents  in  affiliated  non-hospital  ambulatory
    24  settings,  reported  to  the  commissioner.  Such  resident counts shall
    25  reflect the weights established in accordance with rules and regulations
    26  adopted by the state hospital review and planning council  and  approved
    27  by the commissioner for purposes of implementing subdivision twenty-five
    28  of section twenty-eight hundred seven-c of this article and in effect on
    29  July  first,  nineteen  hundred  ninety-five.  Such weights shall not be
    30  applied to specialty hospitals, specified  by  the  commissioner,  whose
    31  primary  care  mission  is  to engage in research, training and clinical
    32  care in specialty  eye  and  ear,  special  surgery,  orthopedic,  joint
    33  disease, cancer, chronic care or rehabilitative services.
    34    [(s)]  (o)  "Adjustment  amount"  means  an amount determined for each
    35  teaching hospital for periods prior to January first, two thousand  nine
    36  by:
    37    (i)  determining the difference between (A) a calculation of what each
    38  teaching general hospital would have been paid if payments made pursuant
    39  to paragraph (a-3) of subdivision one of  section  twenty-eight  hundred
    40  seven-c  of this article between January first, nineteen hundred ninety-
    41  six and December thirty-first, two thousand three were based  solely  on
    42  the  case  mix  of  persons  eligible  for  medical assistance under the
    43  medical assistance program pursuant to title eleven of article  five  of
    44  the social services law who are enrolled in health maintenance organiza-
    45  tions and persons paid for under the family health plus program enrolled
    46  in  approved organizations pursuant to title eleven-D of article five of
    47  the social services law during those years, and (B) the actual  payments
    48  to  each such hospital pursuant to paragraph (a-3) of subdivision one of
    49  section twenty-eight hundred seven-c of  this  article  between  January
    50  first,  nineteen hundred ninety-six and December thirty-first, two thou-
    51  sand three.
    52    (ii) reducing proportionally each of the amounts determined in subpar-
    53  agraph (i) of this paragraph so that the sum of all such amounts  totals
    54  no more than one hundred million dollars;
    55    (iii)  further reducing each of the amounts determined in subparagraph
    56  (ii) of this paragraph by the amount received  by  each  hospital  as  a

        S. 8307                            62                            A. 8807

     1  distribution  from funds designated in paragraph (a) of subdivision five
     2  of this section attributable to the period January first,  two  thousand
     3  three  through December thirty-first, two thousand three, except that if
     4  such  amount  was  provided  to  a  consortium  then  the  amount of the
     5  reduction for each hospital in the consortium  shall  be  determined  by
     6  applying  the  proportion  of  each  hospital's  amount determined under
     7  subparagraph (i) of this paragraph to the total of such amounts  of  all
     8  hospitals in such consortium to the consortium award;
     9    (iv)  further  reducing each of the amounts determined in subparagraph
    10  (iii) of this paragraph by the amounts specified in paragraph [(t)]  (p)
    11  of this subdivision; and
    12    (v)  dividing  each of the amounts determined in subparagraph (iii) of
    13  this paragraph by seven.
    14    [(t)] (p) "Extra reduction amount" shall mean an amount determined for
    15  a teaching hospital for which an adjustment amount is calculated  pursu-
    16  ant  to  paragraph  [(s)] (o) of this subdivision that is the hospital's
    17  proportionate share of the sum of the  amounts  specified  in  paragraph
    18  [(u)]  (q) of this subdivision determined based upon a comparison of the
    19  hospital's remaining liability calculated pursuant  to  paragraph  [(s)]
    20  (o)  of  this  subdivision  to  the sum of all such hospital's remaining
    21  liabilities.
    22    [(u)] (q) "Allotment amount"  shall  mean  an  amount  determined  for
    23  teaching hospitals as follows:
    24    (i)  for  a  hospital for which an adjustment amount pursuant to para-
    25  graph [(s)] (o) of this subdivision does not apply, the amount  received
    26  by  the  hospital  pursuant to paragraph (a) of subdivision five of this
    27  section attributable to the period January  first,  two  thousand  three
    28  through December thirty-first, two thousand three, or
    29    (ii)  for  a hospital for which an adjustment amount pursuant to para-
    30  graph [(s)] (o)  of  this  subdivision  applies  and  which  received  a
    31  distribution  pursuant  to  paragraph  (a)  of  subdivision five of this
    32  section attributable to the period January  first,  two  thousand  three
    33  through  December  thirty-first, two thousand three that is greater than
    34  the hospital's adjustment amount, the difference  between  the  distrib-
    35  ution amount and the adjustment amount.
    36    (f)  Effective January first, two thousand five through December thir-
    37  ty-first, two thousand  eight,  each  teaching  general  hospital  shall
    38  receive  a  distribution  from the applicable regional pool based on its
    39  distribution amount determined under paragraphs (c), (d) and (e) of this
    40  subdivision and reduced by its adjustment amount calculated pursuant  to
    41  paragraph [(s)] (o) of subdivision one of this section and, for distrib-
    42  utions  for the period January first, two thousand five through December
    43  thirty-first, two thousand five, further reduced by its extra  reduction
    44  amount  calculated pursuant to paragraph [(t)] (p) of subdivision one of
    45  this section.
    46    (a) Up to thirty-one million dollars annually for the periods  January
    47  first,  two  thousand through December thirty-first, two thousand three,
    48  and up to twenty-five million dollars plus the sum of the amounts speci-
    49  fied in paragraph [(n)] (k) of subdivision one of this section  for  the
    50  period  January  first, two thousand five through December thirty-first,
    51  two thousand five, and up to thirty-one million dollars annually for the
    52  period January first, two thousand six  through  December  thirty-first,
    53  two  thousand seven, shall be set aside and reserved by the commissioner
    54  from the regional pools established pursuant to subdivision two of  this
    55  section for supplemental distributions in each such region to be made by
    56  the  commissioner to consortia and teaching general hospitals in accord-

        S. 8307                            63                            A. 8807

     1  ance with a distribution methodology developed in consultation with  the
     2  council  and  specified  in rules and regulations adopted by the commis-
     3  sioner.
     4    (d)  Notwithstanding any other provision of law or regulation, for the
     5  period January first, two thousand five through  December  thirty-first,
     6  two  thousand  five,  the  commissioner shall distribute as supplemental
     7  payments the allotment specified in paragraph [(n)] (k)  of  subdivision
     8  one of this section.
     9    5-a.  Graduate  medical  education  innovations pool. (a) Supplemental
    10  distributions. (i) Thirty-one million dollars  for  the  period  January
    11  first,  two  thousand  eight through December thirty-first, two thousand
    12  eight, shall be set aside and reserved  by  the  commissioner  from  the
    13  regional  pools  established pursuant to subdivision two of this section
    14  and shall be available for distributions pursuant to subdivision five of
    15  this section and in accordance with section 86-1.89 of title 10  of  the
    16  codes,  rules  and  regulations of the state of New York as in effect on
    17  January first, two thousand eight[; provided, however, for  purposes  of
    18  funding  the  empire  clinical research investigation program (ECRIP) in
    19  accordance with paragraph eight of subdivision (e) and paragraph two  of
    20  subdivision  (f)  of section 86-1.89 of title 10 of the codes, rules and
    21  regulations of the state of New York, distributions shall be made  using
    22  two  regions  defined as New York city and the rest of the state and the
    23  dollar amount set forth in subparagraph (i) of paragraph two of subdivi-
    24  sion (f) of section 86-1.89 of title 10 of the codes,  rules  and  regu-
    25  lations  of the state of New York shall be increased from sixty thousand
    26  dollars to seventy-five thousand dollars].
    27    (ii) For periods on  and  after  January  first,  two  thousand  nine,
    28  supplemental  distributions pursuant to subdivision five of this section
    29  and in accordance with section 86-1.89 of title 10 of the  codes,  rules
    30  and regulations of the state of New York shall no longer be made and the
    31  provisions  of section 86-1.89 of title 10 of the codes, rules and regu-
    32  lations of the state of New York shall be null and void.
    33    (b) [Empire  clinical  research  investigator  program  (ECRIP).  Nine
    34  million  one  hundred  twenty  thousand  dollars annually for the period
    35  January first, two thousand  nine  through  December  thirty-first,  two
    36  thousand  ten,  and  two million two hundred eighty thousand dollars for
    37  the period January first, two thousand  eleven,  through  March  thirty-
    38  first,  two  thousand  eleven,  nine million one hundred twenty thousand
    39  dollars each state fiscal year for the period April first, two  thousand
    40  eleven  through  March  thirty-first, two thousand fourteen, up to eight
    41  million six hundred twelve thousand dollars each state fiscal  year  for
    42  the  period  April  first,  two  thousand fourteen through March thirty-
    43  first, two thousand seventeen, up to eight million  six  hundred  twelve
    44  thousand  dollars each state fiscal year for the period April first, two
    45  thousand seventeen through March thirty-first, two thousand  twenty,  up
    46  to  eight  million six hundred twelve thousand dollars each state fiscal
    47  year for the period April first, two thousand twenty through March thir-
    48  ty-first, two thousand twenty-three, and up to eight million six hundred
    49  twelve thousand dollars each state fiscal  year  for  the  period  April
    50  first,  two  thousand twenty-three through March thirty-first, two thou-
    51  sand twenty-six, shall be set aside and  reserved  by  the  commissioner
    52  from  the regional pools established pursuant to subdivision two of this
    53  section to be allocated regionally  with  two-thirds  of  the  available
    54  funding  going  to  New York city and one-third of the available funding
    55  going to the rest of the state and shall be available  for  distribution
    56  as follows:

        S. 8307                            64                            A. 8807

     1    Distributions  shall  first  be made to consortia and teaching general
     2  hospitals for the empire clinical research investigator program  (ECRIP)
     3  to  help  secure federal funding for biomedical research, train clinical
     4  researchers, recruit national leaders as faculty to act as mentors,  and
     5  train  residents  and  fellows  in  biomedical  research skills based on
     6  hospital-specific data submitted to the commissioner  by  consortia  and
     7  teaching general hospitals in accordance with clause (G) of this subpar-
     8  agraph.  Such distributions shall be made in accordance with the follow-
     9  ing methodology:
    10    (A) The greatest number of clinical research  positions  for  which  a
    11  consortium  or  teaching general hospital may be funded pursuant to this
    12  subparagraph shall be one percent  of  the  total  number  of  residents
    13  training  at  the consortium or teaching general hospital on July first,
    14  two thousand eight for the  period  January  first,  two  thousand  nine
    15  through December thirty-first, two thousand nine rounded up to the near-
    16  est one position.
    17    (B)  Distributions  made  to a consortium or teaching general hospital
    18  shall equal the product of the total number of clinical  research  posi-
    19  tions  submitted  by  a  consortium  or  teaching  general  hospital and
    20  accepted by the commissioner as meeting the criteria set forth in  para-
    21  graph  (b)  of subdivision one of this section, subject to the reduction
    22  calculation set forth in clause (C)  of  this  subparagraph,  times  one
    23  hundred ten thousand dollars.
    24    (C)  If  the  dollar  amount for the total number of clinical research
    25  positions in the region  calculated  pursuant  to  clause  (B)  of  this
    26  subparagraph  exceeds the total amount appropriated for purposes of this
    27  paragraph, including clinical research positions that continue from  and
    28  were funded in prior distribution periods, the commissioner shall elimi-
    29  nate  one-half  of  the  clinical  research  positions submitted by each
    30  consortium or teaching general hospital rounded down to the nearest  one
    31  position.  Such  reduction shall be repeated until the dollar amount for
    32  the total number of clinical research positions in the region  does  not
    33  exceed  the total amount appropriated for purposes of this paragraph. If
    34  the repeated reduction of the total number of  clinical  research  posi-
    35  tions  in  the region by one-half does not render a total funding amount
    36  that is equal to or less than the total amount reserved for that  region
    37  within  the  appropriation, the funding for each clinical research posi-
    38  tion in that region shall be  reduced  proportionally  in  one  thousand
    39  dollar  increments until the total dollar amount for the total number of
    40  clinical research positions in that region does  not  exceed  the  total
    41  amount  reserved for that region within the appropriation. Any reduction
    42  in funding will be effective for the duration of the award. No  clinical
    43  research  positions that continue from and were funded in prior distrib-
    44  ution periods shall be eliminated or reduced by such methodology.
    45    (D) Each consortium or teaching general  hospital  shall  receive  its
    46  annual distribution amount in accordance with the following:
    47    (I) Each consortium or teaching general hospital with a one-year ECRIP
    48  award  shall  receive  its  annual  distribution  amount  in  full  upon
    49  completion of the requirements set forth in items (I) and (II) of clause
    50  (G) of this subparagraph. The requirements set forth in items  (IV)  and
    51  (V)  of clause (G) of this subparagraph must be completed by the consor-
    52  tium or teaching general hospital in order for the consortium or  teach-
    53  ing  general  hospital  to be eligible to apply for ECRIP funding in any
    54  subsequent funding cycle.
    55    (II) Each consortium or teaching  general  hospital  with  a  two-year
    56  ECRIP  award  shall receive its first annual distribution amount in full

        S. 8307                            65                            A. 8807

     1  upon completion of the requirements set forth in items (I) and  (II)  of
     2  clause  (G)  of  this  subparagraph. Each consortium or teaching general
     3  hospital will receive its second annual distribution amount in full upon
     4  completion  of the requirements set forth in item (III) of clause (G) of
     5  this subparagraph. The requirements set forth in items (IV) and  (V)  of
     6  clause  (G)  of this subparagraph must be completed by the consortium or
     7  teaching general hospital in order for the consortium or teaching gener-
     8  al hospital to be eligible to apply for ECRIP funding in any  subsequent
     9  funding cycle.
    10    (E)  Each  consortium  or teaching general hospital receiving distrib-
    11  utions pursuant to this subparagraph shall reserve seventy-five thousand
    12  dollars to primarily fund salary and fringe  benefits  of  the  clinical
    13  research  position  with  the remainder going to fund the development of
    14  faculty who are involved in biomedical research, training  and  clinical
    15  care.
    16    (F)  Undistributed  or  returned  funds  available  to  fund  clinical
    17  research positions pursuant to this paragraph for a distribution  period
    18  shall  be  available to fund clinical research positions in a subsequent
    19  distribution period.
    20    (G) In order to be eligible for distributions pursuant to this subpar-
    21  agraph, each consortium and teaching general hospital shall  provide  to
    22  the  commissioner by July first of each distribution period, the follow-
    23  ing data and information on a hospital-specific  basis.  Such  data  and
    24  information  shall  be  certified as to accuracy and completeness by the
    25  chief executive officer, chief financial officer or chair of the consor-
    26  tium governing body of each consortium or teaching general hospital  and
    27  shall be maintained by each consortium and teaching general hospital for
    28  five years from the date of submission:
    29    (I)  For  each  clinical  research  position, information on the type,
    30  scope, training objectives,  institutional  support,  clinical  research
    31  experience of the sponsor-mentor, plans for submitting research outcomes
    32  to  peer reviewed journals and at scientific meetings, including a meet-
    33  ing sponsored by the department, the name of a principal contact  person
    34  responsible for tracking the career development of researchers placed in
    35  clinical  research positions, as defined in paragraph (c) of subdivision
    36  one of this section, and who is authorized to certify to the commission-
    37  er that all the requirements of the clinical  research  training  objec-
    38  tives  set  forth  in this subparagraph shall be met. Such certification
    39  shall be provided by July first of each distribution period;
    40    (II) For each clinical research position,  information  on  the  name,
    41  citizenship  status, medical education and training, and medical license
    42  number of the researcher, if applicable, shall be provided  by  December
    43  thirty-first of the calendar year following the distribution period;
    44    (III)  Information on the status of the clinical research plan, accom-
    45  plishments, changes in research activities, progress, and performance of
    46  the researcher shall be provided upon  completion  of  one-half  of  the
    47  award term;
    48    (IV)  A  final report detailing training experiences, accomplishments,
    49  activities and performance of the clinical researcher, and  data,  meth-
    50  ods,  results  and  analyses  of  the  clinical  research  plan shall be
    51  provided three months after the clinical research position ends; and
    52    (V) Tracking information concerning past  researchers,  including  but
    53  not  limited  to (A) background information, (B) employment history, (C)
    54  research status, (D) current research activities, (E)  publications  and
    55  presentations,  (F)  research  support,  and  (G)  any other information
    56  necessary to track the researcher; and

        S. 8307                            66                            A. 8807

     1    (VI) Any other data or information required  by  the  commissioner  to
     2  implement this subparagraph.
     3    (H)  Notwithstanding  any  inconsistent provision of this subdivision,
     4  for periods on and after April first, two thousand thirteen, ECRIP grant
     5  awards shall be made in accordance with rules and regulations promulgat-
     6  ed by the commissioner. Such regulations shall, at a minimum:
     7    (1) provide that ECRIP grant awards shall be made with  the  objective
     8  of  securing  federal funding for biomedical research, training clinical
     9  researchers, recruiting national leaders as faculty to act  as  mentors,
    10  and training residents and fellows in biomedical research skills;
    11    (2)  provide that ECRIP grant applicants may include interdisciplinary
    12  research teams comprised of teaching general hospitals acting in collab-
    13  oration with entities including but  not  limited  to  medical  centers,
    14  hospitals, universities and local health departments;
    15    (3) provide that applications for ECRIP grant awards shall be based on
    16  such  information requested by the commissioner, which shall include but
    17  not be limited to hospital-specific data;
    18    (4) establish the qualifications for  investigators  and  other  staff
    19  required for grant projects eligible for ECRIP grant awards; and
    20    (5)  establish a methodology for the distribution of funds under ECRIP
    21  grant awards.
    22    (c)] Physician loan repayment program. One million nine hundred  sixty
    23  thousand  dollars  for  the  period  January  first,  two thousand eight
    24  through December thirty-first, two  thousand  eight,  one  million  nine
    25  hundred  sixty  thousand dollars for the period January first, two thou-
    26  sand nine through December thirty-first, two thousand nine, one  million
    27  nine  hundred  sixty  thousand dollars for the period January first, two
    28  thousand ten through  December  thirty-first,  two  thousand  ten,  four
    29  hundred  ninety thousand dollars for the period January first, two thou-
    30  sand eleven through March thirty-first, two thousand eleven, one million
    31  seven hundred thousand dollars each state fiscal  year  for  the  period
    32  April  first,  two thousand eleven through March thirty-first, two thou-
    33  sand fourteen, up to one million seven  hundred  five  thousand  dollars
    34  each state fiscal year for the period April first, two thousand fourteen
    35  through  March  thirty-first,  two thousand seventeen, up to one million
    36  seven hundred five thousand dollars each state fiscal year for the peri-
    37  od April first, two thousand seventeen through March  thirty-first,  two
    38  thousand  twenty,  up to one million seven hundred five thousand dollars
    39  each state fiscal year for the period April first, two  thousand  twenty
    40  through  March  thirty-first,  two  thousand twenty-three, and up to one
    41  million seven hundred five thousand dollars each state fiscal  year  for
    42  the  period April first, two thousand twenty-three through March thirty-
    43  first, two thousand twenty-six, shall be set aside and reserved  by  the
    44  commissioner from the regional pools established pursuant to subdivision
    45  two  of  this  section  and shall be available for purposes of physician
    46  loan repayment in accordance  with  subdivision  ten  of  this  section.
    47  Notwithstanding  any  contrary  provision  of this section, sections one
    48  hundred twelve and one hundred sixty-three of the state finance law,  or
    49  any  other  contrary  provision  of law, such funding shall be allocated
    50  regionally with one-third of available funds going to New York city  and
    51  two-thirds  of  available funds going to the rest of the state and shall
    52  be distributed in a manner to be determined by the commissioner  without
    53  a competitive bid or request for proposal process as follows:
    54    (i) Funding shall first be awarded to repay loans of up to twenty-five
    55  physicians  who  train  in  primary care or specialty tracks in teaching

        S. 8307                            67                            A. 8807

     1  general hospitals, and who enter and remain in primary care or specialty
     2  practices in underserved communities, as determined by the commissioner.
     3    (ii)  After  distributions in accordance with subparagraph (i) of this
     4  paragraph, all remaining funds shall be awarded to repay loans of physi-
     5  cians who enter and remain in primary care  or  specialty  practices  in
     6  underserved  communities,  as  determined by the commissioner, including
     7  but not limited to physicians working in  general  hospitals,  or  other
     8  health care facilities.
     9    (iii)  In no case shall less than fifty percent of the funds available
    10  pursuant to this paragraph be distributed in  accordance  with  subpara-
    11  graphs (i) and (ii) of this paragraph to physicians identified by gener-
    12  al hospitals.
    13    (iv)  In addition to the funds allocated under this paragraph, for the
    14  period April first, two thousand fifteen through March thirty-first, two
    15  thousand sixteen,  two  million  dollars  shall  be  available  for  the
    16  purposes described in subdivision ten of this section;
    17    (v)  In  addition to the funds allocated under this paragraph, for the
    18  period April first, two thousand sixteen through March thirty-first, two
    19  thousand seventeen, two million  dollars  shall  be  available  for  the
    20  purposes described in subdivision ten of this section;
    21    (vi) Notwithstanding any provision of law to the contrary, and subject
    22  to the extension of the Health Care Reform Act of 1996, sufficient funds
    23  shall be available for the purposes described in subdivision ten of this
    24  section  in amounts necessary to fund the remaining year commitments for
    25  awards made pursuant to subparagraphs (iv) and (v) of this paragraph.
    26    [(d)] (c) Physician practice support. Four million nine hundred  thou-
    27  sand  dollars  for  the period January first, two thousand eight through
    28  December thirty-first, two thousand eight,  four  million  nine  hundred
    29  thousand  dollars  annually  for  the period January first, two thousand
    30  nine through December thirty-first, two thousand ten,  one  million  two
    31  hundred  twenty-five  thousand dollars for the period January first, two
    32  thousand eleven through March thirty-first, two  thousand  eleven,  four
    33  million  three  hundred  thousand dollars each state fiscal year for the
    34  period April first, two thousand eleven through March thirty-first,  two
    35  thousand  fourteen,  up  to  four  million  three hundred sixty thousand
    36  dollars each state fiscal year for the period April first, two  thousand
    37  fourteen  through March thirty-first, two thousand seventeen, up to four
    38  million three hundred sixty thousand dollars for each state fiscal  year
    39  for  the  period April first, two thousand seventeen through March thir-
    40  ty-first, two thousand twenty, up to four million  three  hundred  sixty
    41  thousand  dollars  for  each fiscal year for the period April first, two
    42  thousand twenty through March thirty-first, two  thousand  twenty-three,
    43  and  up  to  four  million three hundred sixty thousand dollars for each
    44  fiscal year for  the  period  April  first,  two  thousand  twenty-three
    45  through  March thirty-first, two thousand twenty-six, shall be set aside
    46  and reserved by the commissioner from  the  regional  pools  established
    47  pursuant  to  subdivision two of this section and shall be available for
    48  purposes of physician practice  support.  Notwithstanding  any  contrary
    49  provision  of  this section, sections one hundred twelve and one hundred
    50  sixty-three of the state finance law, or any other contrary provision of
    51  law, such funding shall be allocated regionally with one-third of avail-
    52  able funds going to New York city  and  two-thirds  of  available  funds
    53  going  to  the rest of the state and shall be distributed in a manner to
    54  be determined by the commissioner without a competitive bid  or  request
    55  for proposal process as follows:

        S. 8307                            68                            A. 8807

     1    (i)  Preference in funding shall first be accorded to teaching general
     2  hospitals for up to twenty-five awards, to  support  costs  incurred  by
     3  physicians  trained in primary or specialty tracks who thereafter estab-
     4  lish or join practices in underserved communities, as determined by  the
     5  commissioner.
     6    (ii)  After  distributions in accordance with subparagraph (i) of this
     7  paragraph, all remaining funds shall be awarded to physicians to support
     8  the cost of establishing or joining practices  in  underserved  communi-
     9  ties,  as  determined  by  the  commissioner, and to hospitals and other
    10  health care providers to recruit new physicians to provide  services  in
    11  underserved communities, as determined by the commissioner.
    12    (iii)  In no case shall less than fifty percent of the funds available
    13  pursuant to this  paragraph  be  distributed  to  general  hospitals  in
    14  accordance with subparagraphs (i) and (ii) of this paragraph.
    15    [(e)] (d) Work group. For funding available pursuant to paragraphs (b)
    16  and (c)[, (d) and (e)] of this subdivision:
    17    (i)  The  department  shall  appoint a work group from recommendations
    18  made by associations  representing  physicians,  general  hospitals  and
    19  other  health care facilities to develop a streamlined application proc-
    20  ess by June first, two thousand twelve.
    21    (ii) Subject to available funding, applications shall be accepted on a
    22  continuous basis. The department shall provide technical  assistance  to
    23  applicants  to facilitate their completion of applications. An applicant
    24  shall be notified in writing  by  the  department  within  ten  days  of
    25  receipt  of an application as to whether the application is complete and
    26  if the application is incomplete, what information is  outstanding.  The
    27  department  shall act on an application within thirty days of receipt of
    28  a complete application.
    29    [(f)] (e) Study on physician workforce. Five hundred  ninety  thousand
    30  dollars  annually  for  the  period  January  first,  two thousand eight
    31  through December thirty-first, two thousand ten, one hundred forty-eight
    32  thousand dollars for the  period  January  first,  two  thousand  eleven
    33  through  March  thirty-first,  two thousand eleven, five hundred sixteen
    34  thousand dollars each state fiscal year for the period April first,  two
    35  thousand eleven through March thirty-first, two thousand fourteen, up to
    36  four  hundred  eighty-seven  thousand dollars each state fiscal year for
    37  the period April first, two  thousand  fourteen  through  March  thirty-
    38  first,  two thousand seventeen, up to four hundred eighty-seven thousand
    39  dollars for each state fiscal year for the period April first, two thou-
    40  sand seventeen through March thirty-first, two thousand  twenty,  up  to
    41  four  hundred  eighty-seven  thousand dollars each state fiscal year for
    42  the period April first, two thousand twenty through March  thirty-first,
    43  two  thousand twenty-three, and up to four hundred eighty-seven thousand
    44  dollars each state fiscal year for the period April first, two  thousand
    45  twenty-three  through March thirty-first, two thousand twenty-six, shall
    46  be set aside and reserved by the commissioner from  the  regional  pools
    47  established  pursuant  to  subdivision  two of this section and shall be
    48  available to fund a study of physician  workforce  needs  and  solutions
    49  including,  but  not  limited  to, an analysis of residency programs and
    50  projected physician workforce  and  community  needs.  The  commissioner
    51  shall  enter  into  agreements with one or more organizations to conduct
    52  such study based on a request for proposal process.
    53    [(g)] (f) Diversity in medicine/post-baccalaureate  program.  Notwith-
    54  standing any inconsistent provision of section one hundred twelve or one
    55  hundred  sixty-three  of  the  state  finance  law or any other law, one
    56  million nine hundred sixty thousand  dollars  annually  for  the  period

        S. 8307                            69                            A. 8807

     1  January  first,  two  thousand  eight through December thirty-first, two
     2  thousand ten, four hundred ninety thousand dollars for the period  Janu-
     3  ary  first, two thousand eleven through March thirty-first, two thousand
     4  eleven,  one  million  seven  hundred thousand dollars each state fiscal
     5  year for the period April first, two thousand eleven through March thir-
     6  ty-first, two thousand fourteen, up to  one  million  six  hundred  five
     7  thousand  dollars each state fiscal year for the period April first, two
     8  thousand fourteen through March thirty-first, two thousand seventeen, up
     9  to one million six hundred five thousand dollars each state fiscal  year
    10  for  the  period April first, two thousand seventeen through March thir-
    11  ty-first, two thousand twenty, up to one million six hundred five  thou-
    12  sand  dollars  each  state  fiscal  year for the period April first, two
    13  thousand twenty through March thirty-first, two  thousand  twenty-three,
    14  and  up  to  one  million  six  hundred five thousand dollars each state
    15  fiscal year for  the  period  April  first,  two  thousand  twenty-three
    16  through  March thirty-first, two thousand twenty-six, shall be set aside
    17  and reserved by the commissioner from  the  regional  pools  established
    18  pursuant  to  subdivision two of this section and shall be available for
    19  distributions to the Associated Medical Schools of New York to fund  its
    20  diversity program including existing and new post-baccalaureate programs
    21  for  minority  and  economically  disadvantaged  students  and encourage
    22  participation from all medical  schools  in  New  York.  The  associated
    23  medical schools of New York shall report to the commissioner on an annu-
    24  al  basis  regarding  the use of funds for such purpose in such form and
    25  manner as specified by the commissioner.
    26    [(h)] (g) In the event there are undistributed  funds  within  amounts
    27  made  available  for  distributions  pursuant  to this subdivision, such
    28  funds may be  reallocated  and  distributed  in  current  or  subsequent
    29  distribution  periods in a manner determined by the commissioner for any
    30  purpose set forth in this subdivision.
    31    12. Notwithstanding any provision of law to the contrary, applications
    32  submitted on or after April first, two thousand sixteen, for the  physi-
    33  cian  loan repayment program pursuant to paragraph [(c)] (b) of subdivi-
    34  sion five-a of this section and subdivision ten of this section  or  the
    35  physician  practice  support  program pursuant to paragraph [(d)] (c) of
    36  subdivision five-a of this section, shall be subject  to  the  following
    37  changes:
    38    (a)  Awards  shall  be  made  from the total funding available for new
    39  awards under the physician loan  repayment  program  and  the  physician
    40  practice  support  program,  with  neither program limited to a specific
    41  funding amount within such total funding available;
    42    (b) An applicant may apply for an  award  for  either  physician  loan
    43  repayment or physician practice support, but not both;
    44    (c)  An applicant shall agree to practice for three years in an under-
    45  served area and each award shall provide up to  forty  thousand  dollars
    46  for each of the three years; and
    47    (d)  To the extent practicable, awards shall be timed to be of use for
    48  job offers made to applicants.
    49    § 4. Subparagraph (xvi) of paragraph (a) of subdivision 7  of  section
    50  2807-s  of  the  public health law, as amended by section 8 of part Y of
    51  chapter 56 of the laws of 2020, is amended to read as follows:
    52    (xvi) provided further, however, for periods prior to July first,  two
    53  thousand  nine,  amounts set forth in this paragraph shall be reduced by
    54  an amount equal to the actual distribution reductions for all facilities
    55  pursuant to paragraph [(s)] (o) of subdivision one  of  section  twenty-
    56  eight hundred seven-m of this article.

        S. 8307                            70                            A. 8807

     1    §  5.  Subdivision  (c)  of section 92-dd of the state finance law, as
     2  amended by section 9 of part Y of chapter 56 of the  laws  of  2020,  is
     3  amended to read as follows:
     4    (c)  The pool administrator shall, from appropriated funds transferred
     5  to the  pool  administrator  from  the  comptroller,  continue  to  make
     6  payments  as required pursuant to sections twenty-eight hundred seven-k,
     7  twenty-eight hundred seven-m (not including payments  made  pursuant  to
     8  subdivision five-b and paragraphs (b), (c)[, (d),, (f)] and [(g)] (f) of
     9  subdivision  five-a  of section twenty-eight hundred seven-m), and twen-
    10  ty-eight hundred seven-w of the public  health  law,  paragraph  (e)  of
    11  subdivision  twenty-five  of section twenty-eight hundred seven-c of the
    12  public health law, paragraphs (b)  and  (c)  of  subdivision  thirty  of
    13  section twenty-eight hundred seven-c of the public health law, paragraph
    14  (b) of subdivision eighteen of section twenty-eight hundred eight of the
    15  public health law, subdivision seven of section twenty-five hundred-d of
    16  the  public  health  law  and section eighty-eight of chapter one of the
    17  laws of nineteen hundred ninety-nine.
    18    § 6. Paragraph (c) of subdivision 1 of section  461-b  of  the  social
    19  services law is REPEALED.
    20    § 7. Article 27-H of the public health law is REPEALED.
    21    §  8.  Paragraph  (c)  of  subdivision 11 of section 230 of the public
    22  health law, as amended by chapter 343 of the laws of 1980,  subparagraph
    23  (ii)  as  amended  by  section 10 of part B of chapter 57 of the laws of
    24  2023, is amended to read as follows:
    25    (c) Notwithstanding the foregoing, no physician shall  be  responsible
    26  for reporting pursuant to paragraph (a) of this subdivision with respect
    27  to any information discovered by such physician solely as a result of:
    28    [(i)] Participation in a properly conducted mortality and/or morbidity
    29  conference,  departmental  meeting  or  a  medical  or  tissue committee
    30  constituted pursuant to the by-laws of a hospital which is  duly  estab-
    31  lished pursuant to article twenty-eight of the public health law, unless
    32  the  procedures  of  such  conference,  department  or committee of such
    33  hospital shall have been declared to be  unacceptable  for  the  purpose
    34  hereof by the commissioner, and provided that the obligations of report-
    35  ing such information when appropriate to do so shall be the responsibil-
    36  ity of the chairperson of such conference, department or committee, or
    37    [(ii)  Participation  and membership during a three year demonstration
    38  period in a physician committee of the Medical Society of the  State  of
    39  New  York  or the New York State Osteopathic Society whose purpose is to
    40  confront and refer to treatment physicians who are thought to be suffer-
    41  ing from alcoholism, drug abuse, or mental illness.  Such  demonstration
    42  period shall commence on April first, nineteen hundred eighty and termi-
    43  nate  on May thirty-first, nineteen hundred eighty-three.  An additional
    44  demonstration period shall commence  on  June  first,  nineteen  hundred
    45  eighty-three  and  terminate  on  March  thirty-first,  nineteen hundred
    46  eighty-six. An additional demonstration period shall commence  on  April
    47  first,  nineteen hundred eighty-six and terminate on March thirty-first,
    48  nineteen hundred eighty-nine. An additional demonstration  period  shall
    49  commence  April  first, nineteen hundred eighty-nine and terminate March
    50  thirty-first, nineteen hundred ninety-two. An  additional  demonstration
    51  period  shall  commence  April  first,  nineteen  hundred ninety-two and
    52  terminate March thirty-first, nineteen  hundred  ninety-five.  An  addi-
    53  tional  demonstration  period  shall  commence  on April first, nineteen
    54  hundred  ninety-five  and  terminate  on  March  thirty-first,  nineteen
    55  hundred  ninety-eight. An additional demonstration period shall commence
    56  on April first, nineteen hundred ninety-eight  and  terminate  on  March

        S. 8307                            71                            A. 8807

     1  thirty-first,  two  thousand  three.  An additional demonstration period
     2  shall commence on April first, two thousand three and terminate on March
     3  thirty-first, two thousand thirteen. An additional demonstration  period
     4  shall commence April first, two thousand thirteen and terminate on March
     5  thirty-first,  two thousand eighteen. An additional demonstration period
     6  shall commence April first, two thousand eighteen and terminate on  July
     7  first, two thousand twenty-eight provided, however, that the commission-
     8  er may prescribe requirements for the continuation of such demonstration
     9  program,  including  periodic reviews of such programs and submission of
    10  any reports and data necessary to  permit  such  reviews.  During  these
    11  additional periods, the provisions of this subparagraph shall also apply
    12  to a physician committee of a county medical society.]
    13    §  9.  Paragraph  (g)  of  subdivision 11 of section 230 of the public
    14  health law is REPEALED and paragraph (h) is relettered paragraph (g).
    15    § 10. This act shall take effect immediately and shall  be  deemed  to
    16  have been in full force and effect on and after April 1, 2024; provided,
    17  however, the amendments to subparagraph (xvi) of paragraph (a) of subdi-
    18  vision 7 of section 2807-s of the public health law made by section four
    19  of this act shall not affect the expiration of such section and shall be
    20  deemed to expire therewith.

    21                                   PART M

    22    Section 1. Subparagraph 3 of paragraph (b) of subdivision 4 of section
    23  366 of the social services law, as added by section 2 of part D of chap-
    24  ter 56 of the laws of 2013, is amended to read as follows:
    25    (3) (A) A child [under] between the [age] ages of six and nineteen who
    26  is  determined  eligible  for medical assistance under the provisions of
    27  this section, shall, consistent with  applicable  federal  requirements,
    28  remain eligible for such assistance until [the earlier of:
    29    (i)]  the  last  day of the month which is twelve months following the
    30  determination [or redetermination] or renewal of  eligibility  for  such
    31  assistance[; or
    32    (ii)  the  last day of the month in which the child reaches the age of
    33  nineteen].
    34    (B) A child under the age  of  six  who  is  determined  eligible  for
    35  medical assistance under the provisions of this section, shall, consist-
    36  ent  with  applicable federal requirements, remain continuously eligible
    37  for medical assistance coverage until the later of:
    38    (i) the last day of the twelfth month following the  determination  or
    39  renewal of eligibility for such assistance; or
    40    (ii)  the  last day of the month in which the child reaches the age of
    41  six.
    42    § 2. Subdivision 6 of section 2510 of the public health law is amended
    43  by adding a new paragraph (e) to read as follows:
    44    (e) an eligible child under six years of age  shall,  consistent  with
    45  applicable  federal requirements, remain continuously enrolled until the
    46  later of:
    47    (i) the last day of the twelfth month following the date of enrollment
    48  or recertification in the child health insurance plan; or
    49    (ii) the last day of the month in which the child reaches the  age  of
    50  six.
    51    § 3. This act shall take effect January 1, 2025.

    52                                   PART N

        S. 8307                            72                            A. 8807

     1    Section 1. Paragraph (d) of subdivision 4 of section 206 of the public
     2  health  law, as added by chapter 602 of the laws of 2007, is amended and
     3  a new paragraph (e) is added  to read as follows:
     4    (d)  assess  civil  penalties  against  a  public  water  system which
     5  provides water to the public for  human  consumption  through  pipes  or
     6  other  constructed conveyances, as further defined in the state sanitary
     7  code or, in the case  of  mass  gatherings,  the  person  who  holds  or
     8  promotes  the  mass  gathering as defined in subdivision five of section
     9  two hundred twenty-five of this article not to exceed twenty-five  thou-
    10  sand  dollars  per  day, for each violation of or failure to comply with
    11  any term or provision of the state sanitary code as it relates to public
    12  water systems that serve a population of five thousand or  more  persons
    13  or any mass gatherings, which penalty may be assessed after a hearing or
    14  an opportunity to be heard[.];
    15    (e) notwithstanding section sixty-five hundred thirty of the education
    16  law,  issue  a  non-patient  specific  statewide  standing order for the
    17  provision of doula services for pregnant, birthing, and postpartum indi-
    18  viduals through twelve months postpartum.
    19    § 2.  Subdivision 3 of section 2504 of the public health law, as added
    20  by chapter 976 of the laws of 1984, is amended to read as follows:
    21    3. Any person, including a minor, who is pregnant may  give  effective
    22  consent  for  any  and all medical, dental, health and hospital services
    23  relating to [prenatal] reproductive health care,  including  consent  to
    24  terminate a pregnancy for any reason.
    25    §  3.  The  opening  paragraph of section 2599-aa of the public health
    26  law, as added by chapter 1 of the laws of 2019, is amended  to  read  as
    27  follows:
    28    The legislature finds that comprehensive reproductive health care is a
    29  fundamental   component   of  every  individual's  health,  privacy  and
    30  equality, including minors. Therefore, it is the  policy  of  the  state
    31  that:
    32    §  4.  The  public  health  law  is  amended  by  adding a new section
    33  2599-bb-1 to read as follows:
    34    § 2599-bb-1. Contraception. 1. A health  care  practitioner  licensed,
    35  certified,  or authorized under title eight of the education law, acting
    36  within their lawful scope of practice, may  prescribe  or  distribute  a
    37  contraceptive device or medication when, according to the practitioner's
    38  reasonable  and  good  faith professional judgment based on the facts of
    39  the patient's case, they determine the  patient  is  able  to  medically
    40  tolerate such treatment.
    41    2.  This  article  shall  be construed and applied consistent with and
    42  subject to applicable laws and  applicable  and  authorized  regulations
    43  governing health care procedures.
    44    §  5.  This  act  shall take effect immediately and shall be deemed to
    45  have been in full force and effect on and after April 1, 2024.

    46                                   PART O

    47    Section 1. Subdivision 1 of section 2807-k of the public health law is
    48  amended by adding a new paragraph (h) to read as follows:
    49    (h) "Underinsured" shall mean an individual with out of pocket medical
    50  costs that amount to more than ten percent of  such  individual's  gross
    51  annual income for the past twelve months.
    52    §  2.  Subdivision  9-a of section 2807-k of the public health law, as
    53  added by section 39-a of part A of chapter 57 of the laws  of  2006  and

        S. 8307                            73                            A. 8807

     1  paragraph (k) as added by section 43 of part B of chapter 58 of the laws
     2  of 2008, is amended to read as follows:
     3    9-a.  (a)  As  a  condition  for  participation  in pool distributions
     4  authorized pursuant to this section  and  section  twenty-eight  hundred
     5  seven-w  of  this  article  for  periods on and after January first, two
     6  thousand nine, general hospitals shall, effective  for  periods  on  and
     7  after  January  first, two thousand seven, establish financial aid poli-
     8  cies and procedures, in accordance with the provisions of this  subdivi-
     9  sion,  for  reducing charges otherwise applicable to low-income individ-
    10  uals without health insurance or underinsured individuals, or  who  have
    11  exhausted  their  health  insurance benefits, and who can demonstrate an
    12  inability to pay full charges, and also, at the  hospital's  discretion,
    13  for  reducing  or  discounting  the collection of co-pays and deductible
    14  payments from those individuals who can demonstrate an inability to  pay
    15  such amounts.
    16    (b) Such reductions from charges for [uninsured] patients with incomes
    17  below at least [three] four hundred percent of the federal poverty level
    18  shall  result  in a charge to such individuals that does not exceed [the
    19  greater of] the amount that would have been paid for the  same  services
    20  [by  the  "highest volume payor" for such general hospital as defined in
    21  subparagraph (v) of this paragraph, or for services provided pursuant to
    22  title XVIII of the  federal  social  security  act  (medicare),  or  for
    23  services]  provided pursuant to title XIX of the federal social security
    24  act (medicaid), and provided further that such amounts shall be adjusted
    25  according to income level as follows:
    26    (i) For patients with incomes [at or] below at least [one] two hundred
    27  percent of the federal poverty level, the  hospital  shall  [collect  no
    28  more  than  a  nominal payment amount, consistent with guidelines estab-
    29  lished by the commissioner] waive all charges. No nominal payment  shall
    30  be collected;
    31    (ii)  For  patients  with  incomes  between at least [one] two hundred
    32  [one] percent and [one] up to  three  hundred  [fifty]  percent  of  the
    33  federal  poverty  level,  the  hospital  shall  collect no more than the
    34  amount identified after application of a proportional sliding fee sched-
    35  ule under which patients with lower incomes shall pay the lowest amount.
    36  Such schedule shall provide that the amount the hospital may collect for
    37  such patients increases [from the nominal amount described  in  subpara-
    38  graph  (i)  of  this paragraph] in equal increments as the income of the
    39  patient increases, up to a  maximum  of  [twenty]  ten  percent  of  the
    40  [greater  of the] amount that would have been paid for the same services
    41  [by the "highest volume payor" for such general hospital, as defined  in
    42  subparagraph (v) of this paragraph, or for services provided pursuant to
    43  title  XVIII  of  the  federal  social  security  act  (medicare) or for
    44  services] provided pursuant to title XIX of the federal social  security
    45  act  (medicaid),  or  for  underinsured patients, up to a maximum of ten
    46  percent of the amount  that  would  have  been  paid  pursuant  to  such
    47  patient's insurance cost sharing;
    48    (iii)  For  patients with incomes between at least [one] three hundred
    49  [fifty-one] one percent and [two] four hundred [fifty]  percent  of  the
    50  federal  poverty  level,  the  hospital  shall  collect no more than the
    51  amount identified after application of a proportional sliding fee sched-
    52  ule under which patients with lower income shall pay the lowest amounts.
    53  Such schedule shall provide that the amount the hospital may collect for
    54  such patients increases from the [twenty] ten percent  figure  described
    55  in subparagraph (ii) of this paragraph in equal increments as the income
    56  of  the  patient  increases,  up  to  a  maximum of [the greater] twenty

        S. 8307                            74                            A. 8807

     1  percent of the amount that would have been paid for  the  same  services
     2  [by  the "highest volume payor" for such general hospital, as defined in
     3  subparagraph (v) of this paragraph, or for services provided pursuant to
     4  title  XVIII  of  the  federal  social  security  act  (medicare) or for
     5  services] provided pursuant to title XIX of the federal social  security
     6  act  (medicaid), or for underinsured patients, up to a maximum of twenty
     7  percent of the amount  that  would  have  been  paid  pursuant  to  such
     8  patient's insurance cost sharing; [and
     9    (iv)  For patients with incomes between at least two hundred fifty-one
    10  percent and three hundred percent of  the  federal  poverty  level,  the
    11  hospital shall collect no more than the greater of the amount that would
    12  have  been  paid for the same services by the "highest volume payor" for
    13  such general hospital as defined in subparagraph (v) of this  paragraph,
    14  or  for  services provided pursuant to title XVIII of the federal social
    15  security act (medicare), or for services provided pursuant to title  XIX
    16  of the federal social security act (medicaid).
    17    (v)  For  the purposes of this paragraph, "highest volume payor" shall
    18  mean the insurer, corporation or  organization  licensed,  organized  or
    19  certified  pursuant  to  article thirty-two, forty-two or forty-three of
    20  the insurance law or article forty-four of this chapter, or other third-
    21  party payor, which has  a  contract  or  agreement  to  pay  claims  for
    22  services  provided  by  the  general  hospital  and incurred the highest
    23  volume of claims in the previous calendar year.
    24    (vi) A hospital may implement policies and procedures to  permit,  but
    25  not  require, consideration on a case-by-case basis of exceptions to the
    26  requirements described in subparagraphs (i) and (ii) of  this  paragraph
    27  based upon the existence of significant assets owned by the patient that
    28  should  be  taken  into  account  in determining the appropriate payment
    29  amount for that patient's care, provided, however,  that  such  proposed
    30  policies  and  procedures  shall  be  subject  to  the  prior review and
    31  approval of the commissioner and, if approved, shall be included in  the
    32  hospital's  financial  assistance  policy  established  pursuant to this
    33  section, and provided further that, if such  approval  is  granted,  the
    34  maximum amount that may be collected shall not exceed the greater of the
    35  amount  that  would have been paid for the same services by the "highest
    36  volume payor" for such general hospital as defined in  subparagraph  (v)
    37  of  this  paragraph, or for services provided pursuant to title XVIII of
    38  the federal social security act (medicare),  or  for  services  provided
    39  pursuant  to title XIX of the federal social security act (medicaid). In
    40  the event that a general hospital reviews a patient's assets  in  deter-
    41  mining  payment  adjustments  such  policies  and  procedures  shall not
    42  consider as assets a patient's primary residence, assets held in a  tax-
    43  deferred  or  comparable  retirement  savings  account,  college savings
    44  accounts, or cars used  regularly  by  a  patient  or  immediate  family
    45  members.
    46    (vii)]  (iv)  Nothing  in this paragraph shall be construed to limit a
    47  hospital's  ability  to  establish  patient  eligibility   for   payment
    48  discounts  at income levels higher than those specified herein and/or to
    49  provide greater payment  discounts  for  eligible  patients  than  those
    50  required by this paragraph.
    51    (c)  Such  policies  and procedures shall be clear, understandable, in
    52  writing and publicly available in summary form and each general hospital
    53  participating in the pool shall ensure that every patient is made  aware
    54  of  the  existence of such policies and procedures and is provided, in a
    55  timely manner, with a summary of  such  policies  and  procedures  [upon
    56  request].  Any summary provided to patients shall, at a minimum, include

        S. 8307                            75                            A. 8807

     1  specific information as to income levels used to  determine  eligibility
     2  for  assistance, a description of the primary service area of the hospi-
     3  tal and the means of applying for assistance. For general hospitals with
     4  twenty-four  hour  emergency  departments,  such policies and procedures
     5  shall require the written notification of patients during the intake and
     6  registration process, and during discharge of the patient,  and  through
     7  the  conspicuous  posting  of  language-appropriate  information  in the
     8  general hospital, and  information  on  bills  and  statements  sent  to
     9  patients,  that financial aid may be available to qualified patients and
    10  how to obtain further information. For specialty hospitals without twen-
    11  ty-four hour emergency departments, such notification shall  take  place
    12  through  written  materials  provided  to patients during the intake and
    13  registration process prior to the provision of any health care  services
    14  or procedures, and during discharge of the patient, and through informa-
    15  tion on bills and statements sent to patients, that financial aid may be
    16  available  to  qualified patients and how to obtain further information.
    17  Application materials shall include  a  notice  to  patients  that  upon
    18  submission  of  a  completed  application,  including any information or
    19  documentation needed to determine the patient's eligibility pursuant  to
    20  the  hospital's  financial  assistance policy, the patient may disregard
    21  any bills until the hospital has rendered a decision on the  application
    22  in accordance with this paragraph.
    23    (d) Such policies and procedures shall include clear, objective crite-
    24  ria  for  determining  a patient's ability to pay and for providing such
    25  adjustments to payment requirements as are  necessary.  In  addition  to
    26  adjustment  mechanisms  such  as  sliding fee schedules and discounts to
    27  fixed standards, such policies and procedures shall also provide for the
    28  use of installment plans for the  payment  of  outstanding  balances  by
    29  patients  pursuant to the provisions of the hospital's financial assist-
    30  ance policy. The monthly payment under such  a  plan  shall  not  exceed
    31  [ten]  five  percent  of  the  gross  monthly  income  of  the patient[,
    32  provided, however, that if patient assets are considered  under  such  a
    33  policy,  then  patient  assets which are not excluded assets pursuant to
    34  subparagraph (vi) of paragraph (b) of this subdivision may be considered
    35  in addition to the limit on monthly  payments].  The  rate  of  interest
    36  charged  to  the patient on the unpaid balance, if any, shall not exceed
    37  [the rate for a ninety-day security issued by the United States  Depart-
    38  ment  of  Treasury,  plus  .5]  two percent and no plan shall include an
    39  accelerator or similar clause under which a higher rate of  interest  is
    40  triggered upon a missed payment. If such policies and procedures include
    41  a  requirement  of  a deposit prior to non-emergent, medically-necessary
    42  care, such deposit must be included as part of any financial aid consid-
    43  eration. Such policies and procedures shall be applied  consistently  to
    44  all eligible patients.
    45    (e)  Such  policies  and procedures shall permit patients to apply for
    46  assistance [within at least ninety days of the date of discharge or date
    47  of service and provide at least twenty days for  patients  to  submit  a
    48  completed  application] at any time during the collection process.  Such
    49  policies and  procedures  may  require  that  patients  seeking  payment
    50  adjustments  provide appropriate financial information and documentation
    51  in support of their application, provided, however, that  such  applica-
    52  tion  process  shall not be unduly burdensome or complex. General hospi-
    53  tals shall, upon request, assist patients in  understanding  the  hospi-
    54  tal's  policies  and procedures and in applying for payment adjustments.
    55  Application forms  shall  be  printed  in  the  "primary  languages"  of
    56  patients  served by the general hospital. For the purposes of this para-

        S. 8307                            76                            A. 8807

     1  graph, "primary languages" shall include any language that is either (i)
     2  used to communicate, during at least five percent of patient visits in a
     3  year, by patients who  cannot  speak,  read,  write  or  understand  the
     4  English  language  at  the  level of proficiency necessary for effective
     5  communication with health care providers, or (ii) spoken by  non-English
     6  speaking  individuals  comprising  more  than one percent of the primary
     7  hospital service area population, as calculated using demographic infor-
     8  mation available from the United States Bureau of  the  Census,  supple-
     9  mented  by  data  from school systems. Decisions regarding such applica-
    10  tions shall be made  within  thirty  days  of  receipt  of  a  completed
    11  application.  Such policies and procedures shall require that the hospi-
    12  tal issue any denial/approval of such application in writing with infor-
    13  mation on how to appeal the denial and shall  require  the  hospital  to
    14  establish  an appeals process under which it will evaluate the denial of
    15  an application. Nothing in this  subdivision  shall  be  interpreted  as
    16  prohibiting a hospital from making the availability of financial assist-
    17  ance contingent upon the patient first applying for coverage under title
    18  XIX  of  the social security act (medicaid) or another insurance program
    19  if, in the judgment of the hospital, the patient  may  be  eligible  for
    20  medicaid  or  another  insurance program, and upon the patient's cooper-
    21  ation in  following  the  hospital's  financial  assistance  application
    22  requirements,  including  the  provision of information needed to make a
    23  determination on the patient's application in accordance with the hospi-
    24  tal's financial assistance policy.
    25    (f) Such policies and procedures  shall  provide  that  patients  with
    26  incomes  below [three] four hundred percent of the federal poverty level
    27  are deemed presumptively eligible  for  payment  adjustments  and  shall
    28  conform  to the requirements set forth in paragraph (b) of this subdivi-
    29  sion, provided, however, that  nothing  in  this  subdivision  shall  be
    30  interpreted  as precluding hospitals from extending such payment adjust-
    31  ments to other patients, either generally or on  a  case-by-case  basis.
    32  Such  policies  and procedures shall provide financial aid for emergency
    33  hospital services, including emergency transfers pursuant to the federal
    34  emergency medical treatment and active labor act  (42  USC  1395dd),  to
    35  patients who reside in New York state and for medically necessary hospi-
    36  tal  services  for patients who reside in the hospital's primary service
    37  area as determined according to criteria established by the  commission-
    38  er.  In  developing  such  criteria, the commissioner shall consult with
    39  representatives of the hospital industry, health care consumer advocates
    40  and local public health officials. Such criteria shall be made available
    41  to the public no less than thirty days prior to the date of  implementa-
    42  tion and shall, at a minimum:
    43    (i)  prohibit  a  hospital  from  developing  or  altering its primary
    44  service area in a manner designed to avoid medically underserved  commu-
    45  nities or communities with high percentages of uninsured residents;
    46    (ii)  ensure that every geographic area of the state is included in at
    47  least one general hospital's  primary  service  area  so  that  eligible
    48  patients may access care and financial assistance; and
    49    (iii)  require the hospital to notify the commissioner upon making any
    50  change to its primary service area, and to include a description of  its
    51  primary  service  area  in  the  hospital's annual implementation report
    52  filed pursuant to subdivision  three  of  section  twenty-eight  hundred
    53  three-l of this article.
    54    (g)  Nothing  in  this  subdivision shall be interpreted as precluding
    55  hospitals from extending payment  adjustments  for  medically  necessary
    56  non-emergency  hospital  services  to patients outside of the hospital's

        S. 8307                            77                            A. 8807

     1  primary service area. For patients determined to be eligible for  finan-
     2  cial  aid  under  the  terms  of a hospital's financial aid policy, such
     3  policies and procedures shall prohibit any limitations on financial  aid
     4  for services based on the medical condition of the applicant, other than
     5  typical  limitations  or  exclusions  based  on medical necessity or the
     6  clinical or therapeutic benefit of a procedure or treatment.
     7    (h) Such policies and procedures shall prohibit the denial  of  admis-
     8  sion or denial of treatment for services that are reasonably anticipated
     9  to  be  medically  necessary  because  the patient has an unpaid medical
    10  bill. Such policies and  procedures  shall  [not  permit]  prohibit  the
    11  forced  sale or foreclosure of a patient's primary residence in order to
    12  collect an outstanding medical bill and shall require  the  hospital  to
    13  refrain from sending an account to collection if the patient has submit-
    14  ted  a  completed  application for financial aid, including any required
    15  supporting documentation, while the hospital  determines  the  patient's
    16  eligibility  for  such  aid. Such policies and procedures shall prohibit
    17  the sale of medical debt accumulated pursuant to this section to a third
    18  party, unless the third party explicitly purchases such medical debt  in
    19  order  to  relieve the debt of the patient. Such policies and procedures
    20  shall provide for written notification, which shall include notification
    21  on a patient bill, to a patient not less than thirty days prior  to  the
    22  referral  of  debts for collection and shall require that the collection
    23  agency obtain the hospital's written consent prior to commencing a legal
    24  action. Such policies and procedures  shall  prohibit  a  hospital  from
    25  commencing  a  legal  action  related to the recovery of medical debt or
    26  unpaid bills against patients with incomes below four hundred percent of
    27  the federal poverty level. In any legal action related to  the  recovery
    28  of  medical  debt  or  unpaid  bills  by or on behalf of a hospital, the
    29  complaint shall be accompanied by an affidavit by the  hospital's  chief
    30  financial  officer  stating  that  based  upon the hospital's reasonable
    31  effort to determine the patient's income,  the  patient  whom  they  are
    32  taking  legal  action against does not have an income below four hundred
    33  percent of the federal poverty level. Such policies and procedures shall
    34  require all general hospital staff who interact with  patients  or  have
    35  responsibility  for  billing and collections to be trained in such poli-
    36  cies and procedures, and require the implementation of a  mechanism  for
    37  the  general  hospital  to measure its compliance with such policies and
    38  procedures.  Such  policies  and  procedures  shall  require  that   any
    39  collection  agency  under  contract  with  a  general  hospital  for the
    40  collection of debts follow the hospital's financial  assistance  policy,
    41  including  providing  information to patients on how to apply for finan-
    42  cial assistance where appropriate. Such policies  and  procedures  shall
    43  prohibit collections from a patient who is determined to be eligible for
    44  medical  assistance pursuant to title XIX of the federal social security
    45  act at the time services were rendered and for which  services  medicaid
    46  payment is available.
    47    (i) Reports required to be submitted to the department by each general
    48  hospital  as  a  condition  for  participation  in  the pools, and which
    49  contain, in accordance with applicable regulations, a certification from
    50  an independent  certified  public  accountant  or  independent  licensed
    51  public accountant or an attestation from a senior official of the hospi-
    52  tal  that the hospital is in compliance with conditions of participation
    53  in the pools, shall also contain, for reporting  periods  on  and  after
    54  January first, two thousand seven:
    55    (i)  a  report  on  hospital costs incurred and uncollected amounts in
    56  providing services to eligible patients  without  insurance[,  including

        S. 8307                            78                            A. 8807

     1  the  amount  of  care provided for a nominal payment amount,] during the
     2  period covered by the report;
     3    (ii)  hospital  costs incurred and uncollected amounts for deductibles
     4  and coinsurance for eligible patients with insurance or other third-par-
     5  ty payor coverage;
     6    (iii) the number of patients, including their  age,  race,  ethnicity,
     7  gender and insurance status, organized according to United States postal
     8  service  zip  code, who applied for financial assistance pursuant to the
     9  hospital's  financial  assistance  policy,  and  the  number,  organized
    10  according  to  United States postal service zip code, whose applications
    11  were approved and whose applications were denied;
    12    (iv) the reimbursement received for indigent care from the pool estab-
    13  lished pursuant to this section;
    14    (v) the amount of funds that have been expended on charity  care  from
    15  charitable  bequests  made  or  trusts  established  for  the purpose of
    16  providing financial assistance to patients who are eligible  in  accord-
    17  ance with the terms of such bequests or trusts;
    18    (vi)  for  hospitals located in social services districts in which the
    19  district allows hospitals to assist patients with such applications, the
    20  number of applications for eligibility under title  XIX  of  the  social
    21  security  act (medicaid) that the hospital assisted patients in complet-
    22  ing and the number denied and approved; and
    23    (vii) the hospital's financial losses resulting from services provided
    24  under medicaid[; and
    25    (viii) the number  of  liens  placed  on  the  primary  residences  of
    26  patients through the collection process used by a hospital].
    27    (j)  Within ninety days of the effective date of this subdivision each
    28  hospital shall submit to the commissioner a written report on its  poli-
    29  cies  and procedures for financial assistance to patients which are used
    30  by the hospital on the effective date of this subdivision.  Such  report
    31  shall  include copies of its policies and procedures, including material
    32  which is distributed to patients, and a description  of  the  hospital's
    33  financial  aid  policies  and procedures. Such description shall include
    34  the income levels of patients on which eligibility is based, the  finan-
    35  cial  aid  eligible  patients  receive and the means of calculating such
    36  aid, and the service area, if any, used by  the  hospital  to  determine
    37  eligibility.
    38    (k)  In  the event it is determined by the commissioner that the state
    39  will be unable to secure all necessary federal approvals to include,  as
    40  part  of  the  state's  approved  state plan under title nineteen of the
    41  federal social security act, a requirement, as set  forth  in  paragraph
    42  [one]  (a) of this subdivision, that compliance with this subdivision is
    43  a condition of participation in pool distributions  authorized  pursuant
    44  to  this  section and section twenty-eight hundred seven-w of this arti-
    45  cle, then such condition of participation shall be deemed null and  void
    46  and,  notwithstanding  section twelve of this chapter, failure to comply
    47  with the provisions of this subdivision by a hospital on and  after  the
    48  date  of  such determination shall make such hospital liable for a civil
    49  penalty not to exceed ten thousand dollars for each such violation.  The
    50  imposition of such civil penalties shall be subject to the provisions of
    51  section twelve-a of this chapter.
    52    (l)  A  hospital  or  its  collection agent shall not commence a civil
    53  action against a patient or delegate a collection  activity  to  a  debt
    54  collector  for nonpayment for at least one hundred eighty days after the
    55  first post-service bill is issued and until a hospital has made  reason-

        S. 8307                            79                            A. 8807

     1  able  efforts  to  determine  whether  a patient qualifies for financial
     2  assistance.
     3    §  3. The public health law is amended by adding a new section 18-c to
     4  read as follows:
     5    § 18-c. Separate patient consent for treatment and payment for  health
     6  care services. Informed consent from a patient to provide any treatment,
     7  procedure,  examination  or  other  direct health care services shall be
     8  obtained separately from such patient's consent to pay for the services.
     9  Consent to pay for any health care services by a patient  shall  not  be
    10  given prior to the patient receiving such services and discussing treat-
    11  ment  costs.  For  purposes  of  this section, "consent" means an action
    12  which: (a)  clearly  and  conspicuously  communicates  the  individual's
    13  authorization  of  an act or practice; (b) is made in the absence of any
    14  mechanism in the user interface that  has  the  purpose  or  substantial
    15  effect  of obscuring, subverting, or impairing decision-making or choice
    16  to obtain consent; and (c) cannot be inferred from inaction.
    17    § 4. The general business law is amended by adding  two  new  sections
    18  349-g and 519-a to read as follows:
    19    § 349-g.  Restrictions on applications for and use of credit cards and
    20  medical financial products. 1. For purposes of this section, the follow-
    21  ing terms shall have the following meanings:
    22    (a)  "Medical  financial products" shall mean medical credit cards and
    23  third-party medical installment loans.
    24    (b) "Health care provider"  shall  mean  a  health  care  professional
    25  licensed,  registered or certified pursuant to title eight of the educa-
    26  tion law.
    27    (c) "Provider offices" shall mean either of the following:
    28    (i) An office of a health care provider in solo practice; or
    29    (ii) An office in which services or goods are personally  provided  by
    30  the  health  care provider or by employees in that office, or personally
    31  by independent contractors in  that  office,  in  accordance  with  law.
    32  Employees  and  independent  contractors  shall be licensed or certified
    33  when licensure or certification is required by law.
    34    2. It shall be prohibited for any individual to complete  any  portion
    35  of  an  application  for  medical  financial products for the patient or
    36  otherwise arrange for or establish an application that is not completely
    37  filled out by the patient.
    38    § 519-a. Medical financial products; payment for health care services.
    39  1. For purposes of this section, the  following  terms  shall  have  the
    40  following meanings:
    41    (a)  "Credit  card"  shall  have  the  same meaning as in section five
    42  hundred eleven of this article.
    43    (b) "Medical credit card" means a credit card issued under an open-end
    44  or closed-end plan offered specifically for the payment of  health  care
    45  services, products, or devices provided to a person.
    46    2. No health care provider shall require credit card pre-authorization
    47  nor require the patient to have a credit card on file prior to providing
    48  emergency or medically necessary medical services to such patient.
    49    3.  Health care providers shall notify all patients about the risks of
    50  paying for medical services with a credit card. Such notification  shall
    51  highlight  the  fact  that  by  using  a  credit card to pay for medical
    52  services, the patient is forgoing state  and  federal  protections  that
    53  regard medical debt.  The commissioner of health shall have the authori-
    54  ty  and  sole  discretion  to  set requirements for the contents of such
    55  notices.

        S. 8307                            80                            A. 8807

     1    § 5. This act shall take effect six months after it shall have  become
     2  a law.

     3                                   PART P

     4    Section  1.  Section  8  of  part  C of chapter 57 of the laws of 2022
     5  amending the public health law and the education law relating to  allow-
     6  ing  pharmacists  to  direct  limited service laboratories and order and
     7  administer COVID-19 and influenza tests and  modernizing  nurse  practi-
     8  tioners, is amended to read as follows:
     9    §  8.  This  act  shall take effect immediately and shall be deemed to
    10  have been in full force and effect on and after April 1, 2022; provided,
    11  however, that sections [one, two,] three[,] and four[, six and seven] of
    12  this act shall expire and be deemed repealed [two years after  it  shall
    13  have become a law] April 1, 2026.
    14    §  2.  Section 5 of chapter 21 of the laws of 2011 amending the educa-
    15  tion law relating to authorizing pharmacists  to  perform  collaborative
    16  drug  therapy management with physicians in certain settings, as amended
    17  by section 5 of part CC of chapter 57 of the laws of 2022, is amended to
    18  read as follows:
    19    § 5. This act shall take effect on the one hundred twentieth day after
    20  it shall have become a law[, provided, however, that the  provisions  of
    21  sections  two,  three,  and  four of this act shall expire and be deemed
    22  repealed July 1, 2024]; provided, however, that the amendments to subdi-
    23  vision 1 of section 6801 of the education law made  by  section  one  of
    24  this act shall be subject to the expiration and reversion of such subdi-
    25  vision  pursuant  to  section 8 of chapter 563 of the laws of 2008, when
    26  upon such date the provisions of section one-a of this  act  shall  take
    27  effect;  provided,  further,  that  effective immediately, the addition,
    28  amendment and/or repeal of any rule  or  regulation  necessary  for  the
    29  implementation  of  this  act  on  its effective date are authorized and
    30  directed to be made and completed on or before such effective date.
    31    § 3. This act shall take effect immediately and  shall  be  deemed  to
    32  have been in full force and effect on and after April 1, 2024.

    33                                   PART Q

    34    Section 1. Section 6542 of the education law, as amended by chapter 48
    35  of  the  laws  of  2012, subdivisions 3 and 5 as amended by section 1 of
    36  part T of chapter 57 of the laws of 2013, is amended to read as follows:
    37    § 6542. Performance of medical services. 1. Notwithstanding any  other
    38  provision  of  law,  a physician assistant may perform medical services,
    39  but only when under the supervision of a physician and  only  when  such
    40  acts  and  duties  as are assigned to him or her are within the scope of
    41  practice of such supervising physician  unless  otherwise  permitted  by
    42  this section.
    43    1-a. (a) A physician assistant may practice without the supervision of
    44  a physician under the following circumstances:
    45    (i)  Where  the physician assistant, licensed under section sixty-five
    46  hundred forty-one of this article has  practiced  for  more  than  eight
    47  thousand hours; and
    48    (A)  is  practicing  in  primary  care.   For purposes of this clause,
    49  "primary care" shall mean non-surgical care in  the  fields  of  general
    50  pediatrics, general adult medicine, general geriatric  medicine, general
    51  internal  medicine,  obstetrics and gynecology, family medicine, or such
    52  other related areas as determined by the commissioner of health; or

        S. 8307                            81                            A. 8807

     1    (B) is employed by a health system or hospital established under arti-
     2  cle twenty-eight of the public health law,  and  the  health  system  or
     3  hospital  determines the physician assistant meets the qualifications of
     4  the medical staff bylaws and the health system  or  hospital  gives  the
     5  physician assistant privileges; and
     6    (ii)  Where  a  physician  assistant licensed under section sixty-five
     7  hundred forty-one of this article has completed a  program  approved  by
     8  the department of health, in consultation with the department, when such
     9  services are performed within the scope of such program.
    10    (b)  The  department  and  the  department of health are authorized to
    11  promulgate and update regulations pursuant to this section.
    12    2. [Supervision] Where supervision is required  by  this  section,  it
    13  shall  be continuous but shall not be construed as necessarily requiring
    14  the physical presence of the supervising physician at the time and place
    15  where such services are performed.
    16    3. [No physician shall employ or supervise more  than  four  physician
    17  assistants in his or her private practice.
    18    4.]  Nothing  in this article shall prohibit a hospital from employing
    19  physician assistants provided they [work  under  the  supervision  of  a
    20  physician  designated  by the hospital and not beyond the scope of prac-
    21  tice of such physician. The numerical limitation of subdivision three of
    22  this section shall not apply to services performed in a hospital.
    23    5. Notwithstanding any other provision of this article, nothing  shall
    24  prohibit a physician employed by or rendering services to the department
    25  of corrections and community supervision under contract from supervising
    26  no  more  than  six  physician assistants in his or her practice for the
    27  department of corrections and community supervision.
    28    6. Notwithstanding any  other  provision  of  law,  a  trainee  in  an
    29  approved  program  may  perform  medical services when such services are
    30  performed within the scope of such program.] meet the qualifications  of
    31  the medical staff bylaws and are given privileges and otherwise meet the
    32  requirements of this section.
    33    4.  A  physician assistant shall be authorized to prescribe, dispense,
    34  order, administer, or procure items necessary to commence or complete  a
    35  course of therapy.
    36    5.  A  physician  assistant may prescribe and order a patient specific
    37  order or non-patient specific regimen to a licensed pharmacist or regis-
    38  tered professional nurse, pursuant to  regulations  promulgated  by  the
    39  commissioner  of  health, and consistent with the public health law, for
    40  administering immunizations. Nothing in this subdivision shall authorize
    41  unlicensed persons to administer immunizations, vaccines or other drugs.
    42    [7] 6. Nothing in this article, or  in  article  thirty-seven  of  the
    43  public  health law, shall be construed to authorize physician assistants
    44  to perform those specific functions and duties specifically delegated by
    45  law to those persons licensed as allied health professionals  under  the
    46  public health law or this chapter.
    47    §  2.  Subdivision  1  of  section  3701  of the public health law, as
    48  amended by chapter 48 of the  laws  of  2012,  is  amended  to  read  as
    49  follows:
    50    1.  to  promulgate  regulations  defining  and  restricting the duties
    51  [which may be assigned to] of physician assistants [by their supervising
    52  physician, the degree of supervision required and the  manner  in  which
    53  such duties may be performed] consistent with section sixty-five hundred
    54  forty-two of the education law.;
    55    §  3.  Section 3702 of the public health law, as amended by chapter 48
    56  of the laws of 2012, is amended to read as follows:

        S. 8307                            82                            A. 8807

     1    § 3702. Special provisions. 1. Inpatient medical  orders.  A  licensed
     2  physician  assistant  employed or extended privileges by a hospital may,
     3  if permissible under the bylaws, rules and regulations of the  hospital,
     4  write  medical  orders,  including  those  for controlled substances and
     5  durable  medical equipment, for inpatients [under the care of the physi-
     6  cian responsible for his or her supervision.  Countersignature  of  such
     7  orders may be required if deemed necessary and appropriate by the super-
     8  vising physician or the hospital, but in no event shall countersignature
     9  be required prior to execution].
    10    2.  Withdrawing  blood.  A  licensed  physician assistant or certified
    11  nurse practitioner acting within his or her lawful scope of practice may
    12  supervise and direct the withdrawal of blood for the purpose  of  deter-
    13  mining  the  alcoholic or drug content therein under subparagraph one of
    14  paragraph (a) of subdivision four of section eleven hundred  ninety-four
    15  of  the  vehicle  and  traffic law, notwithstanding any provision to the
    16  contrary in clause (ii) of such subparagraph.
    17    3. Prescriptions  for  controlled  substances.  A  licensed  physician
    18  assistant,  in  good  faith and acting within his or her lawful scope of
    19  practice, and to the extent assigned by his or her supervising physician
    20  as applicable by section sixty-five hundred forty-two of  the  education
    21  law, may prescribe controlled substances as a practitioner under article
    22  thirty-three  of this chapter, to patients under the care of such physi-
    23  cian responsible for  his  or  her  supervision.  The  commissioner,  in
    24  consultation  with  the  commissioner  of education, may promulgate such
    25  regulations as are necessary to carry out the purposes of this section.
    26    § 4. Section 3703 of the public health law, as amended by  chapter  48
    27  of the laws of 2012, is amended to read as follows:
    28    §  3703. Statutory construction. A physician assistant may perform any
    29  function in conjunction with a medical service lawfully performed by the
    30  physician assistant, in any health care setting, that a statute  author-
    31  izes  or  directs  a physician to perform and that is appropriate to the
    32  education, training and experience of the licensed  physician  assistant
    33  and within the ordinary practice of the supervising physician, as appli-
    34  cable  pursuant to section sixty-five hundred forty-two of the education
    35  law. This section shall not be construed to  increase  or  decrease  the
    36  lawful  scope  of  practice of a physician assistant under the education
    37  law.
    38    § 5. Paragraph a of subdivision 2 of section 902 of the education law,
    39  as amended by chapter 376 of the laws of 2015, is  amended  to  read  as
    40  follows:
    41    a.  The  board  of  education, and the trustee or board of trustees of
    42  each school district, shall employ, at a compensation to be agreed  upon
    43  by the parties, a qualified physician, a physician assistant, or a nurse
    44  practitioner  to  the  extent  authorized  by the nurse practice act and
    45  consistent with subdivision three of section six thousand  nine  hundred
    46  two  of  this  chapter,  to perform the duties of the director of school
    47  health services, including any duties conferred on the school  physician
    48  or  school  medical inspector under any provision of law, to perform and
    49  coordinate the provision of health services in the public schools and to
    50  provide health appraisals of students attending the  public  schools  in
    51  the  city  or  district.  The physicians, physicians assistants or nurse
    52  practitioners so employed shall be duly licensed pursuant to  applicable
    53  law.
    54    §  6.  Subdivision 5 of section 6810 of the education law, as added by
    55  chapter 881 of the laws of 1972, is amended to read as follows:

        S. 8307                            83                            A. 8807

     1    5. Records of all prescriptions filled or refilled shall be maintained
     2  for a period of at least five years and upon request made available  for
     3  inspection  and  copying  by  a  representative  of the department. Such
     4  records  shall  indicate  date  of  filling  or  refilling,   [doctor's]
     5  prescriber's  name,  patient's name and address and the name or initials
     6  of  the  pharmacist  who  prepared,   compounded,   or   dispensed   the
     7  prescription.  Records  of prescriptions for controlled substances shall
     8  be maintained pursuant to requirements of article  thirty-three  of  the
     9  public health law.
    10    §  7.  Subdivision  27  of  section  3302 of the public health law, as
    11  amended by chapter 92 of the  laws  of  2021,  is  amended  to  read  as
    12  follows:
    13    27. "Practitioner" means:
    14    A  physician,  physician assistant, dentist, podiatrist, veterinarian,
    15  scientific investigator, or other person licensed, or otherwise  permit-
    16  ted  to  dispense,  administer  or  conduct  research  with respect to a
    17  controlled substance in the course of a licensed  professional  practice
    18  or  research  licensed  pursuant  to  this article. Such person shall be
    19  deemed a "practitioner" only as to such substances, or conduct  relating
    20  to  such  substances,  as is permitted by [his] their license, permit or
    21  otherwise permitted by law.
    22    § 8. Section 6908 of the education law is  amended  by  adding  a  new
    23  subdivision 3 to read as follows:
    24    3.  This  article  shall  not  be  construed as prohibiting medication
    25  related tasks provided by a certified medication aide working in a resi-
    26  dential health care facility, as defined in section twenty-eight hundred
    27  one of the public health law, in accordance with  regulations  developed
    28  by  the  commissioner,  in consultation with the commissioner of health.
    29  The commissioner, in consultation with the commissioner of health, shall
    30  adopt regulations governing certified medication aides that, at a  mini-
    31  mum, shall:
    32    a.  specify  the  medication-related  tasks  that  may be performed by
    33  certified medication aides pursuant  to  this  subdivision.  Such  tasks
    34  shall  include  the  administration of medications which are routine and
    35  pre-filled or otherwise packaged in a manner that promotes relative ease
    36  of  administration,  provided  that  administration  of  medications  by
    37  injection,  sterile  procedures,  and  central line maintenance shall be
    38  prohibited. Provided, however,  such  prohibition  shall  not  apply  to
    39  injections  of  insulin  or  other  injections  for  diabetes  care,  to
    40  injections of low molecular weight heparin, and to  pre-filled  auto-in-
    41  jections  of  naloxone  and  epinephrine  for  emergency  purposes,  and
    42  provided, further, that entities employing  certified  medication  aides
    43  pursuant  to  this  subdivision shall establish a systematic approach to
    44  address drug diversion;
    45    b. provide that medication-related tasks performed by certified  medi-
    46  cation aides may be performed only under the supervision of a registered
    47  professional  nurse  licensed  in  New  York state, as set forth in this
    48  subdivision and subdivision twelve of section sixty-nine hundred nine of
    49  this article;
    50    c. establish a process by which a registered  professional  nurse  may
    51  assign  medication-related  tasks  to  a certified medication aide. Such
    52  process shall include, but not be limited to:
    53    (i) allowing assignment of medication-related  tasks  to  a  certified
    54  medication  aide  only  where  such certified medication aide has demon-
    55  strated to the satisfaction of the supervising  registered  professional
    56  nurse  competency  in  every medication-related task that such certified

        S. 8307                            84                            A. 8807

     1  medication aide is authorized to perform, a willingness to perform  such
     2  medication-related tasks, and the ability to effectively and efficiently
     3  communicate  with  the individual receiving services and understand such
     4  individual's needs;
     5    (ii)  authorizing  the  supervising  registered  professional nurse to
     6  revoke any assigned medication-related task from a certified  medication
     7  aide for any reason; and
     8    (iii)  authorizing  multiple registered professional nurses to jointly
     9  agree to assign medication-related tasks to a certified medication aide,
    10  provided further that only one registered professional  nurse  shall  be
    11  required  to determine if the certified medication aide has demonstrated
    12  competency in the medication-related task to be performed;
    13    d. provide that medication-related tasks  may  be  performed  only  in
    14  accordance  with  and  pursuant  to  an authorized health practitioner's
    15  ordered care;
    16    e. provide that only a certified nurse aide may perform medication-re-
    17  lated tasks as a certified medication aide when such aide has:
    18    (i) a valid New York state nurse aide certificate;
    19    (ii) a high school diploma, or its equivalent;
    20    (iii) evidence of being at least eighteen years old;
    21    (iv) at least one year of experience providing nurse aide services  in
    22  a  residential health care facility licensed pursuant to article twenty-
    23  eight of the public health law  or  a  similarly  licensed  facility  in
    24  another state or United States territory;
    25    (v) the ability to read, write, and speak English and to perform basic
    26  math skills;
    27    (vi) completed the requisite training and demonstrated competencies of
    28  a  certified medication aide as determined by the commissioner of health
    29  in consultation with the commissioner;
    30    (vii) successfully completed competency examinations  satisfactory  to
    31  the commissioner of health in consultation with the commissioner; and
    32    (viii)  meets  other  appropriate  qualifications as determined by the
    33  commissioner of health in consultation with the commissioner;
    34    f. prohibit a certified medication aide from holding  themselves  out,
    35  or  accepting employment as, a person licensed to practice nursing under
    36  the provisions of this article;
    37    g. provide that a  certified  medication  aide  is  not  required  nor
    38  permitted to assess the medication or medical needs of an individual;
    39    h. provide that a certified medication aide shall not be authorized to
    40  perform  any  medication-related  tasks  or  activities pursuant to this
    41  subdivision that are outside the scope of practice of a licensed practi-
    42  cal nurse or any medication-related tasks that have not  been  appropri-
    43  ately assigned by the supervising registered professional nurse;
    44    i. provide that a certified medication aide shall document all medica-
    45  tion-related  tasks  provided  to  an  individual,  including medication
    46  administration to each individual through the use of a medication admin-
    47  istration record; and
    48    j. provide that the supervising registered  professional  nurse  shall
    49  retain  the  discretion  to  decide whether to assign medication-related
    50  tasks to certified medication aides under this program and shall not  be
    51  subject to coercion, retaliation, or the threat of retaliation.
    52    §  9.  Section  6909 of the education law is amended by adding two new
    53  subdivisions 12 and 13 to read as follows:
    54    12. A registered professional nurse, while working for  a  residential
    55  health  care  facility  licensed pursuant to article twenty-eight of the
    56  public health law, may, in  accordance  with  this  subdivision,  assign

        S. 8307                            85                            A. 8807

     1  certified medication aides to perform medication-related tasks for indi-
     2  viduals  pursuant  to  the  provisions  of  subdivision three of section
     3  sixty-nine hundred eight of this article and supervise certified medica-
     4  tion aides who perform assigned medication-related tasks.
     5    13.  Notwithstanding  subdivision  seven of section sixty-five hundred
     6  nine of this title, a certified nurse practitioner may  directly  assign
     7  and  supervise  a medical assistant in an outpatient setting the task of
     8  drawing and  administering  immunizations  to  patients,  provided  such
     9  medical assistant receives appropriate training from the certified nurse
    10  practitioner  and  the  certified nurse practitioner remains responsible
    11  for the actions of the medical assistant.
    12    § 10. Paragraph (a) of subdivision 3 of section 2803-j of  the  public
    13  health  law,  as added by chapter 717 of the laws of 1989, is amended to
    14  read as follows:
    15    (a) Identification of individuals who have  successfully  completed  a
    16  nurse aide training and competency evaluation program, [or] a nurse aide
    17  competency evaluation program, or a medication aide program;
    18    §  11.  Section  6527  of the education law is amended by adding a new
    19  subdivision 12 to read as follows:
    20    12. Notwithstanding subdivision eleven of section  sixty-five  hundred
    21  thirty  of  this  title,  a  licensed  physician may directly assign and
    22  supervise a medical assistant in an outpatient setting the task of draw-
    23  ing and administering immunizations to patients, provided  such  medical
    24  assistant  receives appropriate training from the licensed physician and
    25  the licensed physician  remains  responsible  for  the  actions  of  the
    26  medical assistant.
    27    §  12.  Section 6545 of the education law, as amended by chapter 48 of
    28  the laws of 2012, is amended to read as follows:
    29    § 6545. [Emergency services rendered by physician  assistant]  Special
    30  provisions.  1. Notwithstanding any inconsistent provision of any gener-
    31  al,  special  or local law, any physician assistant properly licensed in
    32  this state who voluntarily  and  without  the  expectation  of  monetary
    33  compensation renders first aid or emergency treatment at the scene of an
    34  accident  or other emergency, outside a hospital, doctor's office or any
    35  other place having proper and necessary medical equipment, to  a  person
    36  who  is unconscious, ill or injured, shall not be liable for damages for
    37  injuries alleged to have been sustained by such person  or  for  damages
    38  for  the  death  of such person alleged to have occurred by reason of an
    39  act or omission in the rendering of such first aid or  emergency  treat-
    40  ment  unless it is established that such injuries were or such death was
    41  caused by gross negligence on the  part  of  such  physician  assistant.
    42  Nothing  in  this  section  shall  be  deemed  or construed to relieve a
    43  licensed physician assistant from liability for damages for injuries  or
    44  death  caused by an act or omission on the part of a physician assistant
    45  while rendering professional services in the normal and ordinary  course
    46  of his or her practice.
    47    2.  Notwithstanding  subdivision  eleven of section sixty-five hundred
    48  thirty of this title, a licensed physician assistant authorized pursuant
    49  to section sixty-five hundred forty-two  of  this  article  to  practice
    50  without  supervision of a physician, may directly assign and supervise a
    51  medical assistant in an outpatient  setting  the  task  of  drawing  and
    52  administering immunizations to patients, provided such medical assistant
    53  receives  appropriate training from the licensed physician assistant and
    54  the licensed physician assistant remains responsible for the actions  of
    55  the medical assistant.

        S. 8307                            86                            A. 8807

     1    §  13. Section 6601 of the education law, as amended by chapter 576 of
     2  the laws of 2001, is amended to read as follows:
     3    § 6601. Definition  of  practice  of  dentistry.  The  practice of the
     4  profession of dentistry is defined as diagnosing,  treating,  operating,
     5  or  prescribing  for  any  disease, pain, injury, deformity, or physical
     6  condition of the oral and maxillofacial area related  to  restoring  and
     7  maintaining  dental  health.  The  practice  of  dentistry  includes the
     8  prescribing and fabrication of dental  prostheses  and  appliances.  The
     9  practice  of  dentistry  may  include performing physical evaluations in
    10  conjunction with the provision of dental treatment, including the admin-
    11  istration of vaccinations against influenza, SARS-CoV-2, Human  papillo-
    12  mavirus  (HPV),  and  vaccinations  related  to a declared public health
    13  emergency. The practice of dentistry may also include offering  of  HIV,
    14  hepatitis C, and hemoglobin A1C screening or diagnostic tests.
    15    §  14. Section 6605-b of the education law, as added by chapter 437 of
    16  the laws of 2001 and subdivision 1 as amended by chapter 198 of the laws
    17  of 2022, is amended to read as follows:
    18    § 6605-b. Dental  hygiene  restricted  local  infiltration  and  block
    19  anesthesia/nitrous  oxide  analgesia certificate.  1. A dental hygienist
    20  shall not administer or monitor nitrous oxide analgesia or local  infil-
    21  tration  or block anesthesia in the practice of dental hygiene without a
    22  dental    hygiene    restricted    local    infiltration    and    block
    23  anesthesia/nitrous  oxide  analgesia  certificate  and  except under the
    24  personal supervision of a dentist and  in  accordance  with  regulations
    25  promulgated  by  the commissioner. Personal supervision, for purposes of
    26  this section, means that the supervising dentist remains in  the  dental
    27  office where the local infiltration or block anesthesia or nitrous oxide
    28  analgesia  services  are  being  performed,  personally  authorizes  and
    29  prescribes the use of local infiltration or block anesthesia or  nitrous
    30  oxide  analgesia  for  the patient and, before dismissal of the patient,
    31  personally examines the condition of the patient after the use of  local
    32  infiltration   or   block  anesthesia  or  nitrous  oxide  analgesia  is
    33  completed. It is professional  misconduct  for  a  dentist  to  fail  to
    34  provide  the supervision required by this section, and any dentist found
    35  guilty of such misconduct under the  procedures  prescribed  in  section
    36  sixty-five  hundred  ten of this title shall be subject to the penalties
    37  prescribed in section sixty-five hundred eleven of this title.
    38    2. The commissioner shall promulgate regulations  establishing  stand-
    39  ards and procedures for the issuance of such certificate. Such standards
    40  shall  require  completion  of  an  educational program and/or course of
    41  training or experience sufficient to ensure that a dental  hygienist  is
    42  specifically  trained  in  the  administration and monitoring of nitrous
    43  oxide analgesia and local infiltration or block anesthesia, the possible
    44  effects of such use, and in the recognition of and response to  possible
    45  emergency situations.
    46    3.  The  fee  for  a  dental hygiene restricted local infiltration and
    47  block anesthesia/nitrous oxide analgesia certificate  shall  be  twenty-
    48  five dollars and shall be paid on a triennial basis upon renewal of such
    49  certificate.  A  certificate  may  be  suspended  or revoked in the same
    50  manner as a license to practice dental hygiene.
    51    § 15. Subdivision 1 of section 6606 of the education law,  as  amended
    52  by chapter 239 of the laws of 2013, is amended to read as follows:
    53    1.  The practice of the profession of dental hygiene is defined as the
    54  performance of dental services which shall include  removing  calcareous
    55  deposits,  accretions  and stains from the exposed surfaces of the teeth
    56  which begin at the epithelial attachment  and  applying  topical  agents

        S. 8307                            87                            A. 8807

     1  indicated for a complete dental prophylaxis, removing cement, placing or
     2  removing  rubber  dam,  removing sutures, placing matrix band, providing
     3  patient education, applying topical medication, placing  pre-fit  ortho-
     4  dontic  bands, using light-cure composite material, taking cephalometric
     5  radiographs, taking two-dimensional and three-dimensional photography of
     6  dentition, adjusting removable appliances including nightguards, bleach-
     7  ing trays, retainers  and  dentures,  placing  and  exposing  diagnostic
     8  dental X-ray films, performing topical fluoride applications and topical
     9  anesthetic applications, polishing teeth, taking medical history, chart-
    10  ing  caries,  taking  impressions  for study casts, placing and removing
    11  temporary  restorations,  administering  and  monitoring  nitrous  oxide
    12  analgesia  and administering and monitoring local infiltration and block
    13  anesthesia, subject to certification in accordance with  section  sixty-
    14  six  hundred five-b of this article, and any other function in the defi-
    15  nition of the practice of dentistry as may be delegated  by  a  licensed
    16  dentist  in accordance with regulations promulgated by the commissioner.
    17  The practice of dental hygiene may be conducted in  the  office  of  any
    18  licensed  dentist  or  in  any  appropriately  equipped school or public
    19  institution but must be done either under the supervision of a  licensed
    20  dentist  or,  in the case of a registered dental hygienist working for a
    21  hospital as defined in article twenty-eight of the public health  law[,]
    22  or  pursuant  to  a collaborative arrangement with a licensed and regis-
    23  tered dentist [who has a formal relationship  with  the  same  hospital]
    24  pursuant  to  section  sixty-six  hundred seven-a of this article and in
    25  accordance with regulations promulgated by the department  in  consulta-
    26  tion  with  the  department  of  health. [Such collaborative arrangement
    27  shall not obviate or supersede any  law  or  regulation  which  requires
    28  identified  services to be performed under the personal supervision of a
    29  dentist. When dental hygiene services are provided pursuant to a  colla-
    30  borative  agreement, such dental hygienist shall instruct individuals to
    31  visit a licensed dentist for comprehensive examination or treatment.]
    32    § 16. The education law is amended by adding a new section  6607-a  to
    33  read as follows:
    34    § 6607-a. Practice of collaborative practice dental hygiene and use of
    35  title "registered dental hygienist, collaborative practice" (RDH-CP). 1.
    36  The  practice of the profession of dental hygiene, as defined under this
    37  article, may be performed  in  collaboration  with  a  licensed  dentist
    38  provided  such services are performed in accordance with a written prac-
    39  tice agreement and written practice protocols to be known as a  collabo-
    40  rative  practice  agreement.  Under  a collaborative practice agreement,
    41  dental hygienists may perform all services which are designated in regu-
    42  lation without prior evaluation of a dentist or medical professional and
    43  may  be  performed  without  supervision  in  a  collaborative  practice
    44  setting.
    45    2.  (a)  The  collaborative practice agreement shall include consider-
    46  ation for medically compromised patients, specific  medical  conditions,
    47  and  age-and  procedure-specific  practice protocols, including, but not
    48  limited to recommended intervals for the performance of  dental  hygiene
    49  services  and  a periodicity in which an examination by a dentist should
    50  occur.
    51    (b) The collaborative agreement shall be:
    52    (i) signed and maintained by the dentist, the  dental  hygienist,  and
    53  the facility, program, or organization;
    54    (ii) reviewed annually by the collaborating dentist and dental hygien-
    55  ist; and

        S. 8307                            88                            A. 8807

     1    (iii)  made  available  to the department and other interested parties
     2  upon request.
     3    (c)  Only one agreement between a collaborating dentist and registered
     4  dental hygienist, collaborative practice (RDH-CP) may be in force  at  a
     5  time.
     6    3.  Before  performing  any  services authorized under this section, a
     7  dental hygienist shall provide the  patient  with  a  written  statement
     8  advising the patient that the dental hygiene services provided are not a
     9  substitute  for a dental examination by a licensed dentist and instruct-
    10  ing individuals to visit a licensed dentist for  comprehensive  examina-
    11  tion  or  treatment.  If the dental hygienist makes any referrals to the
    12  patient for further dental procedures, the dental  hygienist  must  fill
    13  out  a referral form and provide a copy of the form to the collaborating
    14  dentist.
    15    4. The collaborative  practice  dental  hygienist  may  enter  into  a
    16  contractual  arrangement with any New York state licensed and registered
    17  dentist, health care facility, program, and/or  non-profit  organization
    18  to  perform  dental  hygiene  services in the following settings: dental
    19  offices; long-term care facilities/skilled nursing facilities; public or
    20  private  schools;  public  health  agencies/federally  qualified  health
    21  centers;  correctional  facilities;  public  institutions/mental  health
    22  facilities; drug treatment facilities; and domestic violence shelters.
    23    5. A collaborating dentist shall have collaborative agreements with no
    24  more than six collaborative practice dental hygienists.  The  department
    25  may  grant exceptions to these limitations for public health settings on
    26  a case-by-case basis.
    27    6. A dental hygienist must make application to the department to prac-
    28  tice as a registered dental hygienist, collaborative  practice  (RDH-CP)
    29  and  pay  a  fee  set by the department. As a condition of collaborative
    30  practice, the dental hygienist shall have been engaged in  practice  for
    31  at  least three years with a minimum of four thousand five hundred prac-
    32  tice hours and shall complete an eight hour continuing education program
    33  that includes instruction in medical emergency procedures, risk  manage-
    34  ment, dental hygiene jurisprudence and professional ethics.
    35    §  17.  This  act shall take effect immediately and shall be deemed to
    36  have been in full force and effect on and after April 1, 2024; provided,
    37  however, that sections one through seven of this act shall  take  effect
    38  one year after this act shall have become a law.

    39                                   PART R

    40    Section 1. The education law is amended by adding a new article 169 to
    41  read as follows:
    42                                 ARTICLE 169
    43                    INTERSTATE MEDICAL LICENSURE COMPACT
    44  Section 8860. Short title.
    45          8861. Purpose.
    46          8862. Definitions.
    47          8863. Eligibility.
    48          8864. Designation of state of principal license.
    49          8865. Application and issuance of expedited licensure.
    50          8866. Fees for expedited licensure.
    51          8867. Renewal and continued participation.
    52          8868. Coordinated information system.
    53          8869. Joint investigations.
    54          8870. Disciplinary actions.

        S. 8307                            89                            A. 8807

     1          8871. Interstate medical licensure compact commission.
     2          8872. Powers and duties of the interstate commission.
     3          8873. Finance powers.
     4          8874. Organization and operation of the interstate commission.
     5          8875. Rulemaking functions of the interstate commission.
     6          8876. Oversight of interstate compact.
     7          8877. Enforcement of interstate compact.
     8          8878. Default procedures.
     9          8879. Dispute resolution.
    10          8880. Member states, effective date and amendment.
    11          8881. Withdrawal.
    12          8882. Dissolution.
    13          8883. Severability and construction.
    14          8884. Binding effect of compact and other laws.
    15    § 8860. Short  title.  This article shall be known and may be cited as
    16  the "interstate medical licensure compact".
    17    § 8861. Purpose. In order to strengthen access to health care, and  in
    18  recognition  of  the advances in the delivery of health care, the member
    19  states of the interstate medical licensure compact have allied in common
    20  purpose to develop a comprehensive process that complements the existing
    21  licensing and regulatory authority of state medical boards,  provides  a
    22  streamlined  process that allows physicians to become licensed in multi-
    23  ple states, thereby enhancing the portability of a medical  license  and
    24  ensuring  the  safety of patients.   The compact creates another pathway
    25  for licensure and does not otherwise change a state's  existing  medical
    26  practice act. The compact also adopts the prevailing standard for licen-
    27  sure  and affirms that the practice of medicine occurs where the patient
    28  is located at the time of the physician-patient  encounter,  and  there-
    29  fore,  requires  the physician to be under the jurisdiction of the state
    30  medical board where the patient is located. State  medical  boards  that
    31  participate  in the compact retain the jurisdiction to impose an adverse
    32  action against a license to practice medicine in that state issued to  a
    33  physician through the procedures in the compact.
    34    § 8862. Definitions. In this compact:
    35    1.  "Bylaws"  means those bylaws established by the interstate commis-
    36  sion pursuant to section eighty-eight hundred seventy-one of this  arti-
    37  cle for its governance, or for directing and controlling its actions and
    38  conduct.
    39    2.  "Commissioner"  means  the voting representative appointed by each
    40  member board pursuant to section  eighty-eight  hundred  seventy-one  of
    41  this article.
    42    3. "Conviction" means a finding by a court that an individual is guil-
    43  ty  of  a  criminal  offense through adjudication, or entry of a plea of
    44  guilt or no contest to the charge by the offender. Evidence of an  entry
    45  of  a  conviction of a criminal offense by the court shall be considered
    46  final for purposes of disciplinary action by a member board.
    47    4. "Expedited license" means a full and unrestricted  medical  license
    48  granted  by  a member state to an eligible physician through the process
    49  set forth in the compact.
    50    5. "Interstate commission" means  the  interstate  commission  created
    51  pursuant to section eighty-eight hundred seventy-one of this article.
    52    6.  "License" means authorization by a member state for a physician to
    53  engage in the practice of medicine,  which  would  be  unlawful  without
    54  authorization.
    55    7.  "Medical  practice  act"  means laws and regulations governing the
    56  practice of allopathic and osteopathic medicine within a member state.

        S. 8307                            90                            A. 8807

     1    8. "Member board" means a state agency in a member state that acts  in
     2  the  sovereign  interests  of the state by protecting the public through
     3  licensure, regulation, and education of physicians as  directed  by  the
     4  state government.
     5    9. "Member state" means a state that has enacted the compact.
     6    10.  "Practice  of medicine" means the clinical prevention, diagnosis,
     7  or treatment of human disease, injury, or condition requiring  a  physi-
     8  cian  to  obtain  and  maintain a license in compliance with the medical
     9  practice act of a member state.
    10    11. "Physician" means any person who:
    11    (a) Is a graduate of  a  medical  school  accredited  by  the  Liaison
    12  Committee  on  Medical  Education, the Commission on Osteopathic College
    13  Accreditation, or a medical school listed in the  International  Medical
    14  Education Directory or its equivalent;
    15    (b) Passed each component of the United States Medical Licensing Exam-
    16  ination (USMLE) or the Comprehensive Osteopathic Medical Licensing Exam-
    17  ination  (COMLEX-USA)  within  three attempts, or any of its predecessor
    18  examinations accepted by a state medical board as an equivalent examina-
    19  tion for licensure purposes;
    20    (c) Successfully completed graduate medical education approved by  the
    21  Accreditation  Council  for  Graduate  Medical Education or the American
    22  Osteopathic Association;
    23    (d)  Holds  specialty  certification  or  a  time-unlimited  specialty
    24  certificate  recognized  by the American Board of Medical Specialties or
    25  the American Osteopathic Association's Bureau  of  Osteopathic  Special-
    26  ists;
    27    (e)  Possesses  a full and unrestricted license to engage in the prac-
    28  tice of medicine issued by a member board;
    29    (f) Has never been convicted, received adjudication, deferred  adjudi-
    30  cation,  community  supervision, or deferred disposition for any offense
    31  by a court of appropriate jurisdiction;
    32    (g) Has never held a license  authorizing  the  practice  of  medicine
    33  subjected  to discipline by a licensing agency in any state, federal, or
    34  foreign jurisdiction, excluding any action  related  to  non-payment  of
    35  fees related to a license;
    36    (h)  Has  never had a controlled substance license or permit suspended
    37  or revoked by a state or the United  States  drug  enforcement  adminis-
    38  tration; and
    39    (i)  Is  not  under  active investigation by a licensing agency or law
    40  enforcement authority in any state, federal, or foreign jurisdiction.
    41    12. "Offense" means a felony, gross misdemeanor,  or  crime  of  moral
    42  turpitude.
    43    13.  "Rule"  means  a  written  statement by the interstate commission
    44  promulgated pursuant to section eighty-eight hundred seventy-two of this
    45  article that is of general  applicability,  implements,  interprets,  or
    46  prescribes  a  policy or provision of the compact, or an organizational,
    47  procedural, or practice requirement of the  interstate  commission,  and
    48  has  the  force  and  effect  of  statutory  law  in a member state, and
    49  includes the amendment, repeal, or suspension of an existing rule.
    50    14. "State" means any state, commonwealth, district, or  territory  of
    51  the United States.
    52    15.  "State  of principal license" means a member state where a physi-
    53  cian holds a license to practice medicine and which has been  designated
    54  as  such by the physician for purposes of registration and participation
    55  in the compact.

        S. 8307                            91                            A. 8807

     1    § 8863. Eligibility. 1. A physician must meet the eligibility require-
     2  ments as defined in subdivision eleven of section  eighty-eight  hundred
     3  sixty-two  of  this  article  to  receive an expedited license under the
     4  terms and provisions of the compact.
     5    2. A physician who does not meet the requirements of subdivision elev-
     6  en  of section eighty-eight hundred sixty-two of this article may obtain
     7  a license to practice medicine in  a  member  state  if  the  individual
     8  complies  with all laws and requirements, other than the compact, relat-
     9  ing to the issuance of a license to practice medicine in that state.
    10    § 8864. Designation of state of  principal  license.  1.  A  physician
    11  shall  designate  a  member  state as the state of principal license for
    12  purposes of registration for expedited licensure through the compact  if
    13  the  physician  possesses  a  full  and unrestricted license to practice
    14  medicine in that state, and the state is:
    15    (a) the state of principal residence for the physician, or
    16    (b) the state where at least twenty-five percent of  the  practice  of
    17  medicine occurs, or
    18    (c) the location of the physician's employer, or
    19    (d)  if  no  state  qualifies under paragraph (a), (b), or (c) of this
    20  subdivision, the state designated as state of residence for  purpose  of
    21  federal income tax.
    22    2.  A  physician  may redesignate a member state as state of principal
    23  license at any time, as long as the  state  meets  the  requirements  of
    24  subdivision one of this section.
    25    3. The interstate commission is authorized to develop rules to facili-
    26  tate  redesignation  of  another  member state as the state of principal
    27  license.
    28    § 8865. Application and issuance of expedited licensure. 1.  A  physi-
    29  cian seeking licensure through the compact shall file an application for
    30  an  expedited license with the member board of the state selected by the
    31  physician as the state of principal license.
    32    2. Upon receipt of an application for an expedited license, the member
    33  board within the state selected as the state of principal license  shall
    34  evaluate  whether  the physician is eligible for expedited licensure and
    35  issue a letter of qualification, verifying or  denying  the  physician's
    36  eligibility, to the interstate commission.
    37    (a)  Static  qualifications,  which  include  verification  of medical
    38  education, graduate medical education, results of any medical or licens-
    39  ing examination, and other qualifications as determined  by  the  inter-
    40  state commission through rule, shall not be subject to additional prima-
    41  ry  source  verification  where  already  primary source verified by the
    42  state of principal license.
    43    (b) The member board within the state selected as the state of princi-
    44  pal license shall, in the course of  verifying  eligibility,  perform  a
    45  criminal  background  check  of  an  applicant, including the use of the
    46  results of fingerprint or other biometric data checks compliant with the
    47  requirements of the Federal Bureau of Investigation, with the  exception
    48  of  federal  employees  who have suitability determination in accordance
    49  with U.S. C.F.R. § 731.202.
    50    (c) Appeal on the determination of eligibility shall be  made  to  the
    51  member state where the application was filed and shall be subject to the
    52  law of that state.
    53    3. Upon verification under subdivision two of this section, physicians
    54  eligible  for an expedited license shall complete the registration proc-
    55  ess established by the interstate commission to receive a license  in  a

        S. 8307                            92                            A. 8807

     1  member  state  selected  pursuant  to  subdivision  one of this section,
     2  including the payment of any applicable fees.
     3    4.  After  receiving verification of eligibility under subdivision two
     4  of this section and any fees under subdivision three of this section,  a
     5  member  board  shall  issue  an expedited license to the physician. This
     6  license shall authorize the physician to practice medicine in the  issu-
     7  ing  state  consistent  with the medical practice act and all applicable
     8  laws and regulations of the issuing member board and member state.
     9    5. An expedited license shall be valid for a  period  consistent  with
    10  the  licensure  period  in  the  member  state and in the same manner as
    11  required for other physicians holding a full  and  unrestricted  license
    12  within the member state.
    13    6.  An  expedited  license obtained though the compact shall be termi-
    14  nated if a physician fails to maintain a license in the state of princi-
    15  pal licensure for a non-disciplinary reason, without redesignation of  a
    16  new state of principal licensure.
    17    7.  The interstate commission is authorized to develop rules regarding
    18  the application process, including payment of any applicable  fees,  and
    19  the issuance of an expedited license.
    20    § 8866. Fees  for  expedited  licensure.  1. A member state issuing an
    21  expedited license authorizing the practice of medicine in that state may
    22  impose a fee for a license issued or renewed through the compact.
    23    2. The interstate commission is authorized to develop rules  regarding
    24  fees for expedited licenses.
    25    § 8867. Renewal and continued participation. 1. A physician seeking to
    26  renew  an  expedited  license granted in a member state shall complete a
    27  renewal process with the interstate commission if the physician:
    28    (a) Maintains a full and unrestricted license in a state of  principal
    29  license;
    30    (b)  Has  not  been convicted, received adjudication, deferred adjudi-
    31  cation, community supervision, or deferred disposition for  any  offense
    32  by a court of appropriate jurisdiction;
    33    (c) Has not had a license authorizing the practice of medicine subject
    34  to  discipline  by  a licensing agency in any state, federal, or foreign
    35  jurisdiction, excluding  any  action  related  to  non-payment  of  fees
    36  related to a license; and
    37    (d)  Has not had a controlled substance license or permit suspended or
    38  revoked by a state or the United States drug enforcement administration.
    39    2. Physicians shall comply with all continuing  professional  develop-
    40  ment  or  continuing  medical  education  requirements  for renewal of a
    41  license issued by a member state.
    42    3. The interstate commission shall collect any  renewal  fees  charged
    43  for  the  renewal of a license and distribute the fees to the applicable
    44  member board.
    45    4. Upon receipt of any renewal fees collected in subdivision three  of
    46  this section, a member board shall renew the physician's license.
    47    5. Physician information collected by the interstate commission during
    48  the renewal process will be distributed to all member boards.
    49    6. The interstate commission is authorized to develop rules to address
    50  renewal of licenses obtained through the compact.
    51    § 8868. Coordinated  information  system. 1. The interstate commission
    52  shall establish a database of  all  physicians  licensed,  or  who  have
    53  applied  for licensure, under section eighty-eight hundred sixty-five of
    54  this article.
    55    2. Notwithstanding any other provision of  law,  member  boards  shall
    56  report  to  the  interstate  commission  any public action or complaints

        S. 8307                            93                            A. 8807

     1  against a licensed physician who has applied or  received  an  expedited
     2  license through the compact.
     3    3.  Member  boards shall report disciplinary or investigatory informa-
     4  tion determined as necessary  and  proper  by  rule  of  the  interstate
     5  commission.
     6    4. Member boards may report any non-public complaint, disciplinary, or
     7  investigatory  information  not  required  by  subdivision three of this
     8  section to the interstate commission.
     9    5. Member boards shall share  complaint  or  disciplinary  information
    10  about a physician upon request of another member board.
    11    6.  All  information provided to the interstate commission or distrib-
    12  uted by member boards shall be confidential, filed under seal, and  used
    13  only for investigatory or disciplinary matters.
    14    7.  The  interstate  commission  is  authorized  to  develop rules for
    15  mandated or discretionary sharing of information by member boards.
    16    § 8869. Joint investigations. 1. Licensure and disciplinary records of
    17  physicians are deemed investigative.
    18    2. In addition to the authority granted  to  a  member  board  by  its
    19  respective  medical practice act or other applicable state law, a member
    20  board may participate with other member boards in  joint  investigations
    21  of physicians licensed by the member boards.
    22    3.  A  subpoena issued by a member state shall be enforceable in other
    23  member states.
    24    4. Member boards may share any investigative, litigation,  or  compli-
    25  ance  materials  in furtherance of any joint or individual investigation
    26  initiated under the compact.
    27    5. Any member state may investigate actual or  alleged  violations  of
    28  the  statutes  authorizing  the practice of medicine in any other member
    29  state in which a physician holds a license to practice medicine.
    30    § 8870. Disciplinary actions. 1. Any disciplinary action taken by  any
    31  member  board  against a physician licensed through the compact shall be
    32  deemed unprofessional conduct which may  be  subject  to  discipline  by
    33  other  member  boards, in addition to any violation of the medical prac-
    34  tice act or regulations in that state.
    35    2. If a license granted to a physician by  the  member  board  in  the
    36  state  of  principal  license is revoked, surrendered or relinquished in
    37  lieu of discipline, or suspended, then all licenses issued to the physi-
    38  cian by member boards shall automatically  be  placed,  without  further
    39  action  necessary by any member board, on the same status. If the member
    40  board in the state of  principal  license  subsequently  reinstates  the
    41  physician's  license,  a  license  issued  to the physician by any other
    42  member board shall remain encumbered until that respective member  board
    43  takes  action  to  reinstate the license in a manner consistent with the
    44  medical practice act of that state.
    45    3. If disciplinary action is taken against a  physician  by  a  member
    46  board  not in the state of principal license, any other member board may
    47  deem the action conclusive as to matter of law and fact decided, and:
    48    (a) impose the same or lesser sanction or sanctions against the physi-
    49  cian so long as such sanctions are consistent with the medical  practice
    50  act of that state; or
    51    (b)  pursue  separate  disciplinary action against the physician under
    52  its respective medical practice act, regardless of the action  taken  in
    53  other member states.
    54    4.  If  a license granted to a physician by a member board is revoked,
    55  surrendered, or relinquished in lieu of discipline, or  suspended,  then
    56  any  license  or  licenses  issued  to the physician by any other member

        S. 8307                            94                            A. 8807

     1  board or boards shall be suspended, automatically and immediately  with-
     2  out  further  action  necessary by the other member board or boards, for
     3  ninety days upon entry of the order by the disciplining board, to permit
     4  the member board or boards to investigate the basis for the action under
     5  the medical practice act of that state. A member board may terminate the
     6  automatic suspension of the license it issued prior to the completion of
     7  the ninety day suspension period in a manner consistent with the medical
     8  practice act of that state.
     9    § 8871. Interstate medical licensure compact commission. 1. The member
    10  states  hereby  create the "interstate medical licensure compact commis-
    11  sion".
    12    2. The purpose of the interstate commission is the  administration  of
    13  the interstate medical licensure compact, which is a discretionary state
    14  function.
    15    3. The interstate commission shall be a body corporate and joint agen-
    16  cy of the member states and shall have all the responsibilities, powers,
    17  and  duties  set forth in the compact, and such additional powers as may
    18  be conferred upon it by a subsequent concurrent action of the respective
    19  legislatures of the member states in accordance with the  terms  of  the
    20  compact.
    21    4.  The  interstate  commission  shall consist of two voting represen-
    22  tatives appointed by each member state who shall serve as commissioners.
    23  In states where allopathic and osteopathic physicians are  regulated  by
    24  separate  member  boards, or if the licensing and disciplinary authority
    25  is split between multiple member  boards  within  a  member  state,  the
    26  member  state shall appoint one representative from each member board. A
    27  commissioner shall be a or an:
    28    (a) Allopathic or osteopathic physician appointed to a member board;
    29    (b) Executive director, executive secretary, or similar executive of a
    30  member board; or
    31    (c) Member of the public appointed to a member board.
    32    5. The interstate commission shall meet at least  once  each  calendar
    33  year.  A  portion of this meeting shall be a business meeting to address
    34  such matters as may properly come before the commission,  including  the
    35  election  of  officers. The chairperson may call additional meetings and
    36  shall call for a meeting upon the request of a majority  of  the  member
    37  states.
    38    6. The bylaws may provide for meetings of the interstate commission to
    39  be conducted by telecommunication or electronic communication.
    40    7.  Each  commissioner  participating  at  a meeting of the interstate
    41  commission is entitled to one vote. A majority  of  commissioners  shall
    42  constitute  a  quorum  for  the transaction of business, unless a larger
    43  quorum is required by the bylaws of the interstate commission. A commis-
    44  sioner shall not delegate a vote to another commissioner. In the absence
    45  of its commissioner, a member state may delegate voting authority for  a
    46  specified  meeting  to another person from that state who shall meet the
    47  requirements of subdivision four of this section.
    48    8. The interstate commission shall provide public notice of all  meet-
    49  ings  and  all  meetings  shall  be  open  to the public. The interstate
    50  commission may close a meeting, in full or in portion, where  it  deter-
    51  mines  by  a  two-thirds  vote of the commissioners present that an open
    52  meeting would be likely to:
    53    (a) Relate solely to the internal personnel practices  and  procedures
    54  of the interstate commission;
    55    (b)  Discuss  matters specifically exempted from disclosure by federal
    56  statute;

        S. 8307                            95                            A. 8807

     1    (c) Discuss trade secrets, commercial, or financial  information  that
     2  is privileged or confidential;
     3    (d)  Involve  accusing  a  person  of a crime, or formally censuring a
     4  person;
     5    (e) Discuss information of a personal nature  where  disclosure  would
     6  constitute a clearly unwarranted invasion of personal privacy;
     7    (f)   Discuss  investigative  records  compiled  for  law  enforcement
     8  purposes; or
     9    (g) Specifically relate to the participation  in  a  civil  action  or
    10  other legal proceeding.
    11    9.  The  interstate  commission  shall  keep minutes which shall fully
    12  describe all matters discussed in a meeting and shall provide a full and
    13  accurate summary of actions taken, including record  of  any  roll  call
    14  votes.
    15    10.  The interstate commission shall make its information and official
    16  records, to the extent not otherwise designated in the compact or by its
    17  rules, available to the public for inspection.
    18    11. The interstate commission shall establish an executive  committee,
    19  which  shall  include officers, members, and others as determined by the
    20  bylaws. The executive committee shall have the power to act on behalf of
    21  the interstate commission, with  the  exception  of  rulemaking,  during
    22  periods when the interstate commission is not in session. When acting on
    23  behalf of the interstate commission, the executive committee shall over-
    24  see  the administration of the compact including enforcement and compli-
    25  ance with the provisions of the compact, its bylaws and rules, and other
    26  such duties as necessary.
    27    12. The interstate commission shall  establish  other  committees  for
    28  governance and administration of the compact.
    29    § 8872. Powers and duties of the interstate commission. The interstate
    30  commission shall have the duty and power to:
    31    1. Oversee and maintain the administration of the compact;
    32    2.  Promulgate  rules  which shall be binding to the extent and in the
    33  manner provided for in the compact;
    34    3. Issue, upon the request of a member state or member board, advisory
    35  opinions concerning the meaning or interpretation of  the  compact,  its
    36  bylaws, rules, and actions;
    37    4.  Enforce  compliance with compact provisions, the rules promulgated
    38  by the interstate commission, and the bylaws, using  all  necessary  and
    39  proper means, including but not limited to the use of judicial process;
    40    5.  Establish and appoint committees including, but not limited to, an
    41  executive committee as required by section eighty-eight  hundred  seven-
    42  ty-one  of  this article, which shall have the power to act on behalf of
    43  the interstate commission in carrying out its powers and duties;
    44    6. Pay, or provide for the payment of  the  expenses  related  to  the
    45  establishment,  organization,  and  ongoing activities of the interstate
    46  commission;
    47    7. Establish and maintain one or more offices;
    48    8. Borrow, accept, hire, or contract for services of personnel;
    49    9. Purchase and maintain insurance and bonds;
    50    10. Employ an executive director who shall have such powers to employ,
    51  select or appoint employees, agents, or consultants,  and  to  determine
    52  their qualifications, define their duties, and fix their compensation;
    53    11. Establish personnel policies and programs relating to conflicts of
    54  interest, rates of compensation, and qualifications of personnel;
    55    12. Accept donations and grants of money, equipment, supplies, materi-
    56  als and services, and to receive, utilize, and dispose of it in a manner

        S. 8307                            96                            A. 8807

     1  consistent  with  the  conflict  of interest policies established by the
     2  interstate commission;
     3    13.  Lease,  purchase, accept contributions or donations of, or other-
     4  wise to own, hold, improve, or use, any  property,  real,  personal,  or
     5  mixed;
     6    14.  Sell,  convey,  mortgage,  pledge,  lease,  exchange, abandon, or
     7  otherwise dispose of any property, real, personal, or mixed;
     8    15. Establish a budget and make expenditures;
     9    16. Adopt a seal and bylaws governing the management and operation  of
    10  the interstate commission;
    11    17.  Report  annually  to the legislatures and governors of the member
    12  states concerning the activities of the interstate commission during the
    13  preceding year.  Such reports shall also include  reports  of  financial
    14  audits  and any recommendations that may have been adopted by the inter-
    15  state commission;
    16    18. Coordinate education, training, and public awareness regarding the
    17  compact, its implementation, and its operation;
    18    19. Maintain records in accordance with the bylaws;
    19    20. Seek and obtain trademarks, copyrights, and patents; and
    20    21. Perform such functions as  may  be  necessary  or  appropriate  to
    21  achieve the purposes of the compact.
    22    § 8873. Finance  powers.  1. The interstate commission may levy on and
    23  collect an annual assessment from each member state to cover the cost of
    24  the operations and activities  of  the  interstate  commission  and  its
    25  staff. The total assessment must be sufficient to cover the annual budg-
    26  et  approved each year for which revenue is not provided by other sourc-
    27  es. The aggregate annual assessment amount shall  be  allocated  upon  a
    28  formula  to  be  determined  by  the  interstate commission, which shall
    29  promulgate a rule binding upon all member states.
    30    2. The interstate commission shall not incur obligations of  any  kind
    31  prior to securing the funds adequate to meet the same.
    32    3. The interstate commission shall not pledge the credit of any of the
    33  member states, except by, and with the authority of, the member state.
    34    4.  The  interstate  commission shall be subject to a yearly financial
    35  audit conducted by a certified or licensed  public  accountant  and  the
    36  report of the audit shall be included in the annual report of the inter-
    37  state commission.
    38    § 8874. Organization  and  operation  of the interstate commission. 1.
    39  The interstate commission shall, by a majority of commissioners  present
    40  and  voting,  adopt  bylaws to govern its conduct as may be necessary or
    41  appropriate to carry out the  purposes  of  the  compact  within  twelve
    42  months of the first interstate commission meeting.
    43    2.  The  interstate  commission  shall  elect or appoint annually from
    44  among its commissioners a chairperson, a vice-chairperson, and a  treas-
    45  urer, each of whom shall have such authority and duties as may be speci-
    46  fied  in the bylaws. The chairperson, or in the chairperson's absence or
    47  disability, the vice-chairperson, shall preside at all meetings  of  the
    48  interstate commission.
    49    3. Officers selected pursuant to subdivision two of this section shall
    50  serve without remuneration from the interstate commission.
    51    4.  The  officers  and employees of the interstate commission shall be
    52  immune from suit and liability, either personally or in  their  official
    53  capacity,  for  a  claim  for  damage to or loss of property or personal
    54  injury or other civil liability caused or arising out  of,  or  relating
    55  to,  an actual or alleged act, error, or omission that occurred, or that
    56  such person had a reasonable basis for believing  occurred,  within  the

        S. 8307                            97                            A. 8807

     1  scope  of interstate commission employment, duties, or responsibilities;
     2  provided that such person shall not be protected from suit or  liability
     3  for  damage,  loss,  injury,  or  liability caused by the intentional or
     4  willful and wanton misconduct of such person.
     5    (a)  The  liability  of  the  executive  director and employees of the
     6  interstate commission or representatives of the  interstate  commission,
     7  acting  within the scope of such person's employment or duties for acts,
     8  errors, or omissions occurring  within  such  person's  state,  may  not
     9  exceed the limits of liability set forth under the constitution and laws
    10  of that state for state officials, employees, and agents. The interstate
    11  commission  is considered to be an instrumentality of the states for the
    12  purposes of any such  action.    Nothing  in  this  paragraph  shall  be
    13  construed  to  protect  such  person  from suit or liability for damage,
    14  loss, injury, or liability caused by  the  intentional  or  willful  and
    15  wanton misconduct of such person.
    16    (b) The interstate commission shall defend the executive director, its
    17  employees,  and subject to the approval of the attorney general or other
    18  appropriate legal counsel of the member state represented by  an  inter-
    19  state commission representative, shall defend such interstate commission
    20  representative  in  any civil action seeking to impose liability arising
    21  out of an actual or alleged act, error or omission that occurred  within
    22  the  scope  of  interstate commission employment, duties or responsibil-
    23  ities, or that the  defendant  had  a  reasonable  basis  for  believing
    24  occurred  within  the scope of interstate commission employment, duties,
    25  or responsibilities, provided that the actual or alleged act, error,  or
    26  omission  did  not result from intentional or willful and wanton miscon-
    27  duct on the part of such person.
    28    (c) To the extent not covered by the state involved, member state,  or
    29  the  interstate  commission,  the  representatives  or  employees of the
    30  interstate commission shall be held harmless in the amount of a  settle-
    31  ment  or judgment, including attorney's fees and costs, obtained against
    32  such persons arising out of an actual or alleged act, error, or omission
    33  that occurred within the  scope  of  interstate  commission  employment,
    34  duties, or responsibilities, or that such persons had a reasonable basis
    35  for believing occurred within the scope of interstate commission employ-
    36  ment,  duties,  or responsibilities, provided that the actual or alleged
    37  act, error, or omission did not result from intentional or  willful  and
    38  wanton misconduct on the part of such persons.
    39    § 8875. Rulemaking  functions  of  the interstate commission. 1.   The
    40  interstate commission shall promulgate  reasonable  rules  in  order  to
    41  effectively  and  efficiently  achieve  the  purposes  of  the  compact.
    42  Notwithstanding the foregoing, in the event  the  interstate  commission
    43  exercises  its rulemaking authority in a manner that is beyond the scope
    44  of the purposes of the compact, or the powers  granted  hereunder,  then
    45  such an action by the interstate commission shall be invalid and have no
    46  force or effect.
    47    2.  Rules  deemed  appropriate  for  the  operations of the interstate
    48  commission shall be made pursuant to a rulemaking process that  substan-
    49  tially  conforms to the federal Model State Administrative Procedure Act
    50  of 2010, and subsequent amendments thereto.
    51    3. Not later than thirty days after a rule is promulgated, any  person
    52  may file a petition for judicial review of the rule in the United States
    53  District  Court  for  the  District  of Columbia or the federal district
    54  where the interstate commission has its principal offices, provided that
    55  the filing of such a petition shall not stay or  otherwise  prevent  the
    56  rule  from becoming effective unless the court finds that the petitioner

        S. 8307                            98                            A. 8807

     1  has a substantial likelihood of success. The court shall give  deference
     2  to  the  actions of the interstate commission consistent with applicable
     3  law and shall not find the rule to be unlawful if the rule represents  a
     4  reasonable  exercise  of the authority granted to the interstate commis-
     5  sion.
     6    § 8876. Oversight of interstate compact. 1.  The  executive,  legisla-
     7  tive,  and  judicial  branches  of state government in each member state
     8  shall enforce the compact and  shall  take  all  actions  necessary  and
     9  appropriate  to  effectuate  the  compact's  purposes  and  intent.  The
    10  provisions of the compact and the rules promulgated hereunder shall have
    11  standing as statutory law but shall not override existing state authori-
    12  ty to regulate the practice of medicine.
    13    2. All courts shall take judicial notice of the compact and the  rules
    14  in  any judicial or administrative proceeding in a member state pertain-
    15  ing to the subject matter of the compact which may  affect  the  powers,
    16  responsibilities or actions of the interstate commission.
    17    3.  The interstate commission shall be entitled to receive all service
    18  of process in any such proceeding, and shall have standing to  intervene
    19  in  the proceeding for all purposes. Failure to provide service of proc-
    20  ess to the interstate commission shall render a judgment or  order  void
    21  as to the interstate commission, the compact, or promulgated rules.
    22    § 8877. Enforcement  of  interstate compact. 1. The interstate commis-
    23  sion, in the reasonable exercise of its discretion,  shall  enforce  the
    24  provisions and rules of the compact.
    25    2.  The interstate commission may, by majority vote of the commission-
    26  ers, initiate legal action in the United States District Court  for  the
    27  District  of  Columbia,  or, at the discretion of the interstate commis-
    28  sion, in the federal district where the interstate  commission  has  its
    29  principal  offices,  to  enforce  compliance  with the provisions of the
    30  compact, and its promulgated rules and bylaws, against a member state in
    31  default. The relief  sought  may  include  both  injunctive  relief  and
    32  damages.  In the event judicial enforcement is necessary, the prevailing
    33  party shall be awarded all costs of such litigation including reasonable
    34  attorney's fees.
    35    3. The remedies herein shall not be  the  exclusive  remedies  of  the
    36  interstate  commission.    The interstate commission may avail itself of
    37  any other remedies available under state law  or  the  regulation  of  a
    38  profession.
    39    § 8878. Default  procedures.  1.  The grounds for default include, but
    40  are not limited to, failure of a member  state  to  perform  such  obli-
    41  gations or responsibilities imposed upon it by the compact, or the rules
    42  and bylaws of the interstate commission promulgated under the compact.
    43    2.  If  the  interstate  commission determines that a member state has
    44  defaulted in the performance  of  its  obligations  or  responsibilities
    45  under  the  compact,  or the bylaws or promulgated rules, the interstate
    46  commission shall:
    47    (a) Provide written notice to the defaulting state  and  other  member
    48  states,  of  the nature of the default, the means of curing the default,
    49  and any action taken by  the  interstate  commission.    The  interstate
    50  commission  shall  specify  the conditions by which the defaulting state
    51  must cure its default; and
    52    (b)  Provide  remedial  training  and  specific  technical  assistance
    53  regarding the default.
    54    3.  If  the defaulting state fails to cure the default, the defaulting
    55  state shall be terminated from the compact upon an affirmative vote of a
    56  majority of the commissioners and all rights, privileges,  and  benefits

        S. 8307                            99                            A. 8807

     1  conferred by the compact shall terminate on the effective date of termi-
     2  nation.  A  cure  of the default does not relieve the offending state of
     3  obligations or liabilities incurred during the period of the default.
     4    4.  Termination  of  membership  in  the compact shall be imposed only
     5  after all other means of securing compliance have been exhausted. Notice
     6  of intent to terminate shall be given by the  interstate  commission  to
     7  the  governor,  the  majority  and  minority  leaders  of the defaulting
     8  state's legislature, and each of the member states.
     9    5. The interstate commission shall establish rules and  procedures  to
    10  address  licenses  and  physicians  that  are materially impacted by the
    11  termination of a member state, or the withdrawal of a member state.
    12    6. The member state which has been terminated is responsible  for  all
    13  dues,  obligations,  and liabilities incurred through the effective date
    14  of termination including obligations, the performance of  which  extends
    15  beyond the effective date of termination.
    16    7.  The interstate commission shall not bear any costs relating to any
    17  state that has been found to be in default or which has been  terminated
    18  from  the  compact,  unless  otherwise  mutually  agreed upon in writing
    19  between the interstate commission and the defaulting state.
    20    8. The defaulting state  may  appeal  the  action  of  the  interstate
    21  commission  by  petitioning  the  United  States  District Court for the
    22  District of Columbia  or  the  federal  district  where  the  interstate
    23  commission  has  its  principal  offices.  The prevailing party shall be
    24  awarded all costs of such  litigation  including  reasonable  attorney's
    25  fees.
    26    § 8879. Dispute   resolution.   1.  The  interstate  commission  shall
    27  attempt, upon the request of a member state, to resolve  disputes  which
    28  are  subject  to  the compact and which may arise among member states or
    29  member boards.
    30    2. The interstate commission shall promulgate rules providing for both
    31  mediation and binding dispute resolution as appropriate.
    32    § 8880. Member states, effective date and amendment. 1. Any  state  is
    33  eligible to become a member state of the compact.
    34    2.  The  compact  shall  become effective and binding upon legislative
    35  enactment of the compact into law by no less than seven  states.  There-
    36  after,  it  shall become effective and binding on a state upon enactment
    37  of the compact into law by that state.
    38    3. The governors of non-member states, or their  designees,  shall  be
    39  invited to participate in the activities of the interstate commission on
    40  a non-voting basis prior to adoption of the compact by all states.
    41    4. The interstate commission may propose amendments to the compact for
    42  enactment  by the member states. No amendment shall become effective and
    43  binding upon the interstate commission and the member states unless  and
    44  until it is enacted into law by unanimous consent of the member states.
    45    § 8881. Withdrawal.  1.  Once effective, the compact shall continue in
    46  force and remain binding upon each and every member state; provided that
    47  a member state may withdraw from the compact by  specifically  repealing
    48  the statute which enacted the compact into law.
    49    2.  Withdrawal from the compact shall be by the enactment of a statute
    50  repealing the same, but shall not take effect until one year  after  the
    51  effective  date  of  such  statute and until written notice of the with-
    52  drawal has been given by the withdrawing state to the governor  of  each
    53  other member state.
    54    3.  The  withdrawing state shall immediately notify the chairperson of
    55  the interstate commission in writing upon  the  introduction  of  legis-
    56  lation repealing the compact in the withdrawing state.

        S. 8307                            100                           A. 8807

     1    4.  The  interstate commission shall notify the other member states of
     2  the withdrawing state's intent to withdraw  within  sixty  days  of  its
     3  receipt of notice provided under subdivision three of this section.
     4    5.  The withdrawing state is responsible for all dues, obligations and
     5  liabilities incurred through the effective date of withdrawal, including
     6  obligations, the performance of which extend beyond the  effective  date
     7  of withdrawal.
     8    6.  Reinstatement  following  withdrawal of a member state shall occur
     9  upon the withdrawing state reenacting the compact  or  upon  such  later
    10  date as determined by the interstate commission.
    11    7. The interstate commission is authorized to develop rules to address
    12  the  impact  of  the withdrawal of a member state on licenses granted in
    13  other member states to physicians who designated the withdrawing  member
    14  state as the state of principal license.
    15    § 8882. Dissolution.  1. The compact shall dissolve effective upon the
    16  date of the withdrawal or default of the member state which reduces  the
    17  membership in the compact to one member state.
    18    2.  Upon  the dissolution of the compact, the compact becomes null and
    19  void and shall be of no further force or effect, and  the  business  and
    20  affairs  of  the  interstate  commission  shall be concluded and surplus
    21  funds shall be distributed in accordance with the bylaws.
    22    § 8883. Severability  and  construction.  1.  The  provisions  of  the
    23  compact  shall  be  severable,  and  if any phrase, clause, sentence, or
    24  provision is deemed  unenforceable,  the  remaining  provisions  of  the
    25  compact shall be enforceable.
    26    2.  The  provisions  of  the  compact  shall be liberally construed to
    27  effectuate its purposes.
    28    3. Nothing in the compact shall be construed to prohibit the  applica-
    29  bility of other interstate compacts to which the states are members.
    30    § 8884. Binding effect of compact and other laws. 1. Nothing contained
    31  in  this  article  shall  prevent  the enforcement of any other law of a
    32  member state that is not inconsistent with the compact.
    33    2. All laws in a member state in conflict with the compact are  super-
    34  seded to the extent of the conflict.
    35    3.  All  lawful  actions  of  the interstate commission, including all
    36  rules and bylaws promulgated by the commission,  are  binding  upon  the
    37  member states.
    38    4.  All  agreements  between  the interstate commission and the member
    39  states are binding in accordance with their terms.
    40    5. In the event any provision of the  compact  exceeds  the  constitu-
    41  tional  limits  imposed  on  the  legislature  of any member state, such
    42  provision shall be ineffective to the extent of the  conflict  with  the
    43  constitutional provision in question in that member state.
    44    §  2. Article 170 of the education law is renumbered article 171 and a
    45  new article 170 is added to title 8 of the  education  law  to  read  as
    46  follows:
    47                                 ARTICLE 170
    48                           NURSE LICENSURE COMPACT
    49  Section 8900. Nurse licensure compact.
    50          8901. Findings and declaration of purpose.
    51          8902. Definitions.
    52          8903. General provisions and jurisdiction.
    53          8904. Applications for licensure in a party state.
    54          8905. Additional  authorities  invested in party state licensing
    55                  boards.

        S. 8307                            101                           A. 8807

     1          8906. Coordinated licensure information system and  exchange  of
     2                  information.
     3          8907. Establishment of the interstate commission of nurse licen-
     4                  sure compact administrators.
     5          8908. Rulemaking.
     6          8909. Oversight, dispute resolution and enforcement.
     7          8910. Effective date, withdrawal and amendment.
     8          8911. Construction and severability.
     9    § 8900. Nurse  licensure  compact.  The  nurse  license compact as set
    10  forth in the article is hereby adopted and entered into with  all  party
    11  states joining therein.
    12    § 8901. Findings  and  declaration of purpose  1. Findings.  The party
    13  states find that:
    14    a. The health and safety of the public are affected by the  degree  of
    15  compliance  with and the effectiveness of enforcement activities related
    16  to state nurse licensure laws;
    17    b. Violations of nurse licensure and other laws regulating  the  prac-
    18  tice of nursing may result in injury or harm to the public;
    19    c.  The  expanded  mobility of nurses and the use of advanced communi-
    20  cation technologies as part of our nation's health care delivery  system
    21  require  greater  coordination and cooperation among states in the areas
    22  of nurse licensure and regulation;
    23    d. New practice modalities and technology make compliance  with  indi-
    24  vidual state nurse licensure laws difficult and complex;
    25    e.  The  current system of duplicative licensure for nurses practicing
    26  in multiple states is cumbersome  and  redundant  for  both  nurses  and
    27  states; and
    28    f.  Uniformity  of  nurse licensure requirements throughout the states
    29  promotes public safety and public health benefits.
    30    2. Declaration of purpose. The general purposes of  this  compact  are
    31  to:
    32    a.  Facilitate  the  states'  responsibility  to  protect the public's
    33  health and safety;
    34    b. Ensure and encourage the cooperation of party states in  the  areas
    35  of nurse licensure and regulation;
    36    c.  Facilitate the exchange of information between party states in the
    37  areas of nurse regulation, investigation and adverse actions;
    38    d. Promote compliance with the laws governing the practice of  nursing
    39  in each jurisdiction;
    40    e. Invest all party states with the authority to hold a nurse account-
    41  able  for  meeting  all  state  practice  laws in the state in which the
    42  patient is located at the time  care  is  rendered  through  the  mutual
    43  recognition of party state licenses;
    44    f.  Decrease  redundancies  in the consideration and issuance of nurse
    45  licenses; and
    46    g. Provide opportunities for interstate practice by  nurses  who  meet
    47  uniform licensure requirements.
    48    § 8902. Definitions. 1. Definitions. As used in this compact:
    49    a.  "Adverse  action"  means  any  administrative, civil, equitable or
    50  criminal action permitted by a  state's  laws  which  is  imposed  by  a
    51  licensing  board  or  other authority against a nurse, including actions
    52  against an individual's license or multistate licensure  privilege  such
    53  as  revocation, suspension, probation, monitoring of the licensee, limi-
    54  tation on the licensee's practice, or any other encumbrance on licensure
    55  affecting a nurse's authorization to practice, including issuance  of  a
    56  cease and desist action.

        S. 8307                            102                           A. 8807

     1    b.  "Alternative  program" means a non-disciplinary monitoring program
     2  approved by a licensing board.
     3    c.  "Coordinated  licensure  information  system"  means an integrated
     4  process for collecting, storing and sharing information on nurse  licen-
     5  sure  and enforcement activities related to nurse licensure laws that is
     6  administered by a nonprofit organization composed of and  controlled  by
     7  licensing boards.
     8    d.  "Commission"  means  the  interstate commission of nurse licensure
     9  compact administrators.
    10    e. "Current significant investigative information" means:
    11    1. Investigative information that a licensing board, after a  prelimi-
    12  nary inquiry that includes notification and an opportunity for the nurse
    13  to  respond,  if  required  by  state  law, has reason to believe is not
    14  groundless and, if proved true, would indicate more than a minor infrac-
    15  tion; or
    16    2. Investigative information that indicates that the nurse  represents
    17  an  immediate  threat  to public health and safety regardless of whether
    18  the nurse has been notified and had an opportunity to respond.
    19    f. "Encumbrance" means a revocation or suspension of, or  any  limita-
    20  tion  on,  the  full  and  unrestricted practice of nursing imposed by a
    21  licensing board.
    22    g. "Home state" means the party state which  is  the  nurse's  primary
    23  state of residence.
    24    h. "Licensing board" means a party state's regulatory body responsible
    25  for issuing nurse licenses.
    26    i.  "Multistate  license"  means a license to practice as a registered
    27  nurse (RN) or as a licensed practical/vocational nurse  (LPN/VN),  which
    28  is  issued  by  a  home  state licensing board, and which authorizes the
    29  licensed nurse to practice in all party states under a multistate licen-
    30  sure privilege.
    31    j. "Multistate licensure privilege" means a legal authorization  asso-
    32  ciated  with  a multistate license permitting the practice of nursing as
    33  either a RN or a LPN/VN in a remote state.
    34    k. "Nurse" means RN or LPN/VN, as those  terms  are  defined  by  each
    35  party state's practice laws.
    36    l. "Party state" means any state that has adopted this compact.
    37    m. "Remote state" means a party state, other than the home state.
    38    n.  "Single-state  license"  means  a  nurse license issued by a party
    39  state that authorizes practice only within the issuing  state  and  does
    40  not  include  a  multistate licensure privilege to practice in any other
    41  party state.
    42    o. "State" means a state, territory or possession of the United States
    43  and the District of Columbia.
    44    p. "State practice laws" means a party state's laws, rules  and  regu-
    45  lations that govern the practice of nursing, define the scope of nursing
    46  practice,  and  create  the methods and grounds for imposing discipline.
    47  "State practice laws" shall not include requirements necessary to obtain
    48  and retain a license, except for qualifications or requirements  of  the
    49  home state.
    50    § 8903. General provisions and jurisdiction. 1. General provisions and
    51  jurisdiction. a. A multistate license to practice registered or licensed
    52  practical/vocational  nursing  issued  by  a home state to a resident in
    53  that state will be recognized by each party state as authorizing a nurse
    54  to  practice  as  a   registered   nurse   (RN)   or   as   a   licensed
    55  practical/vocational nurse (LPN/VN), under a multistate licensure privi-
    56  lege, in each party state.

        S. 8307                            103                           A. 8807

     1    b.  A  state  shall  implement procedures for considering the criminal
     2  history records of applicants  for  an  initial  multistate  license  or
     3  licensure  by  endorsement. Such procedures shall include the submission
     4  of fingerprints or other biometric-based information by  applicants  for
     5  the purpose of obtaining an applicant's criminal history record informa-
     6  tion from the federal bureau of investigation and the agency responsible
     7  for retaining that state's criminal records.
     8    c.  Each party state shall require its licensing board to authorize an
     9  applicant to obtain or retain a multistate license  in  the  home  state
    10  only if the applicant:
    11    i.  Meets  the home state's qualifications for licensure or renewal of
    12  licensure, and complies with all other applicable state laws;
    13    ii. (1) Has graduated or is eligible  to  graduate  from  a  licensing
    14  board-approved RN or LPN/VN prelicensure education program; or
    15    (2)  Has  graduated from a foreign RN or LPN/VN prelicensure education
    16  program that has been: (A) approved by the authorized  accrediting  body
    17  in  the  applicable  country, and (B) verified by an independent creden-
    18  tials review agency to be comparable to a licensing board-approved prel-
    19  icensure education program;
    20    iii. Has, if a graduate of a foreign  prelicensure  education  program
    21  not  taught  in  English  or  if  English is not the individual's native
    22  language, successfully passed an English  proficiency  examination  that
    23  includes the components of reading, speaking, writing and listening;
    24    iv.  Has  successfully  passed  an NCLEX-RN or NCLEX-PN examination or
    25  recognized predecessor, as applicable;
    26    v. Is eligible for or holds an active, unencumbered license;
    27    vi. Has submitted, in  connection  with  an  application  for  initial
    28  licensure  or  licensure by endorsement, fingerprints or other biometric
    29  data for the purpose of obtaining criminal  history  record  information
    30  from  the federal bureau of investigation and the agency responsible for
    31  retaining that state's criminal records;
    32    vii. Has not been convicted or found guilty, or has  entered  into  an
    33  agreed disposition, of a felony offense under applicable state or feder-
    34  al criminal law;
    35    viii.  Has  not been convicted or found guilty, or has entered into an
    36  agreed disposition, of a misdemeanor offense related to the practice  of
    37  nursing as determined on a case-by-case basis;
    38    ix. Is not currently enrolled in an alternative program;
    39    x.  Is  subject  to  self-disclosure  requirements  regarding  current
    40  participation in an alternative program; and
    41    xi. Has a valid United States social security number.
    42    d. All party states shall be authorized, in accordance  with  existing
    43  state  due  process law, to take adverse action against a nurse's multi-
    44  state licensure privilege such as revocation, suspension,  probation  or
    45  any  other action that affects a nurse's authorization to practice under
    46  a multistate licensure privilege, including cease and desist actions. If
    47  a party state takes such action, it shall promptly notify  the  adminis-
    48  trator  of the coordinated licensure information system. The administra-
    49  tor of the coordinated licensure information system shall promptly noti-
    50  fy the home state of any such actions by remote states.
    51    e. A nurse practicing in a party state shall  comply  with  the  state
    52  practice  laws  of  the state in which the client is located at the time
    53  service is provided. The practice of nursing is not limited  to  patient
    54  care  but  shall  include  all  nursing practice as defined by the state
    55  practice laws of the party state in which the  client  is  located.  The
    56  practice of nursing in a party state under a multistate licensure privi-

        S. 8307                            104                           A. 8807

     1  lege  will  subject  a nurse to the jurisdiction of the licensing board,
     2  the courts and the laws of the  party  state  in  which  the  client  is
     3  located at the time service is provided.
     4    f. Individuals not residing in a party state shall continue to be able
     5  to  apply for a party state's single-state license as provided under the
     6  laws of each party state. However, the single-state license  granted  to
     7  these  individuals  will  not be recognized as granting the privilege to
     8  practice nursing in any other party state. Nothing in this compact shall
     9  affect the requirements established by a party state for the issuance of
    10  a single-state license.
    11    g. Any nurse holding a home state multistate license, on the effective
    12  date of this compact, may retain and renew the multistate license issued
    13  by the nurse's then-current home state, provided that:
    14    i. A  nurse,  who  changes  primary  state  of  residence  after  this
    15  compact's  effective  date,  shall  meet all applicable requirements set
    16  forth in this article to obtain a multistate license  from  a  new  home
    17  state.
    18    ii. A nurse who fails to satisfy the multistate licensure requirements
    19  set  forth  in this article due to a disqualifying event occurring after
    20  this compact's effective date shall be ineligible to retain or  renew  a
    21  multistate  license, and the nurse's multistate license shall be revoked
    22  or deactivated in  accordance  with  applicable  rules  adopted  by  the
    23  commission.
    24    § 8904. Applications  for  licensure in a party state. 1. Applications
    25  for licensure in a party state. a. Upon  application  for  a  multistate
    26  license, the licensing board in the issuing party state shall ascertain,
    27  through the coordinated licensure information system, whether the appli-
    28  cant  has  ever held, or is the holder of, a license issued by any other
    29  state, whether there are any encumbrances on any license  or  multistate
    30  licensure  privilege  held  by the applicant, whether any adverse action
    31  has been taken against any license  or  multistate  licensure  privilege
    32  held by the applicant and whether the applicant is currently participat-
    33  ing in an alternative program.
    34    b. A nurse may hold a multistate license, issued by the home state, in
    35  only one party state at a time.
    36    c. If a nurse changes primary state of residence by moving between two
    37  party  states, the nurse must apply for licensure in the new home state,
    38  and the multistate license issued by the prior home state will be  deac-
    39  tivated in accordance with applicable rules adopted by the commission.
    40    i. The nurse may apply for licensure in advance of a change in primary
    41  state of residence.
    42    ii.  A  multistate  license  shall not be issued by the new home state
    43  until the nurse provides satisfactory evidence of a  change  in  primary
    44  state  of  residence  to the new home state and satisfies all applicable
    45  requirements to obtain a multistate license from the new home state.
    46    d. If a nurse changes primary state of  residence  by  moving  from  a
    47  party  state  to a non-party state, the multistate license issued by the
    48  prior home state will convert to a single-state license, valid  only  in
    49  the former home state.
    50    § 8905. Additional  authorities  invested  in  party  state  licensing
    51  boards. 1. Licensing board authority. In addition to  the  other  powers
    52  conferred by state law, a licensing board shall have the authority to:
    53    a.  Take  adverse action against a nurse's multistate licensure privi-
    54  lege to practice within that party state.
    55    i. Only the home state shall have the power  to  take  adverse  action
    56  against a nurse's license issued by the home state.

        S. 8307                            105                           A. 8807

     1    ii.  For  purposes  of taking adverse action, the home state licensing
     2  board shall give the  same  priority  and  effect  to  reported  conduct
     3  received  from  a  remote state as it would if such conduct had occurred
     4  within the home state. In so doing, the home state shall apply  its  own
     5  state laws to determine appropriate action.
     6    b. Issue cease and desist orders or impose an encumbrance on a nurse's
     7  authority to practice within that party state.
     8    c.  Complete any pending investigations of a nurse who changes primary
     9  state of residence during the course of such investigations. The licens-
    10  ing board shall also have the authority to take  appropriate  action  or
    11  actions and shall promptly report the conclusions of such investigations
    12  to  the  administrator  of the coordinated licensure information system.
    13  The administrator of the coordinated licensure information system  shall
    14  promptly notify the new home state of any such actions.
    15    d.  Issue  subpoenas for both hearings and investigations that require
    16  the attendance and testimony of witnesses, as well as the production  of
    17  evidence. Subpoenas issued by a licensing board in a party state for the
    18  attendance and testimony of witnesses or the production of evidence from
    19  another  party  state shall be enforced in the latter state by any court
    20  of competent jurisdiction, according to the practice  and  procedure  of
    21  that  court applicable to subpoenas issued in proceedings pending before
    22  it.  The issuing authority shall pay any witness fees, travel  expenses,
    23  mileage  and other fees required by the service statutes of the state in
    24  which the witnesses or evidence are located.
    25    e. Obtain and submit, for each nurse licensure applicant,  fingerprint
    26  or  other  biometric-based information to the federal bureau of investi-
    27  gation for criminal background checks, receive the results of the feder-
    28  al bureau of investigation record search on criminal  background  checks
    29  and use the results in making licensure decisions.
    30    f.  If  otherwise  permitted  by  state law, recover from the affected
    31  nurse the costs of investigations and  disposition  of  cases  resulting
    32  from any adverse action taken against that nurse.
    33    g.  Take  adverse  action  based on the factual findings of the remote
    34  state, provided that the licensing board follows its own procedures  for
    35  taking such adverse action.
    36    2.  Adverse  actions.  a. If adverse action is taken by the home state
    37  against a nurse's multistate license, the nurse's  multistate  licensure
    38  privilege  to  practice  in  all other party states shall be deactivated
    39  until all encumbrances have been removed from  the  multistate  license.
    40  All  home state disciplinary orders that impose adverse action against a
    41  nurse's multistate license shall include a statement  that  the  nurse's
    42  multistate licensure privilege is deactivated in all party states during
    43  the pendency of the order.
    44    b.  Nothing  in  this  compact shall override a party state's decision
    45  that participation in an alternative program may  be  used  in  lieu  of
    46  adverse  action.  The  home  state  licensing board shall deactivate the
    47  multistate licensure privilege under the multistate license of any nurse
    48  for the duration of the nurse's participation in an alternative program.
    49    § 8906. Coordinated  licensure  information  system  and  exchange  of
    50  information.  1.   Coordinated licensure information system and exchange
    51  of information. a. All party states shall participate in  a  coordinated
    52  licensure information system of all licensed registered nurses (RNs) and
    53  licensed   practical/vocational  nurses  (LPNs/VNs).  This  system  will
    54  include information on the licensure and disciplinary  history  of  each
    55  nurse,  as  submitted  by party states, to assist in the coordination of
    56  nurse licensure and enforcement efforts.

        S. 8307                            106                           A. 8807

     1    b. The commission, in consultation with the administrator of the coor-
     2  dinated licensure information  system,  shall  formulate  necessary  and
     3  proper  procedures  for  the  identification, collection and exchange of
     4  information under this compact.
     5    c.  All  licensing  boards  shall  promptly  report to the coordinated
     6  licensure information system any adverse action, any current significant
     7  investigative information, denials of applications with the reasons  for
     8  such  denials  and  nurse participation in alternative programs known to
     9  the licensing board regardless of whether such participation  is  deemed
    10  nonpublic or confidential under state law.
    11    d.  Current significant investigative information and participation in
    12  nonpublic or confidential  alternative  programs  shall  be  transmitted
    13  through the coordinated licensure information system only to party state
    14  licensing boards.
    15    e. Notwithstanding any other provision of law, all party state licens-
    16  ing  boards contributing information to the coordinated licensure infor-
    17  mation system may designate information that  may  not  be  shared  with
    18  non-party  states  or disclosed to other entities or individuals without
    19  the express permission of the contributing state.
    20    f. Any personally identifiable information obtained from  the  coordi-
    21  nated  licensure  information  system  by  a party state licensing board
    22  shall not be shared with non-party states or disclosed to other entities
    23  or individuals except to the extent permitted by the laws of  the  party
    24  state contributing the information.
    25    g.  Any  information contributed to the coordinated licensure informa-
    26  tion system that is subsequently required to be expunged by the laws  of
    27  the  party  state  contributing  that information shall also be expunged
    28  from the coordinated licensure information system.
    29    h. The compact administrator of  each  party  state  shall  furnish  a
    30  uniform data set to the compact administrator of each other party state,
    31  which shall include, at a minimum:
    32    i. Identifying information;
    33    ii. Licensure data;
    34    iii. Information related to alternative program participation; and
    35    iv.  Other  information that may facilitate the administration of this
    36  compact, as determined by commission rules.
    37    i. The compact administrator of a party state shall provide all inves-
    38  tigative documents and information requested by another party state.
    39    § 8907. Establishment of the interstate commission of nurse  licensure
    40  compact administrators.  1. Commission of nurse licensure compact admin-
    41  istrators.  The  party states hereby create and establish a joint public
    42  entity known as the interstate commission  of  nurse  licensure  compact
    43  administrators.  The  commission  is  an  instrumentality  of  the party
    44  states.
    45    2. Venue. Venue is proper, and judicial proceedings by or against  the
    46  commission shall be brought solely and exclusively, in a court of compe-
    47  tent  jurisdiction  where  the  principal  office  of  the commission is
    48  located. The commission may waive venue and jurisdictional  defenses  to
    49  the  extent  it adopts or consents to participate in alternative dispute
    50  resolution proceedings.
    51    3. Sovereign immunity. Nothing in this compact shall be  construed  to
    52  be a waiver of sovereign immunity.
    53    4. Membership, voting and meetings. a. Each party state shall have and
    54  be  limited  to one administrator. The head of the state licensing board
    55  or designee shall be the administrator of this compact  for  each  party
    56  state.    Any  administrator  may be removed or suspended from office as

        S. 8307                            107                           A. 8807

     1  provided by the law  of  the  state  from  which  the  administrator  is
     2  appointed.  Any  vacancy  occurring in the commission shall be filled in
     3  accordance with the laws of the party state in which the vacancy exists.
     4    b. Each administrator shall be entitled to one vote with regard to the
     5  promulgation of rules and creation of bylaws and shall otherwise have an
     6  opportunity  to  participate  in the business and affairs of the commis-
     7  sion.  An administrator shall vote in person or by such other  means  as
     8  provided  in  the  bylaws. The bylaws may provide for an administrator's
     9  participation in meetings by telephone or other means of communication.
    10    c. The commission shall meet at least once during each calendar  year.
    11  Additional meetings shall be held as set forth in the bylaws or rules of
    12  the commission.
    13    d.  All  meetings  shall  be  open to the public, and public notice of
    14  meetings shall be given in the same manner as required under  the  rule-
    15  making provisions in section eighty-nine hundred eight of this article.
    16    5. Closed meetings. a. The commission may convene in a closed, nonpub-
    17  lic meeting if the commission shall discuss:
    18    i.  Noncompliance  of  a  party  state with its obligations under this
    19  compact;
    20    ii.  The  employment,  compensation,  discipline  or  other  personnel
    21  matters,  practices or procedures related to specific employees or other
    22  matters related to the commission's  internal  personnel  practices  and
    23  procedures;
    24    iii. Current, threatened or reasonably anticipated litigation;
    25    iv.  Negotiation  of  contracts  for  the  purchase  or sale of goods,
    26  services or real estate;
    27    v. Accusing any person of a crime or formally censuring any person;
    28    vi. Disclosure of trade secrets or commercial or financial information
    29  that is privileged or confidential;
    30    vii. Disclosure of information of a personal nature  where  disclosure
    31  would constitute a clearly unwarranted invasion of personal privacy;
    32    viii. Disclosure of investigatory records compiled for law enforcement
    33  purposes;
    34    ix. Disclosure of information related to any reports prepared by or on
    35  behalf  of the commission for the purpose of investigation of compliance
    36  with this compact; or
    37    x. Matters specifically exempted from disclosure by federal  or  state
    38  statute.
    39    b.  If  a meeting, or portion of a meeting, is closed pursuant to this
    40  paragraph the commission's legal counsel or designee shall certify  that
    41  the  meeting  may  be closed and shall reference each relevant exempting
    42  provision. The commission shall keep  minutes  that  fully  and  clearly
    43  describe all matters discussed in a meeting and shall provide a full and
    44  accurate summary of actions taken, and the reasons therefor, including a
    45  description   of  the  views  expressed.  All  documents  considered  in
    46  connection with an action shall  be  identified  in  such  minutes.  All
    47  minutes  and  documents  of  a  closed  meeting shall remain under seal,
    48  subject to release by a majority vote of the commission or  order  of  a
    49  court of competent jurisdiction.
    50    c.  The  commission  shall,  by a majority vote of the administrators,
    51  prescribe bylaws or rules to govern its conduct as may be  necessary  or
    52  appropriate  to  carry  out the purposes and exercise the powers of this
    53  compact, including but not limited to:
    54    i. Establishing the fiscal year of the commission;
    55    ii. Providing reasonable standards and procedures:
    56    (1) For the establishment and meetings of other committees; and

        S. 8307                            108                           A. 8807

     1    (2) Governing any general or specific delegation of any  authority  or
     2  function of the commission;
     3    iii.  Providing reasonable procedures for calling and conducting meet-
     4  ings of the commission, ensuring reasonable advance notice of all  meet-
     5  ings  and  providing  an  opportunity for attendance of such meetings by
     6  interested parties, with enumerated exceptions designed to  protect  the
     7  public's  interest, the privacy of individuals, and proprietary informa-
     8  tion, including trade secrets. The commission may meet in closed session
     9  only after a majority of the administrators vote to close a  meeting  in
    10  whole  or  in  part.  As  soon  as practicable, the commission must make
    11  public a copy of the vote to close the meeting  revealing  the  vote  of
    12  each administrator, with no proxy votes allowed;
    13    iv.  Establishing  the  titles,  duties  and  authority and reasonable
    14  procedures for the election of the officers of the commission;
    15    v. Providing reasonable standards and procedures for the establishment
    16  of the personnel policies and programs of the commission.  Notwithstand-
    17  ing  any  civil  service  or  other similar laws of any party state, the
    18  bylaws shall exclusively govern the personnel policies and  programs  of
    19  the commission; and
    20    vi. Providing a mechanism for winding up the operations of the commis-
    21  sion  and  the equitable disposition of any surplus funds that may exist
    22  after the termination of this compact after the payment or reserving  of
    23  all of its debts and obligations.
    24    6.  General provisions. a. The commission shall publish its bylaws and
    25  rules, and any amendments thereto, in a convenient form on  the  website
    26  of the commission.
    27    b.  The  commission shall maintain its financial records in accordance
    28  with the bylaws.
    29    c. The commission shall meet and take such actions as  are  consistent
    30  with the provisions of this compact and the bylaws.
    31     7.  Powers of the commission. The commission shall have the following
    32  powers:
    33    a. To promulgate uniform rules to facilitate and coordinate  implemen-
    34  tation  and  administration  of  this  compact. The rules shall have the
    35  force and effect of law and shall be binding in all party states;
    36    b. To bring and prosecute legal proceedings or actions in the name  of
    37  the commission, provided that the standing of any licensing board to sue
    38  or be sued under applicable law shall not be affected;
    39    c. To purchase and maintain insurance and bonds;
    40    d. To borrow, accept or contract for services of personnel, including,
    41  but  not  limited  to, employees of a party state or nonprofit organiza-
    42  tions;
    43    e.  To  cooperate  with  other  organizations  that  administer  state
    44  compacts related to the regulation of nursing, including but not limited
    45  to  sharing  administrative  or  staff  expenses,  office space or other
    46  resources;
    47    f. To hire employees, elect or  appoint  officers,  fix  compensation,
    48  define duties, grant such individuals appropriate authority to carry out
    49  the  purposes of this compact, and to establish the commission's person-
    50  nel policies and programs relating to conflicts of interest,  qualifica-
    51  tions of personnel and other related personnel matters;
    52    g.  To  accept  any and all appropriate donations, grants and gifts of
    53  money, equipment, supplies, materials  and  services,  and  to  receive,
    54  utilize  and dispose of the same; provided that at all times the commis-
    55  sion shall avoid any appearance of impropriety or conflict of interest;

        S. 8307                            109                           A. 8807

     1    h. To lease, purchase, accept appropriate gifts or  donations  of,  or
     2  otherwise  to  own,  hold,  improve  or use, any property, whether real,
     3  personal or mixed; provided that at all times the commission shall avoid
     4  any appearance of impropriety;
     5    i.  To  sell,  convey,  mortgage,  pledge, lease, exchange, abandon or
     6  otherwise dispose of any property, whether real, personal or mixed;
     7    j. To establish a budget and make expenditures;
     8    k. To borrow money;
     9    l. To appoint committees, including advisory committees  comprised  of
    10  administrators,  state  nursing  regulators,  state legislators or their
    11  representatives, and consumer representatives, and other such interested
    12  persons;
    13    m. To provide and receive information from, and to cooperate with, law
    14  enforcement agencies;
    15    n. To adopt and use an official seal; and
    16    o. To perform such other functions as may be necessary or  appropriate
    17  to  achieve the purposes of this compact consistent with the state regu-
    18  lation of nurse licensure and practice.
    19    8. Financing of the  commission.  a.  The  commission  shall  pay,  or
    20  provide  for  the  payment of, the reasonable expenses of its establish-
    21  ment, organization and ongoing activities.
    22    b. The commission may also levy on and collect  an  annual  assessment
    23  from  each  party  state to cover the cost of its operations, activities
    24  and staff in its annual budget as  approved  each  year.  The  aggregate
    25  annual assessment amount, if any, shall be allocated based upon a formu-
    26  la  to  be  determined  by the commission, which shall promulgate a rule
    27  that is binding upon all party states.
    28    c. The commission shall not incur obligations of  any  kind  prior  to
    29  securing  the  funds adequate to meet the same; nor shall the commission
    30  pledge the credit of any of the party states, except by,  and  with  the
    31  authority of, such party state.
    32    d.  The  commission  shall  keep accurate accounts of all receipts and
    33  disbursements. The receipts and disbursements of the commission shall be
    34  subject to the audit and accounting  procedures  established  under  its
    35  bylaws.  However, all receipts and disbursements of funds handled by the
    36  commission shall be audited yearly by a  certified  or  licensed  public
    37  accountant,  and the report of the audit shall be included in and become
    38  part of the annual report of the commission.
    39    9. Qualified immunity, defense and indemnification. a. The administra-
    40  tors, officers, executive director, employees and representatives of the
    41  commission shall be immune from suit and liability, either personally or
    42  in their official capacity, for any claim for damage to or loss of prop-
    43  erty or personal injury or other civil liability caused  by  or  arising
    44  out  of  any  actual or alleged act, error or omission that occurred, or
    45  that the person against whom the claim is made had  a  reasonable  basis
    46  for believing occurred, within the scope of the commission's employment,
    47  duties  or  responsibilities;  provided  that  nothing in this paragraph
    48  shall be construed to protect any such person from suit or liability for
    49  any damage, loss, injury or liability caused by the intentional, willful
    50  or wanton misconduct of that person.
    51    b. The commission shall defend any administrator,  officer,  executive
    52  director,  employee  or  representative  of  the commission in any civil
    53  action seeking to impose liability arising out of any actual or  alleged
    54  act,  error  or  omission  that occurred within the scope of the commis-
    55  sion's employment,  duties  or  responsibilities,  or  that  the  person
    56  against  whom  the  claim  is  made had a reasonable basis for believing

        S. 8307                            110                           A. 8807

     1  occurred within the scope of  the  commission's  employment,  duties  or
     2  responsibilities;  provided  that  nothing  herein shall be construed to
     3  prohibit that person from retaining his or her own counsel; and provided
     4  further that the actual or alleged act, error or omission did not result
     5  from that person's intentional, willful or wanton misconduct.
     6    c. The commission shall indemnify and hold harmless any administrator,
     7  officer,  executive  director, employee or representative of the commis-
     8  sion for the amount of any settlement or judgment obtained against  that
     9  person  arising out of any actual or alleged act, error or omission that
    10  occurred within the scope of  the  commission's  employment,  duties  or
    11  responsibilities, or that such person had a reasonable basis for believ-
    12  ing  occurred within the scope of the commission's employment, duties or
    13  responsibilities, provided that the actual  or  alleged  act,  error  or
    14  omission  did not result from the intentional, willful or wanton miscon-
    15  duct of that person.
    16    § 8908. Rulemaking. 1. Rulemaking. a. The  commission  shall  exercise
    17  its rulemaking powers pursuant to the criteria set forth in this article
    18  and  the  rules  adopted  thereunder.  Rules and amendments shall become
    19  binding as of the date specified in each rule  or  amendment  and  shall
    20  have the same force and effect as provisions of this compact.
    21    b.  Rules  or amendments to the rules shall be adopted at a regular or
    22  special meeting of the commission.
    23    2. Notice. a. Prior to promulgation and adoption of a  final  rule  or
    24  rules by the commission, and at least sixty days in advance of the meet-
    25  ing  at which the rule will be considered and voted upon, the commission
    26  shall file a notice of proposed rulemaking:
    27    i. On the website of the commission; and
    28    ii. On the website of each licensing board or the publication in which
    29  each state would otherwise publish proposed rules.
    30    b. The notice of proposed rulemaking shall include:
    31    i. The proposed time, date and location of the meeting  in  which  the
    32  rule will be considered and voted upon;
    33    ii. The text of the proposed rule or amendment, and the reason for the
    34  proposed rule;
    35    iii.  A  request for comments on the proposed rule from any interested
    36  person; and
    37    iv. The manner in which interested persons may submit  notice  to  the
    38  commission of their intention to attend the public hearing and any writ-
    39  ten comments.
    40    c.  Prior  to  adoption of a proposed rule, the commission shall allow
    41  persons to submit written data, facts,  opinions  and  arguments,  which
    42  shall be made available to the public.
    43    3. Public hearings on rules. a. The commission shall grant an opportu-
    44  nity for a public hearing before it adopts a rule or amendment.
    45    b. The commission shall publish the place, time and date of the sched-
    46  uled public hearing.
    47    i.  Hearings  shall be conducted in a manner providing each person who
    48  wishes to comment a fair and reasonable opportunity to comment orally or
    49  in writing. All hearings will be recorded,  and  a  copy  will  be  made
    50  available upon request.
    51    ii. Nothing in this section shall be construed as requiring a separate
    52  hearing  on  each  rule. Rules may be grouped for the convenience of the
    53  commission at hearings required by this section.
    54    c. If no one appears at the public hearing, the commission may proceed
    55  with promulgation of the proposed rule.

        S. 8307                            111                           A. 8807

     1    d. Following the scheduled hearing date, or by the close  of  business
     2  on  the  scheduled hearing date if the hearing was not held, the commis-
     3  sion shall consider all written and oral comments received.
     4    4.  Voting  on  rules.  The  commission shall, by majority vote of all
     5  administrators, take final action on the proposed rule and shall  deter-
     6  mine  the  effective  date  of the rule, if any, based on the rulemaking
     7  record and the full text of the rule.
     8    5. Emergency rules. Upon determination that an emergency  exists,  the
     9  commission  may  consider  and  adopt  an  emergency  rule without prior
    10  notice, opportunity for comment or  hearing,  provided  that  the  usual
    11  rulemaking procedures provided in this compact and in this section shall
    12  be  retroactively applied to the rule as soon as reasonably possible, in
    13  no event later than ninety days after the effective date  of  the  rule.
    14  For  the  purposes of this provision, an emergency rule is one that must
    15  be adopted immediately in order to:
    16    a. Meet an imminent threat to public health, safety or welfare;
    17    b. Prevent a loss of the commission or party state funds; or
    18    c. Meet a deadline for the promulgation of an administrative rule that
    19  is required by federal law or rule.
    20    6. Revisions. The commission may  direct  revisions  to  a  previously
    21  adopted  rule  or  amendment  for  purposes  of correcting typographical
    22  errors, errors in format, errors in consistency or  grammatical  errors.
    23  Public  notice  of  any  revisions shall be posted on the website of the
    24  commission. The revision shall be subject to challenge by any person for
    25  a period of thirty days after posting. The revision  may  be  challenged
    26  only  on  grounds  that  the  revision results in a material change to a
    27  rule.   A challenge shall be made  in  writing,  and  delivered  to  the
    28  commission,  prior  to  the end of the notice period. If no challenge is
    29  made, the revision will take  effect  without  further  action.  If  the
    30  revision  is  challenged,  the  revision may not take effect without the
    31  approval of the commission.
    32    § 8909. Oversight, dispute resolution and enforcement.  1.  Oversight.
    33  a.  Each  party  state  shall  enforce this compact and take all actions
    34  necessary and appropriate to  effectuate  this  compact's  purposes  and
    35  intent.
    36    b.  The  commission shall be entitled to receive service of process in
    37  any proceeding that may affect the powers, responsibilities  or  actions
    38  of  the  commission,  and  shall  have  standing  to intervene in such a
    39  proceeding for all purposes. Failure to provide service  of  process  in
    40  such  proceeding to the commission shall render a judgment or order void
    41  as to the commission, this compact or promulgated rules.
    42    2. Default, technical assistance and termination. a. If the commission
    43  determines that a party state has defaulted in the  performance  of  its
    44  obligations  or  responsibilities  under this compact or the promulgated
    45  rules, the commission shall:
    46    i. Provide written notice to the  defaulting  state  and  other  party
    47  states  of  the  nature of the default, the proposed means of curing the
    48  default or any other action to be taken by the commission; and
    49    ii.  Provide  remedial  training  and  specific  technical  assistance
    50  regarding the default.
    51    b.  If  a  state  in default fails to cure the default, the defaulting
    52  state's membership in this compact may be terminated upon an affirmative
    53  vote of a majority of the administrators, and all rights, privileges and
    54  benefits conferred by this compact may be terminated  on  the  effective
    55  date  of termination. A cure of the default does not relieve the offend-

        S. 8307                            112                           A. 8807

     1  ing state of obligations or liabilities incurred during  the  period  of
     2  default.
     3    c.  Termination  of  membership  in this compact shall be imposed only
     4  after all other means of securing compliance have been exhausted. Notice
     5  of intent to suspend or terminate shall be given by  the  commission  to
     6  the governor of the defaulting state and to the executive officer of the
     7  defaulting state's licensing board and each of the party states.
     8    d.  A  state  whose  membership in this compact has been terminated is
     9  responsible for all assessments, obligations  and  liabilities  incurred
    10  through  the  effective  date of termination, including obligations that
    11  extend beyond the effective date of termination.
    12    e. The commission shall not bear any costs related to a state that  is
    13  found  to  be  in  default  or whose membership in this compact has been
    14  terminated unless agreed upon in writing between the commission and  the
    15  defaulting state.
    16    f.  The  defaulting  state  may appeal the action of the commission by
    17  petitioning the U.S. District Court for the District of Columbia or  the
    18  federal  district in which the commission has its principal offices. The
    19  prevailing party shall be awarded all costs of such litigation,  includ-
    20  ing reasonable attorneys' fees.
    21    3.  Dispute  resolution. a. Upon request by a party state, the commis-
    22  sion shall attempt to resolve disputes related to the compact that arise
    23  among party states and between party and non-party states.
    24    b. The commission shall promulgate a rule providing for both mediation
    25  and binding dispute resolution for disputes, as appropriate.
    26    c. In the event the commission cannot  resolve  disputes  among  party
    27  states arising under this compact:
    28    i. The party states may submit the issues in dispute to an arbitration
    29  panel,  which  will be comprised of individuals appointed by the compact
    30  administrator in each of the affected party states,  and  an  individual
    31  mutually  agreed  upon  by  the  compact administrators of all the party
    32  states involved in the dispute.
    33    ii. The decision of a majority of the arbitrators shall be  final  and
    34  binding.
    35    4.  Enforcement.  a. The commission, in the reasonable exercise of its
    36  discretion, shall enforce the provisions and rules of this compact.
    37    b. By majority vote, the commission may initiate legal action  in  the
    38  U.S.    District  Court  for  the  District  of  Columbia or the federal
    39  district in which the commission has its  principal  offices  against  a
    40  party state that is in default to enforce compliance with the provisions
    41  of  this compact and its promulgated rules and bylaws. The relief sought
    42  may include both injunctive relief and damages. In  the  event  judicial
    43  enforcement  is  necessary,  the  prevailing  party shall be awarded all
    44  costs of such litigation, including reasonable attorneys' fees.
    45    c. The remedies herein shall not be  the  exclusive  remedies  of  the
    46  commission. The commission may pursue any other remedies available under
    47  federal or state law.
    48    § 8910. Effective  date,  withdrawal and amendment. 1. Effective date.
    49  a.  This compact shall become effective and binding on  the  earlier  of
    50  the  date  of  legislative enactment of this compact into law by no less
    51  than twenty-six states or the effective date of the chapter of the  laws
    52  of  two thousand twenty-four that enacted this compact.  Thereafter, the
    53  compact shall become effective and binding as to  any  other  compacting
    54  state  upon  enactment  of the compact into law by that state. All party
    55  states to this compact, that also were parties to the prior nurse licen-
    56  sure compact, superseded by this compact, (herein referred to as  "prior

        S. 8307                            113                           A. 8807

     1  compact"),  shall  be  deemed  to have withdrawn from said prior compact
     2  within six months after the effective date of this compact.
     3    b.  Each  party  state  to  this compact shall continue to recognize a
     4  nurse's multistate licensure privilege to practice in that  party  state
     5  issued under the prior compact until such party state has withdrawn from
     6  the prior compact.
     7    2.  Withdrawal.  a.  Any party state may withdraw from this compact by
     8  enacting a statute repealing the same. A party state's withdrawal  shall
     9  not  take effect until six months after enactment of the repealing stat-
    10  ute.
    11    b. A party state's withdrawal or  termination  shall  not  affect  the
    12  continuing  requirement of the withdrawing or terminated state's licens-
    13  ing board to  report  adverse  actions  and  significant  investigations
    14  occurring prior to the effective date of such withdrawal or termination.
    15    c.  Nothing contained in this compact shall be construed to invalidate
    16  or prevent any nurse licensure agreement or other  cooperative  arrange-
    17  ment between a party state and a non-party state that is made in accord-
    18  ance with the other provisions of this compact.
    19    3.  Amendment.  a. This compact may be amended by the party states. No
    20  amendment to this compact shall become effective and  binding  upon  the
    21  party  states  unless and until it is enacted into the laws of all party
    22  states.
    23    b. Representatives of  non-party  states  to  this  compact  shall  be
    24  invited to participate in the activities of the commission, on a nonvot-
    25  ing basis, prior to the adoption of this compact by all states.
    26    § 8911. Construction and severability.  1. Construction and severabil-
    27  ity.  This  compact shall be liberally construed so as to effectuate the
    28  purposes thereof. The provisions of this compact shall be severable, and
    29  if any phrase, clause, sentence or provision of this compact is declared
    30  to be contrary to the constitution of any party state or of  the  United
    31  States,  or  if  the  applicability  thereof  to any government, agency,
    32  person or circumstance is held  to  be  invalid,  the  validity  of  the
    33  remainder  of  this compact and the applicability thereof to any govern-
    34  ment, agency, person or circumstance shall not be affected  thereby.  If
    35  this  compact  shall  be  held to be contrary to the constitution of any
    36  party state, this compact shall remain in full force and  effect  as  to
    37  the  remaining party states and in full force and effect as to the party
    38  state affected as to all severable matters.
    39    § 3. This act shall take effect immediately and  shall  be  deemed  to
    40  have been in full force and effect on and after April 1, 2024.

    41                                   PART S

    42    Section  1.  The  public health law is amended by adding a new section
    43  2825-i to read as follows:
    44    § 2825-i. Healthcare safety net transformation program. 1. A statewide
    45  healthcare safety net transformation program shall be established within
    46  the department for the purpose of supporting the transformation of safe-
    47  ty net hospitals to improve access, equity, quality, and outcomes  while
    48  increasing  the  financial  sustainability of safety net hospitals. Such
    49  program may provide or utilize new or existing capital funding, or oper-
    50  ating subsidies, or both. A safety net hospital and a partner  organiza-
    51  tion may jointly apply for this program.
    52    2. The commissioner shall enter an agreement with the president of the
    53  dormitory authority of the state of New York pursuant to section sixteen
    54  hundred eighty-r of the public authorities law, as required, which shall

        S. 8307                            114                           A. 8807

     1  apply  to this agreement, subject to the approval of the director of the
     2  division of the budget, for the purposes of the distribution and  admin-
     3  istration  of available funds pursuant to such agreement and made avail-
     4  able  pursuant  to this section and subject to appropriation. Such funds
     5  may be awarded and distributed by the department to  safety  net  hospi-
     6  tals,  or a partner organization, in the form of grants. To qualify as a
     7  safety net hospital for purposes of this section, a hospital shall:
     8    (a) be either a public hospital, a rural emergency hospital,  critical
     9  access hospital or sole community hospital;
    10    (b)  have  at least thirty percent of its inpatient discharges made up
    11  of medical assistance program eligible individuals,  uninsured  individ-
    12  uals  or  medical  assistance program dually eligible individuals and at
    13  least thirty-five percent of its outpatient visits made  up  of  medical
    14  assistance   program  eligible  individuals,  uninsured  individuals  or
    15  medical assistance program dually-eligible individuals;
    16    (c) serve at least thirty percent of the residents of a  county  or  a
    17  multi-county  area  who are medical assistance program eligible individ-
    18  uals, uninsured individuals or medical assistance program  dually-eligi-
    19  ble individuals; or
    20    (d)  in  the discretion of the commissioner, serve a significant popu-
    21  lation of medical assistance  program  eligible  individuals,  uninsured
    22  individuals or medical assistance program dually-eligible individuals.
    23    3.  Partner  organizations may include, but are not limited to, health
    24  systems, hospitals, health plans, residential  health  care  facilities,
    25  physician  groups,  community-based  organization,  or  other healthcare
    26  entities who can serve as partners in the transformation of  the  safety
    27  net  hospital.    The commissioner shall have the discretion to deem any
    28  organization a partner organization upon a finding that deeming so  will
    29  advance the goals of this section.
    30    4.  Notwithstanding  any  law  to the contrary, and in accordance with
    31  article four of the state finance law, the comptroller is hereby author-
    32  ized and directed to transfer, upon request of the director  of  budget,
    33  on  or  before  March thirty-first, two thousand twenty-five, up to five
    34  hundred million dollars to the department from amounts  appropriated  to
    35  administer  the  programs  established  in sections twenty-eight hundred
    36  twenty-five-g and twenty-eight hundred twenty-five-h of this article  to
    37  support  this program.   Notwithstanding section one hundred sixty-three
    38  of the state finance law, sections one hundred forty-two and one hundred
    39  forty-three  of  the  economic  development  law  or  any   inconsistent
    40  provisions  of  law  to  the  contrary, awards may be provided without a
    41  competitive bid or request for proposal process to safety net  hospitals
    42  or  partner  organizations  for  purposes  of increasing access, equity,
    43  quality, outcomes, and long-term financial sustainability of such safety
    44  net hospitals.
    45    5. Notwithstanding any provision of law to the contrary,  the  commis-
    46  sioner  is  authorized  to  waive  any  regulatory requirements to allow
    47  applicants to more effectively or efficiently implement projects awarded
    48  through the healthcare  safety  net  transformation  program,  provided,
    49  however,  that  regulations pertaining to patient safety, patient auton-
    50  omy, patient privacy, patient rights, due process,  scope  of  practice,
    51  professional  licensure,  environmental protections, provider reimburse-
    52  ment methodologies, or occupational standards and  employee  rights  may
    53  not  be waived, nor shall any regulations be waived if such waiver would
    54  risk patient safety. Such waiver  shall  not  exceed  the  life  of  the
    55  project  or such shorter time periods as the commissioner may determine.
    56  Any regulatory relief granted pursuant  to  this  subdivision  shall  be

        S. 8307                            115                           A. 8807

     1  specifically described and requested within each project application and
     2  be  reviewed  by the commissioner. The waiver of any regulatory require-
     3  ments shall be made in the sole discretion of the commissioner.
     4    6. Qualifying safety net hospitals and their designated partner organ-
     5  ization  or  organizations  shall  provide,  as part of the application,
     6  which shall be in a manner as prescribed by the commissioner,  a  trans-
     7  formation  plan  that includes at least a five-year strategic and opera-
     8  tional plan outlining the roles and responsibilities of each entity  and
     9  specifically  state  any regulatory flexibility which may be required to
    10  implement such plan. The transformation plan shall also include a  time-
    11  line of key metrics and goals related to improved access, equity, quali-
    12  ty,  outcomes,  and increased financial sustainability of the safety net
    13  hospital. The request for level and type of support  shall  be  specific
    14  and  detailed  in the application. Continued support shall be contingent
    15  upon the implementation of the approved plan and key milestones.  Appli-
    16  cations  may  include a range of collaboration models, including but not
    17  be limited to merger, acquisition, a management services contract, or  a
    18  clinical integration.
    19    7.  The release of any funding will be contingent upon compliance with
    20  the transformation plan and a determination that acceptable progress has
    21  been made with such plan. If key milestones and goals are not met, addi-
    22  tional financial resources may be  withheld  and  redirected,  upon  the
    23  recommendation of the commissioner and approval by the director of budg-
    24  et.
    25    §  2.  This  act  shall take effect immediately and shall be deemed to
    26  have been in full force and effect on and after April 1, 2024.

    27                                   PART T

    28    Section 1. Subdivision 1 of section 2130 of the public health law,  as
    29  amended  by  chapter  308  of  the  laws  of 2010, is amended to read as
    30  follows:
    31    1. (a) Every physician or other person  authorized  by  law  to  order
    32  diagnostic tests or make a medical diagnosis, or any laboratory perform-
    33  ing  such  tests  shall  immediately [(a)] (i) upon determination that a
    34  person is [infected] positive/reactive with human immunodeficiency virus
    35  (HIV), [(b)] (ii) upon diagnosis [that a person is afflicted] with  [the
    36  disease  known  as]  acquired  immune  deficiency syndrome (AIDS), [(c)]
    37  (iii) upon diagnosis [that a  person  is  afflicted]  with  HIV  related
    38  illness, and [(d)] (iv) upon periodic monitoring of HIV infection by any
    39  laboratory tests report such case or data to the commissioner.
    40    (b)  Any  permitted  clinical  laboratory,  as defined in section five
    41  hundred seventy-one of this chapter, performing  such  diagnostic  tests
    42  shall   also,   upon   determination   that   a   test   result  is  not
    43  positive/reactive for HIV, report such negative HIV test result  to  the
    44  commissioner.
    45    § 2. Subdivision 1 of section 2102 of the public health law is amended
    46  to read as follows:
    47    1.  Whenever any laboratory examination discloses evidence of communi-
    48  cable disease, and for hepatitis B virus or syphilis upon  determination
    49  that  a  test result is not positive/reactive, the results of such exam-
    50  ination together with all required pertinent facts, shall be immediately
    51  reported by the person in charge of the laboratory or the person  making
    52  such  examination  to  the  local  or  state health official to whom the
    53  attending physician is required to report such case.

        S. 8307                            116                           A. 8807

     1    § 3. The public health law is amended by adding a new section 2172  to
     2  read as follows:
     3    § 2172. HCV infection; duty to report. In addition to reporting that a
     4  hepatitis C virus (HCV) clinical laboratory test is reactive/positive as
     5  required  by section twenty-one hundred two of this article, any permit-
     6  ted clinical laboratory, as defined in section five hundred  seventy-one
     7  of  this  chapter,  performing such tests shall also, upon determination
     8  that a test result is not positive/reactive with HCV, report such  nega-
     9  tive HCV test result to the commissioner.
    10    §  4. Section 2781 of the public health law, as amended by chapter 308
    11  of the laws of 2010, subdivisions 1 and 2 as amended by chapter  502  of
    12  the  laws of 2016 and subdivision 4 as amended by section 2 of part A of
    13  chapter 60 of the laws of 2014, is amended to read as follows:
    14    § 2781. HIV related testing. 1. Except as provided  in  section  three
    15  thousand  one hundred twenty-one of the civil practice law and rules, or
    16  unless otherwise specifically authorized  or  required  by  a  state  or
    17  federal  law,  no  person  shall order the performance of an HIV related
    18  test without first, at a minimum, [orally advising] providing notice  by
    19  means readily accessible in multiple languages to the protected individ-
    20  ual,  or,  when  the  protected  individual lacks capacity to consent, a
    21  person authorized to consent to health care for such individual, that an
    22  HIV-related test is being performed, or over the objection of such indi-
    23  vidual or authorized  persons.  Such  [advisement  and  objection,  when
    24  applicable]  notice  may  be provided orally, in writing, by prominently
    25  displayed signage, or by electronic means or other appropriate  form  of
    26  communication. Such notice shall include information that HIV testing is
    27  voluntary.  A refusal of an HIV related test shall be noted in the indi-
    28  vidual's record.
    29    2. A person ordering the performance of  an  HIV  related  test  shall
    30  provide either directly or through a representative to the subject of an
    31  HIV  related  test  or,  if  the subject lacks capacity to consent, to a
    32  person authorized pursuant to law to consent  to  health  care  for  the
    33  subject, an explanation that:
    34    (a)  HIV  causes AIDS and can be transmitted through sexual activities
    35  and needle-sharing, by pregnant women  to  their  fetuses,  and  through
    36  breastfeeding infants;
    37    (b)  there is treatment for HIV that can help an individual stay heal-
    38  thy;
    39    (c) individuals with HIV or AIDS can adopt safe practices  to  protect
    40  uninfected  and infected people in their lives from becoming infected or
    41  multiply infected with HIV;
    42    (d) testing is voluntary and can be done anonymously at a public test-
    43  ing center;
    44    (e) the law protects the confidentiality of HIV related test results;
    45    (f) the law prohibits discrimination  based  on  an  individual's  HIV
    46  status and services are available to help with such consequences; and
    47    (g)  the  law requires that an individual be advised before an HIV-re-
    48  lated test is performed, and that no test shall be performed over his or
    49  her objection.
    50    Protocols shall be in place to ensure compliance with this section.
    51    4. [A person authorized pursuant to law to order the performance of an
    52  HIV related test shall provide directly or through a  representative  to
    53  the person seeking such test, an opportunity to remain anonymous through
    54  use of a coded system with no linking of individual identity to the test
    55  request or results.] A health care provider who is not authorized by the
    56  commissioner  to  provide  HIV related tests on an anonymous basis shall

        S. 8307                            117                           A. 8807

     1  refer a person who requests an anonymous test to a test site which  does
     2  provide  anonymous testing. The provisions of this subdivision shall not
     3  apply to a health care provider  ordering  the  performance  of  an  HIV
     4  related test on an individual proposed for insurance coverage.
     5    5.  At the time of communicating the test result to the subject of the
     6  test, a person ordering the performance of an HIV  related  test  shall,
     7  directly or through a representative:
     8    (a)  in  the  case  of  a  test  indicating evidence of HIV infection,
     9  provide the subject of the test or, if the  subject  lacks  capacity  to
    10  consent, the person authorized pursuant to law to consent to health care
    11  for the subject with counseling or referrals for counseling:
    12    (i) for coping with the emotional consequences of learning the result;
    13    (ii)  regarding  the  discrimination  problems  that disclosure of the
    14  result could cause;
    15    (iii) for behavior change to prevent transmission  or  contraction  of
    16  HIV infection;
    17    (iv) to inform such person of available medical treatments; [and]
    18    (v) regarding the need to notify his or her contacts; and
    19    (vi)  regarding  pre- and post-exposure prophylaxis medications avail-
    20  able to sexual partners to prevent HIV infection; and
    21    (b) in the case of a test not indicating evidence  of  HIV  infection,
    22  provide  (in  a manner which may consist of oral or written reference to
    23  information previously provided) the subject of  the  test,  or  if  the
    24  subject lacks capacity to consent, the person authorized pursuant to law
    25  to consent to health care for the subject, with information:
    26    (i)  concerning  the  risks  of  participating  in high risk sexual or
    27  needle-sharing behavior; and
    28    (ii) regarding pre- and post-exposure prophylaxis  medications  avail-
    29  able to prevent HIV infection.
    30    5-a.  With the consent of the subject of a test indicating evidence of
    31  HIV infection or, if the subject lacks capacity  to  consent,  with  the
    32  consent  of  the  person authorized pursuant to law to consent to health
    33  care for the subject, the person who ordered the performance of the  HIV
    34  related  test, or such person's representative, shall provide or arrange
    35  with a health care provider for an  appointment  for  follow-up  medical
    36  care for HIV for such subject.
    37    6.  The  provisions of this section shall not apply to the performance
    38  of an HIV related test:
    39    (a) by a health care provider or health facility in  relation  to  the
    40  procuring,  processing,  distributing  or use of a human body or a human
    41  body part, including organs,  tissues,  eyes,  bones,  arteries,  blood,
    42  semen,  or other body fluids, for use in medical research or therapy, or
    43  for transplantation to individuals provided,  however,  that  where  the
    44  test  results  are communicated to the subject, post-test counseling, as
    45  described in subdivision five of  this  section,  shall  nonetheless  be
    46  required; or
    47    (b)  for  the  purpose  of  research  if the testing is performed in a
    48  manner by which the identity of the test subject is not  known  and  may
    49  not be retrieved by the researcher; or
    50    (c) on a deceased person, when such test is conducted to determine the
    51  cause of death or for epidemiological purposes; or
    52    (d)  conducted pursuant to section twenty-five hundred-f of this chap-
    53  ter; or
    54    (e) in situations involving  occupational  exposures  which  create  a
    55  significant  risk  of  contracting  or  transmitting  HIV  infection, as

        S. 8307                            118                           A. 8807

     1  defined in regulations of  the  department  and  pursuant  to  protocols
     2  adopted by the department,
     3    (i) provided that:
     4    (A)  the  person  who  is  the  source of the occupational exposure is
     5  deceased, comatose or is determined by his or her attending health  care
     6  professional  to  lack mental capacity to consent to an HIV related test
     7  and is not reasonably expected to recover in time for the exposed person
     8  to receive appropriate medical treatment, as determined by  the  exposed
     9  person's  attending  health care professional who would order or provide
    10  such treatment;
    11    (B) there is no person available or reasonably likely to become avail-
    12  able who has the legal authority to consent to the HIV related  test  on
    13  behalf  of  the  source person in time for the exposed person to receive
    14  appropriate medical treatment; and
    15    (C) the exposed person will benefit medically by  knowing  the  source
    16  person's  HIV test results, as determined by the exposed person's health
    17  care professional and documented in the exposed person's medical record;
    18    (ii) in which case
    19    (A) a provider shall order an anonymous HIV test of the source person;
    20  and
    21    (B) the results of such anonymous test, but not the  identity  of  the
    22  source  person,  shall  be  disclosed  only to the attending health care
    23  professional of the exposed person solely for the purpose  of  assisting
    24  the  exposed person in making appropriate decisions regarding post-expo-
    25  sure medical treatment; and
    26    (C) the results of the test shall  not  be  disclosed  to  the  source
    27  person or placed in the source person's medical record.
    28    7.  In the event that an HIV related test is ordered by a physician or
    29  certified nurse practitioner pursuant to the provisions of the education
    30  law providing for non-patient specific regimens, then for  the  purposes
    31  of this section the individual administering the test shall be deemed to
    32  be the individual ordering the test.
    33    §  5. Subdivision 4 of section 6909 of the education law is amended by
    34  adding a new paragraph (m) to read as follows:
    35    (m) undertaking the collection  of  specimens  necessary  to  test  to
    36  determine the presence of the hepatitis B virus.
    37    §  6. Subdivision 6 of section 6527 of the education law is amended by
    38  adding a new paragraph (m) to read as follows:
    39    (m) undertaking the collection  of  specimens  necessary  to  test  to
    40  determine the presence of the hepatitis B virus.
    41    §  7.  Section  6801  of  the education law is amended by adding a new
    42  subdivision 10 to read as follows:
    43    10. a. A licensed pharmacist may execute a non-patient specific  order
    44  for  the dispensing of HIV Pre-exposure Prophylaxis (PrEP) prescribed or
    45  ordered by the commissioner of health,  a  physician  licensed  in  this
    46  state  or a nurse practitioner certified in this state pursuant to rules
    47  and regulations promulgated by the commissioner.
    48    b.  Prior to dispensing HIV PrEP to a patient, and  at  a  minimum  of
    49  every twelve months for each returning patient, the pharmacist shall:
    50    (i)  ensure that the patient is HIV negative, as documented by a nega-
    51  tive HIV test result obtained within the previous seven days from an HIV
    52  antigen/antibody test or antibody-only test or from a  rapid,  point-of-
    53  care fingerstick blood test approved by the federal food and drug admin-
    54  istration.  If  the  patient does not provide evidence of a negative HIV
    55  test in accordance with this paragraph, the pharmacist may recommend  or
    56  prescribe  an HIV test. If the patient tests positive for HIV infection,

        S. 8307                            119                           A. 8807

     1  the pharmacist shall direct the patient  to  a  licensed  physician  and
     2  provide  the  patient  with  a list of health care service providers and
     3  clinics within the county where the pharmacist is  located  or  adjacent
     4  counties;
     5    (ii)  provide  the patient with a self-screening risk assessment ques-
     6  tionnaire, developed by the commissioner of health in consultation  with
     7  the commissioner, to be reviewed by the pharmacist to identify any known
     8  risk  factors  and assist the patient's selection of an appropriate PrEP
     9  medication; and
    10    (iii) provide the patient with a fact sheet, developed by the  commis-
    11  sioner  of  health,  that  includes  but is not limited to, the clinical
    12  considerations and recommendations for  use  of  PrEP,  the  appropriate
    13  method for using PrEP, information on the importance of follow-up health
    14  care,  health  care referral information, and the ability of the patient
    15  to opt out of practitioner reporting requirements.
    16    c. No pharmacist shall dispense PrEP under  this  subdivision  without
    17  receiving  training  in  accordance  with regulations promulgated by the
    18  commissioner of health in consultation with the commissioner.
    19    d. A pharmacist shall notify the patient's primary health care practi-
    20  tioner, unless the patient opts out of such notification, within  seven-
    21  ty-two  hours  of dispensing PrEP, that PrEP has been dispensed.  If the
    22  patient does not have a primary health care practitioner, or  is  unable
    23  to provide contact information for their primary health care practition-
    24  er,  the  pharmacist  shall provide the patient with a written record of
    25  the PrEP medications dispensed, and advise the  patient  to  consult  an
    26  appropriate health care practitioner.
    27    e.  Nothing in this subdivision shall prevent a pharmacist from refus-
    28  ing to dispense a non-patient specific order of PrEP  pursuant  to  this
    29  subdivision  if,  in  their  professional  judgment,  potential  adverse
    30  effects, interactions, or other therapeutic complications could endanger
    31  the health of the patient.
    32    § 8. Section 6801 of the education law is  amended  by  adding  a  new
    33  subdivision 11 to read as follows:
    34    11.    A licensed pharmacist within their lawful scope of practice may
    35  administer to patients eighteen years of age or older, immunizing agents
    36  to prevent mpox pursuant to a patient specific order  or  a  non-patient
    37  specific order.  When a licensed pharmacist administers an mpox immuniz-
    38  ing  agent,  they  shall comply with subdivisions two, three and four of
    39  this section.
    40    § 9. Section 2307 of the public health law is REPEALED.
    41    § 10. This act  shall  take  effect  immediately;  provided,  however,
    42  sections  one,  two,  and three of this act shall take effect on the one
    43  hundred eightieth day after it shall have become a law.  Effective imme-
    44  diately, the addition, amendment and/or repeal of any rule or regulation
    45  necessary for the implementation of this act on its effective  date  are
    46  authorized to be made and completed on or before such effective date.

    47                                   PART U

    48    Section  1. Section 3302 of the public health law is amended by adding
    49  two new subdivisions 42 and 43 to read as follows:
    50    42. "Public health  surveillance"  means  the  continuous,  systematic
    51  collection,  analysis,  and interpretation of health-related data needed
    52  for the planning, implementation, and evaluation of public health  prac-
    53  tice.  Public  health  surveillance may be used for all of the following
    54  purposes:

        S. 8307                            120                           A. 8807

     1    (a) as an early warning system for impending  public  health  emergen-
     2  cies;
     3    (b) to document the impact of an intervention;
     4    (c) to track progress towards specified goals;
     5    (d) to monitor and clarify the epidemiology of health outcomes;
     6    (e) to establish public health priorities; and
     7    (f) to inform public health policy and strategies.
     8    43.  "Patient  identifying  information"  means  information or direct
     9  identifiers and demographic information that  can  be  used  to  readily
    10  identify  a  particular  patient  as  may be specified in more detail in
    11  regulations promulgated by the commissioner.
    12    § 2. Subparagraphs (ix) and (x) of paragraph (a) of subdivision  2  of
    13  section 3343-a of the public health law, as added by section 2 of part A
    14  of  chapter  447 of the laws of 2012, are amended and a new subparagraph
    15  (xi) is added to read as follows:
    16    (ix) a situation where the registry is not operational  as  determined
    17  by the department or where it cannot be accessed by the practitioner due
    18  to  a  temporary  technological  or  electrical failure, as set forth in
    19  regulation; [or]
    20    (x) a practitioner who has been granted a waiver due to  technological
    21  limitations  that  are  not reasonably within the control of the practi-
    22  tioner, or other exceptional circumstance demonstrated  by  the  practi-
    23  tioner,  pursuant  to  a  process  established in regulation, and in the
    24  discretion of the commissioner[.]; or
    25    (xi) a practitioner prescribing or ordering a controlled substance for
    26  use on the premises of a  correctional  facility,  an  inpatient  mental
    27  health facility licensed under the mental hygiene law, or a nursing home
    28  licensed under article twenty-eight of this chapter.
    29    §  3. Subdivision 4 of section 3370 of the public health law, as added
    30  by chapter 965 of the laws of 1974 and as renumbered by chapter  178  of
    31  the laws of 2010, is amended to read as follows:
    32    4.  The  department shall cause to be expunged or otherwise destroyed,
    33  within [five] ten years from the date of receipt thereof, any record  of
    34  the  name  of any patient received by it pursuant to the filing require-
    35  ments of subdivision six of  section  thirty-three  hundred  thirty-one,
    36  subdivision  four  of  section  thirty-three  hundred  thirty-three, and
    37  subdivision four of section thirty-three  hundred  thirty-four  of  this
    38  article.
    39    §  4.  Subdivision  1  of  section  3371  of the public health law, as
    40  amended by chapter 178 of the laws of 2010, paragraphs (d)  and  (e)  as
    41  amended and paragraphs (f), (g), (h), (i), and (j) as added by section 4
    42  of  part  A  of  chapter  447 of the laws of 2012, is amended to read as
    43  follows:
    44    1. No person, who has knowledge by virtue of his or her office of  the
    45  identity  of  a  particular patient or research subject, a manufacturing
    46  process, a trade secret or a formula or  possesses  patient  identifying
    47  information shall disclose such knowledge, or any report or record ther-
    48  eof, except:
    49    (a)  to  another  person  employed  by the department, for purposes of
    50  executing provisions of this article;
    51    (b) pursuant to judicial subpoena or court order in a criminal  inves-
    52  tigation or proceeding;
    53    (c)  to an agency, department of government, or official board author-
    54  ized to regulate, license or otherwise supervise a person who is author-
    55  ized by this article to deal in controlled substances, or in the  course

        S. 8307                            121                           A. 8807

     1  of  any investigation or proceeding by or before such agency, department
     2  or board;
     3    (d)  to the prescription monitoring program registry and to authorized
     4  users of such registry as set forth in subdivision two of this section;
     5    (e) a vendor or contractor, as authorized by the department as  neces-
     6  sary  for  the  operation and maintenance of the prescription monitoring
     7  program registry;
     8    (f) to a practitioner to inform him or her that a patient may be under
     9  treatment with a controlled substance by another  practitioner  for  the
    10  purposes  of  subdivision  two  of  this  section, and to facilitate the
    11  department's  review  of  individual  challenges  to  the  accuracy   of
    12  controlled  substances  histories pursuant to subdivision six of section
    13  thirty-three hundred forty-three-a of this article;
    14    [(f)]  (g)  to  a  pharmacist   to   provide   information   regarding
    15  prescriptions  for controlled substances presented to the pharmacist for
    16  the purposes of subdivision two of this section and  to  facilitate  the
    17  department's   review  of  individual  challenges  to  the  accuracy  of
    18  controlled substances histories pursuant to subdivision six  of  section
    19  thirty-three hundred forty-three-a of this article;
    20    [(g)]  (h)  to the deputy attorney general for medicaid fraud control,
    21  or his or her designee, in furtherance of  an  investigation  of  fraud,
    22  waste  or  abuse  of the Medicaid program, pursuant to an agreement with
    23  the department;
    24    [(h)] (i) to a program area within the department for the  purpose  of
    25  conducting public health research, public health surveillance, or educa-
    26  tion  with data contained in the prescription monitoring program and not
    27  for patient-level outreach:
    28    (i) pursuant to an agreement with the commissioner;
    29    (ii) when the release of such information is deemed appropriate by the
    30  commissioner;
    31    (iii) for use in accordance with measures required by the commissioner
    32  to  ensure  that  the  security  and  confidentiality  of  the  data  is
    33  protected;
    34    (iv) for use and retention no longer than ten years; and
    35    (v)  provided  that disclosure is restricted to individuals within the
    36  department who are engaged in  public  health  research,  public  health
    37  surveillance, or education;
    38    (j)  to a local health department for the purpose of conducting public
    39  health research, public health surveillance or  education  and  not  for
    40  patient-level  outreach:   (i) pursuant to an agreement with the commis-
    41  sioner; (ii) when the release of such information is deemed  appropriate
    42  by  the commissioner; (iii) for use in accordance with measures required
    43  by the commissioner to ensure that the security and  confidentiality  of
    44  the  data  is  protected;  (iv) for use and retention no longer than ten
    45  years; and [(iv)] (v) provided that disclosure is restricted to individ-
    46  uals within the local health department who are engaged in the  research
    47  or education;
    48    [(i)]  (k)  to  a  medical examiner or coroner who is an officer of or
    49  employed by a state or local government, pursuant to his or her official
    50  duties; and
    51    [(j)] (l) to an individual for the purpose of providing such  individ-
    52  ual  with his or her own controlled substance history or, in appropriate
    53  circumstances, in the case of a  patient  who  lacks  capacity  to  make
    54  health  care  decisions,  a  person who has legal authority to make such
    55  decisions for the patient  and  who  would  have  legal  access  to  the
    56  patient's health care records, if requested from the department pursuant

        S. 8307                            122                           A. 8807

     1  to subdivision six of section thirty-three hundred forty-three-a of this
     2  article or from a treating practitioner pursuant to subparagraph (iv) of
     3  paragraph (a) of subdivision two of this section.
     4    §  5.  Subdivision  (b)  of  schedule  I of section 3306 of the public
     5  health law is amended by adding eleven new paragraphs 93,  94,  95,  96,
     6  97, 98, 99, 100, 101, 102 and 103 to read as follows:
     7    (93) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]
     8  -1-phenylpropan-2-ol).
     9    (94) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)e
    10  than-1-amine. Some trade or other names: Metonitazene.
    11    (95) meta-fluorofentanyl(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-
    12  yl)propionamide).
    13    (96) meta-fluoroisobutyryl fentanyl(N-(3-fluorophenyl)-N-(1-phenethylp
    14  iperidin-4-yl)isobutyramide).
    15    (97) para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylp
    16  iperidin-4-yl)furan-2-carboxamide).
    17    (98) 3-furanyl fentanyl(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-
    18  carboxamide).
    19    (99) 2',5'-dimethoxyfentanyl(N-(1-(2,5-dimethoxyphenethyl)piperidin-4-
    20  yl)-N-phenylpropionamide).
    21    (100) Isovaleryl fentanyl(3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phe
    22  nylbutanamide).
    23    (101) ortho-fluorofuranyl fentanyl(N-(2-fluorophenyl)-N-(1-phenethylpi
    24  peridin-4-yl)furan-2-carboxamide).
    25    (102) alpha'-methyl butyryl fentanyl(2-methyl-N-(1-phenethylpiperidin-
    26  4-yl)-N-phenylbutanamide).
    27    (103) para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-pheneth
    28  ylpiperidin-4-yl)cyclopropanecarboxamide).
    29    §  6. Paragraphs 11 and 36 of subdivision (d) of schedule I of section
    30  3306 of the public health law, paragraph 11 as added by chapter  664  of
    31  the  laws  of  1985 and paragraph 36 as added by section 5 of part BB of
    32  chapter 57 of the laws of 2018, are amended to read as follows:
    33    (11) [Ibogane] Ibogaine. Some trade and other names: 7-ethyl-6, 6&, 7,
    34  8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido  {1',2':1,2}
    35  azepino {5,4-b} indole: tabernanthe iboga.
    36    (36)  5-methoxy-N,N-dimethyltryptamine.  Some  trade  or  other names:
    37  5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT.
    38    § 7. Subdivision (d) of schedule I  of  section  3306  of  the  public
    39  health  law is amended by adding nineteen new paragraphs 32, 39, 40, 41,
    40  42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 and 56 to read as
    41  follows:
    42    (32) 4-methyl-N-ethylcathinone.  Some trade or other names: 4-MEC.
    43    (39)  4-methyl-alpha-pyrrolidinopropiophenone.  Some  trade  or  other
    44  names:  4-MePPP.
    45    (40) Alpha-pyrrolidinopentiophenone. Some trade or other names: @-PVP.
    46    (41)  1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one.  Some trade
    47  or other names: Butylone; bk-MBDB.
    48    (42) 2-(methylamino)-1-phenylpentan-1-one. Some trade or other  names:
    49  Pentedrone.
    50    (43)  1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one. Some trade
    51  or other names: Pentylone; bk-MBDP.
    52    (44) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one.  Some  trade
    53  or other names: Naphyrone.
    54    (45) Alpha-pyrrolidinobutiophenone. Some trade or other names: @-PBP.
    55    (46) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone).

        S. 8307                            123                           A. 8807

     1    (47)  N-ethylpentylone.    Some  trade  or  other  names:    ephylone,
     2  1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one).
     3    (48)  1-(4-methoxyphenyl)-N-methylpropan-2-amine.  Some trade or other
     4  names: para-methoxymethamphetamine; PMMA.
     5    (49)   N-Ethylhexedrone.        Some    trade    or    other    names:
     6  @-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one.
     7    (50) alpha-Pyrrolidinohexanophenone. Some trade or other names: @-PHP;
     8  alpha-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
     9    (51)  4-Methyl-alpha-ethylaminopentiophenone.    Some  trade  or other
    10  names:  4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one.
    11    (52) 4'-Methyl-alpha-pyrrolidinohexiophenone.    Some trade  or  other
    12  names:          MPHP;          4'-methyl-alpha-pyrrolidinohexanophenone;
    13  1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
    14    (53) alpha-Pyrrolidinoheptaphenone.   Some trade or other names:  PV8;
    15  1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one.
    16    (54)  4-Chloro-alpha-pyrrolidinovalerophenone.  Some  trade  or  other
    17  names:      4-chloro-@-PVP;    4'-chloro-alpha-pyrrolidinopentiophenone;
    18  1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one.
    19    (55)   2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one  (methoxeta-
    20  mine, MXE).
    21    (56) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one. Some trade or
    22  other names: eutylone; bk-EBDB.
    23    § 8. Subdivision (e) of schedule I  of  section  3306  of  the  public
    24  health  law  is amended by adding five new paragraphs 7, 8, 9, 10 and 11
    25  to read as follows:
    26    (7) 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno{3,2-f}{1,2,4}triazol
    27  o{4,3-a}{1,4}diazepine. Some trade or other names: etizolam.
    28    (8) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo{f}{1,2,4}triazolo{4,
    29  3-a}{1,4}diazepine. Some trade or other names: flualprazolam.
    30    (9) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo{f}{1,2,4}triazolo{4,3
    31  -a}{1,4}diazepine. Some trade or other names: clonazolam.
    32    (10) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo{f}{1,2,4}triazolo{4,
    33  3-a}{1,4}diazepine (alternate chemical name: 8-bromo-6-(2-fluorophenyl)-
    34  1-methyl-4H-{1,2,4}triazolo{4,3-a}{1,4}benzodiazepine).  Some  trade  or
    35  other names: flubromazolam.
    36    (11) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo{e}{1,4}
    37  diazepin-2-one. Some trade or other names: diclazepam.
    38    §  9. Paragraphs 13 and 14 of subdivision (f) of schedule I of section
    39  3306 of the public health law, as added by chapter 341 of  the  laws  of
    40  2013, are amended and four new paragraphs 25, 26, 27 and 28 are added to
    41  read as follows:
    42    (13) 3-Fluoromethcathinone.  Some  trade  or  other  names: 3-fluoro-N
    43  -methylcathinone; 3-FMC.
    44    (14) 4-Fluoromethcathinone. Some trade or other names:  4-fluoro-N-me-
    45  thylcathinone; 4-FMC; flephedrone.
    46    (25) 7-[(10,11-dihydro-5H-dibenzo]a,d[cyclohepten-5-yl)amino]heptanoic
    47  acid. Other name: amineptine.
    48    (26)  N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)
    49  carbamimidate. Other name: mesocarb.
    50    (27) N-methyl-1-(thiophen-2-yl)propan-2-amine. Other name:  methiopro-
    51  pamine.
    52    (28) 4,4'-Dimethylaminorex.    Some  trade  or other names: 4,4'-DMAR;
    53  4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4 met
    54  hylphenyl)-4,5-dihydro-1,3-oxazol-2-amine.

        S. 8307                            124                           A. 8807

     1    § 10. Paragraphs 2, 6 and 10 of  subdivision  (g)  of  schedule  I  of
     2  section  3306 of the public health law, as added by section 7 of part BB
     3  of chapter 57 of the laws of 2018, are amended to read as follows:
     4    (2) {1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)
     5  methanone. Some trade names or other names: 5-fluoro-UR-144[,]; XLR11.
     6    (6) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo
     7  [-] le-3-carboxamide. Some trade or other names: AB-FUBINACA.
     8    (10) {1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-[y1]  yl)metha-
     9  none. Some trade or other names: THJ-2201.
    10    § 11. Subdivision (g) of schedule I of  section  3306  of  the  public
    11  health  law is amended by adding nineteen new paragraphs 11, 12, 13, 14,
    12  15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 and 29 to read as
    13  follows:
    14    (11) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
    15  indazole-3-carboxamide. Some  trade  or   other   names:   MAB-CHMINACA;
    16  ADB-CHMINACA.
    17    (12) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylb
    18  utanoate.  Some trade or other names: FUB-AMB; MMB-FUBINACA; AMB-FUBINA-
    19  CA.
    20    (13) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
    21  dimethylbutanoate. Some trade or other names: MDMB-CHMICA; MMB-CHMINACA.
    22    (14) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-
    23  dimethylbutanoate. Some trade or other names: MDMB-FUBINACA.
    24    (15) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-in
    25  dazole-3-carboxamide. Some trade or other names: ADB-FUBINACA.
    26    (16)  N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.
    27  Some trade or other names: 5F-APINACA; 5F-AKB48.
    28    (17)  methyl   2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-meth
    29  ylbutanoate. Some trade or other names: 5F-AMB.
    30    (18) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
    31  dimethylbutanoate. Some trade or other names: 5F-ADB; 5F-MDMB-PINACA.
    32    (19)  Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some
    33  trade or other names: NM2201; CBL2201.
    34    (20)N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol
    35  e-3-carboxamide. Some trade or other names: 5F-AB-PINACA.
    36    (21) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamid
    37  e. Some trade or other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-  BUTI-
    38  NACA;4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78.
    39    (22)  methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methyl
    40  butanoate. Some trade or other names: MMB-CHMICA; AMB-CHMICA.
    41    (23) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo{2,3-b}pyrid
    42  ine-3-carboxamide. Some trade or other names: 5F-CUMYL-P7AICA.
    43    (24) methyl  2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimet
    44  hylbutanoate. Some trade or other names: 4F-MDMB-BINACA; 4F-MDMB-BUTINA-
    45  CA.
    46    (25)  ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimet
    47  hylbutanoate.  Some trade or other names: 5F-EDMB-PINACA.
    48    (26) methyl  2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimeth
    49  ylbutanoate.  Some trade or other names: 5F-MDMB-PICA; 5F-MDMB-2201.
    50    (27)  N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide.
    51  Some   trade   or   other   names:   FUB-AKB48;    FUB-APINACA;    AKB48
    52  N-(4-FLUOROBENZYL).
    53    (28)   1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carbox
    54  amide. Some trade or other names: 5F-CUMYL-PINACA; SGT-25.
    55    (29) (1-4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
    56  methanone. Some trade or other names: FUB-144.

        S. 8307                            125                           A. 8807

     1    § 12. Paragraph 1 of subdivision (b) of schedule II of section 3306 of
     2  the public health law, as amended by section 1 of part C of chapter  447
     3  of the laws of 2012, is amended to read as follows:
     4    (1)  Opium and opiate, and any salt, compound, derivative, or prepara-
     5  tion of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine,
     6  naldemedine,  nalmefene,  naloxefol,   naloxone,   [and]   6&-naltrexol,
     7  naltrexone,  and  samidorphan, and their respective salts, but including
     8  the following:
     9    1. Raw opium.
    10    2. Opium extracts.
    11    3. Opium fluid.
    12    4. Powdered opium.
    13    5. Granulated opium.
    14    6. Tincture of opium.
    15    7. Codeine.
    16    8. Ethylmorphine.
    17    9. Etorphine hydrochloride.
    18    10. Hydrocodone (also known as dihydrocodeinone).
    19    11. Hydromorphone.
    20    12. Metopon.
    21    13. Morphine.
    22    14. Oxycodone.
    23    15. Oxymorphone.
    24    16. Thebaine.
    25    17. Dihydroetorphine.
    26    18. Oripavine.
    27    19. Noroxymorphone.
    28    § 13. Subdivision (c) of schedule II of section  3306  of  the  public
    29  health law is amended by adding a new paragraph 30 to read as follows:
    30    30.    Oliceridine.    (N-{(3-methoxythiophen-2-yl)methyl}({2-{(9R)-9-
    31  (pyridin-2-yl)-6-oxaspiro{4.5}decan-9-yl}ethyl})amine).
    32    § 14. Subdivision (f) of schedule II of section  3306  of  the  public
    33  health  law, as amended by chapter 589 of the laws of 1996, the undesig-
    34  nated paragraph as amended by chapter  575  of  the  laws  of  2001,  is
    35  amended to read as follows:
    36    (f) Hallucinogenic substances.
    37    (1)    Nabilone:    Another    name    for    nabilone:    (+,-)-trans
    38  -3-(1,1-dimethylheptyl)-6,  6a,  7,  8,  10,  10a-hexahydro-1-hydroxy-6,
    39  6-dimethyl-9H-dibenzo{b,d}pyran-9-one.
    40    (2)  Dronabinol  {(-)-delta-9-trans  tetrahydrocannabinol}  in an oral
    41  solution in a drug product approved for marketing by the  United  States
    42  Food and Drug Administration.
    43    §  15.  Subparagraph (i) of paragraph 3 of subdivision (g) of schedule
    44  II of section 3306 of the public health law, as amended by section 2  of
    45  part  BB  of  chapter  57  of  the  laws  of 2023, is amended to read as
    46  follows:
    47    (i)  [4-anilino-N-phenenethylpiperidine]  4-anilino-N-phenethylpiperi-
    48  dine (ANPP).
    49    §  16.  Subdivision  (h)  of schedule II of section 3306 of the public
    50  health law, as amended by section 8 of part C of chapter 447 of the laws
    51  of 2012, is amended to read as follows:
    52    (h) (1) Anabolic steroids.  Unless  specifically  excepted  or  unless
    53  listed  in  another  schedule, "anabolic steroid" shall mean any drug or
    54  hormonal substance, chemically and pharmacologically related to  testos-
    55  terone  (other than estrogens, progestins, corticosteroids and dehydroe-
    56  piandrosterone) and includes:

        S. 8307                            126                           A. 8807

     1    [(1)] (i) 3{beta}, 17-dihydroxy-5a-androstane.
     2    [(2)] (ii) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.
     3    [(3)] (iii) 5{alpha}-androstan-3,17-dione.
     4    [(4)] (iv) 1-androstenediol (3{beta},17{beta}-dihydroxy-5
     5  {alpha}-androst-1- ene).
     6    [(5)] (v) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5
     7  {alpha}-androst-1- ene).
     8    [(6)] (vi) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-
     9  androst-4-ene).
    10    [(7)] (vii) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-  androst-5-
    11  ene).
    12    [(8)] (viii) 1-androstenedione ({5{alpha}}-androst-1-en-3, 17-dione).
    13    [(9)] (ix) 4-androstenedione (androst-4-en-3,17-dione).
    14    [(10)] (x) 5-androstenedione (androst-5-en-3,17-dione).
    15    [(11)] (xi) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta} -hydrox-
    16  yandrost-4-en-3-one).
    17    [(12)] (xii) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene -3-one).
    18    [(13)] (xiii) Boldione (androsta-1,4-diene-3,17-dione).
    19    [(14)] (xiv) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydrox-
    20  yandrost- 4-en-3-one).
    21    [(15)] (xv) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-e n-3-one).
    22    [(16)] (xvi) Dehydrochloromethyltestosterone (4-chloro-17
    23  {beta}-hydroxy-17{alpha}-methyl-androst-1, 4-dien-3-one).
    24    [(17)] (xvii) {Delta} 1-dihydrotestosterone (a.k.a. '1-
    25  testosterone')(17{beta}-hydroxy-5{alpha}-androst-1-en-3-one).
    26    [(18)] (xviii) 4-dihydrotestosterone (17{beta}-hydroxy-
    27  androstan-3-one).
    28    [(19)] (xix) Drostanolone (17{beta}-hydroxy-2{alpha}-methyl
    29  -5{alpha} -androstan-3-one).
    30    [(20)] (xx) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxy
    31  estr-4-ene).
    32    [(21)] (xxi) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta},
    33  17 {beta}-dihydroxyandrost-4-en-3-one).
    34    [(22)] (xxii) Formebolone (2-formyl-17{alpha}-methyl-11{alpha},
    35  17{beta}-dihydroxyandrost-1, 4-dien-3-one).
    36    [(23)] (xxiii) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandros
    37  tano {2, 3-c}-furazan).
    38    [(24)] (xxiv) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.
    39    [(25)] (xxv) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-
    40  4-en-3-one).
    41    [(26)] (xxvi) 4-hydroxy-19-nortestosterone (4,17{beta}-dihydroxy-
    42  estr-4-en-3-one).
    43    [(27)] (xxvii) desoxymethyltestosterone (17{alpha}-methyl-5
    44  {alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).
    45    [(28)] (xxviii) Mestanolone (17{alpha}-methyl-17{beta}- hydroxy- 5-an-
    46  drostan-3-one).
    47    [(29)] (xxix) Mesterolone (1{alpha}methyl-17{beta}-hydroxy-
    48  {5{alpha}}-androstan-3-one).
    49    [(30)] (xxx) Methandienone (17{alpha}-methyl-17{beta}-hydroxyandr
    50  ost-1, 4-dien-3-one).
    51    [(31)] (xxxi) Methandriol (17{alpha}-methyl-3{beta}, 17
    52  {beta}-dihydroxyandrost-5-ene).
    53    [(32)] (xxxii) Methenolone (1-methyl- 17{beta}-hydroxy-5      {alpha}-
    54  androst- 1-en-3-one).
    55    [(33)] (xxxiii) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy   - 5a-an-
    56  drostane.

        S. 8307                            127                           A. 8807

     1    [(34)] (xxxiv) 17{alpha}-methyl-3{alpha}, 17{beta}-  dihydroxy- 5a-an-
     2  drostane
     3    [(35)] (xxxv) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost
     4  -4-ene.
     5    [(36)] (xxxvi) 17{alpha}-methyl-4-hydroxynandrolone (17{alpha}-
     6  methyl-4-hydroxy-17{beta}-hydroxyestr-4-en-3-one).
     7    [(37)] (xxxvii) Methyldienolone (17{alpha}-methyl-17{beta}- hydroxyes-
     8  tra- 4,9(10)-dien-3-one).
     9    [(38)] (xxxviii) Methyltrienolone (17{alpha}-methyl-17{beta}-hyd
    10  roxyestra-4, 9-11-trien-3-one).
    11    [(39)] (xxxix) Methyltestosterone(17{alpha}-methyl-17{beta}-hyd
    12  roxyandrost-4-en-3-one).
    13    [(40)] (xl) Mibolerone (7{alpha},17{alpha}-dimethyl-17
    14  {beta}-hydroxyestr-4-en-3-one).
    15    [(41)] (xli) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone
    16  (17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one)
    17  (a.k.a. '17-{alpha}-methyl-1-testosterone').
    18    [(42)] (xlii) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).
    19    [(43)] (xliii) 19-nor-4-androstenediol (3{beta},17{beta}-dihydro
    20  xyestr- 4-ene).
    21    [(44)] (xliv) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydrox-
    22  yestr-4-ene).
    23    [(45)] (xlv) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).
    24    [(46)] (xlvi) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydrox-
    25  yestr-5-ene).
    26    [(47)] (xlvii) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-
    27  diene-3,17-dione).
    28    [(48)] (xlviii) 19-nor-4-androstenedione (estr-4-en-3,17-dione).
    29    [(49)] (xlix) 19-nor-5-androstenedione (estr-5-en-3,17-dione).
    30    [(50)] (l) Norbolethone (13{beta}, 17{alpha}-diethyl-17
    31  {beta} -hydroxygon-4-en-3-one).
    32    [(51)] (li) Norclostebol (4-chloro-17{beta}-hydroxyestr-4- en-3-one).
    33    [(52)] (lii) Norethandrolone (17{alpha}-ethyl-17{beta}-hydroxyes
    34  tr-4-en-3-one).
    35    [(53)] (liii) Normethandrolone (17 {alpha}-methyl-17{beta}-hydroxy
    36  estr-4-en-3-one).
    37    [(54)] (liv) Oxandrolone (17{alpha}-methyl-17{beta}-hydroxy-2-
    38  oxa- {5{alpha}}-androstan-3-one).
    39    [(55)] (lv) Oxymesterone (17{alpha}-methyl-4, 17 {beta}-dihydroxy
    40  androst-4-en-3-one).
    41    [(56)] (lvi) Oxymetholone (17 {alpha}-methyl-2-hydroxymethylene-
    42  17 {beta}-hydroxy-{5{alpha}}- androstan-3-one).
    43    [(57)] (lvii) Stanozolol (17{alpha}-methyl-17{beta}-hydroxy-{5
    44  {alpha}}- androst-2-eno{3, 2-c}-pyrazole).
    45    [(58)] (lviii) Stenbolone (17{beta}-hydroxy-2-methyl-{5{alpha}}-
    46  androst- 1-en-3-one).
    47    [(59)] (lix) Testolactone (13-hydroxy-3-oxo-13, 17-secoandrosta-
    48  1, 4-dien-17-oic acid lactone).
    49    [(60)] (lx) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).
    50    [(61)] (lxi) Tetrahydrogestrinone (13{beta}, 17{alpha}
    51  -diethyl-17{beta}-hydroxygon-4, 9, 11 -trien-3-one).
    52    [(62)] (lxii) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien- 3-one).
    53    [(63)] (lxiii)5{alpha}-androstan-3,6,17-trione.
    54    (lxiv) 6-bromo-androsta-1,4-diene-3,17-dione.
    55    (lxv) 6-bromo-androstan-3,17-dione.
    56    (lxvi) 4-chloro-17{alpha}-methyl-androsta-1,4-diene-3,17{beta}-diol.

        S. 8307                            128                           A. 8807

     1    (lxvii) 4-chloro-17{alpha}-methyl-androst-4-ene-3{beta},17{beta}-diol.
     2    (lxviii) 4-chloro-17{alpha}-methyl-17{beta}hydroxy-androst-4-en-3-one.
     3    (lxix) 4-chloro-17{alpha}-methyl-17{beta}hydroxy-androst-4-ene-3,11-di
     4  one.
     5    (lxx) 2{alpha}, 17{alpha}-dimethyl-17{beta}-hydroxy-5{beta}-androstan-3
     6  -one.
     7    (lxxi) 2{alpha},3{alpha}-epithio-17{alpha}-methyl-5{alpha}androstan-17
     8  {beta}-ol.
     9    (lxxii) estra-4,9,11-triene-3,17-dione.
    10    (lxxiii) [3,2-c]furazan-5{alpha}-androstan-17{beta}ol.
    11    (lxxiv) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one.
    12    (lxxv) 4-hydroxy-androst-4-ene-3,17-dione.
    13    (lxxvi) 17{beta}-hydroxy-androstano[2,3-d]isoxazole.
    14    ((lxxvii) 17{beta}-hydroxy-androstano[3,2-c]isoxazole.
    15    (lxxviii) 3{beta}-hydroxy-estra-4,9,11-trien-17-one.
    16    (lxxix) Methasterone  (2{alpha},17{alpha}-dimethyl-5{alpha}-androstan-
    17  7{beta}-ol-3-one)or        2{alpha}17{alpha}-dimethyl-17{beta}-hydroxy-5
    18  {alpha}-androstan-3-one).
    19    (lxxx) 17{alpha}-methyl-androsta-1,4-diene-3,17{beta}-diol.
    20    (lxxxi) 17{alpha}-methyl-5{alpha}-androstan-17{beta}-ol.
    21    (lxxxii) 17{alpha}-methyl-androstan-3-hydroxyimine-17{beta}-ol.
    22    (lxxxiii) 6{alpha}-methyl-androst-4-ene-3,17-dione.
    23    (lxxxiv) 17{alpha}-methyl-androst-2-ene-3,17{beta}diol.
    24    (lxxxv) Prostanozol(17{beta}-hydroxy-5{alpha}-androstano[3,2-c]pyrazole)
    25  or[3,2-c]pyrazole-5{alpha}-androstan-17{beta}-ol.
    26    (lxxxvi) [3,2-c]pyrazole-androst-4-en-17{beta}-ol.
    27    (lxxxvii) Any salt, ester or ether of a drug or substance described or
    28  listed in this subdivision.
    29    (2)  (i)  Subject  to  subparagraph  (ii) of this paragraph, a drug or
    30  hormonal substance, other than estrogens,  progestins,  corticosteroids,
    31  and  dehydroepiandrosterone, that is not listed in paragraph one of this
    32  subdivision and is derived from, or has a  chemical  structure  substan-
    33  tially similar to, one or more anabolic steroids listed in paragraph one
    34  of  this  subdivision  shall be considered to be an anabolic steroid for
    35  purposes of this schedule if:
    36    (A) the drug or substance has been created or  manufactured  with  the
    37  intent of producing a drug or other substance that either:
    38    1. promotes muscle growth; or
    39    2.  otherwise  causes  a  pharmacological  effect  similar  to that of
    40  testosterone; or
    41    (B) the drug or substance has been, or is intended to be, marketed  or
    42  otherwise  promoted  in  any  manner  suggesting  that consuming it will
    43  promote muscle growth or any other  pharmacological  effect  similar  to
    44  that of testosterone.
    45    (ii)  A  substance  shall  not  be considered to be a drug or hormonal
    46  substance for purposes of this subdivision if:
    47    (A) it is:
    48    1. an herb or other botanical;
    49    2. a concentrate, metabolite, or extract of, or a constituent isolated
    50  directly from, an herb or other botanical; or
    51    3. a combination of two or more substances described in clause one  or
    52  two of this item;
    53    (B) it is a dietary ingredient for purposes of the Federal Food, Drug,
    54  and Cosmetic Act (21 U.S.C. 301 et seq.); and
    55    (C) it is not anabolic or androgenic.

        S. 8307                            129                           A. 8807

     1    (iii)  In  accordance  with  subdivision  one  of section thirty-three
     2  hundred ninety-six of this article, any person claiming the  benefit  of
     3  an  exemption  or  exception  under  subparagraph (ii) of this paragraph
     4  shall bear the burden of going forward with the evidence with respect to
     5  such exemption or exception.
     6    §  17.  Subdivision  (c) of schedule III of section 3306 of the public
     7  health law is amended by adding two new paragraphs 15 and 16 to read  as
     8  follows:
     9    (15) Perampanel.
    10    (16) Xylazine, its salts, isomers and salts of isomers.
    11    §  18.  Subdivision  (c)  of schedule IV of section 3306 of the public
    12  health law is amended by adding seven new paragraphs 54, 55, 56, 57, 58,
    13  59 and 60 to read as follows:
    14    (54) Alfaxalone.
    15    (55) Brexanolone.
    16    (56) Daridorexant.
    17    (57) Lemborexant.
    18    (58) Remimazolam.
    19    (59) Suvorexant.
    20    (60) Zuranolone.
    21    § 19. Subdivision (e) of schedule IV of section  3306  of  the  public
    22  health  law is amended by adding two new paragraphs 13 and 14 to read as
    23  follows:
    24    (13) Serdexmethylphenidate.
    25    (14) Solriamfetol.
    26    § 20. Subdivision (f) of schedule IV of section  3306  of  the  public
    27  health  law, as added by chapter 664 of the laws of 1985, paragraph 2 as
    28  added by chapter 457 of the laws of 2006 and paragraph  3  as  added  by
    29  section  14  of part C of chapter 447 of the laws of 2012, is amended to
    30  read as follows:
    31    (f) Other substances. Unless specifically excepted or unless listed in
    32  another schedule, any material, compound, mixture or  preparation  which
    33  contains  any quantity of the following substances, including its salts,
    34  isomers, and salts of such  isomers,  whenever  the  existence  of  such
    35  salts, isomers, and salts of isomers is possible:
    36    (1) Pentazocine.
    37    (2) Butorphanol (including its optical isomers).
    38    (3) Tramadol in any quantities.
    39    (4)  Eluxadoline.  (5-{{{(2S)-2-amino-3-{4-aminocarbonyl)-2,6-dimethyl
    40  phenyl}-1-oxopropyl}{(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl}amino}meth
    41  yl}-2-methoxybenzoic acid).
    42    (5) Lorcaserin.
    43    § 21. Subdivision (d) of schedule V of  section  3306  of  the  public
    44  health  law  is  amended  by adding four new paragraphs 4, 5, 6 and 7 to
    45  read as follows:
    46    (4) Brivaracetam ((2S)-2-{(4R)-2-oxo-4-propylpyrrolidin-1-yl} butanam-
    47  ide). Some trade or other names: BRV;  UCB-34714;  Briviact)  (including
    48  its salts).
    49    (5)   Cenobamate      ({1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl}
    50  carbamate;  2H-tetrazole-2-ethanol,  alpha-(2-chlorophenyl)-,  carbamate
    51  (ester), (alphaR)-; carbamic acid
    52  (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester).
    53    (6) Ganaxolone. 3@-hydroxy-3&-methyl-5@-pregnan-20-one.
    54    (7) Lasmiditan
    55  {2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzam
    56  ide}.

        S. 8307                            130                           A. 8807

     1    §  22.  Subdivision  2  of  section  3342 of the public health law, as
     2  amended by chapter 692 of the laws  of  1976,  is  amended  to  read  as
     3  follows:
     4    2.  An  institutional dispenser may dispense controlled substances for
     5  use off its premises only pursuant to a prescription, prepared and filed
     6  in conformity with this title, provided, however, that, in an  emergency
     7  situation  as defined by rule or regulation of the department, a practi-
     8  tioner  in  a  hospital  without  a  full-time  pharmacy  may   dispense
     9  controlled  substances to a patient in a hospital emergency room for use
    10  off the premises of the institutional dispenser  for  a  period  not  to
    11  exceed  twenty-four  hours, unless the federal drug enforcement adminis-
    12  tration has authorized a longer time period for the purpose of  initiat-
    13  ing maintenance treatment, detoxification treatment, or both.
    14    §  23.  Subdivision  1  of  section  3302 of the public health law, as
    15  amended by chapter 92 of the  laws  of  2021,  is  amended  to  read  as
    16  follows:
    17    1.  "[Addict] Person with a substance use disorder" means a person who
    18  habitually uses a controlled substance for a non-legitimate or  unlawful
    19  use, and who by reason of such use is dependent thereon.
    20    § 24. Subdivision 1 of section 3331 of the public health law, as added
    21  by chapter 878 of the laws of 1972, is amended to read as follows:
    22    1. Except as provided in titles III or V of this article, no substance
    23  in  schedules  II,  III,  IV, or V may be prescribed for or dispensed or
    24  administered to [an addict] a person with a substance  use  disorder  or
    25  habitual user.
    26    §  25. The title heading of title 5 of article 33 of the public health
    27  law, as added by chapter 878 of the laws of 1972, is amended to read  as
    28  follows:

    29            DISPENSING TO [ADDICTS] PERSONS WITH A SUBSTANCE USE
    30                         DISORDER AND HABITUAL USERS

    31  §  26. Section 3350 of the public health law, as added by chapter 878 of
    32  the laws of 1972, is amended to read as follows:
    33    § 3350. Dispensing prohibition.   Controlled  substances  may  not  be
    34  prescribed for, or administered or dispensed to [addicts] persons with a
    35  substance  use  disorder  or  habitual  users  of controlled substances,
    36  except as provided by this title or title III.
    37    § 27. Section 3351 of the public health law, as added by  chapter  878
    38  of the laws of 1972, subdivision 5 as amended by chapter 558 of the laws
    39  of 1999, is amended to read as follows:
    40    §  3351.  Dispensing for medical use.  1. Controlled substances may be
    41  prescribed for, or administered or dispensed to  [an  addict]  a  person
    42  with a substance use disorder or habitual user:
    43    (a)  during  emergency  medical  treatment  unrelated  to [abuse] such
    44  substance use disorder or habitual use of controlled substances;
    45    (b) who is a bona fide patient suffering from an incurable  and  fatal
    46  disease such as cancer or advanced tuberculosis;
    47    (c)  who  is aged, infirm, or suffering from serious injury or illness
    48  and the withdrawal from controlled substances would endanger the life or
    49  impede or inhibit the recovery of such person.
    50    1-a. A practitioner may prescribe, order  and  dispense  any  schedule
    51  III, IV, or V narcotic drug approved by the federal food and drug admin-
    52  istration  specifically  for use in maintenance or detoxification treat-
    53  ment to a person with a substance use disorder or habitual user.

        S. 8307                            131                           A. 8807

     1    2. Controlled substances may be ordered  for  use  by  [an  addict]  a
     2  person  with a substance use disorder or habitual user by a practitioner
     3  and administered by a practitioner [or], registered nurse, or  paramedic
     4  to relieve acute withdrawal symptoms.
     5    3.  Methadone,  or  such  other controlled substance designated by the
     6  commissioner as appropriate for such use, may be ordered for use of  [an
     7  addict]  a  person  with  a substance use disorder by a practitioner and
     8  dispensed or administered by a practitioner or his designated  agent  as
     9  interim  treatment  for [an addict on a waiting list for admission to an
    10  authorized maintenance program] a person with a substance  use  disorder
    11  while  arrangements  are  being  made for referral to treatment for such
    12  addiction to controlled substances.
    13    4. Methadone, or such other controlled  substance  designated  by  the
    14  commissioner  as  appropriate  for  such use, may be administered to [an
    15  addict] a person with a substance use disorder by a practitioner  or  by
    16  [his]  their designated agent acting under the direction and supervision
    17  of a practitioner, as part of a [regime] regimen designed  and  intended
    18  as maintenance or detoxification treatment or to withdraw a patient from
    19  addiction to controlled substances.
    20    5.  [Methadone]  Notwithstanding  any  other  law  and consistent with
    21  federal requirements, methadone,  or  such  other  controlled  substance
    22  designated  by  the  commissioner  as  appropriate  for such use, may be
    23  administered or dispensed directly  to  [an  addict]  a  person  with  a
    24  substance  use  disorder  by a practitioner or by [his] their designated
    25  agent acting under the direction and supervision of a  practitioner,  as
    26  part  of a substance [abuse or chemical dependence] use disorder program
    27  approved pursuant to article [twenty-three or] thirty-two of the  mental
    28  hygiene law.
    29    § 28. Section 3372 of the public health law is REPEALED.
    30    § 29. This act shall take effect immediately.

    31                                   PART V

    32    Section  1.  Section  2805-x  of  the  public  health law, as added by
    33  section 48 of part B of chapter 57 of the laws of 2015, paragraph (d) of
    34  subdivision 4 as added by chapter 697 of the laws of 2023, is amended to
    35  read as follows:
    36    § 2805-x. [Hospital-home care-physician] Health care delivery  collab-
    37  oration  program.  1. The purpose of this section shall be to facilitate
    38  innovation in [hospital, home care agency and physician collaboration in
    39  meeting] collaborations  between  licensed  and  certified  health  care
    40  providers  and agencies, including: hospitals, home care agencies, emer-
    41  gency medical services, skilled nursing  facilities,  and  hospices,  as
    42  well  as payors and other interdisciplinary providers, practitioners and
    43  service entities, to meet the community's evolving health care needs  in
    44  a changing health care delivery landscape.  It shall provide a framework
    45  to  support  voluntary  initiatives  in collaboration to improve patient
    46  care access and management, patient health outcomes,  cost-effectiveness
    47  in  the  use  of  health  care services and community population health.
    48  [Such collaborative initiatives may also include payors, skilled nursing
    49  facilities and  other  interdisciplinary  providers,  practitioners  and
    50  service entities.]
    51    2. For purposes of this section:
    52    (a)  "Hospital"  shall  include  a general hospital as defined in this
    53  article or other inpatient facility for rehabilitation or specialty care
    54  within the definition of hospital in this article.

        S. 8307                            132                           A. 8807

     1    (b) "Home care agency" shall mean a certified home health agency, long
     2  term home health care program or licensed home care services  agency  as
     3  defined in article thirty-six of this chapter.
     4    (c)  "Payor"  shall  mean  a  health plan approved pursuant to article
     5  forty-four of this chapter, or article thirty-two or forty-three of  the
     6  insurance law.
     7    (d)  "Practitioner"  shall  mean  any  of the health, mental health or
     8  health related professions licensed  pursuant  to  title  eight  of  the
     9  education law.
    10    (e)  "Physician" shall mean a person duly licensed pursuant to article
    11  one hundred thirty-one of the education law.
    12    (f) "Hospice" shall mean an agency approved  under  article  forty  of
    13  this chapter.
    14    (g)  "Emergency  medical services" shall mean an agency approved under
    15  article thirty of this chapter and authorized pursuant to section  three
    16  thousand eighteen of this chapter to provide community paramedicine.
    17    (h)  "Skilled  nursing  facility" shall mean a residential health care
    18  facility or nursing home licensed pursuant to  article  twenty-eight  of
    19  this chapter.
    20    3.  The commissioner is authorized to provide financing including, but
    21  not limited to, grants or positive  adjustments  in  medical  assistance
    22  rates  or  premium  payments, to the extent of funds available and allo-
    23  cated or appropriated therefor, including funds provided  to  the  state
    24  through  federal  waivers,  funds made available through state appropri-
    25  ations and/or funding through section twenty-eight  hundred  seven-v  of
    26  this  article,  as well as waivers of regulations under title ten of the
    27  New York codes, rules and regulations, to support the  voluntary  initi-
    28  atives and objectives of this section.
    29    4.  [Hospital-home  care-physician] Health care delivery collaborative
    30  initiatives under this section may include, but shall not be limited to:
    31    (a) [Hospital-home care-physician integration] Integration initiatives
    32  between at least two of the following: hospitals,  home  care  agencies,
    33  physician,  physicians'  group, emergency medical services, hospice, and
    34  skilled nursing facilities, including but not limited to:
    35    (i) transitions in care initiatives  to  help  effectively  transition
    36  patients  to  post-acute  care  at  home,  coordinate follow-up care and
    37  address issues critical to care plan success and readmission avoidance;
    38    (ii) clinical pathways for  specified  conditions,  guiding  patients'
    39  progress and outcome goals, as well as effective health services use;
    40    (iii)  application  of  telehealth/telemedicine services in monitoring
    41  and managing patient  conditions,  and  promoting  self-care/management,
    42  improved outcomes and effective services use;
    43    (iv)  facilitation  of  physician  house  calls  to homebound patients
    44  and/or to patients for whom such home visits  are  determined  necessary
    45  and effective for patient care management;
    46    (v)  additional  models  for prevention of avoidable hospital readmis-
    47  sions and emergency room visits;
    48    (vi) health home development;
    49    (vii) development and demonstration of new  models  of  integrated  or
    50  collaborative  care and care management not otherwise achievable through
    51  existing models; and
    52    (viii) bundled payment demonstrations for  hospital-to-post-acute-care
    53  for  specified  conditions  or  categories of conditions, in particular,
    54  conditions predisposed to  high  prevalence  of  readmission,  including
    55  those  currently  subject to federal/state penalty, and other discharges
    56  with extensive post-acute needs;

        S. 8307                            133                           A. 8807

     1    (b) Recruitment, training and retention of hospital/home  care  direct
     2  care  staff  and  physicians,  in geographic or clinical areas of demon-
     3  strated need. Such initiatives may include, but are not limited to,  the
     4  following activities:
     5    (i)  outreach and public education about the need and value of service
     6  in health occupations;
     7    (ii) training/continuing education  and  regulatory  facilitation  for
     8  cross-training  to  maximize  flexibility  in  the utilization of staff,
     9  including:
    10    (A) training of hospital nurses in home care;
    11    (B) dual certified nurse aide/home health aide certification; and
    12    (C) dual personal care aide/HHA certification;
    13    (iii) salary/benefit enhancement;
    14    (iv) career ladder development; and
    15    (v) other incentives to practice in shortage areas; and
    16    (c) [Hospital - home care - physician] Health care delivery collabora-
    17  tives for the care and management of special needs, high-risk and  high-
    18  cost patients, including but not limited to best practices, and training
    19  and education of direct care practitioners and service employees.
    20    (d)  Collaborative  programs  to  address  disparities  in health care
    21  access or treatment, and/or conditions of higher prevalence, in  certain
    22  populations,  where such collaborative programs could provide and manage
    23  services in a more effective, person-centered and cost-efficient  manner
    24  for reduction or elimination of such disparities.
    25    (i)  Such  programs  may  target  one or more disparate conditions, or
    26  areas of under-service, evidenced in defined populations, including  but
    27  not be limited to:
    28    (A) cardiovascular disease;
    29    (B) hypertension;
    30    (C) diabetes;
    31    (D) chronic kidney disease;
    32    (E) obesity;
    33    (F) asthma;
    34    (G) sickle cell disease;
    35    (H) sepsis;
    36    (I) lupus;
    37    (J) breast, lung, prostate and colorectal cancers;
    38    (K)  geographic  shortage  of  primary  care, prenatal/obstetric care,
    39  specialty medical care, home health care,  or  culturally  and  linguis-
    40  tically compatible care;
    41    (L) alcohol, tobacco, or substance abuse;
    42    (M) post-traumatic stress disorder and other conditions more prevalent
    43  among veterans of the United States military services;
    44    (N)  attracting members of minority populations to the field and prac-
    45  tice of medicine; and
    46    (O) such other areas approved by the commissioner.
    47    (ii)  Collaborative   [hospital-home   care-physician]   health   care
    48  delivery, and as applicable additional partner, models may include under
    49  such disparities programs:
    50    (A) service planning and design;
    51    (B)  recruitment  of  specialty personnel and/or specialty training of
    52  professionals or other direct care personnel (including physicians, home
    53  care and hospital staffs), patients and informal caregivers;
    54    (C) continuing medical education and clinical training for physicians,
    55  follow-up evaluations, and supporting educational materials;

        S. 8307                            134                           A. 8807

     1    (D) use of evidenced-based approaches and/or best practices to  treat-
     2  ment;
     3    (E) reimbursement of uncovered services;
     4    (F)  bundled or other integrated payment methods to support the neces-
     5  sary, coordinated and cost-effective services;
     6    (G) regulatory waivers to facilitate flexibility in  provider  collab-
     7  oration and person-centered care;
     8    (H) patient/family peer support and education;
     9    (I) data collection, research and evaluation of efficacy; and/or
    10    (J) other components or innovations satisfactory to the commissioner.
    11    (iii)  Nothing  contained in this paragraph shall prevent a physician,
    12  [physicians] physicians' group, home care agency, or hospital from indi-
    13  vidually applying for said grant.
    14    (iv) The commissioner shall consult with physicians, home  care  agen-
    15  cies,  hospitals,  consumers,  statewide  associations representative of
    16  such participants, and other experts  in  health  care  disparities,  in
    17  developing  an application process for grant funding or rate adjustment,
    18  and for request of state regulatory waivers, to  facilitate  implementa-
    19  tion of disparities programs under this paragraph.
    20    5.    At  a  minimum, applications for collaborative initiatives under
    21  this section must specifically identify the service gaps and/or communi-
    22  ty need the collaboration seeks to  address,  and  outline  a  projected
    23  timeline  for  implementation  and deliverable data to demonstrate mile-
    24  stones to success.
    25    6. Hospitals and home care agencies which are  provided  financing  or
    26  waivers pursuant to this section shall report to the commissioner on the
    27  patient,  service and cost experiences pursuant to this section, includ-
    28  ing the extent to which the project goals are achieved. The commissioner
    29  shall compile and  make  such  reports  available  on  the  department's
    30  website.
    31    §  2. Subdivision 2 of section 3602 of the public health law, as added
    32  by chapter 895 of the laws of 1977, is amended to read as follows:
    33    2. "Home care services agency" means an organization primarily engaged
    34  in arranging and/or providing directly or through  contract  arrangement
    35  one  or  more  of  the  following:  Nursing  services,  home health aide
    36  services, and other therapeutic and related services which may  include,
    37  but  shall not be limited to, physical, speech and occupational therapy,
    38  nutritional services, medical social services, personal  care  services,
    39  homemaker services, and housekeeper or chore services, which may be of a
    40  preventive,   therapeutic,   rehabilitative,   health  guidance,  and/or
    41  supportive nature to persons at home.  For the purposes of this article,
    42  a general hospital licensed pursuant to  article  twenty-eight  of  this
    43  chapter  shall  not be considered "primarily engaged in arranging and/or
    44  providing" nursing, home health, or other therapeutic services  notwith-
    45  standing  that  such  services may be provided in a patient's residence,
    46  provided that at least fifty-one percent of patient care hours for  such
    47  general  hospital is generated from the treatment of patients within the
    48  hospital, and that any patients treated in their residence have a preex-
    49  isting clinical relationship with the general hospital.
    50    § 3. Section 2803 of the public health law is amended by adding a  new
    51  subdivision 15 to read as follows:
    52    15.    Notwithstanding  any contrary provision of this article, or any
    53  rule or regulation to the contrary, the commissioner shall allow general
    54  hospitals to provide off-site primary care and  medical  care  services,
    55  including  but not limited to acute care and preventative wellness care,
    56  that are:

        S. 8307                            135                           A. 8807

     1    (a) not home care services defined in subdivision one of section thir-
     2  ty-six hundred two of this chapter or the professional services  enumer-
     3  ated in subdivision two of such section;
     4    (b)  provided  by  a primary care professional, including a physician,
     5  registered nurse, or physician assistant, to a patient with a pre-exist-
     6  ing clinical relationship with the general hospital, or with the  health
     7  care professional providing the service; and
     8    (c)  provided to a patient who is unable to leave his or her residence
     9  to receive services at the general hospital without unreasonable  diffi-
    10  culty  due  to  circumstances,  including  but  not limited to, clinical
    11  impairment and conditions of immunosuppression.
    12    (d) Nothing in this subdivision shall preclude a  federally  qualified
    13  health  center  from  providing  off-site  services  in  accordance with
    14  department regulations.
    15    (e) The department  is  authorized  to  establish  medical  assistance
    16  program  rates  to  effectuate this subdivision. For the purposes of the
    17  department determining the applicable rates pursuant to such  authority,
    18  any  general hospital approved pursuant to this subdivision shall report
    19  to the department, in the form and format required  by  the  department,
    20  its  annual  operating  costs,  specifically  for  such  off-site  acute
    21  services. Failure to timely submit such cost data to the department  may
    22  result in revocation of authority to participate in a program under this
    23  section  due  to  the  inability  to establish appropriate reimbursement
    24  rates.
    25    § 4. Subdivision 3 of section 3018 of the public health law, as  added
    26  by chapter 137 of the laws of 2023, is amended to read as follows:
    27    3.  (a)  This  program shall authorize mobile integrated and community
    28  paramedicine programs presently operating and approved by the department
    29  as of May eleventh, two thousand twenty-three, under  the  authority  of
    30  Executive Order Number 4 of two thousand twenty-one, entitled "Declaring
    31  a  Statewide  Disaster Emergency Due to Healthcare staffing shortages in
    32  the State of New York" to continue in the same manner  and  capacity  as
    33  currently  approved  [for  a period of two years following the effective
    34  date of this section] through March thirty-first, two  thousand  thirty-
    35  one.
    36    (b)  Any  program  not  lawfully operating and established pursuant to
    37  paragraph (a) of this  subdivision  may  apply  to  the  department  for
    38  approval  to  operate  a  mobile  integrated  and community paramedicine
    39  program, and any program currently operating pursuant to  paragraph  (a)
    40  of  this subdivision for a limited purpose, including but not limited to
    41  vaccination administration, may apply to the department for approval  to
    42  modify  its  existing community paramedicine program. The department may
    43  approve up to two hundred new or  expanded  programs  pursuant  to  this
    44  paragraph.  Such  applications  must be submitted in the form and format
    45  prescribed by the department. Programs approved pursuant to  this  para-
    46  graph  shall  be  permitted  to  operate through March thirty-first, two
    47  thousand thirty-one.
    48    § 5. Section 2 of chapter 137 of the laws of 2023 amending the  public
    49  health  law  relating  to  establishing  a  community-based paramedicine
    50  demonstration program, is amended to read as follows:
    51    § 2. This act shall take effect immediately and shall  expire  and  be
    52  deemed  repealed  [2  years  after  such date] March 31, 2031; provided,
    53  however, that if this act shall have become a law on or  after  May  22,
    54  2023  this act shall take effect immediately and shall be deemed to have
    55  been in full force and effect on and after May 22, 2023.

        S. 8307                            136                           A. 8807

     1    § 6. Subdivision 1 of section  3001  of  the  public  health  law,  as
     2  amended  by  chapter  804  of  the  laws  of 1992, is amended to read as
     3  follows:
     4    1.  "Emergency  medical  service"  means  [initial  emergency  medical
     5  assistance including, but not  limited  to,  the  treatment  of  trauma,
     6  burns,  respiratory,  circulatory and obstetrical emergencies] a coordi-
     7  nated system of healthcare delivery that responds to the needs  of  sick
     8  and injured individuals, by providing: essential emergency, non-emergen-
     9  cy, specialty need or public event medical care; community education and
    10  prevention  programs;  ground  and  air  ambulance  services;  emergency
    11  medical dispatch; training for emergency medical services practitioners;
    12  medical first  response;  mobile  trauma  care  systems;  mass  casualty
    13  management; and medical direction.
    14    §  7.  Section  6909  of  the education law is amended by adding a new
    15  subdivision 12 to read as follows:
    16    12. A certified nurse practitioner may prescribe and order  a  non-pa-
    17  tient  specific  regimen  to  an emergency medical services practitioner
    18  licensed by the department of health pursuant to article thirty  of  the
    19  public  health  law,  pursuant to regulations promulgated by the commis-
    20  sioner, and consistent with the public  health  law,  for  administering
    21  immunizations.    Nothing in this subdivision shall authorize unlicensed
    22  persons to administer immunizations, vaccines or other drugs.
    23    § 8. Section 6527 of the education law is  amended  by  adding  a  new
    24  subdivision 12 to read as follows:
    25    12. A licensed physician may prescribe and order a non-patient specif-
    26  ic regimen to an emergency medical services practitioner licensed by the
    27  department  of  health  pursuant  to article thirty of the public health
    28  law, pursuant  to  regulations  promulgated  by  the  commissioner,  and
    29  consistent  with the public health law, for administering immunizations.
    30  Nothing in this subdivision shall authorize unlicensed persons to admin-
    31  ister immunizations, vaccines or other drugs.
    32    § 9. The public health law is amended by adding a new article 30-D  to
    33  read as follows:
    34                                ARTICLE 30-D
    35              EMERGENCY MEDICAL SERVICES ESSENTIAL SERVICES ACT
    36  Section 3080. Declaration of purpose.
    37          3081. Application of article.
    38          3082. Definitions.
    39          3083. Designation  of  medical  emergency response and emergency
    40                  medical dispatch agencies as essential services.
    41          3084. Provision of emergency medical dispatch.
    42          3085. Rules and regulations.
    43    § 3080. Declaration of purpose. 1. The provision of prompt, efficient,
    44  and effective emergency medical services and emergency medical  dispatch
    45  is crucial to the health and safety of the residents of New York state.
    46    2.  The  establishment  of a comprehensive and standardized system for
    47  medical emergency response  is  essential  to  address  life-threatening
    48  conditions  and  ensure  the well-being of individuals in need of urgent
    49  medical care.
    50    3. Ensuring that every county within New York state has the  necessary
    51  resources,  trained  personnel,  and operational capabilities to provide
    52  medical emergency response is a matter  of  public  interest  and  state
    53  priority.
    54    4.  It  is imperative to standardize the approach to medical emergency
    55  response and dispatch services to enhance the quality of care,  maximize

        S. 8307                            137                           A. 8807

     1  efficiency, and improve outcomes for patients experiencing medical emer-
     2  gencies.
     3    5. The designation of medical emergency response and emergency medical
     4  dispatch  as  essential  services  will ensure a uniform, effective, and
     5  coordinated response to medical emergencies across the state.
     6    6. This article aims to establish a framework for the provision, oper-
     7  ation,  and  regulation  of  medical  emergency  response  and  dispatch
     8  services, thereby safeguarding the health and safety of New York state's
     9  residents and visitors.
    10    §  3081.  Application  of  article.  This article shall apply to every
    11  county except a county wholly contained within a city.
    12    § 3082. Definitions. As used in  this  article,  the  following  terms
    13  shall have the following meanings:
    14    1.  "Medical  emergency  response"  shall mean the rapid deployment of
    15  ambulance services, advanced life support first response  services,  and
    16  other  first  response  services authorized by the department to provide
    17  emergency medical services, as defined in section three thousand one  of
    18  this  chapter,  for the purpose of providing immediate emergency medical
    19  care in response to emergency calls for  acute  conditions  where  rapid
    20  intervention is vital to prevent death or serious harm.
    21    2.   "Emergency  medical  dispatch"  means  a  protocol-driven  system
    22  approved by the department designed to manage,  assess,  and  prioritize
    23  medical  emergency calls, provide critical pre-arrival instructions, and
    24  dispatch medical emergency response  services  or  provide  referral  to
    25  appropriate non-emergency medical services where appropriate.
    26    3.  "EMS  medical  dispatch agency" means any individual, partnership,
    27  association, corporation, municipality or any legal or public entity  or
    28  subdivision thereof licensed by the department who is engaged in receiv-
    29  ing  requests  for  emergency  medical  assistance  from  the public and
    30  dispatching medical emergency response services as needed.
    31    4. "Medical emergency readiness assessment" means  the  rating  system
    32  evaluating  the  preparedness,  efficiency, and effectiveness of medical
    33  emergency response within a community.
    34    § 3083.  Designation  of  medical  emergency  response  and  emergency
    35  medical  dispatch  agencies  as essential services. 1. Medical emergency
    36  response and emergency medical dispatch  agencies  are  hereby  declared
    37  essential services within New York state.
    38    2. Every county, acting individually or jointly with any other county,
    39  city, town, and village, shall ensure that an emergency medical service,
    40  ambulance  service,  advanced life support first response service, other
    41  first response services authorized by the department to provide emergen-
    42  cy medical services, or a combination of such services are provided  for
    43  the purposes of effectuating medical emergency response within the boun-
    44  daries of the county.
    45    3.  Every county acting individually or jointly with any other county,
    46  city, town, and  village,  shall  develop,  implement,  and  maintain  a
    47  comprehensive  county  medical  emergency  response  plan,  in  a format
    48  approved by the department, ensuring the  effective  operation,  coordi-
    49  nation,  and  funding  of  medical emergency response. In furtherance of
    50  that purpose, the county shall designate one  or  more  primary  medical
    51  emergency  response agencies that shall respond to all calls and demands
    52  for such medical emergency response to persons entitled thereto, subject
    53  to any limitations upon such service specified in an  agreement,  within
    54  the  boundaries  of  the  county.  No medical emergency response agency,
    55  designated by the county in the plan, may refuse to respond to a request

        S. 8307                            138                           A. 8807

     1  for service unless they can prove, to the satisfaction  of  the  depart-
     2  ment, that they are unable to respond because of capacity limitations.
     3    4.  Notwithstanding  the provisions of section three thousand eight of
     4  this chapter, any county acting individually or jointly with  any  other
     5  county,  city,  town,  and  village,  that  provides, either directly or
     6  through agreement with existing services, an emergency  medical  service
     7  or  general  ambulance  service  in  accordance with section one hundred
     8  twenty-two-b of the general municipal law, for the purpose of effectuat-
     9  ing medical emergency response, upon meeting or exceeding  all  adminis-
    10  trative and operational standards set by the department, and upon filing
    11  written  notice  to the department in a manner prescribed by the depart-
    12  ment, shall be deemed to have satisfied any  and  all  requirements  for
    13  determination  of  public need for the establishment of additional emer-
    14  gency medical services and the department shall issue  a  non-transfera-
    15  ble,  permanent municipal ambulance service operating certificate. Noth-
    16  ing in this article shall be deemed  to  exclude  any  county  issued  a
    17  municipal  ambulance  service  operating certificate from complying with
    18  any other requirement of article thirty of this  chapter  or  any  other
    19  applicable provision of law or regulations promulgated thereunder.
    20    5.  Any  county  acting individually or jointly with any other county,
    21  city, town, and village,  that  provides,  either  directly  or  through
    22  agreement  with  an  existing  service,  an emergency medical service or
    23  general ambulance service in accordance with section one  hundred  twen-
    24  ty-two-b  of  the general municipal law, for the purpose of effectuating
    25  medical emergency response may establish a special district, after nine-
    26  ty days notice to the department, as defined in subdivision  sixteen  of
    27  section  one hundred two of the real property tax law, for the financing
    28  and operation of such emergency medical  service  or  general  ambulance
    29  service  in  accordance  with  section  one  hundred twenty-two-b of the
    30  general municipal law with an emergency medical services agency licensed
    31  by the department to provide emergency medical services  in  the  state.
    32  Such  special  district  shall  be exempt from the provisions of section
    33  three-c of the general municipal law until five years after  the  estab-
    34  lishment of the special district.
    35    6.  The department shall establish standards, with the advice from the
    36  state emergency medical services council, the  state  emergency  medical
    37  advisory committee and the state trauma advisory committee, establishing
    38  minimum  standards  for  the  provision of emergency medical services by
    39  first aid squads, basic life support first  response  services,  special
    40  event  medical services, and other first response services not otherwise
    41  defined in article thirty of this chapter.
    42    § 3084. Provision of emergency medical dispatch.  1.  Every  emergency
    43  medical  dispatch  agency  operating within New York state shall provide
    44  emergency  medical  dispatch  services  in  accordance  with   protocols
    45  approved by the department.
    46    2.  All  emergency  medical dispatch agencies shall be licensed by the
    47  department. The department shall establish criteria for the licensing of
    48  emergency medical dispatch agencies to ensure compliance with  emergency
    49  medical dispatch standards.
    50    3.  All  emergency  medical  dispatchers employed by emergency medical
    51  dispatch agencies must complete a certification training course approved
    52  by the department and maintain continuous certification  while  employed
    53  by  the  emergency  medical  dispatch  agency  as  an  emergency medical
    54  dispatcher.  The department shall establish minimum standards for  emer-
    55  gency medical dispatch training courses and dispatcher certification.

        S. 8307                            139                           A. 8807

     1    §  3085.  Rules and regulations. The commissioner may promulgate rules
     2  and regulations to effectuate the purposes of this article.
     3    § 10. The public health law is amended by adding a new section 3019 to
     4  read as follows:
     5    §  3019.  Emergency  medical  services  demonstration programs. 1. The
     6  purpose of this section shall be to  facilitate  innovation  in  medical
     7  care  provided by emergency medical service practitioners in meeting the
     8  community's health care needs, including collaboration with other health
     9  care organizations operating under the  provisions  of  section  twenty-
    10  eight  hundred  five-x  of this chapter. It shall provide a framework to
    11  support voluntary initiatives to improve patient care access and manage-
    12  ment, patient health outcomes, and  cost-effectiveness  in  the  use  of
    13  health care services and community population health.
    14    2.  The  commissioner is authorized to provide financing including, to
    15  the extent of funds available and allocated or appropriated therefor, as
    16  well as waivers of certain parts of this article,  article  thirty-A  of
    17  this  chapter,  and  regulations  under title ten of the New York codes,
    18  rules and regulations, to support the voluntary initiatives  and  objec-
    19  tives of this section.
    20    § 11. The public health law is amended by adding a new section 3055 to
    21  read as follows:
    22    §  3055.  EMS licensure and credentialing. 1. The department, with the
    23  approval of the state emergency medical services council, may  establish
    24  minimum  standards for the licensure of emergency medical services prac-
    25  titioners including but not limited to emergency medical technicians and
    26  advanced emergency medical technicians by the department.
    27    2. The department, with the approval of the  state  emergency  medical
    28  services  council,  may  establish  minimum  standards  for  specialized
    29  credentialing of emergency medical  service  practitioners  which  shall
    30  include,  but  not  be  limited to, emergency vehicle operator, critical
    31  care paramedic, emergency medical dispatcher, emergency medical services
    32  field training officer, emergency medical services administrator,  emer-
    33  gency  medical  control physician, and emergency medical services agency
    34  medical director.
    35    § 12. The public health law is amended by adding a new section 3029 to
    36  read as follows:
    37    § 3029. Paramedic urgent care program. 1. The department shall  estab-
    38  lish  a  paramedic urgent care program to evaluate the role of emergency
    39  medical services personnel in the delivery of health  care  services  in
    40  rural counties of New York state.
    41    2.  Any  organization  that  is  authorized  to  provide advanced life
    42  support services, in accordance with section three  thousand  thirty  of
    43  this  article,  may  apply  to  the department for approval to operate a
    44  paramedic urgent care.
    45    3. Any paramedic urgent care programs approved by the department under
    46  this section shall: (a) be under the overall supervision  and  direction
    47  of a qualified physician; (b) be staffed by qualified medical and health
    48  personnel,  physician  assistants,  or  nurse practitioners; (c) utilize
    49  advanced emergency medical technicians whose scope of practice is appro-
    50  priate for the medical services provided; (d) maintain a  treatment-man-
    51  agement  record  for each patient; and (e) be integrated with a hospital
    52  or other appropriate healthcare organization.
    53    4. Paramedic urgent care programs may integrate telehealth provided by
    54  a telehealth provider, as those terms are defined in section twenty-nine
    55  hundred ninety-nine-cc of this chapter.  The commissioner may specify in
    56  regulation additional acceptable modalities for the delivery  of  health

        S. 8307                            140                           A. 8807

     1  care  services  by paramedic care programs via telehealth, including but
     2  not limited to audio-only or video-only telephone communications, online
     3  portals and survey applications.
     4    5.  Nothing  in  this  section  shall  be  deemed to allow a person to
     5  provide any service for which a license, registration, certification  or
     6  other  authorization  under title eight of the education law is required
     7  and which the person does not possess, provided that any  service  being
     8  excluded  pursuant  to this subdivision shall not include a service that
     9  is within the scope of practice for  the  respective  emergency  medical
    10  services personnel.
    11    §  13.  This  act shall take effect immediately and shall be deemed to
    12  have been in full force and effect on and after April 1, 2024; provided,
    13  however, that the amendments to subdivision 3 of  section  3018  of  the
    14  public  health law made by section four of this act shall not affect the
    15  repeal of such section and shall be deemed repealed therewith.

    16                                   PART W

    17    Section 1. The elder law is amended by adding a  new  section  226  to
    18  read as follows:
    19    §  226.  Interagency  elder  justice coordinating council. 1. There is
    20  hereby created within the office an elder justice  coordinating  council
    21  consisting  of  representatives  of  state  agencies whose work involves
    22  elder justice to create greater collaboration  and  develop  overarching
    23  strategies,  systems,  and programs to be carried out in accordance with
    24  the governor's elder justice priorities, with a goal of protecting older
    25  adults from abuse and mistreatment. The  council  shall  collaborate  to
    26  identify  and support consistent policies and program operation, facili-
    27  tate communication among state agencies, foster collaborative  relation-
    28  ships,  and  help  state  agencies  keep  informed  of local, state, and
    29  national developments in elder justice.
    30    2. The council shall be chaired by the director of the office for  the
    31  aging,  and  shall  include  representation  from  the office of victims
    32  services, the office of children and family services, the department  of
    33  financial  services,  the  division  of  criminal  justice services, the
    34  office of mental health, the  office  for  the  prevention  of  domestic
    35  violence,  the department of health, the office for people with develop-
    36  mental disabilities, the New York state police, the justice  center  for
    37  the  protection  of  people  with  special  needs, and the department of
    38  state's division of consumer protection. Additionally, the council shall
    39  request input from stakeholders, advocates, experts, and coalitions.
    40    3. The council shall:
    41    (a) develop and implement a  cohesive,  comprehensive  state  plan  on
    42  elder justice that aligns state elder justice policy and programs across
    43  state agency responsibilities;
    44    (b)  develop  plans  for a coordinated and comprehensive response from
    45  state and local government  and  other  entities  when  elder  abuse  is
    46  reported;
    47    (c)  facilitate  interagency  planning and policy development on elder
    48  justice;
    49    (d) review and propose specific agency initiatives for their impact on
    50  systems and services related to elder justice;
    51    (e) coordinate activities for world  elder  abuse  awareness  day  and
    52  other events; and
    53    (f)  make recommendations to the governor that will improve New York's
    54  elder abuse prevention and intervention efforts.

        S. 8307                            141                           A. 8807

     1    4. Each member agency shall maintain control over, and  responsibility
     2  for, its own programs and policies. The council shall not take the place
     3  of  any  existing interagency councils and committees. The council shall
     4  serve to focus attention on elder justice comprehensively and  create  a
     5  multidisciplinary  mechanism to work toward alignment across agencies to
     6  help achieve the governor's elder justice priorities.
     7    5. The council shall meet regularly and shall submit a report  on  its
     8  activities  to  the  governor and the legislature no later than December
     9  thirty-first, two thousand twenty-five and annually thereafter.
    10    § 2. This act shall take effect immediately.

    11                                   PART X

    12    Section 1. Section 5 of part NN of chapter 57 of laws of 2018 amending
    13  the public health law and other laws relating to the opioid  stewardship
    14  act,  as  amended  by  section 5 of part XX of chapter 59 of the laws of
    15  2019, is amended to read as follows:
    16    § 5. This act shall take effect July 1, 2018 and sections one, two and
    17  four of this part shall expire and be deemed to be repealed on June  30,
    18  2024,  provided  that,  effective  immediately,  the addition, amendment
    19  and/or repeal of any rule or regulation necessary for the implementation
    20  of this act on  its  effective  date  are  authorized  to  be  made  and
    21  completed  on or before such effective date, and, provided that this act
    22  shall only apply to the sale or distribution of opioids in the state  of
    23  New York on or before December 31, 2018.
    24    § 2. This act shall take effect immediately.

    25                                   PART Y

    26    Section  1.  Section  7  of part R2 of chapter 62 of the laws of 2003,
    27  amending the mental hygiene law and the state finance  law  relating  to
    28  the  community mental health support and workforce reinvestment program,
    29  the membership of subcommittees for mental health of community  services
    30  boards  and  the duties of such subcommittees and creating the community
    31  mental health and workforce reinvestment account, as amended by  section
    32  1  of  part  W  of chapter 57 of the laws of 2021, is amended to read as
    33  follows:
    34    § 7. This act shall take effect immediately [and  shall  expire  March
    35  31,  2024 when upon such date the provisions of this act shall be deemed
    36  repealed].
    37    § 2. This act shall take effect immediately.

    38                                   PART Z

    39    Section 1. Section 2 of part NN of chapter 58 of  the  laws  of  2015,
    40  amending  the mental hygiene law relating to clarifying the authority of
    41  the commissioners in the department of  mental  hygiene  to  design  and
    42  implement  time-limited  demonstration programs, as amended by section 1
    43  of part V of chapter 57 of the laws of  2021,  is  amended  to  read  as
    44  follows:
    45    §  2.  This act shall take effect immediately [and shall expire and be
    46  deemed repealed March 31, 2024].
    47    § 2. This act shall take effect immediately.

    48                                   PART AA

        S. 8307                            142                           A. 8807

     1    Section 1. Paragraph 31 of subsection  (i)  of  section  3216  of  the
     2  insurance  law  is  amended  by adding a new subparagraph (J) to read as
     3  follows:
     4    (J) This subparagraph shall apply to facilities in this state that are
     5  licensed,  certified, or otherwise authorized by the office of addiction
     6  services and supports for the provision of outpatient, intensive  outpa-
     7  tient,  outpatient  rehabilitation and opioid treatment that are partic-
     8  ipating in the insurer's provider  network.  Reimbursement  for  covered
     9  outpatient treatment provided by such facilities shall be at a rate that
    10  is not less than the rate that would be paid for such treatment pursuant
    11  to  the medical assistance program under title eleven of article five of
    12  the social services law.
    13    § 2. Paragraph 35 of subsection (i) of section 3216 of  the  insurance
    14  law is amended by adding a new subparagraph (K) to read as follows:
    15    (K)  This subparagraph shall apply to outpatient treatment provided in
    16  a facility issued an operating certificate by the commissioner of mental
    17  health pursuant to the provisions of article thirty-one  of  the  mental
    18  hygiene  law,  or in a facility operated by the office of mental health,
    19  or in a crisis stabilization center licensed pursuant to  section  36.01
    20  of  the  mental  hygiene  law,  that  is  participating in the insurer's
    21  provider  network.  Reimbursement  for  covered   outpatient   treatment
    22  provided by such a facility shall be at a rate that is not less than the
    23  rate  that  would  be  paid  for  such treatment pursuant to the medical
    24  assistance program under title eleven of  article  five  of  the  social
    25  services law.
    26    §  3.  Paragraph  5 of subsection (l) of section 3221 of the insurance
    27  law is amended by adding a new subparagraph (K) to read as follows:
    28    (K) This subparagraph shall apply to outpatient treatment provided  in
    29  a facility issued an operating certificate by the commissioner of mental
    30  health  pursuant  to  the provisions of article thirty-one of the mental
    31  hygiene law, or in a facility operated by the office of  mental  health,
    32  or  in  a crisis stabilization center licensed pursuant to section 36.01
    33  of the mental hygiene  law,  that  is  participating  in  the  insurer's
    34  provider   network.   Reimbursement  for  covered  outpatient  treatment
    35  provided by such a facility shall be at a rate that is not less than the
    36  rate that would be paid for  such  treatment  pursuant  to  the  medical
    37  assistance  program  under  title  eleven  of article five of the social
    38  services law.
    39    § 4. Paragraph 7 of subsection (l) of section 3221  of  the  insurance
    40  law is amended by adding a new subparagraph (J) to read as follows:
    41    (J) This subparagraph shall apply to facilities in this state that are
    42  licensed,  certified, or otherwise authorized by the office of addiction
    43  services and supports for the provision of outpatient, intensive  outpa-
    44  tient,  outpatient  rehabilitation and opioid treatment that are partic-
    45  ipating in the insurer's provider  network.  Reimbursement  for  covered
    46  outpatient treatment provided by such facilities shall be at a rate that
    47  is not less than the rate that would be paid for such treatment pursuant
    48  to  the medical assistance program under title eleven of article five of
    49  the social services law.
    50    § 5. Subsection (g) of section 4303 of the insurance law is amended by
    51  adding a new paragraph 12 to read as follows:
    52    (12) This paragraph shall apply to outpatient treatment provided in  a
    53  facility  issued  an operating certificate by the commissioner of mental
    54  health pursuant to the provisions of article thirty-one  of  the  mental
    55  hygiene  law,  or in a facility operated by the office of mental health,
    56  or in a crisis stabilization center licensed pursuant to  section  36.01

        S. 8307                            143                           A. 8807

     1  of  the  mental  hygiene law, that is participating in the corporation's
     2  provider  network.  Reimbursement  for  covered   outpatient   treatment
     3  provided  by  such facility shall be at a rate that is not less than the
     4  rate  that  would  be  paid  for  such treatment pursuant to the medical
     5  assistance program under title eleven of  article  five  of  the  social
     6  services law.
     7    § 6. Subsection (l) of section 4303 of the insurance law is amended by
     8  adding a new paragraph 10 to read as follows:
     9    (10)  This  paragraph shall apply to facilities in this state that are
    10  licensed, certified, or otherwise authorized by the office of  addiction
    11  services  and supports for the provision of outpatient, intensive outpa-
    12  tient, outpatient rehabilitation and opioid treatment that  are  partic-
    13  ipating in the corporation's provider network. Reimbursement for covered
    14  outpatient treatment provided by such facilities shall be at a rate that
    15  is not less than the rate that would be paid for such treatment pursuant
    16  to  the medical assistance program under title eleven of article five of
    17  the social services law.
    18    § 7. This act shall take effect January 1, 2025  and  shall  apply  to
    19  policies and contracts issued, renewed, modified, altered, or amended on
    20  and after such date.

    21                                   PART BB

    22    Section  1.  Sections  19  and  21  of chapter 723 of the laws of 1989
    23  amending the mental hygiene law and other laws relating to comprehensive
    24  psychiatric emergency programs, as amended by section 1 of part  PPP  of
    25  chapter 58 of the laws of 2020, are amended to read as follows:
    26    §  19. Notwithstanding any other provision of law, the commissioner of
    27  mental health shall[, until July 1, 2024,] be solely authorized, in  his
    28  or  her  discretion, to designate those general hospitals, local govern-
    29  mental units and voluntary agencies which may apply  and  be  considered
    30  for  the  approval  and issuance of an operating certificate pursuant to
    31  article 31 of the mental hygiene law for the operation of  a  comprehen-
    32  sive psychiatric emergency program.
    33    §  21.  This act shall take effect immediately[, and sections one, two
    34  and four through twenty of this act  shall  remain  in  full  force  and
    35  effect,  until  July 1, 2024, at which time the amendments and additions
    36  made by such sections of this act shall be deemed to  be  repealed,  and
    37  any  provision  of law amended by any of such sections of this act shall
    38  revert to its text as it existed prior to the  effective  date  of  this
    39  act].
    40    § 2. This act shall take effect immediately.

    41                                   PART CC

    42    Section 1. Subdivision 2 of section 493 of the social services law, as
    43  added  by  section  1  of  part B of chapter 501 of the laws of 2012, is
    44  amended to read as follows:
    45    2. For substantiated reports of abuse  or  neglect  in  facilities  or
    46  provider  agencies  in  receipt  of  medical assistance and which are no
    47  longer subject to amendment or appeal pursuant to section  four  hundred
    48  ninety-four of this article, such information shall also be forwarded by
    49  the  justice center to the office of the Medicaid inspector general when
    50  such abuse or neglect may [be relevant to an investigation of unaccepta-
    51  ble practices as such practices are defined] result in [regulations  of]
    52  possible  exclusion  or  other  sanction  by  the office of the Medicaid

        S. 8307                            144                           A. 8807

     1  inspector general as determined in consultation with the office  of  the
     2  Medicaid inspector general.
     3    § 2. This act shall take effect immediately.

     4                                   PART DD

     5    Section  1.  Section  3  of  part A of chapter 111 of the laws of 2010
     6  amending the mental hygiene law relating to the receipt of  federal  and
     7  state  benefits  received  by  individuals  receiving care in facilities
     8  operated by an office of the department of mental hygiene, as amended by
     9  section 1 of part T of chapter 57 of the laws of  2021,  is  amended  to
    10  read as follows:
    11    §  3. This act shall take effect immediately[; and shall expire and be
    12  deemed repealed June 30, 2024].
    13    § 2. This act shall take effect immediately.

    14                                   PART EE

    15    Section 1. Subparagraph (v) of  paragraph  (a)  of  subdivision  1  of
    16  section  6908 of the education law is renumbered subparagraph (vi) and a
    17  new subparagraph (v) is added to read as follows:
    18    (v) tasks provided by a direct support  staff  in  non-facility  based
    19  programs certified, authorized or approved by the office for people with
    20  developmental disabilities, so long as such staff does not hold themself
    21  out  as  one who accepts employment solely for performing such care, and
    22  where nursing services are under the instruction of a service  recipient
    23  or  family  or  household member determined by a registered professional
    24  nurse to be capable of providing such instruction.   In the  event  that
    25  the  registered  nurse determines that the service recipient, family, or
    26  household member is not capable of providing such  instruction,  nursing
    27  tasks  may be performed by direct support staff pursuant to subparagraph
    28  (vi) of this paragraph subject to the requirements set forth therein; or
    29    § 2. This act shall take effect immediately and  shall  be  deemed  to
    30  have been in full force and effect on and after April 1, 2024.

    31                                   PART FF

    32    Section  1. 1. Subject to available appropriations and approval of the
    33  director of the budget,  the  commissioners  of  the  office  of  mental
    34  health,  office  for  people  with developmental disabilities, office of
    35  addiction services and supports,  office  of  temporary  and  disability
    36  assistance, office of children and family services, and the state office
    37  for  the  aging  shall  establish  a state fiscal year 2024-2025 cost of
    38  living adjustment (COLA), effective April 1, 2024,  for  projecting  for
    39  the effects of inflation upon rates of payments, contracts, or any other
    40  form of reimbursement for the programs and services listed in paragraphs
    41  (i),  (ii),  (iii),  (iv),  (v),  and  (vi)  of subdivision four of this
    42  section. The COLA established herein shall be applied to the appropriate
    43  portion of reimbursable costs or contract  amounts.  Where  appropriate,
    44  transfers  to the department of health (DOH) shall be made as reimburse-
    45  ment for the state share of medical assistance.
    46    2. Notwithstanding any inconsistent provision of law, subject  to  the
    47  approval  of  the  director  of  the budget and available appropriations
    48  therefore, for the period of April 1, 2024 through March 31,  2025,  the
    49  commissioners  shall  provide  funding  to support a one and five-tenths
    50  percent (1.5%) cost of living adjustment  under  this  section  for  all

        S. 8307                            145                           A. 8807

     1  eligible  programs  and  services  as determined pursuant to subdivision
     2  four of this section.
     3    3.  Notwithstanding any inconsistent provision of law, and as approved
     4  by the director of the budget, the 1.5 percent cost of living adjustment
     5  (COLA) established herein shall be inclusive of all other cost of living
     6  type increases, inflation factors,  or  trend  factors  that  are  newly
     7  applied  effective  April  1,  2024.  Except for the 1.5 percent cost of
     8  living adjustment (COLA) established herein, for the  period  commencing
     9  on  April  1, 2024 and ending March 31, 2025 the commissioners shall not
    10  apply any other new cost of living adjustments for the purpose of estab-
    11  lishing rates of payments, contracts or any other form of reimbursement.
    12  The phrase "all other cost of living type increases, inflation  factors,
    13  or  trend  factors"  as  defined  in  this subdivision shall not include
    14  payments made pursuant to the American Rescue Plan Act or other  federal
    15  relief  programs  related  to  the  Coronavirus  Disease 2019 (COVID-19)
    16  pandemic public health emergency. This subdivision shall not prevent the
    17  office of children and family services from  applying  additional  trend
    18  factors  or  staff  retention  factors to eligible programs and services
    19  under paragraph (v) of subdivision four of this section.
    20    4. Eligible programs and services. (i) Programs and  services  funded,
    21  licensed, or certified by the office of mental health (OMH) eligible for
    22  the  cost  of  living  adjustment  established  herein,  pending federal
    23  approval where applicable, include: office  of  mental  health  licensed
    24  outpatient programs, pursuant to parts 587 and 599 of title 14 CRR-NY of
    25  the office of mental health regulations including clinic, continuing day
    26  treatment,  day  treatment,  intensive  outpatient  programs and partial
    27  hospitalization;  outreach;  crisis  residence;  crisis   stabilization,
    28  crisis/respite  beds;  mobile crisis, part 590 comprehensive psychiatric
    29  emergency program  services;  crisis  intervention;  home  based  crisis
    30  intervention;  family  care;  supported single room occupancy; supported
    31  housing; supported housing  community  services;  treatment  congregate;
    32  supported   congregate;   community  residence  -  children  and  youth;
    33  treatment/apartment; supported  apartment;  community  residence  single
    34  room occupancy; on-site rehabilitation; employment programs; recreation;
    35  respite  care;  transportation;  psychosocial  club; assertive community
    36  treatment; case management; care  coordination,  including  health  home
    37  plus  services;  local  government  unit  administration; monitoring and
    38  evaluation; children and youth  vocational  services;  single  point  of
    39  access;  school-based mental health program; family support children and
    40  youth; advocacy/support services; drop  in  centers;  recovery  centers;
    41  transition management services; bridger; home and community based waiver
    42  services;  behavioral  health waiver services authorized pursuant to the
    43  section 1115 MRT waiver; self-help programs; consumer  service  dollars;
    44  conference  of local mental hygiene directors; multicultural initiative;
    45  ongoing integrated supported employment services;  supported  education;
    46  mentally   ill/chemical  abuse  (MICA)  network;  personalized  recovery
    47  oriented services; children and family treatment and  support  services;
    48  residential treatment facilities operating pursuant to part 584 of title
    49  14-NYCRR;   geriatric  demonstration  programs;  community-based  mental
    50  health family treatment  and  support;  coordinated  children's  service
    51  initiative; homeless services; and promises zone.
    52    (ii)  Programs  and  services  funded,  licensed,  or certified by the
    53  office for people with developmental disabilities (OPWDD)  eligible  for
    54  the  cost  of  living  adjustment  established  herein,  pending federal
    55  approval where applicable, include: local/unified services; chapter  620
    56  services;  voluntary operated community residential services; article 16

        S. 8307                            146                           A. 8807

     1  clinics; day treatment  services;  family  support  services;  100%  day
     2  training;  epilepsy services; traumatic brain injury services; hepatitis
     3  B services;  independent  practitioner  services  for  individuals  with
     4  intellectual  and/or  developmental  disabilities;  crisis  services for
     5  individuals with intellectual and/or developmental disabilities;  family
     6  care  residential  habilitation;  supervised  residential  habilitation;
     7  supportive residential habilitation; respite; day habilitation; prevoca-
     8  tional services; supported employment; community habilitation;  interme-
     9  diate  care  facility  day and residential services; specialty hospital;
    10  pathways to employment; intensive behavioral services;  basic  home  and
    11  community  based  services  (HCBS)  plan  support;  community transition
    12  services; family education and training;  fiscal  intermediary;  support
    13  broker; and personal resource accounts.
    14    (iii)  Programs  and  services  funded,  licensed, or certified by the
    15  office of addiction services and supports (OASAS) eligible for the  cost
    16  of  living adjustment established herein, pending federal approval where
    17  applicable, include: medically supervised withdrawal services - residen-
    18  tial; medically supervised withdrawal services -  outpatient;  medically
    19  managed  detoxification; medically monitored withdrawal; inpatient reha-
    20  bilitation services; outpatient  opioid  treatment;  residential  opioid
    21  treatment; KEEP units outpatient; residential opioid treatment to absti-
    22  nence;  problem  gambling  treatment;  medically  supervised outpatient;
    23  outpatient  rehabilitation;   specialized   services   substance   abuse
    24  programs;  home and community based waiver services pursuant to subdivi-
    25  sion 9 of section 366 of the social services law;  children  and  family
    26  treatment and support services; continuum of care rental assistance case
    27  management;  NY/NY  III  post-treatment  housing;  NY/NY III housing for
    28  persons at risk for homelessness;  permanent  supported  housing;  youth
    29  clubhouse;  recovery  community  centers;  recovery community organizing
    30  initiative; residential rehabilitation services for youth (RRSY); inten-
    31  sive residential; community residential; supportive living;  residential
    32  services;  job  placement  initiative;  case  management; family support
    33  navigator; local government unit administration; peer engagement;  voca-
    34  tional   rehabilitation;   support   services;  HIV  early  intervention
    35  services; dual diagnosis coordinator; problem gambling resource centers;
    36  problem  gambling  prevention;  prevention  resource  centers;   primary
    37  prevention services; other prevention services; and community services.
    38    (iv)  Programs  and  services  funded,  licensed,  or certified by the
    39  office of temporary and disability assistance (OTDA)  eligible  for  the
    40  cost  of  living adjustment established herein, pending federal approval
    41  where applicable, include:  nutrition  outreach  and  education  program
    42  (NOEP).
    43    (v) Programs and services funded, licensed, or certified by the office
    44  of  children  and family services (OCFS) eligible for the cost of living
    45  adjustment established herein, pending federal approval  where  applica-
    46  ble,  include:  programs  for  which  the  office of children and family
    47  services establishes maximum state aid rates pursuant to  section  398-a
    48  of  the social services law and section 4003 of the education law; emer-
    49  gency foster homes; foster family boarding homes and therapeutic  foster
    50  homes;  supervised  settings  as  defined  by  subdivision twenty-two of
    51  section 371 of the  social  services  law;  adoptive  parents  receiving
    52  adoption subsidy pursuant to section 453 of the social services law; and
    53  congregate  and  scattered  supportive  housing  programs and supportive
    54  services provided under the NY/NY III supportive  housing  agreement  to
    55  young adults leaving or having recently left foster care.

        S. 8307                            147                           A. 8807

     1    (vi) Programs and services funded, licensed, or certified by the state
     2  office  for  the aging (SOFA) eligible for the cost of living adjustment
     3  established herein, pending federal approval where applicable,  include:
     4  community  services  for  the elderly; expanded in-home services for the
     5  elderly; and supplemental nutrition assistance program.
     6    5.  Each  local  government unit or direct contract provider receiving
     7  funding for the cost  of  living  adjustment  established  herein  shall
     8  submit  a  written  certification, in such form and at such time as each
     9  commissioner shall prescribe, attesting how such funding will be or  was
    10  used  to  first  promote  the recruitment and retention of non-executive
    11  direct care staff, non-executive direct support professionals,  non-exe-
    12  cutive clinical staff, or respond to other critical non-personal service
    13  costs prior to supporting any salary increases or other compensation for
    14  executive level job titles.
    15    6.  Notwithstanding any inconsistent provision of law to the contrary,
    16  agency commissioners shall be authorized to recoup funding from a  local
    17  governmental  unit  or  direct  contract provider for the cost of living
    18  adjustment established herein determined to have been used in  a  manner
    19  inconsistent  with  the  appropriation,  or  any other provision of this
    20  section. Such agency commissioners shall be  authorized  to  employ  any
    21  legal mechanism to recoup such funds, including an offset of other funds
    22  that are owed to such local governmental unit or direct contract provid-
    23  er.
    24    §  2.  This  act  shall take effect immediately and shall be deemed to
    25  have been in full force and effect on and after April 1, 2024.
    26    § 2. Severability clause. If any clause, sentence, paragraph, subdivi-
    27  sion, section or part of this act shall be  adjudged  by  any  court  of
    28  competent  jurisdiction  to  be invalid, such judgment shall not affect,
    29  impair, or invalidate the remainder thereof, but shall  be  confined  in
    30  its  operation  to the clause, sentence, paragraph, subdivision, section
    31  or part thereof directly involved in the controversy in which such judg-
    32  ment shall have been rendered. It is hereby declared to be the intent of
    33  the legislature that this act would  have  been  enacted  even  if  such
    34  invalid provisions had not been included herein.
    35    §  3.  This  act shall take effect immediately provided, however, that
    36  the applicable effective date of Parts A through FF of this act shall be
    37  as specifically set forth in the last section of such Parts.
feedback